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ABSTRACT
This thesis attempted to investigate the relationship between symptom expression,
medication effects, outcome status and neuropsychological functioning in schizophrenia.
As the heterogeneity of schizophrenia is now widely accepted, symptom ratings from the
comprehensive Positive and Negative Syndrome Scale (Kay et al., 1986) were entered in
to a factor analysis after the work of Liddle (1987) and Liddle and Barnes (1990). The
factor analysis of symptoms was carried out with patients at both the acute stage of
illness and at the chronic stage. Almost twice as many chronic patient subjects were used
in the latter study than had been used before (n=66). The acute stage analysis was seen as
a preliminary investigation as only twenty six patients were recruited. This reflects the
difficulty in recruiting early stage floridly ill patients for demanding psychiatric and
neuropsychological assessment. The emergent factors, at each stage, were correlated with
neuropsychological performance on an array of executive, memory, psychomotor and
hemispatial neglect tests. Neuropsychological assessment was also compared with healthy
control data to assess the degree, if any, of impairment from the norm, independent of
symptoms. In the chronic stage study, four factors coined reality distortion, poverty of
sociability and affect, disorganisation and excitability were generated. Poverty of
sociability and affect was related to impaired short term working memory, episodic
memory and semantic verbal fluency. Disorganisation significantly correlated with
episodic memory functioning and disinhibition of inappropriate responding. None of the
other factors were directly related to neuropsychological performance. The relation
between episodic memory functioning and poverty of sociability and affect was explained
in terms of poor cognition due to developmental experience and the retention and use of
socially appropriate schema Disorganisation appeared to be underpinned by possible
frontal type organisational difficulties in the correct temporal ordering of information for
recall. At the acute stage, five factors emerged reflecting a paranoid state, poverty of
affect, disorganisation/poverty of sociability and delusions. None of these factors or sub
syndromes was significantly related to neuropsychological functioning possibly due to the
instability of symptom expression, at this stage, invalidating the sub syndromes as reliable
indicators of sub pathologies. Both chronic and acute patient groups were impaired on
executive, memory and psychomotor functioning compared to normals. The sub
syndromes expressing abnormal experiential behaviour were considered to be products of
cognitive biasing in social relations underpinned by gross neuropsychological deficits.
No clinical or neuropsychological benefit was seen during a controlled drug trial
involving high doses of chlorpromazine and the atypical neuroleptic, risperidone, and
standard drug regimes with historically treatment resistant patients. Neuropsychological
deficits (and clinical status) may be enduring phenomena of this type of patient and were
proposed as responsible for most of the social and vocational impairment that
characterises treatment resistant chronic schizophrenia. In an attempt to investigate the
particular neuropsychological correlates of poor outcome or treatment resistant
schizophrenia, episodic memory dysfunction was highlighted as characterising poor
outcome functioning. Executive impairments, from initial analysis, became non
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discriminatory of poor outcome after controlling for education background The marked
differences in education background between good and poor outcome groups supported
previous research that suggests early and insidious onset of illness characterises poor
prognosis (Lieberman and Sobel, 1993). The insidious nature of the illness process, in
poor outcome, with poor episodic memory, might lend support for a neurodevelopmental
impoverishment and retention of appropriate social knowledge that manifests itself as
poor social functioning in adult relations. The implications of the poor episodic memory
functioning and its relation to social disability is discussed with reference to therapeutic
strategies for this type of schizophrenic patient.
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1.1 Schizophrenia-the History of the concept: Definitions and Types.
Schizophrenia has been coined the 'heartland of psychiatry' (Kendell, 1986) and persists at
the epicentre of clinical practice. It is an extremely complex and disruptive illness
affecting, on average, 5 out of every 1000 adults (Hamilton, 1984, Warner, 1985) and
many more, indirectly in the form of family, friends and colleagues. Schizophrenia is also
a concept that has been shrouded in controversy for most of the hundred years of its
existence. In fact, hypotheses have been proposed to account for schizophrenic
breakdowns implicating nearly every variable known to effect human behaviour (Bentall
et al1988). The purpose of this thesis is to provide an account of schizophrenic
behaviour in terms of cognitive neuropsychology. That is to provide a description of the
information processes that underlie specific areas of schizophrenic behaviour. Many of
the controversies surrounding the concept will be dealt with in pursuing this explanation
However, primarily the thrust of the following studies is to investigate those possible
neuropsychological functions that, when impaired may singularly or in concert, give rise
to behavioural phenomena characteristic of a recognised schizophrenic illness. This thesis
will also deal with an examination of the relationship between schizophrenic symptoms,
neuropsychological functioning and medication used to ameliorate the disorder Finally,
there will be an examination of the relationship between the neuropsychological
functioning of schizophrenic patients and treatment response to uncover any possible
cognitive correlates of good and poor outcome.
1.1.2 The History of the concept
Emil Kraepelin in the fifth (1896) edition of his 'Lehrbruch' is commonly credited with the
first unambiguous classification of insanity, to date, encompassing that form of disease we
now refer to as schizophrenia.
Kraepelin divided mental illness into 'manic depressive insanity' and 'dementia praecox'
and described them in terms of their long term course. He believed that dementia praecox
was a progressive disease which gradually lead to either chronic invalidism or only partial
recovery, if any improvement arose at all. The term 'dementia praecox' described the
characteristic early onset of the disease and the ensuing intellectual deterioration Among
the major symptoms he described were hallucinations, delusions, negativism, attention
difficulties, stereotypical behaviour and emotional dysfunction.
In 1911 Eugen Bleuler published his 'Dementia Praecox or the Group of Schizophrenias'.
He tried to define the core nature of the disorder and to get away from the prognostic
emphasis of Kraepelin. Although he sought to confirm and develop Kraepelin's original
concept he, in fact, changed the idea of dementia praecox fundamentally. Eventually, his
term 'schizophrenia' won universal acceptance as the overall label for the disease. He
chose this 'split mind' concept since his direction was psychological rather than
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neuropathological. He believed that the core nature of schizophrenia comprised of a
'loosening of associations' in thoughts, speech, emotions, volitional acts and cognitive
acts in general. He differed from Kraepelin on two major points. Firstly, he believed there
was no necessary early onset and, secondly, there was no inevitable progress to dementia.
Psychoanalytical theory had a major influence on Bleuler's theorising and it appeared he
was trying to provide for the psychoses what Freud had done in specifying the underlying
psychological processes responsible for neurotic behaviour.
Kraepelin's descriptions were seen as narrow and limited diagnoses to patients with poor
prognosis; he dismissed those patients with good outcomes as unrepresentative of 'real'
dementia praecox and were rather representative of another category of illness. Bleuler's
concept was broader and possessed more theoretical emphasis. He embraced those
patients with good prognoses and added those whom, he believed possessed 'latent'
schizophrenia in his group of schizophrenias.
Bleuler's greatest influence was in the U.S. where his proposed 'primary' symptoms
(loosening of associations-or thought disorder-, blunting of affect, autism and
ambivalence) were used as the basis for diagnosis whether hallucinations were present or
not (Kendell, 1986). These criteria became so widely used that the concept nearly
embraced the whole of severe mental illness. For instance, its influence can be checked by
the percentage diagnoses of schizophrenia at the New York Psychiatric Institute in the
1930s compared to the 1950s. In the 1930s 20% of patients were diagnosed
schizophrenic compared to a peak of 80% in 1952 (Davison and Neale, 1986).
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The concept was additionally broadened by subtyping. Kasanin (1933) observed
symptoms in a group of patients, originally diagnosed as 'dementia praecox', as a
hybrid of schizophrenic and affective characteristics, suggesting 'schizoaffective
psychosis' as an appropriate label. This concept was listed, along with the
aforementioned diagnoses, in the Diagnostic and Statistical Manual of Mental
disorders I (American Psychiatric Association, 1952) and DSM II (APA, 1968).
In the 1960s and 70s a 'process-reaction' philosophy was embraced; 'process' for the
indication of the basic physiological brain malfunction (involved in insidiously
developing schizophrenia) and 'reactive' due to a stress component (Davison and
Neale, 1986). This philosophy held sway for the ensuing direction of investigation.
Of great influence in the conceptualisation of schizophrenia were those symptoms
collectively defined by Schneider (1959). These 'First Rank Symptoms' were based on
an appraisal of the acute stage of the illness. The symptoms in question consisted of
auditory hallucinations (ie. discussing the subject in the third person, running a
commentary on the subject's thoughts or behaviour), thought insertion or withdrawal,
thought broadcasting, the sensation of actions being controlled externally, passive and
reluctant recipient of sensations from an external agency and delusional perception.
Schneider considered these symptoms as convenient diagnostic aids. However, he
accepted that patients with otherwise typical schizophrenia may exhibit few or none
of them. In spite of this, he felt that such symptoms were worth distinguishing from
so called 'Second Rank Symptoms' eg. perplexity, emotional blunting and
hallucinations and delusions of other kinds
1.1.3 Definitions and Diaenosis.
Schizophrenia is defined by those symptoms or groups of symptoms which
characterise the disorder and which discriminate it from other forms of mental illness.
Problems arise when considering which symptoms are the most discriminating and
which symptoms are the most emphatic. Cooper et al (1972) showed a major
discrepancy between diagnoses of manic depression and schizophrenia when
comparing U.S. and English psychiatrists. There was twice the incidence of diagnosis
of schizophrenia in New York institutions as in London. In the International Pilot
Study of Schizophrenia (World Health Organisation, 1973) psychiatrists in
Washington and Moscow were seen to use a significantly broader concept of
schizophrenia for diagnosis than their counterparts in any of the other seven
international centres studied. Such low reliability necessitated a review of criteria so
that an operational definition could be established for universal clarification and use
A definition was sought in line with the presence of particular symptoms or
combination of symptoms, by the course of the disease or via a combination of the
two. The ideal was to choose a definition useful in predicting response to treatment
or long term course, or how disease expression corresponds most closely with any
putative underlying biological abnormality-however, there is, as yet, no clear
agreement concerning this. It is becoming increasingly apparent that insidious onset is
associated with poor prognosis (Lieberman and Sobel, 1993).
Currently, the most widely used definitions are American and have key elements in
common:
1) The St. Louis Criteria (Feighner et al, 1972) which stipulates the patient as ill, not
necessarily psychotic, for at least 6 months. Any sign of manic depression or mania
Schizophrenia is defined by those symptoms or groups of symptoms which characterise
the disorder and which discriminate it from other forms of mental illness. Problems arise
when considering which symptoms are the most discriminating and which symptoms are
the most emphatic. Cooper et al (1972) showed a major discrepancy between diagnoses
of manic depression and schizophrenia when comparing U.S. and English psychiatrists.
There was twice the incidence of diagnosis of schizophrenia in New York institutions as
in London. In the International Pilot Study of Schizophrenia (World Health Organisation,
1973) psychiatrists in Washington and Moscow were seen to use a significantly broader
concept of schizophrenia for diagnosis than their counterparts in any of the other seven
international centres studied Such low reliability necessitated a review of criteria so that
an operational definition could be established for universal clarification and use A
definition was sought in line with the presence of particular symptoms or combination of
symptoms, by the course of the disease or via a combination of the two. The ideal was to
choose a definition useful in predicting response to treatment or long term course, or how
disease expression corresponds most closely with any putative underlying biological
abnormality-however, there is, as yet, no clear agreement concerning this. It is becoming
increasingly apparent that insidious onset is associated with poor prognosis (Lieberman
and Sobel, 1993).
Currently, the most widely used definitions are American and have key elements in
common:
1) The St. Louis Criteria (Feighner et al, 1972) which stipulates the patient as ill, not
necessarily psychotic, for at least 6 months. Any sign of manic depression or mania
symptoms excludes the patient from diagnosis. The only psychotic symptoms required are
hallucinations and delusions of any type or clear cut signs of thought disorder.
2) The Research Diagnostic Criteria (RDC) (Spitzer et al, 1978). This allows a definition
in 'broad and 'narrow' terms dependent on the number of symptoms present from a
specified list. The RDC requires a two week duration of symptoms in the manner of
thought disorder, hallucinations and delusions of particular (usually Schneiderian) kinds
and that no affective symptoms are present simultaneously.
3) The Diagnostic and Statistical Manual of Mental Disorders (3rd. edition, American
Psychiatric Association (APA), 1980- revised APA, 1987). This requires onset before 45
years of age and that signs of illness be present for at least 6 months. If these are not
fulfilled the diagnosis is usually one of'schizophreniform' psychosis. A diagnosis involves
the presence of at least two of the following: delusions, prominent hallucinations,
incoherence, catatonic behaviour and flat or grossly inappropriate affect. The DSM IV
(APA, 1994) diagnostic criteria for schizophrenia has recently been published but differs
little from the DSM III-R diagnosis. Both these diagnoses highlight social/occupational
dysfunction, the exclusion of schizoaffective and mood disordered patients from diagnosis
along with those patients whose disturbance is directly associated with drug
abuse/medication or is part of a general medical condition. For those patients with a
developmental disorder such as Autism, an additional diagnosis of schizophrenia is only
made if prominent delusions/hallucinations are present.
Other classifications include the 'flexible' criteria of Carpenter et al (1973) which uses
ratings from the Present State Examination (Wing et al, 1974). The 'flexible' system
allows a 'broad' (5+ items) or 'narrow' (6+ items) diagnosis. The CATEGO classification
system (Wing et al, 1974, Wing and Stuart, 1978) is a computer programme which
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processes data from the PSE (or the associated symptom checklist). Nuclear symptoms
carry the most weight and CATEGO is seen as faithfully Schneiderian.
The benefit of comparability of systems for accurate diagnosis may cause confusion for
practitioners when faced with a patient whose symptoms do not fit comfortably into one
of the available systems. A remedy could be available with the advent of the International
Classification of Diseases (10) which provides two sets of definitions, one purely
descriptive for clinical purposes the other of an operational format for research.
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1.1.4 The Stens and Symptoms of Illness
In its acute form schizophrenic onset occurs most commonly during adolescence or early
adulthood, often developing insidiously. Delusions are variable in form but are often
persecutory, grandiose or religious. They are experienced as passive phenomena ie. there
is little control of one's own thoughts, feelings or will and thought insertion, withdrawal
and broadcasting are also commonly perceived. The subjective interpretation of these
phenomena lie beyond normal experience and also appear culturally dependent. Auditory
hallucinations (voices in the second or third person i.e. either keeping a commentary on
the patient's behaviour or conversing about them), again, are common as are sensations
of perplexity. General flattening of affective response and incongruous/inappropriate
behaviour is also a particularly common abnormality at this stage of the illness (Kendeil,
1986).
In chronic illness more episodes are experienced more insidiously and last longer. This
'defect state' is less conspicuous than the florid symptoms that characterise the acute case.
A patient's drive and determination is weakened, there is a loss of interest in others, a
reduction in speech and the capacity to form enduring relationships is reduced. Most
patients in the chronic stage do experience recurrent episodes with delusions and
hallucinations, depression is also a common feature. Many schizophrenics do appreciate
this situation as desperate and 10% die by suicide in the early years of their illness (Miles,
1977).
From the original division of symptoms into positive(abnormal experiences) and
negative(poverty of functioning) clusters by Hughlings-Jackson in the 19th century, Crow
(1980) has attempted to encapsulate the underlying pathology of acute and chronic,
positive and negative symptoms into a new subtyping system. He coined the term 'type 1'
schizophrenia as characteristic of traditional positive symptomatology and encompasses
delusions, hallucinations and thought disorder. 'Type 2' schizophrenia encompasses
mainly negative symptomatology including flattened affect, apathy and poverty of speech.
Crow (1980; 1985) argued that type 1 is particularly responsive to neuroleptics while
type 2 is not. The purpose of this subtyping was to reflect the differing pathological
pathways of the clusters of symptoms expressed. Type 1, the author suggested, is
associated with dopamine transmission dysfunction in the mesolimbic system. Type 2 is
associated with cognitive impairment and structural changes in the brain. Andreasen
(1991) noted that positive symptoms tend to correlate well with each other and not with
the negative (and vice versa). Generally, positive symptoms tend to characterise the acute
phase of the illness, negative the chronic. However, both can often co-exist in the same
patient.
1.1.5 Epidemiology
In most industrialised western European and North American countries the lifetime risk
for schizophrenia is approximately 0.5-2%, with about 15-30 new cases per 100,000 of
the population per year (Kendell, 1986, Bebbington and Mc Guffin, 1988). The
International Pilot Study of Schizophrenia (WHO, 1973) recorded substantial numbers of
schizophrenics in all the countries involved despite widely differing languages, religion,
culture and degree of urbanisation. Sartorius et al (1986) noted that schizophrenics in all
of these centres displayed remarkably similar core symptoms suggesting that
schizophrenia is a fairly stable illness across a wide range of cultures and ethnic groups.
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The age of onset, for schizophrenia, is usually between the ages of 15 and 45, often a few
years earlier in males than females, on average (Kendell, 1986). Generally, there is
agreement that schizophrenics have a raised mortality (shared with other forms of mental
illness) and also raised morbidity (Baldwin, 1979).
The season one is born in has also been noted as possessing some aetiological
significance. In Norway, Sweden, Denmark, England and Wales schizophrenics are more
likely to be born in the first 3 months of the year than the rest of the population and less
likely to be born in the months July to September In Australia this pattern is reversed
reflecting seasonal reverse (Watson et al, 1982). This seasonal variable may be a
consequence of an infective agent or diet acting either in utero or in the early months of
life.
1.1.6 Criticism of the concept.
Recent years have seen an increasing body of psychiatrists and psychologists challenging
the nature of the schizophrenia concept itself (eg Bentall et al, 1988) or, at least, there
has been a questioning of the strict 'medical model' closely adhered to by clinicians and
researchers alike over the last century or so. More social (Scheff, 1966) or psychological
(Laing, 1967) models have been proposed to account for the entity understood as
schizophrenia. Such theories have come to light as the literature seems to have
consistently failed to find the single essential biological substrate schizophrenia
necessitates as a disease entity (Szasz, 1961). Richard Bentall (1988) argued that no
substantial progress has occurred in over a century of research into schizophrenia as a
unitary concept. This, he argued, is due to schizophrenia not fulfilling the criteria of a
meaningful scientific concept-its status as a syndromic disease is undermined by a lack of
an agreed biological basis and that diagnosis is a poor predictor of course, outcome or
treatment response. Patients diagnosed as schizophrenic have been shown as exhibiting
mutually exclusive symptomatology (Bannister, 1968) thus, two patients with the same
diagnosis may exhibit completely different symptoms. Also, differential diagnosis from
other psychiatric disorders presents an additional conceptual problem. In some follow up
studies (of outcome) when first admissions are taken into account, many patients,
initially, diagnosed schizophrenic were subsequently diagnosed as suffering from affective
disorder on their second admission (Kendell et al, 1979). Strauss and Carpenter (1974,
1977) noted that symptoms on admission appear to be a poorer predictor of outcome
than social and family (Vaughn and Leff, 1976).
Bentall et al (1988) concluded "..there would seem to be little reason to feel confident
about the validity of schizophrenic diagnosis" (p.314). The authors criticised the
dominant role of the medical profession in the management of psychosis and their
continuing application of a biological approach concentrating on non-social drug oriented
forms of therapy. Why the concept of schizophrenia, therefore, remains in common
usage, clinically and in research, may be due to the professional interest of psychiatrists
rather than the adherence to sound scientific method.
Researchers and clinicians, therefore, must be aware of the anomalies inherent in the
concept as it stands. This being so, research and evaluation is not seen, by its critics, as
redundant, rather classification requires a wider scope of opinion than is offered
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presently Bentall et al (1988) proposed that an abandoning of classification in favour of
research into particular symptoms maybe more profitable. Other researchers prefer to
concentrate on related clusters of symptoms as providing evidence for specific
subpathologies of illness (Liddle, 1987) or explaining types of symptoms (abnormal
experiences, poverty of action) in terms of different expressions of an underlying global
impairment in consciousness (Frith, 1992). Although these approaches may forge a new
appreciation of schizophrenic symptomatology and how they are psychologically
mediated, they preclude neither an underlying biological basis nor an interaction between
biology, psychology and social factors.
1.2 The Neuropsychology of Schizophrenia
The symptoms and signs of schizophrenia are behavioural phenomena Crudely, positive
symptoms express some form of abnormal beliefs and/or perceptions and negative
symptoms demonstrate deficits in competent activities. However, some commentators
would argue that the degree to which these behaviours can be judged as abnormal is
debatable but would see them rather as normal reactions to abnormal experiences (e.g.
Maher, 1974). Those who suffer these symptoms are experiencing, for the most part,
disturbing psychological phenomena alien to most.
The turn of the century heralded a watershed in neuroscientists' understanding of the
association between brain functioning and behaviour through the study of patterns of
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deficits expressed by patients with neurological problems. Through the work of such
notables as Broca (1861) and Wernicke (1874) psychological models of normal
information processing emerged ascribing certain cognitive functions i.e. language (input
and output processes) to particular areas of the brain Alzheimer (1907) was able to show
that certain intellectual deficits could be ascribed to particular qualitative and quantitative
changes in the neural make up of the brain. Kraepelin thought that it would only be a
matter of time before the functional deficits and behavioural phenomena associated with
schizophrenia (dementia praecox) could be explained in similar neuropathological terms.
Researchers since have been striving to fulfill Kraepelin's optimism in attributing
schizophrenic symptomatology to some specific brain abnormality. However, it was not
until the 1950s with the discovery of antipsychotic medication (chlorpromazine) that a
focus for the consideration of schizophrenia as a brain disease was really found. The
efficacy of this type of medication in ameliorating, at least, the positive aspects of the
illness lead researchers to infer that underlying such symptoms was some form of
abnormality in the activity of the neurotransmitter dopamine. Support for this view has
come from animal studies where dopamine agonist administration was seen to model
some of the behavioural aspects of schizophrenia (see McKinney and Moran, 1981),
indeed behavioural sequelae of amphetamine ingestion in humans appear to reflect many
of the core symptoms of schizophrenia (Angrist et al., 1974). Johnstone et al (1978)
showed that dopamine antagonism was essential for symptom amelioration. Despite this,
Van Kammen et al. (1982) reported improvement in a significant proportion of
schizophrenic patients after amphetamine administration A direct dopamine overactivity
hypothesis has, thus, been seen as too simplistic an explanation of the underlying
physiological abnormality associated with schizophrenic symptoms (Birchwood et al.,
1989). Recent advances in biological assaying techniques have enabled neuroscientists to
investigate the biochemistry and physiology of the brain in greater detail. However, the
results of such studies have tended not to lend unequivocal support for theoretical
positions such as the 'dopamine theory' rather they reveal quite a complex picture of
brain physiology intimating that multiple neurotransmitter systems may work in concert
with each other rather than as separate agents. To what degree these systems work
together in controlling which functions is, as yet, not understood. Within the realm of
schizophrenia research, the physiological abnormality underpinning particular symptoms
has now extended to the investigation of several different neurotransmitter systems
encompassing a range of monoamines (e.g. acetylcholine, serotonin and other types of
dopamine systems), several aminoacids (e.g. GABA) and neuropeptides (e.g. opioid
peptides such as beta-endorphins) whose dysfunction may be implicated, to differing
degrees or acting together, in composing the biological substrate necessary for the
formation of schizophrenic type symptoms. Thus an extremely complex field requires
much more research to single out systems and combinations of neurotransmitter activity
whose dysfunction may be implicated in the expression of schizophrenic symptoms. The
physiological basis of schizophrenia, despite this evidence, also appears to be limited in as
much that neuroleptic amelioration (of usually just positive symptoms) does not occur in
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up to 30% of patients diagnosed as schizophrenic (Davis et al, 1980). Some patients
whose symptoms tend to be characterised by a defict of functioning i.e. negative
symptoms have been seen as less responsive to the pharmacological effects of standard
neuroleptics on their conditions as opposed to more acute forms of illness which are
characterised by positive symptomatology (Crow, 1980). Crow suggested that, based on
this evidence, schizophrenia may result as the expression of more than a single
pathological process. In this light, the negative aspects of the illness have been associated
with some form of structural abnormality in the brain.This has been supported, in part,
by recent advances in scanning technology that have shown increased neurodegeneration
of brain tissue of schizophrenic patients compared to controls (Johnstone et al., 1976;
Golden et al., 1980). However, such observations, as increased ventricle to brain ratio
size, have been recorded in as few as 6% of cases of chronic schizophrenia (Andreasen,
1982) and not at all in a sample of young schizophrenic patients (Jernigen et al., 1982).
However, even structural abnormalities reported tend not to resemble a chronic
degenerative process but rather indicate that the abnormalities may result from some
aberrant maturation process i.e. a neurodevelopmental disorder that expresses itself in
behavioural terms at the end of the maturation process which would tie with most reports
of the age of onset of the first episodes of schizophrenic behaviour (Weinberger, 1987)
In conclusion, attempts to single out a specific brain functional/structural abnormality
implicated in the expression of schizophrenic symptoms have not produced encouraging
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results. The picture is, however, complex and the results to date do not account for all
those suffering the illness. Also, different abnormalities appear to be associated with
different phases or clusters of symptoms attesting to possible differing pathological
processes involved in the expression of the different forms of the illness. Such
observations highlight the heterogeneous nature of the illness and should provide both
caution and alternative routes of investigation in the clarification of a link between
underlying putative brain abnormalities and schizophrenic symptoms.
Assuming some form of brain pathology is associated with specific dimensions of the
illness, the purpose of this thesis is not to debate this subject at length but rather to
acknowledge that the behaviours associated with schizophrenia may indeed have some
underlying biological correlate. However, our aim is rather to examine the nature of
schizophrenic symptoms as psychological phenomena i.e. to investigate the association
between abnormal psychological functioning and abnormal behaviour. It seems necessary
to state that it is inadequate to suggest that an abnormality of dopamine
neurotransmission, for instance, is responsible for auditory hallucinations as such an
explanation emphasises an association rather than causation of the behaviour To examine
the nature of the symptoms of schizophrenia, therefore, researchers are presently more
wont to explain abnormalities whether physiological or psychological as separate 'levels
of explanation' (Mortimer and McKenna, 1994) in an attempt to provide a full
understanding of the nature of these abnormalities within the realm of the medium within
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which they are expressed i.e. psychological phenomena (the 'mind') and physiology (the
brain)(Frith, 1992). When this has been completed then the conditions may be correct for
a mapping of one onto the other, any attempt to do so before merely adds to a confusing
of different types of explanation which are inadequate at either level of interest. The focus
of this thesis, therefore, is to provide an explanation of the nature of schizophrenic
symptomatology at a psychological level, or more accurately in terms of information
processing or neuropsychology.
The term neuropsychology, here, is the study of the relation between brain function and
behaviour. In effect, it tries to bridge the gap between the behavioural expressions of the
illness and any underlying biological abnormalities by addressing the behaviour as an
expression of underlying cognitive impairment that in turn may have a biological
substrate. It has been remarked that 'The only way to understand psychological
phenomena is in terms of psychology' (David, 1993) and this is how we hope to attempt
to investigate, through various studies, the nature of schizophrenic symptomatology in
cognitive terms. Frith and Done (1988) suggest that there is now a need to develop
neuropsychological theories that are able to link the abnormal experiences of
schizophrenic patients to malfunctions in specific brain systems.
Much theorising about the underlying cognitive deficits associated with schizophrenic
symptomatology follows from neuropsychological investigations of patients with known
brain insults. As schizophrenic symptoms show many common behaviours to those
following specific neurological damage, the use of standardised neuropsychological
measures has been used in schizophenia research to provide an explanation of
characteristic cognitive impairments associated with the disease (see Schizophrenia, the
frontal lobes and executive functioning). This approach has been criticised for not
addressing the heterogeneous nature of schizophrenia and not concentratring on
associations between symptoms and test results (Frith, 1992).
In summary, increasing bodies of evidence from the study of neurological patients, animal
studies and psychopharmacological studies in humans, are enabling theorists to produce
increasingly more sophisticated modelling of the cognitive deficits underlying the
symptoms of schizophrenia, to link the putative biological and behavioural dimensions of
the disease.
1.2.1 Early models
Initially, it was Broadbent's (1958) theory of a filter mechanism, for excluding all but
relevant information from an individuals perception, that was taken up by researchers
concerned with neuropsychological models of schizophrenia. Venables (1964) suggested
that the schizophrenic patient suffered an overload of environmental information due to
the failure of this mechanism Frith (1979), in his own version of this 'defective filter
theory' proposed much the same, implying that a malfunction existed affecting how the
schizophrenic handles external information However, this level of inquiry was to be
rejected on the basis of a lack of experimental evidence (Frith and Done, 1984, 1988).
Cohen (1978) had already stressed that speech production rather than perception lay at
the heart of the schizophrenic abnormality. Hemsley (1975) had also proposed that an
output filtering problem or response selection constituted the essence of the abnormality.
The problem seemed, therefore, to lie in terms of self-generated action difficulties rather
than those of perception. Hemsley (1975), therefore, argued that positive symptoms
could be explained in terms of a patient's experience of his or her own actions rather than
their perception of the external world.
1.2.2. Recent models
Frith (1987) ascribed positive symptoms to a fault in the internal labelling of action i.e.
thought insertion, broadcasting and auditory hallucinations could arise due to an inability
to label self generated thoughts as 'my own'. The medium for this incapacity is a
malfunction in the line of information which travels to an internal monitor which is
necessary for the rapid feedback of errors in perception. This system distinguishes
between self generated (spontaneous) action and stimulus driven action (Passingham,
1987; Frith and Done, 1988). When information about self generated actions fails to
reach the monitor the patient will experience themselves carrying out behaviour without
the willed intention to do so. Experimental evidence has supported the proposal that
schizophrenic patients have significantly greater difficulty correcting errors in internal
monitoring compared to groups of other psychotic patients and normals (Frith and Done,
1989). Frith and Done (1988) proposed a model linking the failure to monitor action and
intention with the failure of putative brain structures involved in planning and goal
directed behaviour. Goldberg (1985) had suggested that damage at any point from the
prefrontal cortex to the motor cortex would lead to an incapacity in self generated
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responding. Such a malfunction would account for, at least, some of the positive
symptomatology characteristic of schizophrenia. Frith and Done conform to the idea that
the hypothesised monitor (sometimes known as a 'comparator') may be functionally
related to the hippocampal system. This ties in with the purported role(s) of the
hippocampus as the site necessary for recognition memory and familiarity (Gaffan, 1983)
and working memory (Olton, 1983). In conclusion, therefore, a failure in internal
monitoring has been more specifically attributed to a malfunction of the linkage between
the prefrontal cortex and the hippocampus via the parahippocampal cortex and the
cingulate cortex (Frith and Done, 1988).
The same authors proposed a wholly different mechanism to account for the expression
of characteristic negative symptomatology. After Crow's (1980) suggestion that negative
symptoms have a distinctly different aetiology than positive symptomatology it is likely
that, in this instance, the incapacity is in generating behaviour rather than a failure to
monitor it. This inability (to generate spontaneous action) is thought to be due to a
malfunction along the pathway(s) joining the prefrontal lobes to the striatum.
1.2.3 Schizophrenia as a disorder of self-awareness: Frith (1992) model
Frith (1992), in an attempt to provide a cognitive neuropsychological explanantion of the
signs and symptoms of schizophrenia, suggested that the underlying cognitive
abnormality was one of a disorder of self-awareness. Expanding on his previous work
singularly and in collaboration, expounded above, Frith suggests three principal
abnormalities underlying all the major signs and symptoms of the illness. Firstly, disorders
of willed action or the inability to generate spontaneous (willed) action can lead to
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poverty of action, perseveration and inappropriate action In essence, that behaviour is
elicited by external stimuli only. Secondly, certain auditory hallucinations and delusions
including thought insertion and alien control can be attributed to a disorder of self
monitoring (see above). Finally, core symptoms such as delusions of reference, paranoid
delusions, third person auditory hallucinations and certain types of incoherence i.e.
characterised by speech patterns lacking the use of previously qualified referents, may be
caused by a disorder in monitoring the intentions of others. Frith goes on to explain that
these three pathways to symptom expression may be due to an abnormality in a single
fundamental cognitive process necessary for consciousness. This process is termed
metarepresentation. In other words, the schizophrenic patient has difficulty reflecting on
how s/he represents the world and their own thoughts. To have self-awareness one must
be able not only to experience the content of what is happening mentally or physically,
but one must have knowledge of how that experience is being represented itself i.e. is the
experience my own, as in 'I am watching a football match'- 'I am watching' is the self-
conscious (secondary) representation of the (primary) representation 'a football match'.
For instance, if something is being attended to one must have representational knowledge
concerning that attention otherwise the experience is not part of consciousness. If this
mechanism breaks down then one only experiences content not the appropriate
knowledge of how that content is represented in the world. Frith believes such a failure of
metarepresentation can lead to a lack of awareness of goal directed behaviour and
awareness of personal and interpersonal intentions. These abnormalities derived from a
failure in the mechanism of self-awareness account for the three pathways of cognitive
impairment responsible for the signs and symptoms of schizophrenia cited above As this
is a relatively recent model, of the cognitive abnormality underlying schizophrenic signs
and symptoms, it is too early to accurrately map the theory onto specific brain systems.
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However, as the cognitive mechanism at fault is one of self awareness then a failure in
metarepresentation would imply dysfunction in a distributed brain system involving
structures and systems necessary for goal directed behaviour, action, willed intentions and
social cognition i.e. facial recognition etc. Although specific experimental evidence of
metarepresentation is, only starting to accumulate, at time of writing, greater
understanding of the neural correlate(s) may be gleaned from animal studies and human
investigations using scanning technology such as PET (Frith, 1992).
1.2.4 Schizophrenia as a disorder of the inte2ration of memory on current
perception: Gray et al (1991) model
One of the most comprehensive models to appear in recent years has been formulated by
Jeffrey Gray and his colleagues at the Institute of Psychiatry in London. Particularly
concerned with integrating the neural and cognitive dimensions of acute or the positive
symptomatology of schizophrenia, Gray et al (1991) have combined two major
neuropsychological models that were already established in the literature, Frith's (1987)
and Hemsley's (1987) models.
Frith (1987) and expanded by Frith and Done (1988) has already been discussed (see
above). Hemsley's (1987) theory holds an alternative view with it's history grounded in
Broadbent's (1977) theory of the 'pigeon holing' of information during processing. The
problem for the schizophrenic patient, Hemsley argued, resulted from a weakening of the
influence of stored memories of regularities of previous input on current perception. In
other words, there is a weakening of the capacity to select for cognitive processing only
those stimuli, that, given past experience of similar contexts, are relevant. Cognitive
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abnormalities in schizophrenia are thus seen as associated with a weakening of inhibitory
processes crucial to conscious attention. Hallucinations, therefore, are intrusions into
conscious experience of material from an individual's long term memory which are then
attributed to an external source.
Gray et al (1991) emphasised that, at the core of their model, there exists ". . .a failure in
acute schizophrenia to integrate stored memories of past regularities of perceptual input
with ongoing motor programmes in the control of current perception" (p. 1).
1.2.5 Gray et al. model in detail
Evidence in support of the model was obtained from three major sources; studies into
brain neuropathology and experimental evidence involving animals and humans. In
considering brain dysfunction in schizophrenia, two main avenues of evidence may
provide a more unified picture of the putative 'schizophrenic brain'. The first of these is
the widely documented number of dopamine receptors observed in both post mortem
(Owens et al, 1978) and in vivo (Wong et al, 1986) brains of schizophrenic patients.
Elevated numbers of receptors support a dopamine hyperactivity hypothesis connected, at
least, with positive symptomatology. Secondly, post-mortem studies of the brains of
schizophrenic patients have revealed severe neuronal loss in several regions of the
temporal lobe (parahippocampal gyrus, hippocampal formation, cingulate cortex and the
amygdala) (Falkai and Bogerts, 1986). A link between these two phenomena could paint
a more united picture of brain dysfunction in the schizophrenic patient. Springer and
Isaacson (1982) demonstrated that damage to the hippocampal formation alters dopamine
transmission in the nucleus accumbens and is indicative of a functional increase in
transmission.
The second line of evidence for the model can be derived from animal studies. In
particular, the behavioural phenomena of Latent Inhibition (Lubow et al, 1982), the
Kamin blocking effect (Lubow, 1968) and the Partial Reinforcement Extinction Effect
(PREE, Gray et al, 1975) have been proposed as animal models, that when disrupted, act
as the basis for the cognitive dysfunction underlying schizophrenia. Gray et al (1991)
argued that such effects provide 'face validity' as comparative processes. Each, the
argument goes, can be considered as examples of the influence of stored memories of
regularities of previous input on current perception (Hemsley, 1987), PREE specifically
in terms of motor programming. Each of these phenomena have been shown to be
abolished by amphetamine which is a dopamine releasing psychomimetic drug (Crider et
al, 1982). In addition, the effects of Latent Inhibition (Solomon et al, 1981) and the
Kamin blocking effect (Crider et al, 1982) can be reversed by neuroleptic administration
The amphetamine treated animals in these experiments behave as though their current
perception of pre-exposed stimuli (of non-reward) are less influenced than normal by
experience of previous regularities of input. The functional dopamine overactivity tends
to result in a certain degree of 'overattention' in their perception of current stimuli.
However, in the present formulation Gray et al., stipulated that the disruption of the
subiculo-accumbens projection should yield the same consequences as the above
experimental amphetamine administration. Large hippocampal lesions have been used to
destroy this projection and subsequent experiments have shown that Latent Inhibition, the
Kamin blocking effect and the PREE are all disrupted by damage to the hippocampal
formation (Kaye and Pearce, (1987).
As far as human subjects are concerned, acute schizophrenic patients fail to display
Latent Inhibition and the Kamin blocking effect (Baruch et al, 1988b; Jones, 1989,1991)
although these phenomena have been observed in groups of chronic schizophrenic
patients. Gray et al suggested that the presence of Latent Inhibition in chronic
schizophrenia is possibly due to neuroleptic effects. However, these results highlighted
the fact that Latent Inhibition is not just a nonspecific consequence of the generally poor
cognitive levels characteristic of schizophrenia.
The Gray et al (1991) model provided a single appreciation of the neuropsychology of
the positive signs of schizophrenia, grounded in the previously formulated theoretical
paradigm of the neuropsychology of anxiety (Gray, 1982). Within this paradigm the
septohippocampal system, together with a number of other limbic structures related
closely to the septohippocampal system, are associated with a monitoring or 'comparator'
function (see Frith and Done, 1988).
The overall model proposed that the establishment of a sequence of steps in a motor
programme and its orderly running are guided by the projection from the amygdala to the
nucleus accumbens. The septohippocampal system checks whether the actual outcome of
a motor step matches the expected outcome- this information is transmitted to the
nucleus accumbens by the projection from the subiculum. The activities of these
interacting structures are purported to be coordinated by the prefrontal cortex.
The maintenance of the activity in the structures that make up a motor step result from
excitatory activity in the striatum- these patterns are sometimes disrupted by the firing of
dopamine inputs to the striatum. Duration corresponds to the cooperation of the caudate
system (having many specific connections with the sensory and motor cortices) and the
nucleus accumbens system Timing is coordinated between the comparator and the basal
ganglia. The caudate system and the nucleus accumbens are also believed to play an
important role in organising behavioural response to novelty and controlling interactions
between such responses and motor programming.
The model is, therefore, when applied to the cognitive abnormalites associated with acute
schizophrenia, a disorder of motor programming and monitoring. The Hemsley (1987)
component concerned with the effect of previous experience on programming finds
neuroanatomical reality in the form of the subiculo-accumbens projection- such a
projection, in this case, thought to be impaired in schizophrenia. Frith's (1987) proposal
concerning the monitoring of willed intentions finds its equivalent as the projection from
the subiculum to the nucleus accumbens- again inferring that schizophrenic
symptomatology occurs as the result of the disruption of the subiculo-accumbens
projection. In addition, as the septohippocampal monitoring system, via the projection
from the prefrontal cortex to the entorhinal and cingulate cortices, is provided with the
motor programming information, disruption anywhere along these routes could also be
disrupted in schizophrenia.
Gray et al (1991) admitted that further knowledge of brain pathology is needed before
any speculations to which of the proposed circuitry disruptions is primary. Nor, presently,
does the model speculate as to any indication of aetiology. The model is restricted to
demonstrate those malfunctions that are related to the cognitive abnormalities associated
with the positive symptoms of acute schizophrenia Finally, the authors admonish, it
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would be somewhat astonishing if the myriad of abnormalities expressed by the
schizophrenic were always echoes of the same neuropsychological dysfunction.
As far as an explanation of the cognitive abnormalities associated with negative
symptoms are concerned, Gray et al (1991) posited that the actual nature of the concept
is problematic. For instance, are those sets of symptoms traditionally bracketed as
positive and negative representative of distinct disorders, differing severities of the same
disorder, due to individual differences to the same or different stages of the same disorder
or, indeed due to a combination of any of these? In fact, negative symptoms, in the
context of the model in question, are seen rather as representing a severity threshold on a
continuum of schizophrenic symptoms (Pogue-Geile and Harrow, 1988). Hemsley (1972)
proposed that, on the whole, negative symptoms replace positive symptoms, over time, in
prominence and that the concomitant cognitive deficits due to 'information overload'
seem to go someway to complete this picture. Negative symptoms such as social
withdrawal, poverty of speech and autism are seen, in this light, as adaptive strategies, on
the part of the individual, to minimize the effects on themselves of their cognitive
impairment. The schizophrenic is seen as perceiving the pursuit of meaning as
increasingly ineffective or counterproductive. In line with Anscombe (1987), when
displaying negative symptoms the schizophrenic forms their own impressions less and less
and becomes increasingly and eventually wholly influenced by their environment
1.2.6 Criticism of the Gray et al. model
The Gray et al (1991) model is one of the most comprehensive efforts to attempt a
detailed and testable account of the neuropsychology of schizophrenia. As this enterprise
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was somewhat ambitious, 36 leading researchers were invited to provide their own
criticisms of the model.
Claridge and Beech (1991) criticised the restrictive use of animal studies as models for a
distinctly human pathology. However, Frith (1991) applauded the use of animal studies as
a valuable tool in what he describes as a particularly experimental field Dawson and
Hazlett (1991) stated that not all behavioural phenomena, relying on memories for past
regularities, adhere to the model. Early et al (1991) provided evidence that
hippocampectomy does not produce signs of psychosis. Additional criticisms
encapsulated the failure of the model to include laterality studies (Elkins and Cromwell,
1991) and questioned the centrality of the dopamine hypothesis as neuropathological
evidence (Hoffman, 1991).
Frith (1992) provided a major criticism of the methodology of the Gray et al. model He
argued that the authors have attempted to link animal behaviour to the symptoms of
schizophrenia in terms of impairment in task performance i.e. Latent Inhibition, rather
than as underlying cognitive processes. However, within this task performance paradigm,
using Proactive Interference (PI) as a model of Latent Inhibition with human subjects,
O'Carroll et al (1993) found no significant differences, using the Auditory Verbal
Learning Test (Rey, 1964) as a PI measure, between groups of acute unmedicated
schizophrenic patients, major depressives and controls. The group of schizophrenic
patients would have been expected to show reduced PI compared to the other groups
based on the animal data from LI studies-they demonstrated, however, in this instance,
similar levels of PI to the comparison groups. However, the PI paradigm in the O'Carroll
et al. (1993) study did not involve associate learning, whereas Latent Inhibition studies
do. O'Carroll (1995) utilised a paired learning paradigm and found that acutely ill
schizophrenic patients were just as affected by previous experience as chronic patients.
Gray et al.'s model, therefore, has not been supported experimentally which may
necessitate an elaboration of their findings beyond such a task performance paradigm as
schizophrenic symptomatology in humans would appear to require a more sophisticated
cognitive explanation than can be derived from a behavioural model based largely on
animal studies.
A major area of criticism, however, dealt with problem of focusing on the positive
symptom dimension of schizophrenia (Ingraham; Manschreck and Maher, 1991). Also,
positive and negative symptoms have been shown to coexist over long periods of time
(Andreasen, 1985). On the other hand, Crider (1991) applauded the model as giving
justification for rethinking the contemporary neglect of the motor manifestations of
schizophrenia. Crusio (1991) agreed that damage to the hippocampal system is a good
candidate for the primary lesion that leads ultimately to the symptoms characteristic of
schizophrenia.
Gray et al. (1991) model provided a contemporary attempt to account for the positive
symptoms of schizophrenia within a behavioural paradigm. Pathways of associated neural
dysfunction that may be implicated as underlying the fundamental cognitive impairment
are provided. However, this is an ambitious undertaking and, although open to the
criticisms expressed above, shows the type of rigour and complexity of knowledge to
provide an integrated explanation of schizophrenic symptomatology. A major
contribution of the main tenet of the model, that of an impairment in the access of
previous regularities of input on current functioning, has highlighted the potentially
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fundamental role memory deficits appear to play in the expression of schizophrenic
symptomatology that has also been supported by evidence from other methodolgical
persuasions from the literature on the neuropsychology of schizophrenia (see Memory
and Schizophrenia).
1.3 Schizophrenia the frontal lobes and executive functioning
As stated above, a popular method of investigating the relationship between the
behavioural abnormalities and putative underlying brain abnormalities associated with
schizophrenia has been to use neuropsychological information derived from patients with
localised brain damage. Much of the focus for such research has centred on analogy with
patients with known damage to the frontal lobes. There appear to be many core
behavioural characteristics that are common to both frontal and schizophrenic conditions
Patients with frontal damage display behaviours such as stereotypy or perseveration,
poverty of activity and inappropriate responding to stimuli (Luria, 1973, Frith, 1992)
which are commonly expressed by patients diagnosed with schizophrenia. Specific
neuropsychological tests have been applied to patients with frontal insults allowing
subsequent identification of tests that can be associated with specific areas of damage
Such tests have then been administered to various groups of schizophrenic patients in an
attempt to clarify the nature and degree of the neuropsychological impairment associated
with their behavioural dysfunction. According to Gur et al (1990) there are two main
types of clinical neuropsychological test battery. The first is 'fixed' and includes a
comprehensive set of tests eg the Halstead-Reitan battery (Reitan and Wolfson, 1985). A
'flexible' battery, on the other hand, includes a core set of tests plus a sample of selected
tests of functional domains to investigate specific hypotheses. Either of these schemes
allows a comparison of schizophrenic patients with other patient groups and/ or normals
One aim of such testing has been to infer the region of brain dysfunction responsible from
the pattern of the functioning deficit
The particular core behavioural impairments associated with frontal lobe patients have
been termed the 'Dysexecutive Syndrome' (Baddeley, 1986) and include disturbed
attention and increased distractibility (Baddeley and Wilson, 1988) as well as the
problems in activity stated above. Shallice (1988) suggested that the 'frontal' patient's
behaviour could be due to an impairment in the control of action where activities are
chosen by a process of mutual inhibition, the most highly 'activated' winning its way
towards being carried out. This process works if environmental cues are present for the
selection of appropriate behaviour. Without such cues there is no activity or
perseveration occurs. However, often responses to environmentally driven behaviours
need to be modified or even overridden by a 'supervisory attentional system' (SAS)
which can activate actions not dependent on environmental stimuli. This can prevent
perseveration, inhibit inappropriate responses and produce new action plans rather than
routine ones despite the environment Frontal-type behaviours are, therefore, resultant of
an impairment in this mechanism
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1.3.1 Neuropsychological testing and frontal lobe/executive functioning
Regional brain function, associated with the frontal lobes, has been investigated using
measures such as the Wisconsin Card Sort Test (Heaton, 1981) and the Halstead
Categories Test (Reitan and Wolfson, 1985) designed to measure higher levels of
abstraction and mental flexibility. Deficits related to the frontal system have also been
associated with poor performance on Trails A and B tests (a measurement of mental
flexibility and motor function) (Reitan and Wolfson, 1985) and measures of verbal and
figural fluency (Miller, 1984). These tests have been found to be sensitive to specific
frontal lobe lesions in neurological patients (Ramier and Hecean, 1970). The disruption is
usually associated with particularly anterior lesions resulting in disorganisation of goal
directed behaviour related to attentional processing and conceptual flexibility (Goldberg
et al, 1987).
The Wisconsin Card Sort Test has been described as 'the best available test of
dorsolateral frontal cortex function' (Kolb and Wishaw, 1990 p.487). Requiring a
selection of cards varying in three perceptual dimensions (shape, form or colour), the
subject must continuously pick a card according to one dimension on the basis of trial and
error and feedback from the tester only. When a criterion is reached the rules are
changed. Those subjects with frontal lobe dysfunction tend to attain fewer categories of
set- usually as a result of perseverative responding due to performance related to the
previously correct dimension (Milner, 1964)- this effect is particularly prominent with
lesions to the dorsolateral prefrontal cortex (Weinberger et al, 1986) However, damage
to regions outside the frontal cortex can also produce similar deficits (Drewe, 1974).
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The deficits revealed by use of the WCST can be interpreted in one of several ways.
There may be an inability for abstract thought or for concept formation, for selective
attention or for shifting cognitive set. Frith (1987) predicted that schizophrenic patients
would perform poorly, on the WCST, due to an inability to plan or monitor responses
appropriately in the face of changing circumstances. Particularly poor performance has
been observed in schizophrenic patients displaying predominantly negative
symptomatology, indicated by high numbers of perseverative errors (Weinberger et al,
1988). The same authors have shown a correlation between the degree of'hypofrontality'
in their patient sample, as measured by the WCST, and cerebrospinal fluid levels of the
dopamine metabolite, homovanillic acid (HVA). This was interpreted as reflecting a
decrease in mesocortical dopamine activity. However, Braff et al (1991), in a study of
medicated chronically ill schizophrenic patients, found that their sample displayed
relatively few perseverative errors on the WCST Although this could reasonably reflect
medication effects, a subgroup of particularly disturbed patients did demonstrate a
significant impairment in performance. Therefore, 'hypofrontality', as assessed by WCST
results, appeared to be associated with the more deteriorated or 'Kraepelian' patients in
this sample.
Some authors have argued that while interpreting the significance of WCST results there
may be a disagreement concerning the significance and specificity of such performance
when compared to other deficits expressed in schizophrenia. Tests such as the WCST
appear to tap multiple processing abilities and thus performance may be due to
dysfunction in structures outside the frontal lobes. For instance, patients suffering basal
ganglia disorders eg. Parkinson's Disease and Progressive Supranuclear Palsy have been
seen to produce poor WCST results and, therefore, may also be involved in the
expression of'hypofrontality' (Weinberger, 1986, 1987). In fact, the use of the WCST has
been seen as having reached its peak by some authors as to what new information it can
relay about schizophrenic functioning (Corcoran and Frith, 1993). In the event, the use of
such a tool has been advocated within a broader appreciation of schizophrenic
neuropsychology and its putative underlying neuropathology (Kolb and Wishaw, 1983).
Gur et al (1990) using the WCST and the Californian Verbal Learning Test (a measure of
memory and learning, (Delis et al. (1983) found that their sample of patients were
impaired on both measures. The results showed, however, that the impairment in memory
and learning was significantly worse than the impairment seen in the WCST performance.
The authors believed their study supported a selective and disproportionate temporal lobe
dysfunction in their sample of schizophrenic patients. Support for a differential frontal
lobe dysfunction in schizophrenia was not found. Memory and learning, after profile
analysis, were significantly worse in comparison to all other functioning than functioning
as measured by the WCST results. Troubled by this specificity of the results and the
probability that a constellation of other deficits may implicate other specific brain regions,
Gur et al (1990) developed an algorithm of'behavioural imaging' in an attempt to provide
a standard regional interpretation of their neuropsychological data. Using PET scans,
along with the data from neuropsychological measures, the algorithm yielded values for
specific regions reflecting a prediction that a region is dysfunctional given the pattern of
neuropsychological scoring. As the prediction indicated, the authors found that the
frontal and temporal lobes were implicated (as dysfunctional) in the impaired performance
on the WCST and the CVLT. However, the authors also warned that such 'behavioural
imaging' awaits further verification. This approach, they suggested, is more appropriate
when considering a functional model of schizophrenia, providing functional imaging data
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when individuals are engaged in neurobehavioural tests that are known in normals to
activate specific brain regions. A disproportionate and selective impairment in memory
and learning tests was also reported by Saykin et al (1991) but not on tests purportedly
sensitive to 'frontal lobe' functioning In this case the sample of patients were
unmedicated. The authors interpreted such a pattern of functioning as involving
dysfunction of the temporal-hippocampal system (against a background of diffuse
impairment). Gruzelier et al (1988) had also reported that the selectivity of
neuropsychological dysfunction their group implicated temporal-hippocampal
dysfunction.
An intensive case-study approach, using a wide range of neuropsychological tests,
including many putatively sensitive to 'frontal' functioning has been used to examine the
pattern of dysfunction in schizophrenia (Shallice et al, 1991). The authors stated that,
despite overall ability, all patients performed badly on tests 'sensitive' to frontal
functioning, particularly verbal fluency. They concluded that, although the 'frontal' test
performances were significantly impaired relative to the background level of cognitive
functioning, the performance between individuals was markedly heterogeneous not only
in their degree of impairment but in their patterns of performance. This indicates that the
interpretation of the results of such testing could be misleading if group means are
considered alone. The authors admonished subsequent researchers to take the
heterogeneity of functioning seriously, when interpreting neuropsychological test results,
as this dimension of the disease may possibly be its most characteristic. Such conclusions
also provide support for analyses of the patterns of neuropsychological functioning with
symptom profiles.
3b
A broader appreciation of a specifically 'frontal' hypothesis of schizophrenia has been
elicited through activation studies. Weinberger et al (1986), using regional cerebral blood
flow measures, found an increase in rCBF during the WCST in normals but not with a
group of chronic schizophrenic patients Therefore, the inability of the patient sample to
do the test was attributed to an impairment in frontal lobe activation. The authors argued
that, in the light of previous animal studies, the results were consistent with a lesion
involving the dopamine innervation of the dorsolateral prefrontal cortex. Following on
from this, the authors argued, that the primary abnormality could be due to subcortical
pathology. However, Goldberg et al (1989) found that the pattern of functioning
observed in affected twins of monozygotic pairs results implied frontal-temporal
dysfunction with relative sparing of posterior and subcortical functioning. Despite this,
Pantelis et al (1992) in a review of the evidence for a frontal-subcortical pathology
argued that the neuropathological and neuropsychological data, to date, revealed an
intimate relationship between these brain regions. In line with Weinberger et al (1986)
and Pantelis et al (1992), Brown and White (1992) expressed support, of subcortical
involvement, having demonstrated that the degree of Tardive Dyskinesia displayed by
their patients was significantly associated with the degree of impairment on tests sensitive
to 'frontal' functioning (including the WCST). Subcortical pathology was, therefore,
implicated in determining the pathophysiological mechanism through which 'frontal'
functioning is impaired. Therefore, dysfunction should be seen in terms of system
abnormalities whose components may include regions previously connected with
particular patterns of neuropsychological test performance, including the WCST,
(Robbins,1990). However, to date, there is much controversy concerning which systems
are of primary concern for the researcher.
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Because of the aforementioned problems with goal-directed activity in both 'frontal' and
schizophrenic patients, another popular neuropsychological measure used with these
patients is the Tower of Hanoi or London Test (Shallice, 1982). This test appears to
assess organisational and strategic planning ability. The subject is required to move discs
or balls from an initial to a goal position. Subjects are encouraged to think their solutions
through before activating their sequence of goal directed moves. Shallice (1982) found
that patients with anterior cortical damage made more errors than those with posterior
cortical damage or controls. Owen et al (1991), using a computerised version of Shallice's
test, found that subjects who had undergone surgery on their frontal lobes for epilepsy or
tumours made more errors and were slower than controls to instigate their solutions
subsequent to their first move. Nelson et al (1991) compared test results with Liddle's
(1987) syndrome typing of schizophrenia. They found an association between Tower of
London scores and the 'psychomotor poverty' syndrome, implicating more of a poverty of
action impairment than disorganisational component with regard to the test demands.
Saint Cyr et al (1988), in a comparison with Parkinson's disease and Huntington's disease
patients (both resulting from basal ganglia dysfunction), found that schizophrenic patients
performed worse than the Parkinson's disease patients and a sub group of the
Huntington's patients on a three disc (problem) version of the 'Tower' test. However, the
schizophrenic patients performed better than the other two groups on a four disc
problem. The performance of the schizophrenic patients was characterised, the authors
suggested by 'frontal' rather than basal ganglia dysfunction. The four disc problem was
seen, rather, as a test of procedural learning than planning ability, the former allegedly
associated with basal ganglia function.
3S
It seems increasingly relevant to consider the pattern of schizophrenic functioning,
observed on a wide range of neuropsychological tests, as reflecting different
combinations of cortical damage perhaps with interactions at a subcortical level (Robbins,
1990). It remains that to interpret neuropsychological results as region specific is fraught
with problems not only from a neuropathological view but also from an over optimism
surrounding the specificity of the measures presently in use i.e. most 'frontal' tests
demand multiple processing. The analogy used of the focal neurological patient as model
for the putative pathological problems associated with schizophrenia appeares to
necessitate the incorporation of more intensive approaches to appreciate the difference
between individuals on their test performance but that also test performance, in turn,
ought to be assessed in light of symptom profiles or with more homogeneous groups.
Schizophrenic neuropsychology appears more than an extension of a specific neurological
insult i.e. a 'frontal' impairment, multiple functions are apparently impaired Future
studies must integrate what we have learnt about 'frontal' or executive functioning in
context of other areas of disproportionate dysfunction, to produce an integrated scenario
of characteristic neuropsychological impairments responsible for the expression of
particular symptoms.
1.4. Long term neuropsychological deficits and Symptoms
In a recent study, on a sample of 58 chronic schizophrenic patients, after a follow up
period of between 2 and 12 years, 'substantial' functional cognitive impairments were
observed (Breier et al, 1991). Performance on neuropsychological tests allegedly sensitive
to frontal cortical functioning (Wisconsin Card Sort Test, Trails A&B, Word Fluency)
were significantly correlated with the outcome levels of negative symptom ratings and
social functioning measures rather than with positive symptom levels. The authors
proposed that the lack of a relation between positive symptoms and putative measures of
'frontal' cortical functioning suggests that the symptom components of the schizophrenic
condition may have distinct anatomic origins. From their results the authors attempted to
charter the course of a 'typical' chronic illness. This, they argued, is characterised by
deterioration, stabilization and, finally, (slight) improvement phases. This 'model' was
linked to dopamine alteration in activity ie high dopamine activity was associated with
initial deterioration. Slowing of deterioration and subsequent improvement may be related
to a decrease in activity associated with the normal aging process (Wong et al, 1984).
The study can be severely criticised by the lack of 'non frontal' control tasks in the
methodology.
Nelson et al (1990) compared symptomatology with neuropsychological profiles, in
chronic schizophrenic patients. They investigated the relation between motor and
cognitive speed and symptomatology, finding that it was the severity of negative but not
positive symptoms that was related to the severity of the patients bradyphrenia (cognitive
slowing). Cognitive speed appeared more affected than motor speed. In line with Pantelis
et al (1989b; 1992) and Crow (1980), they argued that such observations are consistent
with a subcortical pathology in patients with type 2 schizophrenia. [Rogers (1986) had
suggested that bradyphrenia was the fundamental phenomenological feature of the
subcortical dementias ] Overall, cognitive functioning, unsurprisingly, was significantly
depressed compared to normals. However, evidence of significant levels of below
average premorbid intelligence (NART scores) was evident in their sample. These
findings have not been replicated by other researchers with similar samples (Bilder et al,
1988, Frith et al, 1991), although compromised NART scores have been observed with
long term hospitalised schizophrenic patients (Crawford et al., 1992), implying poor pre
morbid functioning to be associated with the more resistant and deteriorated form of
illness. These results may, alternatively, question the use of the NART as a pre morbid
measure unaffected by the disease process.
In the Frith et al (1991) study a comprehensive battery of neuropsychological tests was
administered to a sample of 283 schizophrenic patients. Despite no overall impairment in
premorbid functioning, a relationship was found between low premorbid IQ scores and
subsequent symptoms in their large sample. These patients exhibited more severe
negative features of the illness. Again, low pre morbid functioning tended to be
associated with the more severely deteriorated patients. The authors found that, in terms
of cognition, schizophrenic features fell into one of three distinct categories. Firstly,
hallucinations and delusions had very little effect on the cognitive processes examined.
The presence of poverty of speech, flattened affect and motor retardation, however, were
strongly associated with cognitive dysfunction such as deterioration in IQ scoring, verbal
fluency and forced choice recognition. Incoherence of speech and incongruity of affect
were also strongly associated with cognitive dysfunction this time independent of
negative features. These were associated with the failure to inhibit inappropriate
responses (as measured by a continuous performance test) and also with the production
of unconventional responses in a verbal fluency task.
Again Frith and his colleagues noticed a difference between the impairments associated
with positive and negative symptoms respectively. The authors suggest that this could
reflect the true nature of the two types of features. Negative symptoms are possibly,
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therefore, primarily associated with a failure to respond, positive signs being associated
rather with the production of a wrong/inappropriate response.
The 'traditional' positive-negative dichotomy, involved in many of the studies presented
above, has recently been clarified in terms of 'type 1' and 'type 2' schizophrenias in order
to describe the heterogeneity of the condition (Crow, 1980, 1985). However, even the
clusters of symptoms subtyped by Crow have been seen as mutually inexclusive i.e. can
exist simultaneously in the same individual and, thus, present difficulties in clarifying the
underlying associated pathological processes. Therefore, this may lead to confusion
associating pathology directly with symptom type (Liddle and Barnes, 1990).
In order to provide a clearer empirical delineation Liddle (1987a, b) factor analysed
symptom ratings into clusters or sub-syndromes of illness and correlated them with
patients' neuropsychological test performance (Frith et al, 1991 followed similar
methodology). Liddle's methodology revealed three distinct sub-syndromes. The
syndromes which emerged were, firstly, 'psychomotor poverty' associated with deficits in
abstract thinking and long term memory, 'disorganisation' associated with poor
concentration and difficulty in learning new material and, finally, 'reality distortion'
associated only with limited cognitive dysfunction, found only in poor performance in
figural/ground perception measures. The first two of Liddle's syndrome types have been
associated with putative 'frontal lobe' deficits while 'reality distortion', the author argued,
is related to temporal lobe dysfunction (Liddle, 1987). Such results have been supported
by further neuropsychological studies (Liddle and Morris, 1991). In this study slowing of
mental activity was particularly associated with 'psychomotor poverty' while
'disorganisation' was associated with tests where the subject failed to inhibit an
established but inappropriate response 'Reality distortion' was not significantly correlated
with such traditional putative 'frontal lobe' measures. This type of syndrome generation
has been particularly useful in composing a tripartheid syndrome typing of chronic
schizophrenia (Liddle and Barnes, 1990). A final area of support, and direction for further
study, has come from PET studies which have confirmed the three syndrome associations
with particular brain regions. Liddle et al. (1992) again found, via factor analysis,
symptom ratings from a sample of stable chronic schizophrenic patients could be
successfully separated into the three syndromes cited above. PET scanning was used to
record brain functioning due to the degree of cerebral brain blood flow. The study
confirmed earlier predictions in so far as 'psychomotor poverty' and 'disorganisation' were
associated with altered perfusion at different loci in the prefrontal cortex. 'Reality
distortion' was associated with altered perfusion in the medial temporal lobe. However,
the patterns of perfusion observed suggested that any abnormalities of brain function
underlying each syndrome are of a more complex nature and involve abnormalities in
distributed neural networks and are not confined to single loci.
Close study of these groups of chronic schizophrenic patients shows that there appears to
be a clear association between negative symptomatology and impaired cognitive
performance. Any characteristic impairment profile is, as yet unforthcoming. However,
recent research, seems to be pointing to an appreciation of long term or chronic
schizophrenia as a disseminated entity, expressed most probably as groups of related
clusters of symptoms, each possessing a particular neuropsychological profile and thus
indicative of distinct pathophysiologies.
1.5 Memory and Schizophrenia
Memory impairments have been implicated in the neuropsychological mediation of
symptoms in the models of Gray et al. (1991) and Frith (1992), in terms of accessing
appropriate previously learnt knowledge for present functioning and knowledge of
second order representations necessary for self-awareness, respectively. Evidence from
neuropathological sources has shown changes in the medial limbic structures of the
temporal lobe including the hippocampus, in groups of schizophrenic patients, suggestive
of an underlying biological substrate associated with the putative memory deficits
(Bogerts et al, 1985). However, up until relatively recently, authors have dismissed
memory impairments as of little importance in the understanding of the psychology of
schizophrenia (e.g. Cutting, 1990). Despite this, recent research has accummulated
supporting a central role for memory problems as an underlying neuropsychological
deficit responsible for the expression of certain schizophrenic symptoms.
McKenna et al (1990) tested a group of 60 schizophrenic patients, of all grades of
severity of illness, on a wide range of memory tasks. A substantial deficit in long term
episodic memory functioning was recorded disproportionate to the degree of their general
cognitive impairment. The authors believed the underlying dysfunction was similar to that
of the Classic Amnesic Syndrome (CAS; Baddeley, 1982) (where an intact short term
memory but wide ranging deficits in long term memory are observed). This pattern
resembled the dysfunction seen in Korsakoffs syndrome rather than in Alzheimer-type-
dementia (sufferers of ATD display deficits in both short and long term memory). The
deficits were not attributable to the effects of medication but appeared as a function of
the severity and chronicity of the illness. Tamlyn et al. (1992) and Duffy and O'Carroll
(1994) have also observed disproportionately impaired long term episodic memory
functioning with their patient samples. In an analysis of this episodic memory impairment,
Clare et al. (1993) found schizophrenic patients' word and face recognition memories and
prose recall to be equally compromised compared to matched controls. However, Calev
et al. (1984) found recall deficits to be more severe than recognition deficits when using
tests matched for degree of difficulty. Tamlyn et al. (1992) also found that semantic
memory was disproportionally impaired compared to general intellectual impairments
Interestingly, Duffy and O'Carroll (1994) found, in a comparison with a group of
Korsakoffs patients, a disproportionate semantic memory impairment in their
schizophrenic patient and better episodic memory functioning. With respect to symptom
expression, semantic memory dysfunction has been implicated in the generation of
delusions through an impairment in the continuous gathering and 'reality checking' of
knowledge so that false memories are stored which become the false knowledge that are
delusions (McKenna, 1991). In addition, in the Frith (1992) model, metarepresentation
has been suggested as dependent on knowing the source of one's memory of activity, the
impairment of which would putatively compromise one's ability to form second order
representations. The memory impairment observed with various groups of schizophrenic
patients, from the literature, appears to implicate both episodic and semantic memory
impairments as underlying such symptoms as delusions. These observations may be
supported by the suggestion that although episodic and semantic are distinct memory
systems, they appear to act in a highly integrated way (Parkin, 1987).
The specificity of the memory function to schizophrenia was investigated by Sengel and
Lovallo (1983), who tested groups of paranoid and non-paranoid schizophrenic patients,
depressed patients and normal controls on their memory for a categorised word list On
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immediate recall the three psychiatric groups benefitted equally when given category
cues. The schizophrenic patients alone showed a significant recall deficit in the delayed
recall condition regardless of cues. They also lost a number of categories in the non-cued
condition suggesting a more fundamental memory problem compared to the other
groups. In a study by Harvey et al (1986) both schizophrenic and bipolar patients
displayed impaired recall relative to controls. The schizophrenic patients' performance
was attributed to encoding difficulties, whereas the deficits incurred by the bipolars was
attributed, primarily, to thought disorder
Although schizophrenic patients may differ from other psychiatric groups in the nature of
their memory impairment, it also appears that the memory dysfunction may be selectively
dispropotionate to the other widely documented neuropsychological deficits observed
with groups of schizophrenic patients. Saykin et al (1991) reported that a group of 36
unmedicated schizophrenic patients showed a selective and disproportionate deficit on
memory and learning tasks despite their general cognitive impairment, compared to
controls. Such selectivity was not forthcoming on tests allegedly sensitive to frontal lobe
functioning. The finding was of additional interest as the results were not contaminated
with issues surrounding medication effects or long term hospitalisation. This selectivity
had not been documented before and provided support for a hypothesis of temporal-
hippocampal dysfunction in the pathophysiology of schizophrenia. Such a conclusion had
already been implicated by Gruzelier et al (1988) who concluded that temporal-
hippocampal dysfunction most likely explained their schizophrenic patients' poor scores
on verbal and spatial memory measures. Saykin et al. (1994) replicated the results of the
1991 study with 37 patients never exposed to neuroleptics in their first episode
However, Blanchard and Neale (1994) found no disproportionate neuropsychological
deficit with sample of 28 patients whose mediaction had been withdrawn for research.
Deficits were seen on a range of test performances compared to matched controls.
However, memory impairments do not stand alone as commonly observed
neuropsychological deficits associated with schizophrenia. The emerging pattern of
impairments would imply multiple impairments of integrated functions and, thus, diffuse
pathophysiology. For instance, Schwartz et al (1991) found that a group of chronic
schizophrenic patients displayed a significant memory deficit on a recency discrimination
task. This was seen as reflecting poor memory for temporal order. This sample was also
given the Wisconsin Card Sort Test. Their performances, on the recency discrimination
task, were inversely related to the number of perseverative error scores accrued on the
WCST. These results, therefore, once more emphasised the important role of putative
preffontal/executive dysfunction aswell as memory dysfucntion in any appreciation of
overall neuropsychological dysfunction in schizophrenia.
Since the reemergence of memory dysfunction as a focus for schizophrenia research,
workers have attempted to focus on what specific areas of functioning could explain the
deficits. Goldberg et al (1989) found that, in a group of 31 schizophrenic inpatients,
retrieval of verbal material from the Selective Reminding Task (Bushke and Fuld, 1974)
was significantly worse than recognition. However, the schizophrenic patients did show
an apparent ability to encode the material by displaying a learning curve during
performance. Goldberg et al (1989) postulated that the recall (retrieval) deficit suggested
dysfunction of the prefrontal cortex The mechanism underlying these results was
interpreted as differing from that associated with Alzheimer-type-dementia and
KorsakofFs syndrome both of which are characterised by deficits in verbal recognition
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aswell as recall. This is an important observation as recognition memory and recall
memory may well be mediated by different neural systems.
Although the pathophysiology of the condition appears to involve dysfuction in several
neural systems, Calev et al (1991) showed that, by displaying equal deficits on tests of
verbal and visuospatial recall compared to controls, there is little support for a specific
verbal memory deficit in schizophrenia-which might be implied due to the nature of
positive symptoms. This result, albeit with a small sample, questioned the role of
hemispheric differences, which had been widely implicated in schizophrenic performance
(e.g. Saykin et al., 1991), in affecting such memory tasks. The basic verbal and
visuospatial recall deficits, documented by Calev et al appear suggestive of bilateral
hippocampal involvement, particularly in the severely disturbed. Mildly disturbed
schizophrenic (and bipolar) patients memory deficits have been associated with skills that
affect encoding and are, perhaps, secondary to a cortical attention and executive
dysfunction as these groups show different recall patterns to the severely disturbed whose
memory impairment may be more fundamental (Calev et al, 1983, Levin et al, 1989).
1.5.1 Memory, medication and hospitalisation (see also subsection Neuroleptic
effects on memory and learning1)
Though it may appear that memory difficulties may be characteristic of groups of
schizophrenic patients in various stages and states of the illness, it has been disputed
whether the deficits shown are due to the process(es) of the disease alone or are affected
by variables such as medication and/or the effects of long term hospitalisation.
Sweeney et al (1991) reported that neuroleptics and anticholinergics are associated with
poor verbal recognition memory as far as schizophrenia is concerned The effects of the
medication were seen to be influenced by higher doses. Spohn and Strauss (1989)
associated neuroleptic medication with limited 'normalisation' on a broad range of
psychological tests and anticholinergics, particularly, with apparent disruption of some
aspects ofmemory.
Calev et al (1991) tested a group of 8 long stay hospitalised chronic schizophrenic
patients who had been withdrawn from both neuroleptic and anticholinergic medication
Their medication was reduced to zero levels over two weeks and the subjects were left
drug free for four weeks before testing began The patients were tested on Calev et al's
(1983) immediate and delayed matched recall tasks for measurement of their rate of
forgetting of well encoded verbal material. The results showed rapid forgetting in the
schizophrenic patient group (compared to controls). The authors proposed a post
encoding deficit responsible for the poor performance. The retrieval difficulties observed
could have been due to the disruption of any meaningful organisation of the materials to
be remembered. Such disruption has been observed in amnesic groups displaying signs of
hippocampal and temporal lobe dysfunction (Squire 1986; 1987), therefore, similar brain
pathology may be responsible for the memory deficits seen in groups of long term
severely disturbed chronic schizophrenic patients.
There is an important problem, however, associated with the interpretation of the above
results from such a drug free sample Although the evidence is scant, the effects could, in
part, be due to the irreversible effects of long term medication Also, one must question
whether the effects are due to the actual process ofwithdrawal from the medication in the
first place. Another confounding variable, which may have a significant affect on
functioning, is that of the duration of hospitalisation and, therefore, the factor of
institutionalisation arises. However important these observations are, contemporary
evidence tends to support the hypothesis that significant impairment in memory
functioning of schizophrenic patients exists that is due to the more than the sum of effects
of institutionalisation and withdrawal effects on their own (Calev et al, 1991; see also
McKenna et al, 1990, Saykin et al., 1991).
In summary, a consensus seems to be appearing associating poor performance on tests of
long term memory (verbal and non-verbal) in various groups of schizophrenic patients,
some studies showing a disproportionate deficit over other areas of cognitve impairment
There also seems to be marked deficits in the recall/retrieval of material over recognition
These observations have also been noted when medication and institutionalisation effects
have been considered Present evidence, however, has yet to determine a profile of
memory impairment characteristic of groups of schizophrenic patients. More importantly,
because of the heterogeneous nature of such groups evidence is even more lacking in
associating specific memory deficits to the expression of particular symptoms.
Optimistically, researchers are beginning to address these questions, in earnest, in order
to contextualise the emerging memory deficits within more complex models of
psychological dysfunction which give rise to particular schizophrenic symptoms.
So
1.6 Lateralization studies and schizophrenia
It has been suggested that the cognitve dysfunction associated with memory dysfunction,
at least, implicates bilateral impairment in schizophrenia (Calev et al., 1991) However,
this has only sought to exaggerate the amibiguity surrounding the question whether the
pathophysiology responsible for schizophrenic symptoms is hemisphere specific (Cororan
and Frith, 1993) Left hemispheric dysfunction has been popularly presented as
characterising a relative hemispheric imbalance in functioning in schizophrenia (Gur,
1978). Left turning bias or circling behaviour associated with right hemispatial neglect
(i.e. left hemispheric dysfunction) has been widely reported in groups of schizophrenic
patients in recent years (Bracha, 1987; Lyon and Satz, 1991) with unmedicated and
medicated subjects respectively. This specific behaviour, particularly in animal studies,
has been related to asymmetry in dopaminergic activity between the left and right basal
ganglia and the left and right frontal cortex (Glick and Ross, 1981, Stewart et al, 1985).
In more recent times it has been suggested that the presence of dopaminergic activity in
unmedicated patients, at least, reflects right anterior subcortical or cortical structures
manifesting a relative dopaminergic overactivity compared to the left anterior structures
(Bracha, 1987). Schizophrenic patients have also been observed demonstrating deficits in
attention reflective of patients with unilateral lesions of the left hemisphere (Posner et al,
1988).
Tomer and Flor-Henry (1989) found attention asymmetry clearly related to the
medication status of the patient Unmedicated schizophrenic patients would show
inattention to the right visual field (right hemispatial neglect expressed by left turning bias
behaviour) which changed to more prominent left sided inattention after medication This
'shift' was associated with longer duration or higher daily dose of medication All in all,
this appears suggestive that medication helps normalise left hemisphere performance
whilst deterioration of right side performance occurs, as the 'shift' did not herald a
difference in the level of functioning only the nature Therefore, evidence of lateralization
of dysfunction appears to be affected by medication, which should be considered in future
studies. This may also help determine dopaminergic innervation of arousal in each
hemisphere responsible for the emerging pattern of neuropsychological functioning
associated with schizophrenic symptoms.
In terms of symptom expression, positive thought disorder has been associated with
speech and language dysfunction in the left hemisphere, but negative thought disorder has
been attributed to more bilateral damage (Silverstein et al., 1991). However, Cutting
(1994) suggests that right parietal damage has been associated with experiencing one's
voice as alien. Thus contemporary evidence for a specific hemispherical dysfunction in
schizophrenia is far from conclusive. Future studies ought to clarify the association of
hemispheric differences in terms of specific symptoms. Also, care ought to be taken in
attributing hemispherical dysfunction to certain patterns of neuropsychological
performance as many tests involve multiple processes and thus more interactive, including
interhemispheric, brain systems.
1.7 Pru2 treatment. Neuropsychology and Schizophrenia
The two main reasons why neuroleptics are prescribed are for the effective reduction or
removal of acute symptoms and the prevention of relapse in those recovered from an
episode. There are three major groups of standard neuroleptics; the phenothiazines, the
butyrophones and the thioxanthenes These drugs are limited in their usage as they are
not effective for all, can generate serious side effects and are restricted to the kinds of
symptoms they can actually ameliorate. However, when a drug is chosen, consideration is
given to the patients pharmacological history, and their particular response. There are,
however, no particular individual characteristics of a patient that can reliably predict their
response to a particular drug (Goldberg et al, 1972).
The potency of standard neuroleptics e.g. phenothiazines correlates well with its affinity
for the postsynaptic D2 receptor (Tune et al, 1980). Although low doses appear less able
to effect clinical response, there is evidence that high doses may exacerbate symptoms
and reveal cognitive dysfunction (Spohn et al, 1985 -see later). However, all neuroleptics
show varying and diverse side effects. The high potency drugs eg. haloperidol and
fluphenazine seem to cause less sedation, few anticholinergic effects (eg. tachychardia)
but are responsible for producing more extrapyramidal side effects (eg. drug induced
Parkinsonism, akathisia and tardive dyskinesia). Thus the particular group of side effects
assumed least harmful would be of importance clinically when choosing a drug suitable
for an individual. Although high potency drugs seem to be favoured clinically (and at
higher doses) over low potency drugs, as they are seen as better tolerated by the
individual patient, the concomitant side effects usually necessitate compensatory medicine
ie. anticholinergics. Anticholinergics are primarily prescribed for the management of
extrapyramidal side effects ie. pseudoparkinsonism, dystonia, ak&thjsia Johnson (1978)
observed that approximately 10% of patients' extrapyramidal side effects reappear on
discontinuation of their anticholinergic medication. Such medication can also manage
depressive symptoms concomitant to the primary disease (Johnson, 1981) The
Si
disadvantages of anticholinergics are discussed later with particular reference to cognitive
abilities.
The question of appropriate dosage has not, as yet, been absolutely answered. The
advocation of'rapid neuroleptization' (Donlon and Tupin, 1974)- the acutely psychotic
receiving frequent doses of high potency drugs until overt sedation occurred- was
proposed at one time. Van Putten et al (1987) has addressed the subject of optimal dose
and observed that 20mg (haloperidol) resulted in significantly more improvement (as
measured by the BPRS) than 5mg, but held only a marginal advantage over lOmg per
day. Patients on 20mg showed greater deterioration in blunted affect, emotional
withdrawal and motor retardation amongst other symptoms. As a caveat, therefore, it is
necessary to see the high dosage advantages in context of the obvious toxic effects.
Baldessarini et al (1988) reported that no additional benefit is likely with doses above
600mg chlorpromazine (CPZ) equivalent (approx. 12mg haloperidol)- there is, in fact, a
slight trend towards decreasing efficacy above 600mg CPZ equivalent. The same
decreased efficacy was observed when the dose went below 250mg CPZ equivalent when
compared to mid range doses. Thus, there appears a curvilinear relation existing between
dose and response.
1.7.1 Treatment of neuroleptic-unresponsive schizophrenia
A small but significant proportion, approximately 10-20%, of schizophrenic patients
derive little benefit from typical neuroleptic administration (Davis et al, 1980; Friedhoff,
1983). Six to eight per cent essentially show no response from the beginning of their
illness (Tuma and May, 1979, McMillan et al., 1986). However, there are, as yet, no clear
predictors who will comprise this group (Kane, 1987), although chronic hospitalised
patients are predominantly these kind of sufferers.
Reports have supported the use of very high doses in the management of treatment
resistant populations (Rifkin et al, 1971). Qitkin et al (1975) suggested that reported
results favour 'standard' rather than 'megadoses'of neuroleptics. This assumes high doses
would only benefit a small proportion of treatment-resistant schizophrenic patients. Small
et al (1975) showed that adding lithium therapy to standard neuroleptic administration
reduced symptomatology in a chronically hospitalised and, relatively, treatment-resistant
group.
A source of optimism for the treatment of patients unresponsive to standard neuroleptic
medication has been the development of atypical neuroleptics such as clozapine and
risperidone. These drugs have different psychopharmacological properties to the standard
dopamine antagonists such as chlorpromazine. Clozapine has a weak affinity for
dopamine receptors but possesses powerful blocking effects for serotinergic receptors.
Risperidone has both potent serotinergic (S2) and dopaminergic (D2) blocking
properties. Both clozapine and risperidone have had significant ameliorating effects on
symptoms with patients unresponsive to haloperidol (Kane et al., 1988, Marder and
Meibach, 1994).
1.7.2 Long term strategies: maintenance and mana2ement.
The symptom reducing effects of neuroleptics are dependent on continuous treatment. If
drug therapy is discontinued, on average, 40% of patients relapse within 6 months and
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70% within one year (Hogarty et al, 1973). Long term maintenance substantially reduces
such relapse rates but is also associated with serious neurological side effects eg. tardive
dyskinesia. If, therefore, discontinuation is unfeasible, the only realistic strategy for
reducing tardive dyskinesia is management via the lowest effective dose. This point is
extremely important as tardive dyskinesia has been associated with both cognitive and
psychophysiological problems in schizophrenia (Waddington, 1987). Another advantage
of low dose maintenance is that the extrapyramidal side effects have the potential for
lowering the mood of the patient. According to Spohn and Strauss (1989) two strategies
exist for the investigation of this effect,
a) Treating patients intermittently with maintenance drugs, on a gradual decrease, until
signs of relapse are evident, then the drug is reinstituted. Not only is close clinical
supervision of the utmost importance, in this strategy, but also family training is necessary
for the detection of the first signs of relapse. Jolley et al (1989) argued that patients here
are more likely to suffer recurrence of their psychotic symptoms.
b) The 'dose reduction' strategy involves doses administered at lower levels than usually
prescribed. Kane et al (1983) reported that relapse rates on these lower levels were
significantly lower than on placebo and that patients had better outcomes on
measurements of social adjustment and dyskinesia ratings. Marder et al (1984, 1987)
suggested that lowering the doses, substantially in well stabilised patients is relatively safe
if the clinician is sensitive to a worsening condition to make an appropriate dose
adjustment. Dosage reduction reduces the likelihood of side effects and extremely few
reports of anxiety or depressive symptoms have been recorded (Marder et al, 1991)
Compliance seems to increase the advantage. However, the results of such strategies
Sb
ought not to be generalised to whole populations as most studies rely on well-stabilised
populations of schizophrenics.
In summary, neuroleptics have been a therapeutic leap forward for the reduction of acute
symptoms and prevention of relapse in chronically occurring schizophrenia. However,
drugs of this nature are limited in their usefulness by the concomitant side effects Drugs,
in themselves, presently provide little optimism for cure and most patients will continue
to display schizophrenic symptoms to one degree or another despite their drug regime
However, with the development of new atypical neuroleptics some hope of relief and
effective management is beginning to be available for a proportion of the schizophrenic
population who had previously been impervious to the effects of medication
1.7.3 Drugs, behaviour and schizophrenia
The heterogeneity of symptom expression in groups of schizophrenic patients and
individual demographics i.e chronicity and duration and type of medication, pose a major
problem for the interpretation of the literature concerned with the relationship between
drug effects and behaviour. Spohn and Strauss (1989) proposed two general
methodological considerations for investigations in this field. Firstly, the demonstration or
dismissal of 'direct effects' is problematic. Drug manipulation exercises are always
mediated by clinical judgement before any interpretation of psychological functioning
takes place. It is, therefore, almost impossible to determine cause and effect relationships
in this way. Secondly, clinical efficacy scales do not require patient cooperation. Studies
of drug effects on psychological functioning require the willingness to participate.
Relapsed patients are untestable. Testing, therefore, cannot avoid a form of selection bias
1.7.4 Designs used in drug-behaviour studies.
Common methodologies include:
a) Comparison of an 'on drug' population to an 'off drug' population. There is the problem
that group differences cannot definitely be attributable to medication effects. Long term
residual side effects of previous medication and hospitalisation factors could affect
inferences here.
b) Comparison of the same group at the end of 'washout' and after a period of
resumption.
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c) A counterbalanced or crossover design, where patients serve as controls-one subgroup
tested on drug then off Another subgroup is tested obversely, all under double blind
conditions. Problems accrue when drug influence may carry itself over into the off drug
phase. At least, a three week washout, between on and off drug stages, should negate
this influence (Spohn and Strauss, 1989).
d) The independent group placebo controlled design (patients are randomised to an on
drug or placebo condition-under double blind conditions). The groups are then tested
over a period to allow the neuroleptic to take full effect. This design can differentiated in
light of traditional schizophrenic subclassification,
i) acute treatment-patients are randomised whilst in an acute episode,
ii) chronic sufferers are withdrawn from their standard medication, washed out and then
randomised- this is known as a 'discontinuation design'.
1.7.5 Neuroleptics and effects on co£nitive functioning in schizophrenia.
In a recent review Cassens et al (1990) concluded that the effect of neuroleptics on
cognitive, perceptual and motor behaviour has remained ambiguously defined throughout
the literature. Although the area has far from been ignored, unfortunately, it has been
characterised by contradiction. On a more progressive note, there is a desirability for
order in this area due to the present increased interest in the aetiological and prognostic
significance of neuropsychological abnormalities in schizophrenia. In addition, there is
also a need to differentiate such abnormalities from drug effects. The knowledge of drug
effects on cognition, of course, may clarify those neural regions and transmitter systems
primarily involved in the expression of schizophrenic behaviour.
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1.7.5.1 Reviews of drug effects on co2nition in schizophrenia
Spohn and Strauss (1989) concluded that neuroleptic administration was associated with
a significant degree of 'normalisation' of disordered thinking and attention/general
information processing, although this normalisation was not directly related to clinincal
improvement. Cassens et al. (1990), reviewing neuropsychological test peformance and
medication effects, observed that acute administration impaired some but not all tasks
requiring vigilance/attention and some motor skills. Improvement could be seen, after
chronic administration, on tasks of sustained attention and visuospatial problem solving,
less so at high doses. Saletu et al. (1986) found that chronic administration of haloperidol
and flurperlapine improved 75% of a range of neuropsychological test performances,
although acute administration compromised performance. Heaton and Crowley (1981)
concluded that very few changes of neuropsychological functioning occur after chronic
continuous neuroleptic administration. These reviews reinforce the ambiguous state of
drug-cognition relations in schizophrenic research. Despite these reviews specific areas
of functioning have been investigated in an attempt to clarify the effects of neuroleptics
on cognition which provide a more detailed appreciation of the field.
1.7.5.2 Neuroleptic effects on intelligence.
Pearl (1962) observed no general improvement in intellectual functioning associated with
neuroleptic administration. Improvement was observed, solely, on performance of the
subtest 'similarities' (WAIS and Wechsler-Bellvue batteries). Although the author
thought this improvement might have been due to chance, it is, interesting to note that
performance on 'similarities' subtest can be considered as sensitive to idiosyncratic
to
thinking or thought disorder and, thus, corroborates the theory that neuroleptics can
ameliorate this type of thinking. Although Gorham (1956) had reported significantly more
examples of concrete thinking in schizophrenic patients than normals, Shimkunas et al
(1966) found no change in measures of abstract and concrete thinking over a 5 week
neuroleptic treatment period. Shimkunas et al (1966) proposed that verbal IQ accounts
for more of the variance observed, than the ratings of severe psychopathology, in
measures of concrete thinking. Harrow et al (1977) supported this conclusion and
suggested that intelligence was the most powerful influence on abstract or concrete
thinking despite medication.
1.7.5.3 Neuroleptic effects on measures of attention and vigilance.
Daston (1959) reported that chronic schizophrenic patients on chlorpromazine showed
particular improvement in tests of 'immediate memory' or 'span of concentrative
attention'. Concentrative attention (sustained attention or vigilance) has been gauged
widely by the use of the Continuous Performance Test (CPT) (Rosvold et al, 1956). The
test yields error of omission or commission scores (ie failure to respond to a target,
usually a letter, occurring randomly among a continuous presentation of non-targets or
responding to non-target letters), perceptual sensitivity is judged to be derived from the
raw scores. Orzack and Kornetsky (1966) found that schizophrenic patients were
significantly more impaired on the CPT than alcoholics or normals (no difTerence was
observed between schizophrenic patients and normals on a digit symbol substitution test)
Orzack et al (1967), in a study of hospitalised chronic schizophrenic patients, off
medication one month prior to testing and then treated with phenothiazines and then
tested after a period of 12 weeks, found a significant decrease in errors of omission on
the CPT and no change in the DSST scores. The improved performance on the CPT was
positively correlated with clinical improvement. This result was replicated by Spohn et al
(1977). Such studies are, therefore, suggestive that an association exists linking
neuroleptic treatment, clinical improvement and the 'normalisation' of sustained attention,
particularly in samples of chronic schizophrenic patients. However, this observation may
be restricted to certain functions and possibly not found with others. Pugh (1968) noted
that no neuroleptic induced alteration of performance could be reported during trials
using the Trail Making Test. Killian et al (1984) noted, in addition, that neuroleptics
show no significant effect on Stroop Test scores; these tests putatively sensitive to frontal
lobe functioning (Stroop, 1935; Reitan, 1958)
1.7.5.4 Neuroleptic effect and distractibilitv.
Oltmans et al (1978), using a digit span test (with and without a distractibility
component) found, with a sample of chronic schizophrenic patients, that antipsychotic
medication helped in the alleviation of the disrupting influence of the distracting stimuli.
The decrease in distractibility was positively correlated with a reduction of thought
disorder in the experimental group. Spohn et al (1985) also recorded a significant
decrease in the influence of distracters on a digit span test after neuroleptic
administration, compared to a control group Strauss et al (1985) found that a decrease in
distractibility was associated with higher serum neuroleptic levels.
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1.7.5.5 Neuroleptic effect on visuospatial/visuomotor tasks.
Improvement has been observed, with chronic schizophrenic patients, after the
administration of chlorpromazine on, at least, two subtests of the Wechsler Adult
Intelligence Scale, allegedly sensitive to spatial ability, those of'block design' and 'picture
arrangement' (Small et al, 1972). The authors used patients on 300mg/day of
chlorpromazine for a period of 3-6 weeks. However, Abrams (1958) had reported no
change when 400-600mg/day were administered over an 8 week period. Killian et al
(1984) found similar results to Abrams but, unfortunately, did not specify the dose of
neuroleptic used. It appears, then, that the dose level may be integral in determining any
neuropsychological benefit as far as visuospatial skills are concerned. Although in any
appreciation of WAIS scores are concerned (especially if improvement is observed)
attention must be paid to potential practice effects after repeated administration.
1.7.5.6 Neuroleptic effect on memory and learning tasks (See also 'Memory and
Schizophrenia').
There have, as yet, been relatively few studies on the effects of neuroleptics on memory
tasks (Spohn and Strauss, 1989). However, this field is gaining increasing interest
focusing, moreover, on the effects of anticholinergics on memory in schizophrenia (and,
also, the particular anticholinergic properties of typical and atypical antipsychotics).
Daston (1959) found that 400mg/day of chlorpromazine enhanced paired associate
learning on the Wechsler Memory Scale in a sample of 26 chronic schizophrenic patients,
promazine, at the same dose, did not A chlorpromazine dose of 1400mg/day, again,
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resulted in no significant drug effects. However, this study's results could not be
replicated by Pearl (1962) and thus the effect is in want of further research. Pearl (1962)
also reported few benefits of neuroleptic administration for the ability to retain narrative
stories or enhancing mental control, with groups of schizophrenic patients
1.7.5.6.1 Anticholiner£ic effects on memory.
Frith (1984) proposed that the memory impairment observed with many schizophrenic
patients maybe consequential to treatment with anticholinergics (drugs given to combat
the side effects of the neuroleptics). Such an assumption was based on neuropathological
evidence associating the loss of acetylcholine secreting neurones with the onset of
dementia with its characteristic impairment of memory (against a backdrop of global
intellectual decline) (Deutsch, 1983). In a review, Drachman (1977) suggested there is
widening evidence to support an instrumental role for anticholinergics in the impairment
of memory observed in schizophrenic patient populations. Tune et al (1982) found a
significant inverse correlation between word list recall and serum levels of
anticholinergics such that serum levels were associated with poor performance This was
confirmed by Perlick et al (1986) using radioreceptor assays Research has also arisen
implicating benzodiazepines in affecting memory similarly to that associated with
anticholinergics (Frith et al, 1984). However, the effect is probably not mediated, in this
instance, by the cholinergic system (Ghoreim and Mewdalt, 1975).
In a slightly different study, Eitan et al (1992) compared the effects of four antipsychotics
possessing varying anticholinergic properties on various memory tasks. They found that
chlorpromazine and thioridazine impaired functioning on measures of verbal short term
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memory (after 6 hours sequential administration). Trifluoperazine and haloperidol
improved verbal STM from the 3rd to the 5th administration. Immediate memory, long
term memory and visual short term memory were unaffected by any drug. It is interesting
to note that deterioration effects were only noticeable after the cumulative administration
of the drugs responsible Therefore, the effect of such drugs on memory functioning may
well be dependent on the duration of administration. These results appear to support
previous findings i.e. the more potent the anticholinergic properties of the drug the
greater the memory impairment. Fennig et al (1986) showed that the anticholinergic
trihexyphenidyl did not impair immediate memory in schizophrenic patients but did impair
STM and LTM functions. It can be hypothesised, therefore, that anticholinergics do play
a key role in the memory deterioration observed in schizophrenic patinets receiving such
medication. Spohn and Strauss (1989) beg caution by imploring further research to
explain the individuality of results since, even in the Eitan et al (1992) report, the drugs in
question did not affect short term visual memory or long term memory functions.
Research into the effects of anticholinergic medication on memory functioning has been
complicated since recent evidence points to a distinct memory impairment with various
groups of schizophrenic patients, even when medication free or drug naive (Saykin et al.,
1991; 1994). Thus, in turn, any investigation into memory impairment in schizophrenia
should account for anticholinergic administration.
1.7.5.7 Atypical neuroleptics and cognition
In one of the few studies to date, concerning the effects of the new antipsychotic
neuroleptics on cognitive performance, Goldberg et al (1993) found that
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neuropsychological performance did not significantly improve, despite significant
symptom improvement, from testing when on standard neuroleptics and 15 months
duration on clozapine. The levels of performance were well below the norm at either
point. The authors suggested this pattern reflected a fundamental neuropsychological
impairment in schizophrenia that, although here independent of symptom expression,
probably accounted for much of the social and occupational dysfucntion seen in their
sample.
1.7.5.8 Future studies.
From the increasing body of knowledge of the various ameliorating effects of
neuroleptics on symptoms, it may be logical to assume a concomitant improvement in
neuropsychological functioning in groups of schizophrenic patients. However, the present
state of this research reveals a complex and contradictory state of affairs. In line with
Cassens et al. (1990), this area of research will only become clearer when studies
unambiguously compare specific areas of neuropsychological functioning with symptom
expression in controlled drug trials involving neuroleptics with known biochemical
activity. The advent of the atypical neuroleptics may offer an opportunity to enhance
knowledge of the neurochemical substrates involved in symptom expression, while
parallel neuropsychological investigations may clarify the mediation of putative brain
dysfunction that results in particular symptoms of schizophrenia.
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1.8 General Aims of the Studies reported in this Thesis.
1) To assess the relationship between empirically related signs/symptoms of schizophrenia
and neuropsychological performance across both acute and chronic phases of illness.
2) To investigate the relationship between typical and atypical neuroleptic medication,
symptom expression and neuropsychological functioning with treatment resistant
schizophrenic patients.
3) To assess the neuropsychological functioning profiles of schizophrenic patients
dichotomised by clinical, and social outcome status to determine the neuropsychological
correlates of good and poor outcome in schizophrenia.
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CHAPTER 2: METHODS
THE NEUROPSYCHOLOGICAL TEST BATTERY USED IN THE
STUDY OF THE NEUROPSYCHOLOGY OF SCHIZOPHRENIA,
SYMPTOMS AND MEDICATION
2.1 What is the purpose of neuropsychological assessment?
Muriel Lezak (1983) stated that, ' . .to do justice to a field of inquiry as complex
as brain-behaviour relationships ...an adaptable assessment methodology that
incorporates the strengths of both quantitative and qualitative approaches is
required. Standardized procedures [i.e. psychometric testing] provide objectivity
and the potential to make fine distinctions and comparisons which would be
unattainable by clinical observation alone (p.4)'. However, she admonished that
comprehensive knowledge of the subject/patient background is also required as
behaviour is psychologically and socially contextual. More specifically, the
author defines the area of clinical neuropsychology as an applied science
concerned with the behavioural sequelae of brain dysfunction. The purpose of
such investigations is to identify, assess and aid rehabilitation of brain injured
patients. Serial testing may gauge the course of an underlying neurological
condition and may assess intervention procedures such as drug therapy or
training over time (Lezak, 1983).
2.1.1 Neuropsvcholoeical assessment and Schizophrenia
As schizophrenia is a condition characterized by abnormal perceptions and
expressions of abnormal behaviour, researchers have turned to
neuropsychological methodology to try to explain the defining symptoms in
terms of abnormal psychological processes. Neuropsychologists such as
Gray et al. (1991) and Frith (1992) (see Introduction) have tried to provide
comprehensive and testable theories of information processing abnormalities
that underlie various schizophrenic symptoms. This field of investigation has
its foundations in neuropsychological studies of brain-damaged individuals,
which provide important information concerning the cognitive processes
involved in 'normal' functioning. This 'cognitive neuropsychological'
approach is deemed suitable for the investigation of schizophrenic behaviour
as it may give clear indications to the nature of the key underlying cognitive
abnormalities associated with particular signs and symptoms schizophrenia.
Therefore, the neuropsychological approach used in the present study
involved administering a battery of specific psychometric instruments, the
content of which has been dictated by theoretical considerations and
behavioural characteristics associated with the study group(s) i.e.
schizophrenic patients The object of such testing was to provide a profile of
neuropsychological functioning for the study group(s) and to relate any
emergent patterns with symptom ratings. In this way we may be able to
discriminate particular neuropsychological functions/modalities associated
with specific signs/symptoms of schizophrenic behaviour.
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2.2 DESCRIPTION OF THE NEUROPSYCHOLOGICAL MEASURES
USED IN THE PRESENT STUDIES
2.2.1 MEASURES OF GENERAL INTELLECTUAL ABILITY
2.2.1.1 Pre morbid Indices
Pre morbid indices are essential in improving the detection and quantification of
impairment [of functioning] by providing an individualized standard against
which contemporary performance may be compared (Crawford, 1992).
Nelson (1982) points out that background demographic data e.g. occupation or
education, give only a crude appraisal of the pre morbid intellectual functioning
of an individual. Assessing ability in terms of the complexity and demands of one
particular job against another, in terms of intellectual ability, is not easily
quantifiable and is confounded by variations in social class highlighting social
advantage. Similarly, for education background, opportunity and differences in
matriculation standards across age groups does not readily proffer reliable
indications of pre morbid ability-to be compared with present functioning-
assessed on standardized measures.
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2.2.1.1.1 The National Adult Reading Test (NART) (Nelson and O'Connell,
1978, Nelson, 1982),
Background
Nelson and McKenna (1975) demonstrated a significant correlation between
word reading ability and general intelligence in a group of normal adults. Results
from a group of dementing patients showed that reading ability was relatively
well maintained in the face of significant impairment in other cognitive functions.
The National Adult Reading Test (NART; Nelson and O'Connell, 1978, Nelson,
1982) was, therefore, developed incorporating words enabling reliable
discrimination along a wide spectrum of intellectual abilities. Thus the NART
was designed to provide an estimate of pre morbid intellectual ability, based on
word reading ability, of adult patients demonstrating signs of current intellectual
deterioration.
Description of the NART
The NART is a single word oral reading test It comprises of 50 irregular words
not following normal grapheme-phoneme correspondence e.g. 'Depot'. The
words are short, therefore no complex visual analysis is required and, because
they are irregular, guesswork will be unsuccessful. A successful test
performance, therefore, requires previous familiarity with the words and makes
minimal demands on current cognitive capacity (Nelson and O'Connell, 1978).
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That the NART is a valid and reliable measure of pre morbid intellectual
functioning is based on the following assumptions (Crawford, 1992);
a) The pronunciation of irregular words is unaffected in various clinical
(neuropathological) disorders.
b) NART performance is highly correlated with general intellectual ability.
Reliability of the NART
The NART has been highlighted as one of the most reliable psychometric tests
used in present clinical practice (Crawford, 1989). It has excellent inter-rater and
test/retest reliability (Crawford et al, 1989b; O'Carroll et al, 1987).
Validity of the NART
Crawford et al (1989b) examining Nelson's (1982) original standardization
sample reported that the NART predicted 55%, 60% and 32% of the variance in
WAIS Full Scale, Verbal and Performance IQ respectively They concluded that
the NART has high construct validity as a measure of general ability and is a
powerful predictor of WAIS Full Scale IQ, Verbal IQ but relatively poor at
predicting Performance IQ. In addition, NART performance has shown to be
intact despite the presence of dementia (Sharpe and O'Carroll, 1991).
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NART Performance in Neurological and Psychiatric disorders
Nelson and O'Connell (1978) reported that, after an investigation involving MRI
scanning, NART performance was unaffected by the presence of cortical
atrophy. O'Carroll et al. (1987), in a longitudinal study of patients with
dementia, retested their sample on the NART after one year. Although dementia
severity and physical disability had worsened significantly in the intervening
period, NART performance had remained constant. In general, Crawford (1992)
suggests that NART performance shows a relative resistance to a wide range of
neurological disorders.
Crawford (1992) provides a caveat for the usage and interpretation of the
NART. Firstly, NART should not be used with groups of dyslexic patients or
with clients exhibiting obvious articulatory problems. In addition, as a
methodological issue, the author advises caution in assuming that performance
on any measure of current ability would be entirely unaffected by severe cerebral
dysfunction. Some studies have indeed shown deterioration in NART
performance, particularly with Huntington's patients (Crawford et al., 1988) and
Korsakoff's Psychosis patients (Crawford et al., 1988; O'Carroll et al., 1992)
Patterson et al. (1994) found that NART scores might underestimate pre morbid
intellectual functioning by up to 15 IQ points with patients suffering only
moderate dementia. These results caution against the indescriminant usage of the
NART, as a pre morbid index of intellectual functioning, with all groups and
severities ofmental illness or pathological brain disorders. To overcome some of
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the methodological problems associated with the NART, O'Carroll (1995)
suggests that placing NART words in context in meaningful sentences may
provide a more accurate estimate of premorbid functioning. This type of test
requires lexical decision-making competency and avoids problems associated
with pronunciation based formats. In addition, this type of test may be more
sensitive to those patients who are familiar with the word and its meaning but
are unsure as to its pronuciation.
NART Performance and Schizophrenia
When acute unmedicated schizophrenic patients were compared with a group of
acutely ill unmedicated patients suffering other forms of psychosis and a group
of healthy controls, no difference in NART performance was recorded between
all three groups (O'Carroll et al, 1992). The acutely ill schizophrenic patients
did, however, show a significant deterioration in functioning between NART
performance and current intellectual ability. In conclusion, the NART was seen
as a reasonable estimate of pre morbid ability for patients at this stage of their
illness. However, Crawford et al. (1992) reported that, although NART
performance did not differ between community based schizophrenic patients and
matched controls, there was a significant disparity in functioning between a
group of long term hospitalized schizophrenic patients and their matched
controls. Thus, within the latter group of patients, interpreting NART
performance poses a problem. Although poor performance may highlight
genuine low levels of pre morbid intellectual functioning, performance may also
have been affected by the disease process itself and/or the effects of long term
treatment and institutionalisation. If the disease process results in poor NART
performance, the use of the NART as an index of'pure' pre morbid ability in this
group must be called into question Such observations warrant caution in the
usage of the NART with such groups of more chronically ill schizophrenic
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patients. Jones and Rodgers (1993) provided alternative explanations for the low
NART scores in the long term hospitalised sample to that of the putative
influence of the disease process in this group Firstly, the lack of other long term
hospitalized psychiatric patients in the control group did not address the effects
of long term stay and long term exposure to psychotropic medication,
independent of illness, on performance. Secondly, studies showing an
appreciable continuation of acquired reading skills into later life in the general
population (Rodgers, 1986) might also provide an alternative account for the
difference in NART performance here. Although the long term schizophrenic
patients showed a poorer NART performance it could be due to the disease
affecting later reading skill acquisition compared to healthy controls rather than
any disease effect on pre morbid reading skill acquisition. The authors did admit,
however, that it would be unwise to ignore the possible difficulties inherent in
using NART error scores in providing distinct pre morbid IQ levels for long
term hospitalised groups where a combination of factors may yield poor
performance. However, they concluded that, on balance, with the obvious
cautions, the NART is probably a more accurate assessment of pre morbid
intellectual functioning in schizophrenia than is presently provided by any
alternative methods.
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Administration (The NART was administered according to the NART
manual (Nelson, 1982).
Scoring
An error score was calculated for each word mispronounced. A WAIS
conversion table was used to equate NART errors with a 'predicted' Full
Scale IQ score. [NB A WAIS rather than WAIS-R table was used as the
measure assessing current IQ- the Quick IQ -is based on WAIS equivalent
scores]
2.2.1.2 Measures ofCurrent Intellectual Performance
2.2.1.2.1 The Quick Test tAmmons and Ammons, 1962).
The Quick Test (QT) was chosen as a relatively easily administered 'quick'
test to assess current intellectual functioning in terms of verbal picture
recognition ability. Although comprehensive measures of global intellectual
functioning exist (e.g. WAIS-R (Wechsler, 1981)) administration time is
approximately 15-2 hours. As the object of the present studies was to assess
schizophrenic performance on tests measuring a wide range of specific
cognitive abilities, the use of protracted measures of global intellectual
functioning was deemed impractical. The use of complex and time
consuming global measures of intellectual functioning, therefore, seemed
unnecessary especially in the light of the restricted attention and cooperation
one could expect from groups of severely disturbed individuals.
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Background
The Quick Test was developed from the Full Range Picture Vocabulary Test
(FRPV) (Ammons and Huth, 1949) to reflect the following characteristics: brief
(to save time and to make possible the testing of persons with very short
attention spans), covering the full range of abilities; suitable for examining the
severely brain-injured and physically handicapped, both children and adults, of
sufficient reliability and validity to justify making important diagnostic and
training decisions on the basis of its scores (Ammons and Ammons, 1962). This
type of test makes use of pictorial representations among which the testee
chooses one which best illustrates the concept suggested by the examiner i.e. the
word 'sweet' would be associated with the picture of a drink rather than pictures
of a race track, people dancing or a policeman. The authors suggest that both
the FRPV and QT tap a very fundamental behavioural process, the visual-
perceptual recognition of basic concepts utilized in language, and, therefore, in a
great deal of thinking
Description of the OT
The Quick Test is seen as a verbal-perceptual test of [current] intelligence. It
comprises simple black and white line drawings among which the testee chooses
the ones that best illustrate a variety of concepts, thus obtaining responses that
are easy to interpret and score objectively.
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Reliability and Validity of the OT
The FRPV, on which the QT is modelled showed a .80 test-retest reliability with
a group of 48 aphasic patients (Shuell et al, 1961). As far as validity goes, a
correlation of .86 was recorded between the FRPV and the Wechsler-Bellevue
Vocabulary with 69 deteriorated schizophrenic patients (Blatt, 1959). Amnions
and Ammons (1962) suggested such reliability and validity should, therefore,
apply to the use of the Quick Test. The authors provided a large database of
reliability studies for the QT. The authors suggested that the evidence
demonstrates that single forms of the QT are likely to be suitable for screening
of intelligence at single age levels and very effective where wider ranges of
ability are being handled, as in clinical populations. Frith et al. (1991) found a
high correlation of performance between the WAIS and the Quick Test with
nine chronic schizophrenic patients (mean (sd) WAIS 83.6 (17.3), Quick 78.7
(19.2), r (Quick, WAIS=0.91).
As far as validation of the QT is concerned, Ammons and Ammons (1962)
pointed to the high correlational relationships between the QT the FRPV and
'longer' intelligence tests of more heterogenous content. QT scores significantly
correlated with percentile scores in a number of areas on the Iowa Test of Basic
Skills (Lindquist and Hieronymous, 1955) and with school grades in several
subjects.
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The Quick Test and Schizophrenia
The Quick Test has been used previously to estimate current IQ in groups of
schizophrenic patients (Gessler et al., 1989). Some evidence of its validity was
shown in that there was no discrepancy in IQs assessed by the Quick and the
NART in the normal control group. However, there was a 12.8 discrepancy
between pre morbid and current measures in their group of chronic
schizophrenic patients, as might be expected. Frith et al (1991) tested a sample
of 283 schizophrenic patients on theses measures of intellectual functioning. Pre
morbid functioning was similar to control data. There was, however, a
substantial decline in IQ (Quick scores) similar to that observed by Nelson et al
(1990) and Gessler et al (1989), the former group using the WAIS-R (Wechsler,
1981).
Administration
Form A of the Quick was administered according to the test manual (Ammons
and Ammons, 1962). Testing proceeded with all 50 items or until six words
were failed consecutively (the Ss having previously passed at least six easier
words).
Scoring
The QT scoring was objective and simple. The testee was given credit for each
item correctly answered and for no item incorrectly answered Separate
percentiles and Wechsler-type IQ norms were provided for adults based on the
assumption of a mean of 100 and a standard deviation of 15 IQ points. It was
possible, therefore, to calculate an IQ score for each S based on WAIS
equivalents.
2.2.1.2.2 The Mini Mental State Examination (MMSE) (Folstein et al, 1975,
Dick et al, 1984).
This test was designed to assess global cognitive functioning simply and quickly.
It has no abstract items but includes a diagnostically valuable verbal retention
test (Lezak, 1983). Full details of the individual questions can be seen in the
Appendices. The examination essentially deals with orientation, simple memory
performance, mental control (backward serial sevens) and several verbal and
non-verbal copying tasks.
MMSE administration takes approximately 5 to 10 mins.
Sixty three elderly healthy normals comprised the standardised population (mean
age: 73.9). With a maximum score of 30, the controls (and a younger group of
patients with 'functional' psychiatric disorders achieved scores in the 24.6-27.6
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range. The scores of several groups of 'senile' (dementing) patients ranged from
9.6-12.2. There was no overlap between these patients and controls (Folstein et
al., 1975). Dick et al (1984) suggest a score of 23 or less is indicative of
cognitive impairment This cut off point was derived from comparisons with
significantly impaired WAIS IQ performance. Finally, the authors warn that the
MMSE is relatively insensitive to right hemisphere damage on account of the
high verbal content of the test.
2.2.3 MEASURES OF EXECUTIVE FUNCTIONING.




c) Carrying out goal-directed plans
d) 'Effective' [use of strategies in] performance.
The author suggested that the above are necessarily involved in 'appropriate, socially
responsible and effectively self-serving conduct'. Executive functioning can breakdown at
any point in the behavioural sequence that constitutes planned or intentional behaviour.
Therefore, a systematic assessment of the capacities that enter into the above four aspects
of executive functioning may help identify the stage(s) at which the dysfunction occurs.
Shallice (1988) proposed that executive or 'supervisory' functions are critical for the non-
routine selection and control of cognitive processes. This supervisory system must have
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access to the intentions of the individual and be involved in the 'supervision' of willed
acts.
Patients with frontal lobe lesions appear to display disorganised and inappropriate
behaviour that may be associated with impairment of executive functioning (Parker and
Crawford, 1992) even in the face of intact IQ (Shallice and Burgess, 1991)
2.2.3.1 Executive functioning and Schizophrenia
Patterns of behaviour similar to those expressed by patients with frontal lobe pathology
have been seen in groups of schizophrenic patients, particularly in relation to
perseveration, disinhibition and negative symptoms e.g. psychomotor poverty, flattened
affect and poverty of speech (see Introduction 1.3). Neuroimaging studies have provided
evidence supporting a putative abnormality in the functioning of the frontal lobes in
schizophrenia (Weinberger et al, 1986; 1988). As far as neuropsychological investigations
are concerned, heterogeneous groups of schizophrenic patients have been seen to do
particularly poorly on batteries of tests putatively sensitive to frontal lobe damage (Kolb
and Wishaw, 1983, Gruzillier et al., 1988), this has also been shown in single case studies
(Shallice et al, 1991), although not all patients showed the same performance profiles on
such tests. Significantly poorer 'frontal'/ executive functioning performance has also been
observed in comparison to performance on so-called non-frontal tests (Morrison-Stewart,
1992). Although, Braff et al. (1991) suggested 'frontal' problems, particularly on the
Wisconsin Card Sort Test (WCST) (a measure of mental flexibility-see later) may be
associated with a sub population of more deteriorated 'Kraepelian' patients. Saykin et al
(1991) found that, with a group of unmedicated schizophrenic patients, though 'frontal' or
executive tests were poorly performed, there was significantly greater impairment in
performance (relative to controls) on tests of memory and learning. Therefore, the
emergent evidence suggests that impairment in executive functioning test performance
may account for only part of a network of impaired cognitive modalities involved in
schizophrenic behaviour and may be characteristic of particular stages of the illness. Frith
(1992), however, warns that, although differing groups of neurological and psychiatric
patients can exhibit similar behaviours clinically, they may not necessarily be indicative of
the same underlying cognitive abnormalities. Therefore, whatever the degree of
impairment, the putative executive functioning impairment of the schizophrenic patient
ought to be assessed in its own right and preferably with respect to symptom profiles.
2.2.3.1 Verbal Fluency
Poverty of speech is a commonly observed 'negative' or residual symptom observed in
schizophrenia (DSMIII-R, American Psychiatric Association, 1987). It has been
explained in terms of an impairment of self-directed search (Frith, 1992).
The purpose of a verbal fluency test is to assess the spontaneous verbal production of
words, beginning with a particular letter or of a given class, within a limited amount of
time.
Background
Benton (1973) studied the ability to produce words by using a controlled word
association test requiring the production of words according to an initial letter category,
in a limited time span, with a group of aphasic patients. Isaacs and Kennie (1973) used a
variant of the word production test involving the recall of words in semantically distinct
categories e.g. colours, animals, fruit, flowers as an aid to screening dementia in the
elderly.
Description
In the present studies 'easy' letters (letters with a high frequency of occurrence in the
English language) were used derived from the Thorndike and Lorge (1944) index of
linguistic frequency i.e. an index of the frequency letters of the alphabet have to mean
linguistic associations in the English language.
As a deterioration of intelligence (relative to pre morbid ability) has been associated with
different groups of schizophrenic patients (Frith et al, 1991), easy letters were used in the
projects' batteries as they may be more discriminating between schizophrenic patients and
controls rather than using more obscure letters demanding greater 'cognitive effort'.
Verbal fluency was also measured in terms of words belonging to particular semantic
categories e.g. animals. This 'Set Test' was developed by Isaacs and Kennie (1973) as a
screening procedure for dementia.
The two ways of measuring verbal fluency were seen as different tasks according to the
nature of the discrimination the Ss would have to use for correct word production Word
generation by initial letter requires the discrimination of words from non-words. Word
generation by category, however, requires both discriminating words from non-words
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and words from other words and provides a greater challenge to semantic memory
systems. The two verbal fluency tasks together, therefore, give a comprehensive
assessment of the Ss' ability to discriminate and select appropriate words for articulation.
Verbal fluency Studies
Borkowski et al (1967) found that for brain damaged patients with low intelligence 'easy'
letters (e.g. F, A and S) were more effective in differentiating verbal fluency ability
between brain damaged and control groups.
Scores for a mixed group of 200 aphasic adults ranged from 0-46 with a mean of 11.5;
unselected brain damaged non-aphasic patients scores ranged from 5-46+ (mean: 28.2)
(Spreen and Benton, 1977). Cavalli et al (1981) found no serious impairment with
patients with right hemisphere lesions. Miceli et al (1981) observed a high sensitivity of
performance on this test to frontal lobe damage regardless of the side of the lesion.
However, Parks et al (1988) found more impairment for patients with left frontal lesions
and Benton (1968) found the most severe impairment for patients with bilateral frontal
lesions. Parks et al (1988) in a PET study using normal volunteers indicated that verbal
fluency activated bilateral frontal and temporal lobes.
Reliability
Spreen and Strauss (1991) note that 'interscorer reliability [for the verbal fluency test] is
near perfect'. One year retest reliability in older adults has been reported as high as .70
(Snow et al, 1988).
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Verbal fluency and Schizophrenia
Groups of schizophrenic patients have been found to perform poorly on test of verbal
fluency according to initial letter category (Kolb and Wishaw, 1983, Gruzelier et al,
1988) and on a semantic category (Gruzelier et al, 1988). Shallice et al. (1991), however,
found that verbal fluency, in their small sample of five case studies, was performed
relatively normally despite gross impairment on a range of other putatively frontal tests.
Administration (from Spreen and Strauss, 1991)
The Ss were required to produce as many words as possible within one minute for each
of the categories. They were told to avoid recounting proper names e.g. Andrew and
words with the same stem e.g. assess and assessing.
Test variations across studies
a) Risperidone trial (chronic treatment resistant patients): The letters A, W, D, H and the
semantic category Animals were used individually for four different test sessions (i.e. a
letter and the semantic category per session) The letters were chosen specifically to
match for frequency of occurrence (from Thordike and Lorge (1944) index of linguistic
frquency) to provide parallel versions for repeat testing
b) Treatment resistant versus treatment responsive patients A and Animals.
c) Acute schizophrenic patient group: F, A, S and Animals.
d) Chronic schizophrenic patients: A and Animals.
%
e) Healthy controls: F, A, S and Animals.
These categories were in a sense arbitrary and composed to take into account the
theoretical basis expounded above, the abilities of the individual groups and the overall
construction of the individual test batteries undertaken for each study (see relevant
chapter for further justification).
Scoring
The number of items correctly recalled in one minute was recorded. Proper names and
words with the same stem were counted as incorrect.
2.2.3.2 Trail Making Test
This is a two part test of speed for visual search, attention, mental flexibility and motor
function (Spreen and Strauss, 1991).
Originally, the Trails test comprised part of the Army Individual Test battery (1944) and
was added to the Halstead-Reitan battery in 1958.
Des Rosiers and Kavanagh (1987) suggested that test loaded both on 'rapid visual search'
and a 'visuo-spatial sequencing factor'.
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Description
The test required the connection by making a continuous pencil line between 25 encircled
numbers arranged on a page in proper order of increasing value (Part A) and 25 encircled
numbers and letters in alternating order (Part B)
Reliability
The reliability of Part A remained high throughout 3 administrations to 19 normal
controls at 6 and 12 month intervals (W(coeflficient of concordance)=0.78). For Part B,
reliability was somewhat lower (W=0.67) (Lezak, 1983).
Trail Making Test and Neurotica! Studies
Large differences between A and B have been interpreted as indicative of left lateralised
lesions (Lewinsohn, 1973). More recent studies, however, have not confirmed this
(Wedding, 1979).
Lezak (1983) suggested that slow times for both A and B point to the likelihood of brain
damage, but do not indicate whether the underlying problem is one of motor slowing,
coordination deficits, visual scanning difficulties, poor motivation or conceptual
confusion. It is plainly obvious that performing the Trails test involves multiple brain
systems i.e. speed, visual acuity, tracking and set shifting. Any interpretation of slow
times for the performance of this test must be made within the context of the complexity
of the test.
Trail Making Performance and Schizophrenia
Shallice et al. (1991) found that in an intensive single case study report the 4 out of 5 of
the sample were severely impaired on the numbers and letters form of the Trails test (Part
B). Liddle and Morris (1991) found that this form of the test was highly correlated with
their 'disorganisation' syndrome of symptoms after controlling for Part A (solely
numbers).
Administration (see Spreen and Strauss, 1991)
Scoring
The time for Part A was subtracted from the time for completion of Part B to give a
measure of attentional set switching, controlling for psychomotor speed.
2.2.3.3 The Stroop Test
The Stroop test is a test of focused attention in terms of operationalised visual search
(Crawford et al, 1992). It measures the ease with which a person can shift perceptual set
to conform to changing demands and suppress a habitual response in favour of an unusual
one (Spreen and Strauss, 1991) or the ability to shift between conflicting response modes
(Lezak, 1983).
Background
The test was first conceived by Stroop in 1935, after Cattell (1886) who found that
reading colour names required less time than naming colours. Brown (1915), who noticed
that this difference persisted after practice, suggested that the two tasks involved separate
cognitive mechanisms.
Jensen and Rohwer (1966), in a review of the literature, noted that the accumulated
research to date demonstrated:
a) The Stroop procedure was reliable.
b) The timed scores for word, colour and colour-word tasks were of respectively
increasing magnitude.
c) The Stroop effect was maintained even after practice.
The form used in the present studies was that of Trenerry et al (1989) consisting of a
'colour' task and a 'colour-word' task.
The Stroop Test and Neurological Studies
Nehemkis and Lewinsohn (1972) were the first examiners to assess Stroop performance
with brain-damaged subjects. They found that the colour word task required more time
than the colour task for both a normal group and for severely brain-damaged patients.
The Stroop procedure was assessed as having considerable potential as a research and
clinical tool. Perret (1974) studied patients classified as having frontal, temporal and
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posterior brain-damage on a modified Stroop task. Left frontal patients performed
significantly more poorly than patients with the other types of lesions. The greatest
discrepancy was revealed on colour-word performance. It has been suggested that the left
frontal lobe plays an essential role in this form of focused attention (Crawford et al,
1992). Performance of the Stroop test has been analysed using PET (Bench et al, 1993).
They found that performance engaged a wide network of anterior brain regions and
reciprocal inhibition of posterior brain regions.
Stroop test performance and Schizophrenia
Unmedicated schizophrenic patients have shown impaired visual-motor performance
including Stroop and Trail Making at a level two standard deviations below the mean for
a control sample (Saykin et al, 1991). Liddle and Morris (1991) found that symotms of
incongruity and incoherence were associated with poor performance on the Stroop.
Shallice et al (1991) found Stroop colour naming to be particularly poorly performed in
their intensive case study of five schizophrenic patients tested on a wide range of
putatively frontal tests.
Administration
Administration followed that of Trenerry et al (1989).
Scoring
The subject was timed for each form of the test (maximum 2 mins) and the times and
correct responses were recorded. The difference between the number of correct
responses for each condition was calculated to give a index of the ability to suppress
habitual behaviour in the face of conflicting demands. Normal standardised population
data are provided by Trenerry et al (1989).
2.2.3.4 The Continuous Performance Test (CPT)
The Continuous Performance Test is a simple test of sustained attention which requires
the S to suppress inappropriate responses. The test was first devised by Rosvold et al
(1956). The CPT is used here with schizophrenic patients because symptoms of
incoherence of speech and incongruity of affect have been associated with defects in
willed action (Frith, 1992). The present studies used a computerised version of the CPT
devised by Frith et al (1991).
CPT performance of Neurological and Schizophrenic patients
The CPT has been used with various neurological groups including epileptics and brain
injured patients (Greber and Perret, 1985). The CPT has shown both chronic and
remitted (drug free) schizophrenic patients to perform poorly on the task (Orzack and
Kornetsky, 1966; Wohlberg and Kornetsky, 1973). Frith et al (1991) found that
incoherence and incongruity were associated with a failure to inhibit inappropriate
responses on the CPT in their sample of 283 schizophrenics. The present version of the
CPT is almost identical to that described by Frith et al (1991) except here 80 stimuli were
used instead of 100 (including 20 Es and 20 XEs) as the programme was designed to
present stimuli in blocks of 10
Administration
The S saw a sequence of letters (X,M,T,E) on a VDU at the rate of one every 1.5
seconds. The task required the S to press the space bar on a keyboard every time the
letter E appeared, except when it was immediately preceded by the letter X. Eighty letters
were presented (10 blocks of 8) including 20 Es requiring a response and 20 Es preceded
by an X which do not require a response All the Ss had two practice sessions of eight
trials each to ensure that they understood the demands of the test before the data
collection began.
Scoring
Two scores were taken along with mean reaction latencies for each particular type of
response: the number of times the S failed to respond to an E (omission error) and the
number of times the S responded inappropriately to an E after an X (comission error).
2.2.3.5 The Cognitive Estimation Test
Background
The Cognitive Estimation Test was first conceived by Shallice and Evans (1978). The test
was constructed after the authors observed that IQ test scores can be relatively
unaffected after substantial frontal damage. Clinical reports of 'frontal' cognitive deficits
stress a failure in 'judgement and dealing with novel situations while lower level cognitive
skills are retained'; research largely based on the observations of Luria (1966). Shallice
and Evans (1978) reported that a patient JS, who showed intact WAIS performance after
an explosion, resulting in massive right frontal damage, had a gross inability to produce
adequate cognitive estimations. The authors constructed a series of general knowledge
questions obscure enough to require answers of one's best estimation. The answers were
seen as necessitating the appropriate selection of a suitable cognitive plan and the ability
to check any putative answer for 'degree of absurdity' as much as the ability of carrying
out the selected plan. An example of a typical question is: 'How heavy is a full pint bottle
of milk9'
Description
A modified version of Shallice and Evans (1978) original 26 questions was used in the
present studies comprising of 9 questions putatively more sensitive to 'frontal'
performance (2,3,4,5,6,9,10,12 and 15) plus the UK population question from the
Information subtest of the WAIS (after Shoqeirat et al, 1990). Normative data on 150
healthy controls have been provided by O'Carroll et al (1994).
Cognitive Estimation Test performance of Neurological and Schizophrenic patients.
Both alcoholic amnesics and post-encephalitic amnesics demonstrated impairment on the
CET (Shoqeirat et al, 1990). Similarly, patients with Korsakoff syndrome have
demonstrated significantly impaired CET performance (Taylor and O'Carroll, 1995).
These same authors, however, found no significant difference in CET scores between
anterior and posterior lesioned patients. Shallice and Evans (1978) found extremely poor
CET performance with 4/5 patients in their intensive case study approach to
schizophrenia.
2.3 COMPUTERISED NEUROPSYCHOLOGICAL MEASURES FROM THE
CAMBRIDGE AUTOMATED NEUROPSYCHOLOGICAL TEST BATTERY
(CANTAB)
The CANTAB (Cambridge Automated Neuropsychological Test Battery) is a suite of
tasks developed by the Department of Experimental Psychology at Cambridge and the
Department of Psychiatry at the Institute of Psychiatry, London (copyright 1991) to
measure aspects of visuo-spatial memory, learning, attention and planning in individuals
with, or suspected of having, cognitive impairment
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Selected tests were chosen, from the CANTAB, for the present studies with
schizophrenic patients according to their theoretical relevance, novel format, accuracy of
recording data and ease of use for an often uncooperative set of subjects.
Development of the CANTAB
The measures employed in the CANTAB were developed from animal studies
investigating visual discrimination learning and recognition memory. Researchers have
found visual discrimination learning, in the form of set shifting behaviour (see later), to be
compromised in monkeys with lesions of the frontal cortex (Passingham, 1972).
Recognition memory has shown impairment in trained monkeys after selected lesions to
the temporal lobes (Mishkin et al, 1982) when a delayed matching to sample paradigm
was used The effects were seen as delay dependent i.e. recognition memory deteriorates
more if the delay is increased between sample presentation and choice presentation.
Animals have also been administered computerized visual discrimination problems after
training (Roberts et al, 1988). The authors were able to establish that both monkeys and
human subjects discriminated between stimuli according to specific attributes of the
stimulus rather than relying on discrimination based on reinforcement
The following computerized tests used in the studies, therefore, comprised specific
neuropsychological measures based on previous animal studies for the purpose of
highlighting the nature of learning, memory and planning abilities in human populations.
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CANTAB provides performance profiles of different patient groups by testing various
mental functions across a broad range of abilities (Morris et al 1987). The presentation
medium is advantageous as the tests employ visually attractive non-verbal stimuli and
incorporate positive feedback to enhance motivation. The tests require non-verbal
responses minimizing the verbal components of the tasks.
In addition, CANTAB contains four parallel batteries which are suitable for repeated
testing, especially in investigations involving therapeutic interventions (including drugs)
and/or charting the course of illness across time The use of a touch sensitive screen
provided an easy medium for the Ss to respond.
Administration of the CANTAB measures
In the present studies, all CANTAB measures employed an IBM personal computer and a
touch sensitive screen (Microvitec Touchtec 501). The S sat approximately 5m away
from the screen. Training was carried out using simple psychomotor tests (Motor
Screening and Big Circle/ Little Circle-see later) to get the S used to the screen The S
was told to use their dominant hand at much as possible. These initial tests were
demonstrated by the E to the S and repeated if the S was unsure of the requirements
This procedure was followed before all CANTAB sessions were attempted
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2.3.1 The Motor Screenine Task (from CANTAB)
Description
A series of crosses was shown to the Ss at different locations on the screen. After a
demonstration by the Examiner, the Ss were instructed to touch the centre of the crosses
as quickly as possible. The test was administered to ensure the Ss could point accurately
at target stimuli and to provide an elementary index of the Ss' motor performance.
Instructions and Scoring
Instructions followed the CANTAB manual (9Downes et al., 1991). As this was a
preliminary training test, a record of mean response time was the only measure taken to
assess any indication of gross motor problems that might confound the utilization of the
ensuing tasks.
2,3.2 Big Circle/ Little Circle Test (from CANTAB)
Description
This test was administered as a preliminary training task and to provide an index of the
Ss' simple discrimination ability. A series of pairs of circles, one large and one small, was
presented to the Ss. They were instructed, initially to point to the smaller of the two as
quickly as possible. After 20 trials the Ss were told to point to the larger one.
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Instructions and Scoring
The instructions followed the CANTAB manual The number of correct responses to
target stimuli appearing on the left and right hand sides of the screen was recorded along
with a total correct score and associated mean reaction times. Again, this task was by
way of an introduction to the equipment rather than assessing a particular area of
cognitive functioning pertinent to schizophrenia.
2.3.3 EXECUTIVE FUNCTIONING MEASURES FROM CANTAB
2.3.3.1 The ID/ED Set Shifting Task
Set Shifting Ability and frontal pathology
It has been well documented in the clinical literature that patients with frontal lobe
pathology exhibit behavioural rigidity or stereotyped behaviour (Luria, 1973). The
Wisconsin Card Sorting Test (Berg, 1948, Heaton, 1981) has become an extremely
popular tool in clinical neuropsychological studies of frontal lobe pathology. This test of
sorting, assessing mental flexibility, appears to be particularly sensitive to frontal lobe
pathology, especially when assessing attentional shifting ability (Drewe, 1974; Ciceroni et
al, 1983 )-see also Introduction p.26. However, the test is not differentially sensitive to
frontal lobe pathology and generalised or diffuse brain damage can demonstrate similar
cognitive impairment (Robinson et al, 1980). Some studies have shown particular cases
where no impairment has been recorded in the face of known frontal lobe damage
(Drewe, 1974). Significant effects have been observed following localized damage to
specific non-frontal areas (Canavan et al, 1989) It has also been suggested that such
cognitive functions are more vulnerable to the effects of normal aging than other 'non-
frontal' functions (Albert and Kaplan, 1980)- more relevantly in performance of the
WCST (Haaland et al, 1987). Despite this the WCST has persisted as a major tool in the
psychometric investigation of'frontal-type' behaviour.
Schizophrenia and WCST performance
As schizophrenic patients have been observed as expressing 'frontal-type' behaviours (e.g.
psychomotor retardation, behavioural rigidity/perseveration) especially associated with
the negative features of the condition (Frith, 1992), the WCST has been widely
administered to various groups of schizophrenic patients
Evidence to support a set shifting impairment (i.e. perseveration in the face of changing
contingencies) in schizophrenia has arisen from reports of poor WCST performance in
groups of heterogeneous medicated (Morrison-Stewart et al, 1992) and unmedicated
schizophrenic patients (Saykin et al, 1991). Recent support for a 'frontal-type' pathology
has come from rCBF studies where activation of the dorsolateral prefrontal cortex has
been negatively correlated with the number of perseverative errors on the WCST
(Weinberger et al, 1988). Such WCST performance is probably not representative of
global impairment as groups of 'frontal' patients demonstrated poor results despite
having intact WAIS IQs (Milner, 1963). How this can be extended to the performance of
schizophrenic patients is debatable, but at least shows that the WCST may tap distinct
cognitive impairments characterised by behavioural rigidity, despite other modalities
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being intact. However, poor WCST performance has also been recorded in groups of
bipolar (manic) patients implying that cognitive inflexibility may be associated with other
psychiatric conditions and, therefore, not specific to schizophrenia. Braff et al (1991)
proposed that the poor WCST results may be more representative of a sub population of
schizophrenic patients of more deteriorated or 'Kraepelian' types. Van der Does and Van
den Bosch (1992) noted that not all schizophrenic patients have difficulty with the WCST
and those that show an initial impairment performance can actually be improved
following brief training.
What does the WCST measure?
Set shifting ability appears to be the main cognitive function of interest in the
investigation of mental flexibility or perseveration. However, with the WCST an account
of the constituent mechanism of the set-shifting impairment is problematic as the WCST
involves several distinct cognitive abilities. Firstly, a matching to sample principle
(between two exemplars of a stimulus dimension) is required. In addition, a conditional
visuospatial learning ability is necessary to sort out the pack of cards in front of one of
four exemplars which remain the same and stay in the same place throughout the test. A
S could conceivably show a non-perseverative difficulty in sorting that was due to
impaired control over responding by a matching principle or by inappropriate visuospatial
associations. A third requirement is to cease responding to a particular dimension and
shift to another- again this response probably requires separate cognitive abilities. The
WCST involves more than reversal learning and appears analogous to paradigms of
intradimensional (ID) and extradimensional (ED) shifts used in human and animal learning
experiments (Downes et al., 1989). What we are particularly interested in is using the
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ability to shift set whether intra- or extradimensionally as an index of behavioural rigidity
in our groups of schizophrenic patients, accounting for both matching to sample and
visuospatial learning contingencies simultaneously. The use of complementary subtests
from the CANTAB can enable this. The set shifting abilities of the patients can be
measured using the Intradimensional/Extradimensional set shifting test while delayed
matching to sample and visuospatial abilites can be assessed separately (see later) and
compared to the final ID/ED set shifting results.
Explanation of shift behaviour as measured by the ID/ED set shifting test
Animals and humans can attend selectively to a dimension if only one dimension of a
compound is reliably correlated with reinforcement Evidence comes from studies
involving compound stimuli, constructed from new exemplars of the original stimulus
dimensions, which become the discriminanda for successive stages of learning If one is
required to transfer to such new stimuli, with the dimension relevant to reinforcement
remaining constant, one must perform an intradimensional shift (IDS). If the relevant
dimension is changed to a previously irrelevant dimension then an extradimensional shift
(EDS) is required. Therefore, mental flexibilty can be assessed by the degree to which the
S can discriminate the stimuli relevant to reinforcement in the face of different
contingencies either along the same dimension or along a previously irrelevant one.
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Description of the ID/ED set shifting task from CANTAB (from CANTAB manual,
1991)
In the present studies this computerised test examined the Ss ability to attend to specific
attributes of compound stimuli and to shift that attention when required. Two artificial
dimensions were used in the test, purple-filled shapes and white lines. Simple stimuli were
made up of just one of these dimensions, whereas compound stimuli were made up of
both, namely white lines overlying purple-filled shapes (see fig. 1 p. i°T).
Ideally, the S progressed through the test by satisfying a set of criterion of learning at
each stage (6 consecutive correct responses). If at any stage the S failed to reach this
criterion, the test was automatically terminated after a predetermined number of trials
(50). The test started with the presentation of two different stimuli along a common
dimension, here white lines. The S had to learn which of the stimuli was correct by
pointing to it. The computer provided positive or negative feedback for every choice
made (stage 1). Once criterion was reached the contingencies were reversed so that the
previously incorrect stimulus was now correct (stage 2). The second dimension was then
introduced, initially lying adjacent to, and then overlapping, the first dimension. The
contingencies did not change, remaining the same at the end of the simple discrimination
(stage 3). Once criterion had been reached with the overlapping compound stimulus, the
contingencies were reversed within the original dimension (stage 4). It is important to
note that the second dimension was entirely redundant to the solution of the problem at
this stage.
5impte discrimination and reversal
Compound discrimination (separate)
Compound discrimination and reversal
Intra-dimensional shift and reversal
Extra-dimensional shift and reversal
Fig. 1. The nine stages of the ID/ED task.
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Once the S had learned the compound discrimination, new compound stimuli were
presented, still varying along the same 2 dimensions (of shape and line) (stage 5). The S
was then required to continue to attend to the previously relevant dimensions and learn
which of the two new exemplars was now correct (this is termed an intradimensional
shift) (stage 6). The contingencies were then reversed (stage 7). After this ID shift the Ss
were required to shift attention to the previously irrelevant dimension and learn which of
the two exemplars in this dimension is now correct (an extradimensional shift) (stage 8)
and again, after, the contingencies are reversed depending on success at the first ED stage













ID/ED Set Shifting Studies
Roberts et al (1988) found that superiority of ID discrimination learning (over ED) was
found for both humans and non-human primates, suggesting common principles
governing discrimination learning in both these groups The most likely interpretation is
that both groups were using category information to solve the problem
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Downes et al (1989) compared visual discrimination learning following an ID and ED
shift using a 'total change' design in which each shift was made in the presence of novel
exemplars of the compound stimuli used as discriminanda with Parkinson's Disease (PD)
patients both medicated and unmedicated(early in the course). There was a selective
deficit for both groups of PD patients in their ability to perform the ED shift A similar
result was found with medicated, unmedicated, and early in the course (unmedicated) PD
patients, interestingly though, these groups were unimpaired on a pattern recognition (i.e.
a 'non-frontal') test but were impaired on a computerised planning test which is more
associated with problems following frontal lesions (Owen et al, 1992).
Owen et al (1991) assessed attentional set shifting in 20 patients with localised excisions
of the frontal lobes, 20 patients with unilateral temporal lobe lesions and 11 patients who
had undergone amygdalohippocampus removal. All patients were compared with both
young (age-matched) and elderly normal controls on a computerised test of visual
discrimination learning involving an IDS and EDS The frontal lobe patients were
selectively impaired in their ability to shift response set to a previously irrelevant
dimension but not to a previously relevant dimension-this pattern held for the elderly
normal controls. Both the temporal lobe patients and the amygdalohippocampectomy
patients were unimpaired in their ability to perform either shift, although both groups had
significantly prolonged selection latencies at the EDS stage.
No research appears to have been published, at the time of writing, comparing groups of
schizophrenic patients on computerised versions of the ID/ED set shifting paradigm,
including comparison of results against symptom expression.
10G
Administration and Instructions (See CANTAB manual)
Scoring
The number of stages successfully reaching criterion were recorded. The number of trials
to reach criterion and number of errors incurred on each stage were recorded as an index
of visual discrimination learning. The trials to reach criterion on stages 6 (ID shift) and 8
(ED shift) were of particular interest as these 'shifts' were seen as of particular interest as
indices sensitive to perseverative responding.
2.3.3.2 A Computerised Version of the Tower of London Test tfrom CANTAB)
The Tower of London Test (Shallice and McCarthy, 1982) is a graduated problem
solving task, involving spatial planning, in which the S must move coloured 'balls' from an
initial to a goal position in the smallest number ofmoves possible.
Background
Shallice and McCarthy (1982) devised the Tower of London test to examine planning
ability in groups of patients with frontal lobe lesions. The test was developed after
observations of frontal lobe damaged patients who demonstrated a lack of initiative and
those organizational abilities necessary for everyday functioning (Luria, 1969). Such
impairment has been attributed to those cognitive functions involved in planning (Shallice,
1988). Shallice and McCarthy (1982) found that, in terms of the number of moves taken
to complete the task, a group of patients with left anterior frontal lobe damage performed
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poorly on the Tower of London task. In comparison, patients with left posterior, and
right, anterior or posterior damage did not display impaired performance.
Morris et al. (1988) suggested that in order to solve the Tower of London problems,
several cognitive processes are involved. Firstly, a S must generate the sub-units which
together comprise the plan, here individual spatial moves. Then, these sub-units must be
organized into a sequence which allows them to change the current pattern to the
end/goal state. Lastly, the derived sequence must be held in spatial working memory as
the solution is being executed.
Description (derived from the CANTAB manual, 1991)
The S was shown two displays of coloured balls (see fig. 1 p ^). The displays were
presented in such a way that they could easily be perceived as stacks of coloured balls
held in stockings or socks suspended from a beam. This enabled the S to come to terms
with some of the rules of the problems which involve 3-D concepts, and to fit in with the
verbal instructions (see later), The S had to use the balls in the lower display to copy the
pattern shown in the upper one. The balls could be moved one at a time by touching the
required ball, then touching the position to which it should be moved. The time taken to
complete the pattern and the number ofmoves required were taken as measures of the S's
planning ability. Initially, it was only necessary to move one ball. The degree of difficulty
was then increased in steps to four move solutions. At this point, a procedure controlling
for motor performance was inserted. The upper display moved one ball at a time,
repeating the moves made by the S in the corresponding previous planning phase. The S





problem from the TOL task
number of moves required increased from 2 to 4. A second block of 2, 4 and 5 moves
then followed, and the test was completed by a second block of motor control problems.
If the S made more than double the number of moves for the simplest solution, the
problem was terminated If the computer terminated three problems in a row, the whole
test was terminated. There was no time limit.
The Tower of London test (CANTAB version) and Neurological studies
Few studies using the new computerised technology have assessed planning ability with
patients suffering frontal lobe lesions. However, Owen et al (1990) found that a group of
mixed frontal lobe damaged patients required more moves to complete the Tower of
London problems than did an age and IQ matched control group Initial thinking times
(experimental-motor control initiation times) did not discriminate between the groups
However, thinking times for moves subsequent to the first move were significantly
different, the frontal patients taking longer.
Groups of patients with idiopathic Parkinson's Disease have shown impaired Tower of
London performances when medicated (Morris et al, 1988) when number of moves taken
to complete the problems and thinking times were analysed compared to matched
controls. Owen et al (1992) found that those medicated PD patients with the severest
symptoms performed worst on the Tower of London test. Unmedicated PD patients 'early
on' in the course of the illness were not impaired on this test. However, both groups were
impaired relative to controls on the putative frontal task of set shifting, the ID/ED set
shift.
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To date there is little published data on the use of the computerised Tower of London
with schizophrenic patient samples The only study known at the time of writing is that
conducted by Pantelis et al (1991) with a group of 45 chronically ill schizophrenic
patients. They found that patients exhibiting symptoms of the disorganisation syndrome
(see Liddle, 1987a) were significantly slower in their 'thinking' times to initiate problem
solving than subsequent thinking time (time to complete the problem after the first move)
than patients exhibiting other symptom profiles matched along a range of clinical and
demographic variables.
Administration and Instructions (see CANTAB manual)
Scoring
The number of completed sets i.e. trials correctly performed was recorded for each level
of task difficulty. Average moves per level of task difficulty were also calculated.
Times to initiate problem solving were calculated for each type of problem The
difference between the time taken to complete each problem and the time taken to
complete the yoked following (motor) task per degree of task difficulty was taken as an
index of the additional time taken to plan the solution. A 'pure' thinking or 'planning' time
was, therefore, calculated for each type of problem. This result was then divided by the
total number ofmoves taken for each solution to yield a 'planning' time per move for each
level of task difficulty.
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2.4 MEMORY TESTS
Recent research indicates gross memory deficits in groups of schizophrenic patients
which are disproportionate to the level of overall intellectual impairment (McKenna et al,
1990; Tamlyn et al., 1992) and disproportionate to deficits on other neuropsychological
tests, including putative 'frontal' measures (Saykin et al, 1991).
Mayes and Warburg (1992) suggested that the psychometric assessment of putative
memory disorders warrants the selection of a comprehensive battery of tests to provide a
profile of a patient's pattern ofmemory impairment.
As stated previously (see Introduction p.35), there is much contemporary evidence to
support a fundamental memory impairment in schizophrenia, perhaps underlying at least
some of the positive symptoms of the condition, particularly in the formation of delusions
(e.g. McKenna, 1991). However, it is also clear that various groups of schizophrenic
patients have demonstrated impairments on a range of memory tests putatively measuring
different dimensions ofmemory. It has long been suggested that memory is not a unitary
concept. Rather that fundamental aspects of memory include short term (up to 30secs)
versus long term storage (for time anything beyond short term) (Baddeley, 1982) and that
long term storage has been divided into episodic (memory,usually autobiographical, with
a temporal context) and semantic (memory or factual knowledge with no temporal
component) memories (Tulving, 1983; Baddeley, 1990). In addition, memory can be
further subdivided into visual and verbal components and recognition and recall (i.e.
memory with and without external cues, respectively).
U A
The tests that were chosen for the present studies needed to account for the
multidimensional nature of memory as a concept More importantly, the presenting
evidence would suggest that an array of memory functions may be impaired in
schizophrenia associated with differing symptoms The tests used, therefore, were
intended to fully assess the various aspects of memory previously implicated in
schizophrenic neuropsychological dysfunction with different groups of schizophrenic
patients. Also, the battery chosen was designed to assess the degree of impairment, if any,
against symptom profiles and with regard to performance on other tests putatively
measuring different areas of cognition implicated in schizophrenic pathology The
literature justifying the use of each test is relayed alongside the discription of the
particular test.
2.4.2 The Rivermead Behavioural Memory Test (RBMT) (Wilson, Cockburn and
Baddeley, 1985)
The Rivermead Behavioural Memory Test was constructed to detect impairment in
'everyday' (episodic) memory functioning and to assess change following treatment for
memory difficulties (Wilson et al, 1991). The RBMT sought to provide ecologically valid
information of memory functioning as opposed to more traditional testing using
'experimental' material. The availability of four parallel forms of the RBMT avoids
practice effects associated with repeated testing, a crucial factor in attempting to quantify
within subject changes with treatment (see chapter 5).
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Reliability and Validity
Standardisation of the RBMT was carried out by administration to 176 brain-damaged
patients and to 118 control subjects (Wilson et al, 1989). They found that inter rater
reliability and parallel form correlations were highly significant. When RBMT scores were
correlated with a battery of tests measuring a wide range of memory functions all results
were highly significant, especially recognition memory for words and faces, least
significant was performance on a test of sentence verification (Baddeley, 1981) which,
although sensitive to brain damage, is less sensitive to everyday memory problems
(Sunderland et al, 1983). The RBMT manual (Wilson et al., 1991) provides cut off points
for severity of memory dysfunction from an analysis of the relationship between RBMT
performance and clinically subjective accounts of everyday memory problems. Additional
subgroup cut off points for patients with expressive language problems and those with
perceptual problems are also provided (Wilson et al, 1989). These sub group gradations
were required because of the mixed aetiologies of brain damage in the original validation
group.
The RBMT and Schizophrenia
Several studies have investigated the level of memory functioning, assessed by the
RBMT, in groups of heterogeneous schizophrenic patients. Significant impaired
performance on the task has been reported disproportionate to the degree of general
intellectual impairment and relative to short term memory performance (McKenna et al,
1990; Tamlyn et al, 1992; Duffy and O'Carroll, 1994). This emergent pattern of
impairment has been likened to that of the Classic Amnesic Syndrome (CAS) (Baddeley,
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1982; McKenna et al, 1990) rather than that found in Alzheimer-type dementia where
both short and long term memory functions are affected (Morris and Koppelman, 1986).
Duffy and O'Carroll (1994) pointed out that the severity of memory impairment in their
schizophrenic patient sample was much milder than that observed in CAS.
When analysing specific tests of episodic memory, Clare et al (1993) found that prose
recall and word and face recognition tasks were performed equally poorly when a group
of schizophrenic patients were compared with age, sex and estimated pre morbid IQ
matched controls. However, Calev et al (1984), found recall deficits to be greater than
recognition deficits when using tests matched for degree of difficulty.
Administration
Administration followed that set out in the test manual ofWilson et al. (1985)
Scoring
Aswell as raw scores for the individual tests, a profile score was calculated (0 to 24- 0, 1,
2 per item) which is a sensitive measure of memory function and provides the basis for
the categorization ofmemory dysfunction developed by Wilson et al. (1991).
2.4.3 Digit Span
This is a test for measuring span of immediate verbal recall. As memory has been
traditionally divided into short term memory and long term memory (Baddeley, 1982),
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the digit span test has been popular in measuring the former e g WAIS-R (Wechsler,
1981).
Description
The digit span test used in the present studies was taken from the Randt Memory Battery
(Randt and Brown, 1983). This was used because there are four parallel versions of the
test 'specifically designed for longitudinal studies of patients with mild to moderate
impairment of storage and retrieval functions'; the parallel forms are also helpful in
looking at drug effects over time (Lezak, 1983).
The Randt digit span test comprised of two tasks, repeating digits forward from 3-9
digits and repeating digits reversed, 2-8 digits in length. Each S was given two chances at
each level of task difficulty to correctly recall the digit sequence, failure on both
terminated the test. Digit span was defined as the number of items in a string of numbers
that a S could immediately recall before termination/end of the test (i.e. maximum
forwards = span of 9; backwards span of 8).
Most digit span tests comprise part of a wider investigation of overall cognitive ability
e.g. WAIS-R (Wechsler, 1981). However, Tamlyn et al (1992) found that 86% of a
heterogeneous group of schizophrenic patients passed a digit span (forwards only) test
i.e. scoring 5 on the MEAMS subtest. Duffy and O'Carroll (1994) found no difference on
digits forwards and backwards between a group of schizophrenic patients and Korsakoff's
patients. Cutting (1985) believed short term memory to be compromised in
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schizophrenia, although several contemporary researchers believe STM to remain intact
despite poor long term memory (McKenna et al, 1990, Tamlyn et al, 1992).
2.4.4 The Silly Sentences Test (Collins and Quillian, 1969)
Long term memory has been subdivided into episodic (everyday or autobiographical)
memory and semantic memory dimensions (Tulving, 1983, Baddeley, 1990). Semantic
memory refers to the storage of information without specification for time and place i.e
factual knowledge (e.g. What is the capital of France"7).
This test was designed to measure the integrity of semantic (factual knowledge) memory
through a sentence verification task.
Description
The S was required to classify as true or false 50 statements such as 'Beer is an alcoholic
drink' (true) or 'Prime ministers have feathers' (false). The S was encouraged to respond
as quickly as possible to each statement.
The Silly Sentences Test and Schizophrenia
Gross deficits in semantic memory performance have been identified, using the Silly
Sentences Test. Tamlyn et al (1992) found that their heterogeneous group of
schizophrenics performed significantly poorly on the task, aswell as on an episodic
memory task, both disproportionately to degree of overall intellectual impairment.
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In addition, schizophrenic patients have been seen to perform significantly worse than
matched controls on this test (Clare et al, 1993). Duffy and O'Carroll (1994) found an
interesting dissociation in their comparison of memory functioning between groups of
schizophrenic and Korsakoff's patients. While the schizophrenic patients appeared to have
greater episodic memory capability than the Korsakoff's patients, as assessed by the
RBMT, their(the schizophrenic patient's) performance on the Silly Sentences Test was
significantly worse, both in terms of response time and number of errors.
Scoring
Speed of verification was recorded for each statement as was the number of correct and
incorrect responses.
2.4.5 The Auditory Verbal Learning Test (AVLT) (Rev, 1964)
The AVLT is essentially a measure of verbal learning and memory Specifically, it enables
the assessment of immediate memory span, new learning, susceptibility to interference,
and recognition memory (Spreen and Strauss, 1991).
Taylor (1959) and Lezak (1983) developed the test for English speaking subjects. The
version used in the present studies is that described by Spreen and Strauss (1991 pp 149-
157).
Description
The Ss were required to read a list of 15 nouns (list A) at one second intervals for five
consecutive trials. The Ss were required to recall as many words as possible from the list
in any order they chose, although the order of the presentation remained constant across
all the trials. Instructions for recall were repeated before each trial. After trial 5 of list A
another list of 15 nouns (list B) was read to the Ss again for recall just once. After a delay
of 30 minutes the Ss were required to recall what they could of the words contained in
list A. Finally, the Ss were read a list of 50 words containing all the words from lists A
and B and 20 phonemically and/or semantically similar words to those in the two stimulus
lists. The Ss were then required to identify solely words from list A. Spreen and Strauss
(1991) believe the addition of the recognition stage of the test permits the identification
of Ss with retrieval problems who would show better performance on the recognition
compared to the recall task.
Studies involving the AVLT.
The AVLT has modest test-retest reliability, over one year intervals (Snow et al, 1988) It
has been shown to be sensitive to (left) lateralized brain damage and to verbal memory
deficits in a variety of groups (Bigler, 1989, Lezak, 1983).
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The AVLT and Schizophrenia
Gray et al (1991) proposed a theoretical model explaining positive schizophrenic
symptomatology in terms of a weakening of the influence of memories of previous input
on current perception O'Carroll et al. (1993) used proactive interference as a paradigm
to test this hypothesis. The authors tested 3 groups, acutely ill unmedicated
schizophrenics, patients with major depressive disorder and healthy controls, on the
AVLT. In the event, the resulting PI index, from the AVLT results, did not discriminate
between the groups, thus failing to support the Gray et al. (1991) model
The measure is used in the study of acutely ill schizophrenic patients, here, as an index of
new verbal learning and immediate and delayed recall and recognition memory. The
AVLT is advantageous in that it allows the assessment of the effect of interference on
new learning. Therefore, these dimensions ofmemory were assessed within the context a
larger battery of memory tests and also as a replication of the PI paradigm of O'Carroll
(1993) with respect to Gray et al. (1991) model of positive symptomatology. The
recording of comprehensive symptom profiles would also allow the assessment of the
relationship between specific clusters of symptoms and the dimensions of memory
recorded on the AVLT.
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Administration and Instructions (see Spreen and Strauss, 1991)
Scoring
The number of correct items was recorded for trials 1 to 5, the post interference trial and
for the delay condition. The number of correct items recognized from the 50 item
recognition list was also recorded. The difference between the number of correct
responses from trials 5 and 6, as a percentage, was also calculated in order to give an
indication of the effect of the interference trial (list B) on recall.
2.4.6 Hebbs Recurring Digits Test (see Spreen and Strauss, 1991)
This is an implicit learning test for verbally presented strings of numbers one digit longer
than the S's digit forwards span (Milner, 1970). In the present studies, the Ss were
unaware that every third string was identical. Normal controls tend to learn this fact
quicker than patients with verbal learning difficulties (Lezak, 1983). This test appears to
be sensitive to left but not right temporal lobe insults (Milner, 1971). This test appeared
in the battery to extend analysis of verbal learning skills and auditory short term
memory/attention justified above. Poor Hebb's digits 'time to learn' component has been
shown to be significantly correlated with abnormal P300 (an auditory event-related
potential) in a group of schizophrenic patients and their relatives compared to normal
P300 responders controls (Blackwood et al., 1993).
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2.4.7 MEMORY TESTS FROM THE CANTAB
The materials (computer and touch sensitive screen) and preliminary methodology (the
setting up of the testing session and the use of introductory tests) for the following
CANTAB memory tests were exactly the same as those used for the CANTAB measures
described in the tests of executive functioning section.
For all administration/instructions see CANTAB manual (1991).
2.4.7.1 Computerized Short Term Recognition Memory Tests
These computerised tests of short term memory were administered as complementary
measures to the more complex CANTAB tests used in the investigation of executive
functioning e.g. ID/ED Set Shifting and Tower of London. The recognition tests were
used to discriminate the composite neuropsychological elements necessary for the
successful performance of the more complex tests. The advantage of using these tests in
the investigation of putatively frontal tests is that the former do not appear to be sensitive
to excisions of the frontal lobes (Owen et al, 1992).
Computerized Recognition Memory Tests and Neurological Studies
Very few studies using the CANTAB short term recognition tests, described above, have
been carried out. Owen et al (1992) found that both unmedicated and medicated
Parkinson's disease patients were unimpaired on pattern recognition despite gross
impairment on a computerized measure of set shifting. Patients with dementia of
Alzheimer type (DAT) and medicated Parkinson's disease (PD) patients have
demonstrated impairment on both pattern and spatial recognition tests along with deficits
on a measure of delayed matching to sample (DMTS) (Sahakian et al, 1988). However,
the deficit on the DMTS differentiated the two groups as the DAT patients' deficit was
delay dependent and the medicated PD patients deficit was delay independent. To the
knowledge of the author at time of writing, no studies involving these type of tests have
been used with groups of schizophrenic patients.
2.4.7.2 Pattern Recognition Test
This test of short term pattern recognition memory was derived from animal studies
investigating visual memory for lists of objects using a type of serial recognition test
(Gaffan, 1974; Mishkin, 1982).
Description
The Ss were presented with series of simple visual patterns for three seconds each in the
centre of the screen. The patterns were designed to avoid the possibility of verbal
labelling. After a block of twelve patterns had been shown the Ss were instructed to
choose between a pattern they had already seen and a novel pattern (different form, same
colour). The pairs of patterns in the recognition phase were presented in the reverse order
to the original presentation. The Ss were offered feedback for their responses in the way
of green ticks and red crosses superimposed on the Ss' responses. The test was then
repeated with a new set of twelve patterns.
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Scoring
The number of correct responses and the associated mean reaction time was recorded
2.4.2.3 Spatial Recognition Test
This is a computerized test of short term visuo-spatial memory.
Description
The Ss were shown a white empty square which moved in sequence to five different
locations on the screen, each appearing for three seconds each The Ss were then
presented with pairs of squares, one of which was in a location visited by the square in
the presentation phase. The other square was situated in an unfamiliar location As with
the pattern recognition phase, the pairs of squares were presented in the reverse of the
original presentation order. The test was repeated three more times, each time with five
new locations. Again, the Ss were provided with feedback for their responses in the same
way as for pattern recognition.
Scoring
The number of correct responses was recorded (maximum=20) along with associated
mean reaction latency.
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2.4.7.4 Delayed Matching to Sample (DMTS)
The delayed matching to sample measure used in the present studies was similar to that
described by Sahakian et al. (1988). Again the use of this test was seen as complementary
to the more complex testing. However, successful performance involves the recognition
of stimuli along two dimensions, form and colour and the ability to hold information in
short term memory across a range of increasingly delayed response intervals. Therefore,
performance on this test could be seen as an accurate index of the Ss' non-verbal short
term memory abilities in its own right and as an assessment of delay upon the degredation
of this memory store. Delayed responding also formed part of the test as patients with
frontal lobe damage have shown impairments with testing involving such demands
(Petrides, 1985), unlike the non delay dependent pattern and spatial recognition tests.
Description
The test used in the present studies involved both simultaneous and delayed matching to
sample The Ss were shown a complex visual pattern (the sample) that appeared within a
red square. The presentation of the sample was preceded by an auditory cue. After a brief
delay, four choice patterns were presented under the sample in white squares. Each of
these patterns was made up of differently coloured quadrants. Only one of the choice
patterns was exactly the same as the sample. One was a distractor pattern, one had the
shape of the sample and the colours of the distractor and the fourth had the colours of the
sample and the shape of the distractor. One quadrant of all four choice patterns was
common with the sample, this was to discourage strategies based on encoding single
quadrants. In some trials the sample and the choice patterns were shown simultaneously.
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The other trials involved a delay of 0, 4 or 12 seconds between covering of the sample
and the showing of the choice patterns. The Ss were given three practice trials with
appropriate verbal instructions, and then after 40 counterbalanced trials, including 10
simultaneous and 10 at each of the three delay intervals. If the first choice made was
incorrect, the Ss were encouraged to make a second choice and so on until a correct
choice was made.
Scoring
The number of correct choices for each of the simultaneous and different delay types was
recorded (maximum=10 for each) along with associated mean reaction latencies.
2.5 TESTS OF PSYCHOMOTOR FUNCTION
The following tests were used as indices of psychomotor speed Recently, Liddle (1987)
and Liddle and Barnes (1990) have identified a subsyndrome of schizophrenia
characterized by 'psychomotor retardation', the following tests were administered to give
an accurate appraisal of speed of functioning in the studies' groups of schizophrenic
patients.
2.5.1 The Digit Symbol Substitution Test
This is essentially a timed test of visuospatial coding from the WAIS-R battery
(Wechsler, 1981). It also tests motor persistence, sustained attention, response speed and
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visual-motor coordination (Lezakl983). See the WAIS-R manual for administration,
instructions and scoring (Wechsler, 1981).
2.5.2 Reaction Time (from CANTAB)
This computerised test of reaction time formed a part of the larger procedure of tests
administered from the CANTAB The preliminary methodology described in the
executive functioning section was again followed so that the Ss were used to the demands
of responding to a touch sensitive screen which the present test required.
Description
The task was divided into five consecutive stages involving increasingly more complex
responses. The Ss were instructed to respond with their dominant hand at all times,
placed on the desk ,5m from the touch sensitive screeen, if possible. Firstly, the Ss had to
touch the screen, as quickly as possible, when a small yellow dot appeared in the centre
of a larger empty white circle. Responding too soon or too late to the dot resulted in a
void trial. Once the Ss had scored 5/6 correct responses or completed a maximum of 18
attempts, a choice reaction task was introduced. The yellow dot now appeared in one of
five locations; the Ss must again achieve 5/6 correct responses in a maximum of 30
attempts. If the Ss failed to reach criterion in the first two stages the test was terminated.
On successful completion of the second stage the Ss were introduced to a manually
operated pad that they were instructed to hold down until the yellow dot appeared in the
centre of the screen. The Ss at this stage did not have to touch the screen. In the fourth
stage the Ss were again instructed to hold the pad down until the yellow dot appeared
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and then, with the same hand, were told to touch where the dot appeared. The fifth and
final stage was a choice reaction task base on the procedure at stage four but involving
five possible locations where the dot could appear. At this stage the Ss had to reach a
criterion of 5/6 correct responses within a maximum of 40 attempts
The task parameters consisted of a stimulus display time of 250 msecs, hold on the pad
was limited to 5000 msecs and each intertrial interval was 1000 msecs.
Scoring
Simple reaction times were recorded for stages 1 to 3. Stages 4 and 5 involved a reaction
latency and a movement latency. The movement latency was calculated as the time from
the dot appearing (after the pad had been pressed) and the Ss releasing the pad. The
reaction latency was calculated as the time between releasing the pad and touching the
screen. A subtraction of the motor times from the reaction latencies, therefore, resulted in
a pure 'thinking' time index independent ofmotor problems.
2.6 TESTS OF VISUOSPATIAL NEGLECT
A wealth of neuropathological, neuropsychological and neuroimaging studies have
demonstrated asymmetries in brain functioning in various groups of schizophrenic
patients (see Introduction p.40 and below). However, researchers are divided whether
dysfunction can be attributed to the left (Crow, 1990, Friston et al., 1992) or to the right
(Cutting, 1985) cerebral hemisphere. For the present studies, cancellation tests involving
verbal and non-verbal stimuli and a line bisection estimation test, after Wilson et al.
(1987), were used to assess the degree of hemispatial neglect expressed by the different
groups of schizophrenic patients.
Visuospatial Asymmetry and Schizophrenia
Studies of 'circling behaviour' in schizophrenia have indicated right hemispatial neglect as
characterizing the behavioural asymmetry in this groups of patients (Bracha, 1987, Lyon
and Satz, 1991). Tomer and Flor-Henry (1989), however, found that, using simple
cancellation, tests there was a relative shift in hemispatial neglect from right to left when
patients scores were compared when in an unmedicated state and after a period on
medication. This relative shift in hemispatial neglect was not replicated by O'Carroll et al
(1995) who found that although a group of chronic schizophrenic patients demonstrated
significantly more omissions than unmedicated schizophrenic patients, patients with major
depression and healthy controls, there was no difference in omission asymmetry scores
between the groups. Mather et al. (1990) in an analysis of asymmetry found no difference
in performance between schizophrenic patients and controls using the line bisection task.
So, although groups with specific hemispheric insults using the line bisection task appear
to show a hemispheric asymmetry in function (Heilman and Valenstein, 1978), this effect
may be more subtle in schizophrenia. The lateralization effects seen may be of higher
order functioning not sensitive to crude tests of hemispatial neglect, such as line
bisection (Mather et al., 1990). The line bisection test was used in the present studies to
complement the other tests of neglect and to see whether a functional lateralization effect
may be characteristic of particularly defined groups of schizophrenic patients or may be




Cancellation Tests (from Wilson et al (1987) Behavioural Inattention Test)
A test of letter cancellation was used This comprised of a sheet of paper containing 4
rows of 34 letters. The Ss were instructed to cross out all the 'Es' and 'Rs' on the page, in
their own time. A star cancellation test was then administered. This test consisted of a
sheet of paper containing large and small stars, letters and short words randomly
arranged. The Ss were this time told to cross out all the small stars they could see, again
in their own time.
Line Bisection Test
The Ss were presented with a sheet of paper on which were three staggered lines each
204 mm in length. The Ss had to estimate the midpoint of each line and mark it with a
cross.
Scoring
For both of the cancellation tests the number of omissions for each hemispace were
recorded. Following Tomer and Flor-Henry (1989) an asymmetry index was calculated by
subtracting the number of right hemispace omissions from the left hemispace omissions,
the result was then divided by the total number of omissions. Therefore, a positive value
indicated a neglect in the right hemispace and vice versa
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An asymmetry index was also calculated from the line bisection performances. The length
of each line right of the estimated midpoint was subtracted from the length to the left.
The three lengths in mm were then added and divided by three to give an average
asymmetry index. Again, a positive value was indicative of right hemispatial neglect and
vice versa.
2.7 The Positive and Negative Syndrome Scale (PANSS) (Kay et al (1989)
The psychiatric rating scale used in chapters 3-5 was the Positive and Negative Syndrome
Scale (PANSS; Kay et al. (1989)-see appendix3 ) This scale was developed and
constructed along the guidelines for test construction laid out by the American
Psychological Association (1985). The result was a thrity point item scale including seven
positive symptoms and seven negative symptoms of schizophrenia. In the present studies
only the particular symptoms directly relevant to schizophrenia were used in analysis, the
remaining sixteen symptom ratings refer to general states of psychopathology e g anxiety.
The positive items, used in the present studies, included delusions, conceptual
disorganisation, hallucinatory behaviour, excitement, grandiosity, suspiciousness/
persecution and hostility. The negative or deficit symptoms included blunted affect,
emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in
abstract thinking, lack of spontaneity and flow of conversation and stereotyped thinking
Although such symptoms as stereotyped thinking have been considered as not exactly
positive or negative as traditionally understood (Frith, 1992), the items included in the
scale, as a whole, were picked to be broadly representative of symptoms from the
cognitive, social, emotional and communicational realms of clinical pathology expressed
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by schizophrenic patients (Kay, 1990) The authors also held that such a scale was
generally more sensitive to other established scales e.g. BPRS (Overall and Gorham,
1962) in terms of the types and degree of symptom expression able to be recorded (Kay
et al., 1989). The PANSS is, therefore, sensitive to a wide range of schizophrenic
symptomatology and, is also sensitive to the severity of symptoms, by including a seven
point scale of severity from absent through minimal, mild, moderate, moderately severe,
severe and extreme expressions of the symptom Studies have shown a high degree of
inter rater reliability and validity with other scales e.g. Andreasen and Olsen (1982) scale
(Kay et al. 1988, 1989b). With the scale comes formal criteria for conducting the
psychiatric interview and a video training package. The PANSS was used, in the present
thesis in chapters three to five, as a comprehensive analysis of presenting symptom states,
especially useful for the empirical analysis of symptom ratings that formed the basis of
chapters three and four.
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CHAPTER 3: NEUROPSYCHOLOGY AND SYMPTOMS OF
CHRONIC SCHIZOPHRENIA
3.1 INTRODUCTION
Any investigation of the putative underlying cognitive deficits associated with
schizophrenic behaviour is problematic due to the hetrogeneous nature of the
behaviours expressed by those patients diagnosed as schizophrenic This
problem has encouraged researchers to find new ways of categorising the
behaviour of schizophrenic patients. Researchers hoped, therefore, that clinical,
physiological or neuropsychological information, may be understood more
clearly in context with variables such as related behaviours or symptom clusters,
chronicity of illness or treatment response.
The traditional dichotomy of positive (abnormal experiences) and negative
(absence of normal functioning) symptoms arose from the respective types of
symptoms having little correlation with each other (Mortimer et al., 1990).
Studies have shown distinct cognitive profiles associated with positive and
negative symptoms respectively (e.g. Nelson et al., 1990; Addington et al.,
1991), usually with negative symptoms associated with greater cognitive
slowing. The positive-negative dichotomy led Crow (1980) to suggest that two
differing sub pathologies of schizophrenia might exist, one associated with
positive symptoms and good treatment response to dopamine antagonists (type
1) , the other characterised by a deficit state, poor treatment response and
cortical atrophy resulting in poor cognitive functioning (type 2) Although
Crow's classification allowed patients to express both types of symptoms
simultaneously, some central symptoms, associated with schizophrenia, have
been suggested as falling into neither 'pathological camp' i.e. stereotyped
behaviour (Frith, 1992).
In order to clarity the relationship between symptoms, Liddle (1987) and Liddle
and Barnes (1990), rated chronically ill, but stable, schizophrenic patients on the
Comprehensive Assessment of Symptoms and History (CASH; Andreasen,
1983) and the Scale for the Assessment of Negative Symptoms (SANS;
Andreasen, 1982) and the Manchester scale (Krawiecka et al., 1977) in the
respective studies. This approach was based entirely on associations between
presenting signs/symptoms and not on idiosyncratic theoretical models of the
condition Using factor analysis of the emergent ratings the investigators were
able, empirically, to produce three clusters or syndromes of related symptoms.
The syndromes generated were coined 'psychomotor poverty' (including:
poverty of speech, flattened affect and decreased spontaneous movement),
disorganisation' (incoherence of speech and inappropriate affect) and 'reality
distortion' (hallucinations and delusions) The authors hoped that these emergent
syndromes represented different underlying sub pathologies of illness with
distinct cognitive profiles. Subsequent work, on the cognitive dysfunction that
might underlie these syndromes, revealed significant associations between
psychomotor poverty and slowness of mental activity, in particular word
generation Disorganisation was significantly associated with poor performance
in suppressing inappropriate responses. Reality distortion was only related to
impairment in figure-ground perception (Liddle, 1987) but not significantly
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related to cognitive testing on a range of purtative 'frontal1 tests (Liddle and
Morris, 1991). The first two syndromes were proposed as different expressions
of frontal lobe dysfunction, while reality distortion was putatively related to an
abnormality of the temporal lobes. Such conclusions have been partially
supported by PET studies (Liddle et al., 1992), although the authors admitted
that the rCBF results indicated that the brain abnormalities associated with each
syndrome would involve wider more distributed neural networks than the foci
indicated previously from the neuropsychological studies.
Other studies have replicated Liddle's empirical studies (Johnstone et al., 1991,
Brown and White, 1992). However, Brown and White (1992) did not find any
neuropsychological sequelae associated with disorganisation and suggest that
psychomotor poverty may result from expressions of extrapyramidal side effects.
Liddle's factor analysis approach is, of course, dependent on the content of the
scales used for analysis. Some researchers have called into question the use of
factor analytic measures, as clusters of related symptoms are bound to appear
whatever the data set to which they are applied (Kendall, 1975). This would call
into question the meaningfulness of any emergent clusters. In addition, inflation
of the correlations between symptoms may result from the use of solely
hospitalised samples (Bentall et al., 1988) It would appear to be important,
therefore, that such studies use valid rating scales particularly designed to cover
the widest range and degree of schizophrenic symptoms derived from clinical
experience and operational criteria Also, differing groups characterised by
status and chronicity ought to be involved to check the reliability of the Liddle
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subpathologies across different populations of schizophrenic patients (see also
Neuropsychology, Symptoms and Acute Schizophrenia chapter).
3.1.1 Purpose of the Studv
The purpose of the present study was to address some of the issues cited above
to develop the methodology of Liddle and colleagues in a more exhaustive
understanding of the inter-relationship between schizophrenic symptoms and the
cognitive characteristics of any meaningful empirically derived sub syndromes of
illness. An opportunity to explore this was offered by the recruitment of an
extremely large group of schizophrenic patients (over twice the number ever
used in the Liddle et al., samples) of chronic status, who represented a wide
range of long term hospital based patients and those who had been community
based for some time.
3.1.2 Aims of the Studv
The purpose of the present study was to replicate Liddle's syndromic approach
to the signs and symptoms of schizophrenia The object of the study, specifically,
was to clarify if the proposed syndromes of chronic schizophrenia can be shown
to exist in a large sample of patients using a new more comprehensive rating
system, the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1989)
than more traditional and limited, rating scales used to date, in terms of type and
severity of symptoms.
Again, with regard to contemporary research and theoretical modelling of
schizophrenic symptoms, the neuropsychological investigations of syndrome
expression to date have been limited, by the type and range of
neuropsychological measures used. The present study's intent was to use a
larger battery of contemporarily relevant neuropsychological measures to assess
syndromic associations with functioning considered as underpinning a wide
range of schizophrenic symptoms Relevant measures were grouped under
executive or 'frontal', memory, psychomotor and hemispatial functioning
domains. As explained more thoroughly in the Methods chapter, these particular
domains of functioning appear to be characteristic of the major areas of
cognitive dysfunction observed in various heterogeneous groups of
schizophrenic patients. The methodology of investigating the association
between cognitive dysfunction and symptom expression has been less well
documented, but none the less important. The use of this methodology, in
research into the neuropsychology of schizophrenia, has been gaining ground
and has lead to a more definitive understanding of the cognitive mechanisms that
underpin the various expressions of schizophrenic behaviour (Corcoran and
Frith, 1993).
Executive or 'frontal' problems have been widely observed in schizophrenic
patient samples (Kolb and Wishaw, 1983; Shallice et al., 1991) and have been
associated with a fundamental deficiency in the Supervisory Attention System
(SAS) in the control of self generated activity Support for this has come from
the the inability of schizophrenic patients, displaying first rank symptoms, to
monitor their own self generated actions (Frith and Done, 1989) Symptoms
ill
derived from this impairment migh include third person hallucinations and
passivity phenomena With the previous Liddle et al., studies in mind, it was
deemed necessary to include tests both of executive type and psychomotor
measures to assess both inappropriate responding (related to incoherence and
incongruity of affect) and cognitve speed (related to deficit state symptoms)
Memory measures were deemed as extremely important as, not only have
specific disproportionate memory deficits been observed in heterogeneous
groups of schizophrenic patients (McKenna et al., 1990; Tamlyn et al., 1992,
Saykin et al., 1991) but memory impairments have been associated with
delusions, hallucinations and thought disorder, in terms of the generation and
use of'false knowledge' in contemporary functioning (Mortimer and McKenna,
1994). Episodic memory dysfunction has also been suggested as underpinning
symptoms such as paranoid delusions and poverty of social and communicative
functioning (Frith, 1992). These symptoms might result from poor social
judgements due to either a misinterpretation of others actions (due to faulty
social cogntion) or a poverty of accessible social knowledge for successful
interaction. This battery of tests should, therefore, be able to establish the
underlying cognitive dysfunction, if any, associated with any emergent
syndrome A closer investigation of the effect extrapyramidal side effects was
warranted as syndromes such as psychomotor poverty may be allied to treatment
effects. The neuropsychological performance of the patients necessitated being
put into context with normal functioning and thus a comparison with healthy
controls was carried out
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The design of the study allowed a comprehensive analysis of the relationship
between the symptoms expressed by a large, and varied, group of chronic
schizophrenic patients and how any emergent groups of related symptoms were
associated with comprehensive neuropsychological performance. In addition,
there was the opportunity to compare neuropsychological functioning with a
group of healthy controls allowing an appreciation of the degree and nature, if
any, of cognitive impairment, displayed by the schizophrenic patient group
3.2 METHOD
3.2.1 Subjects
Sixty six patients with DSM-IIIR (American Psychiatric Association, 1987)
diagnoses of chronic schizophrenia were recruited. The patients were either in-
or out-patients of the Royal Edinburgh Hospital Forty patients were recriuted
from the RIS-GBR-006 study of treatment resistant schizophenia, see chapter 5
for the definition and selection of these patients. The other twenty six patients
were independently recruited by the investigator from the REH. Twenty five
controls (13 males, 12 females) were also tested on the neuropsychological
measures. All patients and controls were screened for alcohol and/or drug abuse,
history of head injury, and for the patients, history of ECT in the previous six
months. None of the controls had any history of psychiatric problems
whatsoever. Age, sex and number of full time years of education are recorded on
table 6 for both groups. Hospitalisations, duration of illness and drug histories to
be added can also be see on table 6
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3.2.2 Psychiatric Ratings
All patients were assessed on the Positive and Negative Syndrome Scale
(PANSS) (Kay et al 1989) to cover a wide range of positive and negative
symptom ratings Full details are given in the main Methods chapter The
patients were also assessed on the Abnormal Involuntary Movement Scale
(AIMS; US Department of Health, Education and Welfare, 1976) and the
Targeting Abnormal Kinetic Effects (TAKE) scale (Wojcik et al., 1980) for
evidence of extra pyramidal side effects at interview All psychiatric ratings and
movement disorder scales were carried out by experienced and trained
psychiatrists
3.2.3 Neuropsychological Measures
As stated above, the chronically ill patients and the control group were tested on
a battery of neuropsychological tests designed to measure/target the cognitive
deficits that may underlie those symptoms that characterise a group of relatively
stable chronically ill patients with a diagnosis of schizophrenia. The measures
used are discussed fully in the main Methods chapter
General intellectual functioning was measured by using the National Adult
Reading Test (NART) (Nelson, 1982) as an index of pre morbid ability Current
intellectual ability was measured with the Quick Test (Ammons and Ammons,
1962)
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Executive functioning was measured by using a verbal fluency task ( initial
letter 'A' and Animal categories) (Spreen and Strauss, 1991), a computerised
Continuous Performance Test (CPT) (Frith et al, 1991), the Stroop test
(Trenerry et al., 1989) and the Trail Making Task (A&B) (Reitan, 1958). Two
further computerised tests of executive functioning were administered from the
CANTAB (Robbins et al., 1991); the Intra/Extradimensional Set Shifting task
and the Tower of London task- a measure of planning ability.
Memory functioning was assessed by the Rivermead Behavioural Memory
Test (RBMT) (Wilson et al., 1985), a measure of long term episodic memory,
and digit span forwards and backwards to assess short term verbal working
memory (Randt and Brown, 1983) . A computerised Delayed Matching to
Sample task was also administered from the CANTAB (Robbins et al., 1991) to
assess delay dependent non verbal short term memory Measures of pattern and
spatial recognition memory were also administered from the CANTAB practice
battery
Psychomotor functioning was assessed using the reaction and motor time
measure from the CANTAB (stage 5 of the Reaction Time measure) and the
Digit Symbol Substitution Test (from the WAIS-R, Wechsler, 1981)
Tests of hemispatial neglect were also administered to assess hemispatial
acuity. Letter and star cancellation tests and a line bisection task (Wilson et al.,
1987) were used.
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Details of the administration and scoring of all the above tests with theoretical
backgrounds can be seen in the main Methods chapter
All subjects were tested at one sitting, if possible, if not, all were done on the
same day with convenient breaks The patients' performance from the RIS-GBR-
006 was recorded from baseline The psychiatric ratings and movement disorder
scales were carried out on the same day as testing (+/-1)
3.2.4 Data Analysis
Factor analysis was undertaken with rating scores of the 14 signs/symptoms (7
positive, 7 negative) from the PANSS scale (see appendices for scale). Analysis
was similar to that carried out by Liddle and Barnes (1990) Initial factors were
extracted by the method of principal components. An oblique rotation was
performed as, prior to Liddle (1987) and Liddle and Barnes (1990), there was
no a priori evidence that symptoms should be related. Factor scores were
calculated by the regression method All analyses were performed using SPSS
4.0 on a Macintosh personal computer.
Pearsons correlations (two-tailed) were carried out between factor scores and
neuropsychological test results of the chronically ill schizophrenic patient group
Partial correlations were also obtained for this relationship after correcting for
extrapyramidal side effect ratings due to Brown et al (1991) having shown that
tardive dyskinesia itself to be associated with 'frontal1 type psychological
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deficits. Partial correlations were also obtained, correcting for Quick IQ i.e
current IQ, as current IQ was seen as significantly associated with the third
significant emergent factor in preliminary analysis Therefore, it was deemed
necessary to statistically account for the effect of current IQ performance on the
relationship between syndrome 3 score and the more specifc neuropsychological
test performances.
The chronic schizophrenic patients results were compared with the control
group to assess the degree of any domain specific dysfunction. Test performance
between the two groups was analysed by combining the measures into groups by
function i.e. executive function performance, memory performance etc.
Comparison was calculated using the multivariate analysis of variance
(MANOVA) to assess any overall effects by function In the case of test results
expecting missing data due to the design of the test i.e. fewer subjects reaching
the more difficult stages of the ID/ED Set Shifting Task, chi squared statistics
were used to analyse the proportion of subjects per group reaching each stage of
the Set Shifting Task The between group comparison was also repeated using
full time years of education as a covariate as preliminary analysis revealed
superior educational experience in favour of the control group.
3.3 RESULTS
3.3.1 Factor analysis
Factor analysis generated four groups of related symptoms (see table 1). Only
those factors yielding an eigen values greater than one were considered
statistically meanigful for further analysis. The first factor or 'syndrome' loaded
heavily on delusions, hallucinations and suspiciousness/ persecution This factor
accounted for 23.4% of the variance in scores. The second factor was
characterised by lack of spontaneity and flow of speech, poor rapport, emotional
withdrawal and passive/apathetic social withdrawal This factor accounted for
18.4% of the total variance of scores. The third factor revealed association in
ratings between difficulty in abstract thinking, conceptual disorganisation, and
stereotyped thinking, accounting for 14.9% of the total variance in scores. The
fourth and last factor showed related ratings between grandiosity and hostility,
accounting for 8 4% of the total variance in psychiatric scores. Almost 35% of
the variance of scores, therefore was not accounted for by the emergent factors
3 3? f'.->rrHstlor-t hpt-jyppr. hological test performance and
factors/syndromes (see table 2 for individual correlations)
Syndrome 1, characterised by hallucinations and delusions, did not correlate
significantly with performance on any of the neuropsychological tests.
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Syndrome 2, characterised by poverty of sociability and affect, showed
significant positive correlations with verbal fluency-semantic category, digit span
forwards and Rivermead Behavioural Memory Test (RBMT) profile scores
Syndrome 3, encompassing conceptual disorganisation and difficulty in abstract
thinking, was highly negatively correlated with current IQ (Quick IQ), digit span
forwards and backwards and Rivermead Behavioural Memory Test profile
scores. Verbal fluency (words beginning with letter 'A'), Continuous
Performance Test (CPT) total target letters ('E's) and inappropriate responses
(positive correlation), pattern and spatial recognition memory test results were
less highly but still significantly correlated with syndrome 3.
Syndrome 4, characterised by grandiosity and hostility, was not significantly
correlated with any neuropsychological test performance.
Correlations between Tower of London Test results and syndrome scores can
be seen on table 3.
Syndrome 1 was significantly negatively correlated with motor initiation times
for four move solutions and significantly positively correlated with initial
'planning' times for two move solutions.
Syndrome 2 was significantly negatively correlated with initial 'planning' time for
four move solutions only.
Syndrome 3 was significantly negatively correlated with the number of
completed sets for all (two to five move solutions) levels of task difficulty
No performance variables from the Tower of London Test were significantly
correlated with syndrome 4 scores
As syndrome 3 was highly correlated with current IQ, the correlations were
repeated to produce partial correlations after correcting for Quick IQ scores.
This procedure was carried out to allow for the influence of current global IQ
scores on the other more specific neuropsychological test performances. The
analysis revealed digit span forwards (r=-.3058, p<05) and backwards (r=-
.2519, p<05), and RBMT profile scores (r=-.2409, p<05) to be still
significantly, negatively, correlated with the syndrome but at a reduced level of
significance. CPT total number of target letters correct was significantly
negatively correlated at the same level of significance (r=-.3058, p<05). The
verbal fluency, pattern and spatial recognition memory tests and the CPT
inappropriate responses correlations all became non significant.
As far as the Tower of London results were concerned, no significant
correlations were produced in terms of number of completed sets. This
procedure did, however, expose significant negative correlations for motor
initiation times for two move solutions (r=- 2500, p< 05) and 'planning times'
per move subsequent to the first move for three move solutions (r=-.2501,
P< 05).
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3.3.3 Neuropsychological test performance, syndrome scores and extra
pyramidal side effects (see tables 4&5)
Partial correlations, of syndrome scores and neuropsychological test
performances, were calculated, correcting for extrapyramidal side effect ratings
(AIMS & TAKE), as researchers have found that such common side effects as
tardive dyskinesia to be related to 'frontal' or executive type deficts on
psychological testing (see Brown et al., 199])
After this procedure:
Syndrome 1 was not significantly correlated with any test performance.
Correcting for TAKE scores, the verbal fluency 'animals' scores, CPT
inappropriate responses and digit span forwards were all highly positively
partially correlated with syndrome 2. To a lesser, but still significant, level of
significance, Quick IQ scores, verbal fluency initial letter 'A' scores, CPT number
of target 'Es', spatial recognition memory test scores, digit span backwards,
RBMT profile scores were significantly positively partially correlated with
syndrome 2 scores; motor latency stage 5 from the CANTAB reaction time
measure was significantly negatively partially correlated with syndrome 2
Correcting for AIMS scores, high positive significant partial correlations were
revealed between verbal fluency initial letter 'A' and semantic category 'Animals'
and digit span forwards with syndrome 2.
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As far as partial correlations with syndrome 3 were concerned, after correcting
for TAKE scores, highly significant correlations were revealed between the
syndrome and Quick IQ scores, CPT inappropriate responses (positively), digit
span forwards and backwards and RBMT profile scores (all negatively unless
otherwise stated) Verbal fluency initial letter 'A', CPT number of target 'Es',
Stroop word-colour scores and pattern recognition memory performance also
produced significant partial correlations with syndrome 3, but at a lower level of
significance The same significant correlations were generated after correcting
for AIMS scores.
Number of completed stages of the ID/ED set shifting task, trail making task
(B-A) times and letter asymmetry indices were significantly partially correlated
with syndrome 4 when correcting for TAKE scores Only trail making and letter
asymmetry indices were significantly partially correlated with syndrome 4 when
correcting for AIMS scores.
As far as the Tower of London performances were concerned, partial
correlations, with correcting for TAKE scores, revealed significant correlations
between syndrome 1 and motor initiation and subsequent motor times for four
move solutions (both negative), and initial planning times for two move
solutions (positive)
Syndrome 2 was significantly negatively partially correlated with subsequent
planning times per move for three move solutions
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Syndrome 3 was significantly positively partially correlated with average moves
for four move solutions and times per move subsequent to the first move for five
move solutions.
No Tower of London variables were correlated significantly with syndrome 4
after correcting for TAKE scores.
Correcting for AIMS scores, revealed negative significant partial correlations
with syndrome 1 for motor initiation times for three and four move solutions, a
high significant correlation with subsequent (to the first move) motor times for
four move solutions. Initial planning times for two move solutions were
significantly positively correlated with syndrome 1.
After correcting for AIMS scores, initial planning times for four move solutions
and planning times per move subsequent to the first move for three move
solutions were significantly negatively partially correlated with syndrome 2.
In the same vein, syndrome 3 revealed only one significant negative partial
correlation with planning times per move subsequent to the first move for five
move solutions.
No significant partial correlations were recorded between neuropsychological
test performances and syndrome 4
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3.3.4 Neuropsychological test performance of Chronic Schizophrenic
patient group versus Controls
3.3.4.1 Demoeraphics and General Intellectual functionin2 (see table 6)
The groups were well matched for sex ratio, age and pre morbid IQ (assessed by
NART error scores) and current IQ (Quick IQ performance). However, the
controls demonstrated significantly greater educational experience, in terms of
the number of full time years of education, than the chronic schizophrenic
patient group.
The between analysis of neuropsychological functioning was, therefore, carried
out with and without the number of full time years of education as a covariate.
This was to assess the effect of the disparity in education background on the
comparison of neuropsychological performance as education appears to have a
'potent and pervasive' influence on nearly all types of neuropsychological test
performance (Lezak, 1983).
3.3.4.2 Executive functioning performance (see table 7)
An extremely high significant difference was observed, showing better
performances on an array of executive functioning tests in favour of the control
group. Univariate analyses showed the chronic patient group to be functioning at
extremely lower levels of executive functioning as assessed by verbal fluency
(both initial letter and semantic categories), number of completed stages and
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trials to reach stage six (an intradimensional shift) on the ID/ED set shifting task,
numbers of correct and inappropriate responses recorded from the Continuous
Performance Test (CPT), Stroop word- colour condition results and trail making
part B-A times. A trend towards significance was observed on trials to reach
stage eight (an extradimensional shift) on the ID/ED set shifting task.
After controlling for education background, the highly significant overall
difference in executive functioning remained. As far as univariate differences
were concerned, CPT correct response performance was the only performance
variable that changed to non significance. Trials to criterion on stage eight of the
ID/ED set shifting task now showed no trend toward significance.
Table 8 shows the proportion of subjects passing each stage of the ID/ED set
shifting task. Apart from simple discrimination and simple reverse discrimination,
stages one and two, all other stages showed a higher proportion of controls
passing those stages i.e. reaching criterion than the chronic schizophrenic
patients, including stage six (an intradimensional shift) and stage eight (an
extradimensional shift).
Analysis of the Tower of London test results for the groups can be seen on
tables 9 to 14. No overall difference in number of completed sets was observed,
though univariate analysis showed significantly fewer five move problems
completed by the patients. This, however, became non significant after
controlling for education A significant overall difference in number of average
moves to complete each type of problem was seen in favour of the controls,
particularly concerning three and five move problems. This difference was still
significant after controlling for education but at a lower level of significance.
The controls showed overall quicker motor times to initiate problem solving
especially for three, four and five move problems. The overall difference became
non significant after controlling for education. There remained significant
univariate differences for three and five move problems despite this. Motor times
subsequent to the first move also showed large differences with the controls
being far quicker completing two, three and four move problems. These
differences remained, still at high level of significance, after controlling for
education.
No overall differences were seen between the groups when planning times per
move to initiate and complete the Tower of London problems were analysed
Despite this, after univariate analysis, only planning times for five move
problems, subsequent to the first move, were significantly different before and
after controlling for education in favour of the controls.
3.3.4.3 Memory test performance (see table 15)
An extremely high overall level of significance was recorded both before and
after controlling for education on an array of memory tests. The control group
appeared to be vastly superior on many measures of memory functioning
compared to the patient sample, in particular delayed matching to sample,
pattern and spatial recognition memory, digit span backwards and Rivermead
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Behavioural Memory Test (RBMT) profile scores. No significant difference was
seen on digit span forwards performance. The difference in simultaneous
matching to sample became non significant, after controlling for education.
3.3.4.4 Psychomotor ability (see table 16)
The control group were vastly superior on tests measuring psychomotor
performance,
this was unaffected by controlling for education.
3.3.4.5 Hemispatiai neglect and lateralisation (see table 17)
No overall or univariate differences were revealed after comparing the groups'
hemispatiai acuity on tests of hemispatiai neglect.
TABLE 1
FACTOR LOADINGS OBTAINED BY FACTOR ANALYSIS OF SYMPTOMS
SYMPTOMS FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4
DELUSIONS 797 -.027 .006 -.256
HALLUCINATIONS .776 .142 .121 .159
SUSPICIOUSNESS/
PERSECUTION
.773 -.187 -.084 -.280




.271 -.722 - 076 148
HOSTILITY .267 -.096 .051 - 684
EMOTIONAL
WITHDRAWAL
.250 -.779 -.149 -.132
STEREOTYPED
THINKING
.230 -.239 .526 - 216
EXCITEMENT .140 .452 458 -.238
CONCEPTUAL
DISORGANISATION
.008 .061 .816 -.130
GRANDIOSITY -.049 .070 .028 -.746
DIFFICULTY IN
ABSTRACT THINKING
-.053 .073 .827 .199




-.212 -.825 .303 .215
EIGEN VALUE 3.272 2.574 2.087 1.181
% VARIANCE 23.4 18.4 14.9 8.4
CUM % VARIANCE 23.4 41.8 56.7 65.1
TABLE 2
CORRELATIONS OF SYNDROME SCORES AGAINST
NEUROPSYCHOLOGICAL TEST PERFORMANCE
TEST SYND1 SYND2 SYND3 SYND4
QUICK IQ -.1054 .1632 . 4981** -.0895
A -.1081 .2354 -.3003* -.1702
ANS .1137 .3867** -.1741 - 1675
CIDC .0274 .2216 - 1910 -.2773
TTC6 .0042 -.0756 .2298 .3348
TTC8 .0105 -.1093 .0597 1935
CPTE - 0154 .1018 -.2910* -.1527
CPTI -.0437 -.0390 .2751* -.0804
STPWC - 0490 -.0470 .2914 .1609
TRLBA -.0432 .0133 1888 .2736
CDT -.0960 -.0821 -.2023 - 1123
CPR .0343 .1954 -.2662* .0009
CSR .0650 1861 -.2485* .0252
DF .0525 .2612* -.3893** -.0998
DB .0573 .1288 -.4506** -.1924
RPT .0083 .2547* -.4530** -.0104
CML5 .0488 -.1981 .1252 1470
CRL5 .0276 -.0431 .0676 -.0804
DSS -.1047 .0095 - 1 121 .0142
LAI .1611 .0674 -.1151 -.0817
SAI -.0620 - 0560 -.0885 .0055
LINE .0414 .0340 -.1103 .0224
**p< 01 *p< 05
KEY
A: VERBAL FLUENCY LETTER 'A'
ANS: VERBAL FLUENCY 'ANIMALS'
CIDC: NUMBER OF SUCCESSFULLY COMPLETED STAGES ON THE ID/ED
SET SHIFTING TEST
TTC6: TRIALS TO CRITERION ON INTRADIMENSIONAL SHIFT ID/ED SET
SHIFTING TASK
TTC8: TRIALS TO CRITERION ON EXTRADIMENSIONAL SHIFT ID/ED SET
SHIFTING TASK
CPTE: NUMBER OF CORRECT RESPONSES ON THE CONTINUOUS
PERFORMANCE TEST
CPTI: NUMBER OF INAPPROPRIATE RESPONSES ON THE CONTINUOUS
PERFORMANCE TEST
STPWC: STROOP TEST WORD-COLOUR CONDITIONS
TLSBA TRAIL MAKING TEST PARTB-A
CDT: DELAYED MATCHING TO SAMPLE TOTAL CORRECT
CPR: PATTERN RECOGNITION MEMORY TEST
CSR: SPATIAL RECOGNITION MEMORY TEST
DF: DIGIT SPAN FORWARDS
DB DIGIT SPAN BACKWARDS
RPT: RIVERMEAD BEHAVIOURAL MEMORY TEST PROFILE SCORE
CML5: CANTAB MOTOR TIME STAGE 5
CRL5: CANTAB REACTION TIME STAGE 5
DSS: DIGIT SYMBOL SUBSTITUTION TEST
LAI LETTER CANCELLATIONASYMMETRY INDEX
SAL STAR CANCELLATION ASYMMETRY INDEX
LINE: LINE BISECTION INDEX
TABLE 3
CORRELATIONS BETWEEN TOWER OF LONDON PERFORMANCE AND
SYNDROME SCORES
SYND1 SYND2 SYND3 SYND4
CS2 -.0213 .0059 -.2559* -.1244
CS3 -.0534 .0391 -.2897* -.1431
CS4 -.0319 .0079 -.3115* -.1255
CS5 -.0943 -.0493 -.2881* -.0570
AV2 -.0207 .0156 - 0516 -.1049
AV3 -.1026 .1576 .0329 -.0640
AV4 .0061 .1509 1685 -.1489
AV5 .1450 .1546 -.0953 -.2216
MI2 -.1856 .1220 .0595 -.0200
MI3 -.2476 - 0450 .0170 -.0500
MI4 -.2758* .2049 .0893 -.1216
MI5 -.2026 .1023 -.0816 -.0415
MS2 -.2201 .2196 -.0292 .2205
MS3 -.1736 .0701 -.1292 .0533
MS4 -.1662 -.0051 .1718 -.0670 j
MS5 .1169 .0125 -.0836 .1769
PI2 .2832* - 0836 -.0755 .0387
PI3 -.0621 .0599 -.0333 -.0526
PI4 -.0947 -.2691* .0216 -.2037
PI5 -.0616 .0426 -.1291 -.2018
PS2 .0372 -.0197 .1945 .0867
PS3 - 1949 -.1757 -.1045 - 0723
PS4 -.1447 .0267 -.1629 - 0080





MI: MOTOR INITIATION TIMES
MS: MOTOR TIMES SUBSQUENT TO THE FIRST MOVE
PI: PLANNING INITIATION TIMES
PS: PLANNING TIMES PER MOVE SUBSEQUENT TO THE FIRST MOVE
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TABLE 4
PARTIAL CORRELATIONS OF NEUROPSYCHOLOGICAL TEST RESULTS
AGAINST SYNDROME SCORES CONTROLLING FOR TAKE AND AIMS
RATINGS.
SYND1 SYND2 SYND3 SYND4
TAKE AIMS TAKE AIMS TAKE AIMS TAKE AIMS
QIQ -.2240 -.1802 .2636* .2242 -.4579** -.4681** -.0208 -.0408
A -.1235 -.0572 .3621* .3161** -.2506* -.2753* -.0575 -.0895
ANS -.0080 .0332 .3985** .3289** -.0922 -.1108 -.1521 -.1730
croc .0657 .0736 -.0972 .1978 -.0972 -.1017 -.2359* -.2402
TTC6 -.0414 -.0971 .1427 -.0352 .1427 .1666 .2232 .2482
TTC8 -.1063 -.0799 .0142 -.1568 .0142 .0028 .1916 .1773
CPTE -.0193 -.0587 -.2793* .0715 -.2793* -.2560* -.0995 -.0760
CPTI .0496 -.0045 .3200** -.0700 .3200** .3373** .0597 .0873
STPWC .1245 .0698 -.0563 -.0133 .2775* .2951* .0827 .1083
TRLBA .0480 -.0150 -.0718 -.0308 .1787 .2039 .2579* .2843*
CDT -.1667 -.1220 -.1876 -.2104 -.1178 -.1351 -.0537 -.0764
CPR .0602 .0358 .1960 .1937 -.2941* -.2825* -.0641 -.0522
CSR .0440 .0881 .2521* .2073 -.2155 -.2335* .0283 .0019
DF .1292 .1460 3489** .3155** -.4171** -.4231** .0059 -.0064
DB .0618 .1021 .2358* .1716 -.4230** -.4343** -.0860 -.1095
RPT -.0870 -.0704 .2612* .2187 -.4373** -.4430** .0041 -.0062
CML5 .0131 .0472 -.2667* -.2620* .0047 -.0112 .2192 .2030
CRL5 -.0097 .0165 -.0503 -.0555 .0608 .0481 -.1043 -.1170
DSS -.2068 -.1525 .0067 -.0031 .0039 -020 .2111 .1849
LAI .1940 .1703 .0523 .0555 -.1827 -.1727 -.2406* -.2288*
SAI -.0958 -.0892 -.0028 -.0300 .0008 -.0021 .0395 .0349
LINE .0179 -.0019 1403 .1239 -.0691 -.0609 0607 .0695
*p< 05 **p< 01
TABLE 5
TOWER OF LONDON PARTIAL CORRELATIONS WITH SYNDROME
SCORES WITH RESPECT TO TAKE AND AIMS SCORES
SYND1 SYND2 SYND3 SYND3
TAKE AIMS TAKE AIMS TAKE AIMS TAKE AIMS
AV2 -.0884 -.0857 .0307 -.0664 -.1730 -.1748 .0098 .0095
AV3 - 1930 -.1688 .0723 .1218 -.0025 -.0202 .1678 .1967
AV4 .0763 .0499 .0928 .1164 .3016* .3156* .0201 .0329
AV5 .1192 .0774 .1136 .1324 -.0998 -.0746 -.1385 -.1264
MI2 -.2167 -.2424 .0110 .0344 -.0852 .0702 -.1658 -.1519
MI3 -.2422 -.2665* -.0662 -.0860 .0473 .0598 -.0560 -.0672
MI4 -.2564* -.2923* .1856 .2071 .0713 .0918 -.1326 -.1180
MI5 -.2306 -.2346 .1179 .0951 -.0702 -.0695 -.0347 -.0463
MS2 -.2380 -.2701 .2332 .2149 -.0886 -.0732 .2050 .1959
MS3 -.0976 - 1161 .0304 .0594 -.1316 -.1204 .0589 .0738
MS4 -.3305* .3423** -.0669 -.0552 -.0299 -.0251 -.1258 -.1196
MS5 .1400 .1354 .0001 0173 -.0962 -.0930 .1716 1802
PI2 .2668* .2584* -.0414 -.0765 .0330 -.0224 .2251 .2071
PI3 -.0635 .0036 .0167 -.0083 -.0148 -.0558 -.0465 -.0578
PI4 -.1462 -.0715 -.2623 -.2813* .0393 -.0046 -.2310 -.2388
PI5 -.0673 -.1220 .0466 .0247 -.1282 -.0999 -.2012 -.2175
PS2 .0548 .0581 -.1031 -.1290 .1410 .1397 .1752 .1601
PS3 -.2315 -.2288 -.2760* -.2769* -.1003 -.1038 -.0005 .0200
PS4 -.0571 -.0830 .0152 .0349 -.2065 -.1910 -.0523 -.0416
PS5 -.0836 -.1326 .0282 .0631 -.2849* .2499 -.1249 -.1034
*p< 05 **P< oi
iS0!
TABLE 6
DEMOGRAPHICS OF CHRONIC SCHIZOPHRENIC PATIENTS VERSUS
CONTROLS (means and sds)
CHRONICS CONTROLS SIGNIFICANCE
SEX (M:F) 48:18 13:12 LR=3 41 df=l p=.065
AGE (yrs) 40.0 (10 7) 34.1 (13.6) t=-1.43 df=89 p= 156
EDUCATION (yrs) 11.9(2.4) 13.4 (2.8) t=2 61 df=89 p=011
NART (WAIS
equivalent))
107.9(10.6) 110.6 (10 2) t=l ,07 dl=87 p=288
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TABLE 8
PROPORTION OF CHRONIC SCHIZOPHRENIC PATIENTS AND
CONTROLS SUCCESSFULLY PASSING EACH STAGE OF THE ID/ED
SET SHIFTING TASK
STAGE CHRONICS CONTROLS LIKELIHOOD PROBABILITY
n=63(100%) n=25(100%) RATIO
1 61(97) 25(100) 1.36 .244
2 59(94) 25(100) 2.75 .097
3 53(84) 25(100) 7.18 .007
4 53(84) 25(100) 7.18 .007
5 50(79) 25(100) 9.56 .002
6 42(69) 24(96) 10.37 001
7 32(59) 24(96) 14.71 .000
8 29(46) 19(76) 6.77 .009
9 28(44) 19(76) 7.47 .006
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The factor analysis of symptom ratings of a very large group of chronically
ill schizophrenic patients, of a wide range of severity and chronicity,
produced four distinct groups or syndromes of related symptoms. The first
three syndromes, accounting for the largest percentages of variance in
ratings, appeared to closely resemble the syndromes or sub pathologies of
schizophrenia as reported by Liddle (1987) and Liddle and Barnes (1990).
The association between delusions, hallucinations and
suspiciousness/persecution symptoms fit well with Liddle's reality distortion
syndrome, here with general delusional behaviour related to paranoid type
behaviour . Lack of spontaneity and flow of speech, poor rapport, emotional
withdrawal and passive/apathetic social withdrawal resembles Liddle's
psychomotor poverty syndrome. However, to describe this group of
symptoms as characterising psychomotor poverty may be slightly misleading.
Rather this syndrome encapsulates the idea of 'poverty of sociability and
affect'. The associations between difficulty in abstract thinking, conceptual
disorganisation and stereotyped thinking mirrors Liddle's disorganisation
syndrome. A fourth related group of symptoms emerged, characterised by
grandiosity and hostility. This syndrome may attest to an additional sub
pathology not unearthed by the limitations of Liddle's ratings scales i.e. the
Manchester scale (Krawiecka et al., 1977) does not assess the
aforementioned symptoms. The presence and association between these
symptoms may, therefore, reflect the composition of the comprehensive
scale i.e. the PANSS, used in the present study. However, this does not
necessarily detract from any meaningful interpretation of such a syndrome.
In fact, recently, researchers have argued for the inclusion of symptom
ratings reflecting affective and overarousal dimensions of the illness, which
appear to be clinically valid (Liddle et al., 1994). In the present instance, the
association may be a product of the kind of symptoms expressed by a
significant sub group of patients in the sample i.e. recruited from the
treatment resistant study, who might express more florid or 'excitable'
behaviour than groups of stabilised chronic schizophrenic patients. Further
analysis of this sub population's symptom profiles might clarify this. This
fourth syndrome accounted for the smallest level of symptom variance and
what may be concluded, at least, is that these type of grandiose symptoms
are not related to the symptoms characterised by abnormal experiences,
deficit states or disorganisation. These sub syndromes or putative sub
pathologies of illness, it must be emphasised, were derived from strictly
empirical analysis. The degree of meaning which one must give to each
syndrome ought to be dictated by face validity along with an explaination on
a cognitive level. An explaination of the composition of the syndromes is
warranted by which symptoms can be predicted to coexist having a common
cognitive substrate.
Like Liddle and Morris (1991), the present study's reality distortion
syndrome was not correlated with executive/'frontal' type test performance.
Memory performance was also not significantly correlated which may be
surprising as delusions and hallucinations have been associated with
fundamental problems in memory functioning (McKenna, 1991, Gray et al.,
1991). However, in the present study only episodic memory was assessed,
whereas the theory surrounding the generation and use of 'false knowledge'
i.e. delusions, has been attributed to an impairment in the semantic memory
system (McKenna et al., 1994). Despite this, knowledge of any kind must be
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acquired and researchers have highlighted that both semantic and episodic
memory systems constitute a highly interactive system themselves (Parkin,
1987). Therefore, the acquisition of new semantic memories depends, in
part, on normal episodic memory functioning. Here, however, episodic
memory functioning was not associated with the reality distortion syndrome
directly, therefore, abnormal experiences would appear to arise out of a
more indirect and complex cognitive mechanism. Of course, future research
ought to involve specific semantic memory tests to clarify this. Time
limitation and the overall size of the test battery dictated preference of the
episodic memory assessment, particularly in the light of recent literature
implicating an impairment in this system, with various heterogeneous groups
of schizophrenic patients (McKenna et al., 1990; Tamlyn et al., 1992). An
alternative explaination for the genesis of such symptoms i.e. abnormal
experiences, within the context of the other findings in this study, is
addressed below.
The poverty of sociability and affect syndrome here expectedly significantly
negatively correlated with semantic word production but, however, not with
initial letter production. In fact, this syndrome seemed to be characterised
rather by poor simple working memory and episodic memory. Surprisingly,
perhaps, it was not significantly related to psychomotor ability. We,
therefore, have deficit type symptoms, characterised by muted social and
expressive functioning, related to short term and long term episodic memory
dysfunction, although the verbal fluency correlation might suggest slowing
of functioning, as well as a semantic accessing problem. Poor social
cognition, in terms of using inappropriate social knowledge, has been
implicated in formation of schizophrenic symptoms, especially in the realm of
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misinterpreting others social behaviour in terms of intentions and beliefs,
resulting in persecutory delusions (Frith, 1992). This inability to represent
the intentions and beliefs of others has been termed as lacking a 'theory of
mind'. Frith (1992; 1994) has also shown that an inability to represent
intentions can apply to individuals' personal goal directed behaviour which
might explain the delusional passivity phenomena characteristic of
schizophrenic behaviour. However, the inability to correctly assess the
intentions of others might go far to explain the deficits in social functioning
described in the present study. Frith (1992) also states that the fundamental
impairment associated with deficit or negative symptoms is an inability to
generate self initiated spontaneous action. Therefore, if an individual has an
inability in determining others social behaviour and has difficulties initiating
their own social behaviour, poor social relations predictably occur Within
the context of the present results, we might hypothesise that the connection
between poor memory functioning and social and affective deficits arises
from the inability to either access appropriate social knowledge for present
functioning or that the memory dysfunction is developmental and insidious
so that appropriate social understanding/knowledge memories have failed to
be encoded in the first place. Experimental studies have confirmed that
schizophrenic patients display a significant level of'social naivete' compared
to manic patients and depressed patients (Cutting and Murphy, 1990). The
case for this lack of social knowledge as resulting from poor developmental
social experiences has been supported by Foerster et al (1991) who found
that the chronic negative features of schizophrenia are significantly
associated with social difficulties in childhood. It is also interesting that
similar social empoverishment has been observed as a fundamental feature of
autism, which is usually of early onset, and has been associated with lacking
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a 'theory ofmind' (Wing and Gould, 1979; Frith, 1994). The evidence might
suggest that poor episodic memory functioning (and, speculatively,
associated semantic memory dysfunction) resulting in poor social cognition
and judgement, and social empoverishment, exists at an early stage of
development and is an insidious process that affects adult social relations.
The evidence would also suggest that poor episodic memory is a central
feature of adult schizophrenic functioning and thus might have implications
for therapeutic programmes involving social education.
The association between disorganisation and memory dysfunction involving
recognition tests, working memory and long term episodic memory was
robust despite current global intellectual levels. Only continuous
performance test correct responses, from the executive test battery,
remained significantly associated with disorganisation, after controlling for
current intellectual levels. This lack of association with many of the
executive functioning test performances does not support Liddle and Morris
(1991) who found strong correlations between Stroop test perffomance,
verbal fluency and perseverative errors on the Wisconsin Card Sort Test and
their disorganisation syndrome. These results were suggestive of an inability
to inhibit the effect of inappropriate mental activity on current functioning.
This pattern of results resembles the neuropsychological functioning of
patients with frontal lobe lesions (Liddle and Morris, 1991). Instead, in the
present study those behaviours traditionally associated with frontal lobe
deficits i.e stereotypy and disorganisation of thinking are related to deficits
in memory functioning. This pattern may suggest a form of frontal lobe
amnesia as the organisational difficulties seen with frontal lobe patients can
have a major effect on either the encoding, storage or retrieval of
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information (Shallice, 1988) Before controlling for current intellectual
levels, there was some evidence to suggest that the disorganisation syndrome
was related to executive or 'frontal' type deficits in the form of verbal
fluency (initial letter version) and continuous performance test (CPT) correct
and incorrect responding Correct answers on the CPT were still related to
the disorganisation syndrome after controlling for current IQ. Therefore, the
memory difficulties related to the disorganisation syndrome may be due to
organisational problems involving access to and appropriate use of the
memory store The association between frontal type disorganisation and
memory difficulties might also be due to confabulation problems in recall
(Grafman, 1985). Further analysis of the content of the patients' recall could
clarify if this mechanism exacerbated the poor performance. However, the
influence of any executive problems must be subtle as tests involving
planning ability and set shifting ability were not directly related to the
disorganisation syndrome, which is surprising with regard to the latter when
stereotyped thinking was a constituent symptom of the syndrome
After controlling for extrapyramidal side effects, the patterns of the
relationships between syndromes and neuropsychological functioning were
similar but exaggerated. This was quite surprising as one would expect
movement disorders to be associated with impaired functioning, especially in
the executive or 'frontal' domain (Brown et al., 1991). Reality distortion
was still not significantly related to neuropsychological functioning, as a
whole, as was grandiosity. The pattern of significant correlations for poverty
of sociability and affect and disorganisation appeared to resemble significant
associations with current intellectual levels, executive functioning
characterised by verbal fluency and the inability to suppress inappropriate
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material and memory functioning involving short term working memory and
episodic memory. However, these more marked associations could be
products of current levels of intellect, therefore, the associations on
preliminary analysis were seen as more conservative and had been
dissociated from current levels of intellectual ability, and thus more valid
indicators of the connection between syndromes and neuropsychological
functioning.
In summary, it appears that, despite Liddle and Morris (1991) findings, in
the present study, the emergent syndromes of poverty of sociability and
affect and disorganisation are rather more robustly related to poor memory
functioning than executive/'frontal' dysfunction. However, in accordance
with Liddle and Morris (1991), there was some evidence to implicate some
degree of executive association with both syndromes, and that the possibly
expected association between reality distortion and memory dysfunction did
not materialise.
The neuropsychological performance of the chronic group was robustly
inferior to normal healthy controls on executive, memory and psychomotor
functioning but not on tests of hemispatial neglect The latter may be due, in
part, to the 'normalising' of left hemispheric functioning after long periods
on neuroleptics (Tomer and Flor-Henry, 1989). This pattern remained even
after accounting for the poorer educational background of the patients. This
extremely marked deficit in functioning domains of the chronic sample was
seen in the light of the schizophrenic patients showing pre morbid and
current intellectual levels of functioning well within normal limits. The
patients, therefore, showed domain specific neuropsychological dysfunction
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while experiencing intact global intellectual ability. This contrasts with
studies that have demonstrated a decline in intellectual ability in chronic
schizophrenic patients (Nelson et al., 1990) but fits in with models of
execuitve and memory dysfunction, in schizophrenia, that exist
disproportionate to current IQ and/or global cognitive ability (Saykin et al.,
1991, McKenna et al., 1990, Tamlyn et al., 1992). However, in the present
study the relationship between neuropsychological dysfunction and
symptoms appeared more selective. Memory dysfunction was particularly
associated with the sub syndromes or pathologies generated with the large
group of patients, especially poverty of sociability and affect and
disorganisation. Thus, the executive dysfunction expressed by the group
appeared to be independent of the expressions of related symptoms. This
would call into question the emphasis previous research has had on frontal
type functioning in the manifestation of schizophrenic behaviour. The
present results would suggest that although groups of schizophrenic patients
may show extremely marked deficits in executive functioning it is memory
problems that appear to be more associated with symptom expression With
the recent interest in memory dysfunction and schizophrenia (McKenna et
al., 1990; Tamlyn et al., 1992), a pattern may be emerging that memory
problems are more directly responsible for the organisation and coping
strategies needed for purposeful behaviour and that frontal type problems
play an adjunctive role in this manifestation (see Saykin et al, 1991).
Delusions and hallucinations and grandiose behaviours, therefore, do arise
not as a direct result of neuropsychological dysfunction but rather from
cognitive problems associated with abnormal beliefs and social reasoning
with neuropsychological dysfunction, perhaps, playing a complementary role
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by magnifying stressors or depriving individuals of the abilities essential for
coping with them (Bentall, 1994). The cognitive processes responsible for
these types of syndromes may be, therefore, understood in terms of cognitive
biasing, rather than deficts, underpinned by gross neuropsychological
deficits, but also implying that personal and environmental factors have a
major part to play in the formation and maintainance of abnormal
experiences. The data in the present study cannot confirm the influence of
such factors, however, Bentall (1994) suggested a model in which paranoid
delusional behaviour and grandiose behaviour may be different
manifestations of self serving protective behaviour that helps an individual
cope in a threatening environment The perceived threat arises from a
continual catalogue of negative experiences throughout an individual's life.
Therefore, in an attempt to preserve self esteem, persecutory delusions and
grandiose behaviour result to reduce the attribution of such experiences to
the self. It is of note that both these two syndromes could not be explained
by neuropsychological performance profiles alone in the present study, and,
with regard to reality distortion, had not been in similar previous analyses of
syndrome expression with neuropsychological performance e.g. Liddle and
Morris (1991) and Brown and White (1992). Therefore, further study is
warranted that analyses such abnormal experiential behaviour in context of
schizophrenic individual's environment and personal histories along with the
neuropsychological deficits, characteristic of chronically ill schizophrenic
patients, in a wider appreciation of the cognitive mechanisms that underpin
such behaviours.
CHAPTER 4: NEUROPSYCHOLOGY. SYMPTOMS AND ACUTE
SCHIZOPHRENIA
4.1 Introduction
It has long been established that patients diagnosed as schizophrenic perform
poorly on a range of tests of cognitive functioning (Kolb and Wishaw,
1983). Because of the variable expressions of the illness, it is extremely
difficult to derive any understanding of which cognitive impairments
underpin which symptoms of the illness through group studies involving
heterogeneous samples of patients who happen to have the blanket diagnosis
of schizophrenia Researchers have deemed it necessary to either classify
patients into relevant subgroups of the condition according to treatment
response (May et al., 1988), or to dispense with group characteristics and
analyse the nature of symptom expression individually (see Bentall, 1988) or
by analysing related symptom patterns or subsyndromes of the illness (Crow,
1980; Liddle, 1987). The purpose of which is to clarify which particular
facets of cognitive dysfunction underlie particular symptoms or 'sub-
syndromes' of related symptoms. Studies have shown that patients
expressing the positive features of schizophrenia perform better than those
with predominantly negative symptoms, across a wide range of tests
(Andreasen and Olsen, 1982). However, seeing schizophrenia as a simple
dichotomy of symptom profiles does not appear to account for the observed
variation in symptom profiles or cognitive performance (Liddle, 1987).
Liddle (1987) and Liddle and Barnes (1990) suggested that the
heterogeneous nature of schizophrenia arises from the occurrence of
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particular pathological processes possibly associated with some fundamental
abnormality, peculiar to schizophrenia as a distinct disease entity, rather than
expressions of distinct illness types The different pathological processes
ought to have particularly related sets of symptoms or syndromes that can
coexist in an individual to differing degrees depending on environmental
and/or constitutional factors. Such a system of potentially coexisting
differing dimensions of psychopathology had been previously proposed by
Crow (1980), although this was based on the traditional positive (acute
phase) and negative (chronic phase) dichotomy, encompassing the problems
cited above and highlighting the potential to confuse symptom profiles and
stages of the illness.
Liddle (1987) and Liddle and Barnes (1990) tried to clarify the relations
between symptoms, by factor analysis of symptom profiles, in order to
produce empirically derived syndromes of the illness. The authors were able
to segregate the symptoms, from samples of stable chronic schizophrenic
patients, into three factors or sub syndromes of illness Firstly, their self-
termed 'psychomotor poverty' syndrome was characterised by poverty of
speech, flatness of affect and decreased spontaneous movement The
'disorganisation' syndrome was associated with thought disorders and
inappropriate affect. Lastly, delusions and hallucinations were associated as a
'reality distortion' syndrome. Other researchers have been able to produce
similar three syndrome analyses of symptom profiles with similar samples of
patients (Johnstone et al., 1991, Brown and White, 1992).
As an extension of this syndromic approach, Liddle and Morris (1991)
attempted to assess the nature of their emergent syndromes in terms of
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cognitive performance. Psychomotor poverty was related to slowness of
mental activity (including word generation) while disorganisation was
characterised by the inability to inhibit established but inappropriate
responses. Reality distortion was not significantly related to performance on
any of the cognitive tests provided. Brown and White (1992) found
psychomotor poverty to be associated with an impairment on a range of
'frontal' or executive tests but, was also significantly related to tardive
dyskinesia and drug induced Parkinsonism. The same authors had previously
shown that tardive dyskinesia was, on its own, associated with frontal lobe
or executive deficits (Brown et al., 1991). However, the neuropsychological
results remained significant after controlling for the presenting
extrapyramidal side effect ratings. Disorganisation and reality distortion were
not related to psychometric test results, which in the case of the former does
not support Liddle's results. The batteries of tests used in the above studies
concentrated on the well documented evidence for 'frontal' or executive
type deficits seen in schizophrenia (Shallice et al., 1991). The present study
aimed to expand the appreciation of other more recently implicated areas of
functioning to provide a wider appreciation of the variation and integration
of cognitive deficits putatively responsible for schizophrenic
symptomatology i.e. memory dysfuction (McKenna et al., 1990; Tamlyn et
al., 1992; Saykin et al., 1991).
A feature of the above studies is that only stable chronic patients were used.
David (1992) criticised the sole use of such patients in this type of
investigation as chronic schizophrenic patients are well known to show
cognitive impairment on nearly all types of testing, along with apathy
towards prolonged testing that might affect performance. In addition, to
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solely use stable chronic patients is to avoid those patients who, having
experienced florid periods of illness, do get better Therefore, the chronic
group studies are somewhat biased and do not count for the wide range of
illness types, and heterogeneous outcome, seen under the schizophrenia
umbrella. As indicated above, it would be safe to assume that patients in the
early stages of the illness or patients with acute exacerbation's of symptoms
may well express different symptom profiles than chronic stable patients and,
therefore, possibly different cognitive performance profiles. The aims of the
present study were:
a) to factor analyse symptom profiles of a group of schizophrenic patients in
the subchronic phase of the illness or patients with acute exacerbation's of
the illness.
b) In order to assess the nature of the pathological processes involved in the
illness at this stage, any emergent factors were related to neuropsychological
functioning. This study was a preliminary analysis of the nature of florid
symptomatology as the numbers of patients used was relatively small with
regard to the demands of the statistical methods employed. Of course, it was
also necessary to establish the pattern of neuropsychological test
performance exhibited by the acutely ill patients against healthy controls to
assess dysfunction in this group from the norm
The cognitive analysis of this group was determined by theoretical
considerations of the nature of primarily positive symptomatology. The
cognitive impairments putatively associated with negative or deficit
symptoms were also assessed due to the observation that different
syndromes of illness can co-exist at any point in the illness process (Crow,
1980). The types of tests used in the present study followed, in part, the
considerations of the recent work of researchers such as Gray et al (1991),
who proposed a comprehensive neuropsychological model of the positive
symptomatology of schizophrenia as being characterised by a 'failure to
integrate stored memories of past regularities of perceptual input with
ongoing motor programs in the control of current perception' (p.l ). This
type of cognitive impairment, it is suggested, results in ambiguous and
unstructured sensory input. In this context, thought disorder can be seen as
the weakening of moment by moment associations between elements in
discourse resulting in abnormal associations (Gray et al., 1991) Hemsley
(1987) implied that hallucinations resulted from the inability to inhibit the
emergence of material from long term memory resulting in ambiguous
messages entering consciousness and then attributing this to an external
source A deficit in the appropriate awareness of knowledge in current
perception is implied in the work of Frith (1992), where various internally
generated actions are perceived as external in origin due to a failure to
monitor one's own intentions ('source memories' or 'memories for action').
Such impairments may give rise to positive symptoms charactersied as
passivity phenomena. Frith (1992) has also offered an explaination of
negative symptomatology as an inability to generate goal directed behaviour.
Therefore, accounting for the theoretical bases of the above models, in the
present study tests of inhibition, the ability to carry out goal directed
planning and, as indicated above, memory tests were included. Psychomotor
functioning was also assessed with respect to abnormal involuntary
movement disorders and extrapyramidal side effects in light of the
psychomotor poverty syndrome characteristics of the studies with chronic
patient groups so far.
4.2 METHOD
4.2.1 Subjects
Twenty six subjects, (22 males and 4 females) with DSM-IIIR (American
Psychiatric Association, 1987) diagnoses of either schizophreniform
psychosis (7), subchronic schizophrenia (15) or chronic schizophrenia with
acute exacerbation (4), were recruited. The patients were either in- or out¬
patients of the Royal Edinburgh Hospital. Twenty five controls (13 males, 12
females) were also tested on the neuropsychological measures. All patients
and controls were screened for alcohol and/or drug abuse, history of head
injury, and for the patients, history of ECT in the previous six months. None
of the controls had any history of psychiatric problems whatsoever. Age, sex
and number of full time years of education are recorded (see table 1) for
both groups. Table 1 also provides group information for the length of
schizophrenic illness, number of in-patient admissions to a psychiatric
hospital and duration of hospitalisations. Lifetime exposure to neuroleptic
medication and the average maximum dose is also provided calculated in
chlorpromazine equivalents following the procedure of Rey et al. (1989).
Sixteen patients were on neuroleptic medication at testing, 15 on medication
that could be calculated in CPZ equivalents, one female patient was also
taking 1200mg lithium daily and one male patient was solely on 200mg




All patients were assessed on the Positive and Negative Syndrome Scale
(PANSS) (Kay et al 1989) to cover a wide range of positive and negative
symptom ratings. Full details are given in the main Methods chapter. The
patients were also assessed on the Abnormal Involuntary Movement Scale
(AIMS, US Department of Health, Education and Welfare, 1976) and the
Targeting Abnormal Kinetic Effects (TAKE) scale (Wojcik et al., 1980) for
evidence of tardive dyskinesia and parkinsonian side effects, respectively, at
interview. All psychiatric ratings and movement disorder scales were carried
out with the collaboration of experienced and trained psychiatrists.
4.2.3 Neuropsychological Measures
Both the acutely ill patients and the control group were tested on a battery
of neuropsychological tests designed to clarify the cognitive deficits that may
underlie those symptoms that characterise a group of florid and acutely ill
patients with a diagnosis of schizophrenia.
General intellectual functioning was measured by using the National Adult
Reading Test (NART) (Nelson, 1982) as an index of pre morbid ability.
Current intellectual ability was measured with the Quick Test (Ammons and
Ammons, 1962) and general cognitive functioning by use of the Mini Mental
State Examination (MMSE) (Folstein et al., 1975; Dick et al., 1984).
Executive functioning was measured by using a verbal fluency task (FAS
and Animal categories) (from Spreen and Strauss, 1991), a cognitive
estimation task (Shallice and Evans, 1978), a computerised continuous
performance task (Frith et al, 1991), the Stroop test (Trenerry et al., 1989)
and the Trail Making Task (A&B) (Reitan, 1958). Two further computerised
tests of executive functioning were administered from the CANTAB
(Robbins et al., 1991); the Intra/Extradimensional Set Shifting task and the
Tower of London task- a measure of planning ability.
Memory functioning was measured using the Auditory Verbal Learning
Test (AVLT) (Rey, 1964), the Rivermead Behavioural Memory Test
(RBMT) (Wilson et al., 1985), Hebbs Recurring Digits test (Milner, 1970),
the Silly Sentences test (Collins and Quillian, 1969). A computerised
Delayed Matching to Sample task was also administered from the CANTAB
(Robbins et al., 1991).
Psychomotor functioning was assessed using the reaction and motor time
measure from the CANTAB and the Digit Symbol Substitution Test (from
the WAIS-R, Wechsler, 1981).
Details of the administration and scoring of all the above tests with
theoretical backgrounds can be seen in the main Methods chapter.
All subjects were tested at one sitting, if possible, if not all were done on the
same day with convenient breaks. The psychiatric ratings and movement
disorder scales were carried out on the same day as testing (+/-1).
4.2.4 Data Analysis
Factor analysis was undertaken with rating scores of the 14 symptoms (7
positive, 7 negative) from the PANSS scale (for specific symptoms see
Methods). Analysis was similar to that carried out by Liddle and Barnes
(1990). Initial factors were extracted by the method of principal
components. An oblique rotation was performed as there was no a priori
evidence that symptoms should be related. Factor scores were calculated by
the regression method. All analyses were performed using SPSS 4.0 on a
Macintosh personal computer
Pearsons correlations (two-tailed) were used between factor scores and
neuropsychological test results of the acutely ill schizophrenic patient group
Correlations were also performed between factors and education
background, illness duration, length of hospitalisations, duration of
antipsychotic medication and neuroleptic and anticholinergic medication at
interview. The movement disorder scale totals were also analysed with
respect to the emergent factors by correlation.
To analyse the pattern of the acutely ill schizophrenic patient group's
neuropsychological test performance, their results were compared with the
control group Test performance between the two groups was analysed by
combining the measures into groups by function i.e. executive function
performance, memory performance. Comparison was calculated using the
multivariate analysis of variance (MANOVA) to assess any overall effects by
function. Group means were used to account for missing data In the case of
test results, with expected missing data due to the design of the test i.e.
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fewer subjects reaching the more difficult stages of the ID/ED Set Shifting
Task, t-tests (two tailed) were used to analyse group differences. Chi
squared statistics were used to analyse the proportion of subjects per group
reaching each stage of the Set Shifting Task.
4.3 RESULTS
4.3.1 Factor Analysis (see table 2)
Five factors emerged having an eigenvalue greater than one These factors
accounted for 75.8% of the variance. Factor 1 accounted for 33.6% of the
total variance loaded highly on hostility, excitement,
suspiciousness/persecution, stereoptyped thinking poor rapport and
hallucinations. Such a syndrome comprises related symptoms characteristic
of a state of paranoia. This is the most prevalent syndrome in this particular
group of patients. Factor 2, accounting for 16.5% of total variance, loaded
negatively but highly on emotional withdrawal and blunted affect. This
syndrome appears to signify poverty of emotional functioning or affect.
Factor 3, variance 10.8%, loaded very highly but solely on grandiosity.
Factor 4, variance 7.7%, loaded highly on conceptual disorganisation,
passive/apathetic social withdrawal and stereotyped thinking. Such a
syndrome appears to be highlighting aspects of disorganisation and social
dysfunction. Finally, the fifth factor loaded highly on delusions alone.
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4.3.2 Correlations between demographics, neuropsychological test
performance and factors/syndromes (see table 3 for individual
correlations)
As the group of patients was relatively small for a factor analysis comprising
14 variables, only correlation levels of significance between the emergent
factors and performances at the p<01 level were considered. Very few
significant correlations emerged. No significant correlations were found
between the Factors and illness duration, full time years of education, length
of hospitalisations, lifetime exposure to neuroleptic medication or medication
(antipsychotics and anticholinergics) at time of interview. There were no
significant correlations with either movement disorder scale.
Factor 4, 'disorganisation and social dysfunction', was significantly negatively
correlated with completed sets on the ID/ED Set Shifting Task. Factor 5,
'delusions', was significantly correlated with errors incurred on the
intradimensional and extradimensional shift stages of the ID/ED Set Shifting
Task. The only other correlation of note is that between Factor 4 and
number of correct responses on the Delayed Matching to Sample Task for
the 12 second delay condition.
4.3.3 Neuropsychological test performance of Acute Schizophrenic
patients versus Controls
4.3.3.1 Demoeraphics (see table 1)
Firstly, the two groups were not matched for sex ratio. This may not be all
that surprising due to the well known imbalance between the sexes
experiencing schizophrenia at a young age (Kendell, 1986). Since the acutely
ill patients were indeed a young sample, there was a significant difference in
mean age between the groups. There was no difference in the number of full
time years of education or academic history (LR=9.26 df=4 p= 055)
experienced by each group The two groups did, however, come from
differing family backgrounds. The control group came from more privileged
backgrounds as measured by paternal occupation (LR=12.82 df=6 p<05)
while there was a greater likelihood that the schizophrenic patients had a
relative who had or was suffering the same illness (LR=7.26 df=l p<01).
There was also no difference between the groups on a handedness scale
(LR=695 df=l p=.404). The groups did not significantly differ on NART
performance, an estimate of pre morbid intellectual functioning.
Because of the difference in ages between the groups all the comparison
analyses of neuropsychological test performance were carried out using age
as a covariate
4.3.3 2 General Intellectual Performance (see table 4)
There was overall and univariate significant differences in performance on
global measures of current intellectual functioning.
4.3.3.3 Executive functioning performance (see table 5)
On initial analysis of the executive tests the overall group difference was just
more than the p<05 level of significance, at p=069. With this in mind,
univariate analysis showed significantly poorer Stroop performance (word-
colour conditions), reaction time on the continuous performance test number
correct, the semantic (animals) category on the verbal fluency test and the
Trail Making test performances, on behalf of the schizophrenic patients.
The patient grouped performed poorly on the ID/ED Set Shifting Test
reaching criteria on fewer stages of the problem than the healthy controls.
Similar proportions of patients as controls completed each stage except for
15 patients (58%) against 24 (96% )that successfully completed stage 7 (ID
shift reversal) (LR=8.210 df=l p<01). There were no group differences on
trials to reach criteria on either the intradimensional shift (stage 6) (AX:
16.7(19.5), CX: 9(8.9) F=3.012 df(l,45) p=.09) or on the extradimensional
shift (stage 8) (AX: 22.3(17.6), CX: 22(17.7) F=. 124 df(l,38) p=.727).
The computerised Tower of London task showed no group differences
whether considering number of completed sets, number of average moves
per set to complete the problem, motor initiation times, planning initiation
times or subsequent planning times (see tables 6 & 7). The patients showed
slower movement times subsequent to the first move than did the control
subjects.
4.3.3.4 Memory test performance (see table 8)
Overall, the acutely ill patients did not differ significantly from healthy
controls on a wide range of memory tasks. Univariate analyses, however,
showed the healthy controls performing better on a digits forward task
(Hebbs digits), on an episodic memory test (RBMT) and on a test of
semantic memory (Silly Sentences test; number correct and error response
latency). These univariate differences were at a high level of significance.
There was also a trend for the acutely ill patients to score progressively
poorer the longer the delay between the target stimuli and choice stimuli on
the delayed matching to sample task.
4.3.3.5 Psychomotor ability (see table 9)
The acutely ill patients performed significantly worse on a computerised
movement and reaction latency task and also a task of timed visuo-spatial
coding (Digit Symbol Substitution Test). There appears to be a great
difference in overall psychomotor ability in favour of the healthy controls as
assessed on these measures.
TABLE 1
DEMOGRAPHIC VARIABLES FOR ACUTELY ILL
SCHIZOPHRENIC PATIENTS AND CONTROLS
ACUTES CONTROLS SIGNIFICANCE








EDUCATION(yrs) 12.4(2.2) 13.4(2.8) t=-l .44 df(49)
P>1

































FACTOR LOADINGS OBTAINED BY FACTOR ANALYSIS OF
SYMPTOMS OF A SAMPLE OF ACUTELY ILL SCHIZOPHENIC
PATIENTS
SYMPTOMS FAC 1 FAC 2 FAC 3 FAC 4 FAC 5
HOSTILITY 864 -.019 -.058 -.016 -.068
EXCITEMENT .852 .353 .108 .194 -.099
SUSPICIOUSNESS/
PERSECUTION
.823 -.055 -.010 -.121 .230
STEREOTYPED
THINKING
.694 -.140 -.009 .448 .032
POOR RAPPORT .545 -.492 .035 .263 -.017
HALLUCINATIONS .499 -.350 -.339 -.134 -.409
EMOTIONAL
WITHDRAWAL
.346 -.847 .228 -.123 -.132
DIFFICULTY IN
ABSTRACT THINKING
.181 .440 -.041 -.023 .054
CONCEPTUAL
DISORGANISATION
.174 .148 -.240 .825 -.203
BLUNTED AFFECT .138 -.777 -.065 -.002 .289
DELUSIONS .125 -.042 -.140 -.062 893




-.108 -.238 .282 .682 .120
EIGEN VALUE 4.698 2.308 1.516 1.075 1.014
% VARIANCE 33.6 16.5 10.8 7.7 7.2
CUM % VARIANCE 33.6 50.0 60.9 68.6 75.8
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TABLE 3
CORRELATIONS BETWEEN FACTORS, DEMOGRAPHICS AND
NEUROPSYCHOLOGICAL TEST SCORES OF ACUTELY ILL
SCHIZOPHRENIC PATIENTS
DEMOS. FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4 FACTOR 5
ILLNESS -.2652 .4449* .0520 .1692 .0603
DURATION
EDUC. -.1481 .0439 .0348 -.1489 -.1081
DURATION -.4206 -.1477 .0948 -.0346 -.1738
OF
ADMINS.
NEUROLEP -.4101* .0225 .0706 .0591 -.1003
-TIC
DURATION








AIMS .0018 -.0180 .3037 -.0030 .0188
TOTALS
TAKE -.4051 -.2528 .1932 .1336 .1434
TOTALS
TESTS
F .0011 -.2644 .3184 -.1959 .0349
A -.3184 .2210 .1163 -.0435 -.0603
S -.0963 .0320 .1124 -.0506 -.1931
ANS -.2254 .1944 .1808 .0194 -.1226
COG EST. .0165 .0460 -.1504 .1555 -.0745
STROOP .0168 .1655 -.3475 .4183* .0750
TRLSB-A .0010 .0855 -.3035 .1669 -.1225
CPTI -.1311 .0076 -.0106 .3174 -.0864
CPTIRT -.0630 -.2765 -.2514 .3072 .4905*
CPTE .2933 .2944 .0321 -.1224 .0638
CPTERT -.2080 -.1921 -.1118 .1494 .2579
\C\tr
TEST FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4 FACTOR 5
ID/ED
SETS .0816 .4365* -.0060 -.5483** -.1786
TTC ID -.0820 -.2140 -.2323 .2160 .3717
TTC ED .3690 -.4663 -.0391 .4474 .5950
ERR ID .1023 -.1484 -.1422 .2651 .6455**
ERRED .3610 -.4678 .0370 .4858 .6467**
TOWER
AV MOVE2 -.1300 .0227 -.1043 .1558 -.1726
AV MOVE3 -.2323 -.1513 -.2441 .0812 -.1579
AV MOVE4 .0055 .0835 5956** -.0240 -.1284
AV MOVE5 .1541 -.0161 -.4005 -.2427 .0849
MOTORIT2 .1019 -.3481 -.1199 -.0877 .0239
MOTORIT3 -.3745 -.4131 -.1887 .0351 .0209
MOTORIT4 -.2065 -.3652 -.1084 .1586 .0014
MOTORIT5 -.2509 -.2694 -.1028 .2066 -.0863
MOTORST2 .1019 -.3481 -.1199 .0877 .2239
MOTORST3 .3745 -.4131 -.1887 -.0357 .0209
MOTORST4 -.1206 -.3200 -.2659 .2687 .1806
MOTORST5 -.1037 -.2204 -.3156 -.1227 -.1774
PLANIT2 -.1184 -.1491 -.1838 -.0447 -.2630
PLANIT3 .4844* -.3012 .2456 -.2106 -.2411
PLANIT4 .0943 -.0597 -.0648 -.2049 -.2455
PLANIT5 -.1454 .2484 .2261 .5249* -.0266
PLANST2 .0491 -.1727 -.1856 .0252 -.3133
PLANST3 .0975 .0640 -.0740 -.0645 -.1395
PLANST4 .2502 -.2216 -.0488 -.0879 -.2527
PLANST5 .2022 -.1950 .0727 -.1038 -.0415
TEST FACTOR 1 FACTOR 2 FACTOR 3 FACTOR 4 FACTOR 5
AVLT5-6 .3561 -.0089 .0863 -.1452 .3810
HEBS -.2801 -.2002 .4883* -.0843 .1489
HEBS
LEARN
-.1096 -.0499 -.1032 .3440 .3903*
RBMT PRO -.3541 -.2604 .1873 -.4474* .0703
SILLY SENT .0354 -.0378 1851 .1675 0890
SSRT .0595 .1880 -.0870 -.0021 -.1551
CDMS .0704 .0120 .0932 -.1052 .2303
CDMSL -.0376 .0690 .0188 .2721 .3462
CDMO .1482 -.0986 .1519 -.2228 .1148
CDMOL -.1806 .1804 .0355 .1795 .3688
CDM4 -.0084 .0227 -.0963 -.1175 .1243
CDM4L -.0398 .3538 .0979 .3866 -.0288
CDM12 -.0164 -.0521 .0751 .4969** -.2015
CDM12L -.0866 .3139 -.1569 .2035 -.1241
CDMT .0763 -.0288 .0577 -.3263 .0424
CDMTL -.0920 .2988 -.0140 .2973 .1333
MOTOR L .1393 -.3329 -.0970 .1430 -.0781
REACT. L .0019 .0206 -.2334 - 0998 -.0342
DSSR .0920 .1797 .3641 -.1399 .0115
KEY:
EDUC. FULL TIME YEARS OF EDUCATION
ANS ANIMALS
COG EST COGNITIVE ESTIMATION TEST
STROOP STROOP TEST WORD-COLOUR CONDITION
TRLSB-A TRAILS PARTB-A
CPTI CONTINUOUS PERFORMANCE TEST INAPPROPRIATE
RESPONSES
CPTIRT CPTI REACTION TIME
CPTE CPT CORRECT RESPONSES
CPTERT CPTE REACTION TIME
ID/ED SET SHIFT
SETS NUMBER OF COMPLETED SETS
TTC ID TRIALS TO CRITERION OF STAGE 6 (ID SHIFT)
TTC ED TTC OF STAGE 8 (ED SHIFT)
ERR ID ERRORS TO CRITERION STAGE 6
ERR ED ERR TO STAGE 8
TOWER OF LONDON
AV MOVE 2-5 AVERAGE MOVES TAKEN TO COMPLETE EACH SET
MOTORIT 2-5 INITIATION OF MOTOR TIME RESPONSE





PLANNING TIME FOR INITIATING FIRST MOVE
PER SET





















AUDITORY VERBAL LEARNING TEST NUMBER
CORRECT STAGE 5-6
DIGITS SPAN FORWARDS
HEBBS STAGES TO LEARN SPAN
RIVERMEAD BEHAVIOURAL MEMORY TEST
PROFILE SCORE
SILLY SENTENCES TEST NUMBER CORRECT
SS RESPONSE TIME







CDM 12 REACTION LATENCY
CDM TOTAL
CDMT REACTION LATENCY
MOTOR LATENCY ON CANTAB REACTION TIME
TEST STAGE 5
REACTION LATENCY ON CRT STAGE 5
DIGIT SYMBOL SUBSTITUTION TASK FROM WAIS-R
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TABLE 4
PERFORMANCE ON MEASURES OF CURRENT GLOBAL
INTELLECTUAL FUNCTIONING OF ACUTELY ILL SCHIZOPHRENIC
PATIENTS VERSUS CONTROLS WITH AGE (MEANS & SDSL




QUICKIQ 94.6(13.0) 107.4(14 3) 5.229 .027
MMSE 26.9(3.4) 28.9(2.0) 6.068 .017
TABLE 5
PERFORMANCE ON TESTS OF EXECUTIVE FUNCTIONING OF
ACUTELY ILL SCHIZOPHRENIC PATIENTS VERSUS CONTROLS WITH
AGE (MEANS & SDSI.




F 11.3(4.8) 13.5(4.0) 3.383 .072
A 9.5(3.2) 11.5(4.1) 2.753 .104
S 12.2(4.0) 14.6(4.1) 4.013 .051
ANIMALS 17.8(5.0) 21.2(5.8) 4.950 .031
COG EST 8.3(6.5) 4.7(5.5) 3.657 .062




26.8(24.5) 6.6(9.5) 13.259 .001
CPTI 1.9(2.0) 8(8) 3.832 .056
CPTIRT 585(367) 304(346) 7.188 .010
CPTE 9.8(8) 9.8(4) .709 .404
CPTERT 657(96) 586(148) 8.114 .006
TABLE 6
COMPLETED SETS AND AVERAGE MOVES TAKEN PER SET FOR
PERFORMANCE ON THE TOWER OF LONDON TASK OF ACUTELY ILL
SCHIZOPHRENIC PATIENTS VERSUS CONTROLS WITH AGE (MEANS
& SDS).







4 39(6) 4(0) .954 .334






2 2.1(3) 21(4) .317 .576
3 3.6(8) 3.2(4) 5.040 .030
4 5.5(1.0) 5.7(1.0) .236 .630
5 7.3(1.2) 6.9(1.4) .254 .617
\c\c(
TABLE 7
INITIAL MOTOR AND PLANNING TIMES PER DEGREE OF TASK
DIFFICULTY AND SUBSEQUENT MOTOR AND PLANNING TIMES PER
MOVE PER DEGREE OF TASK DIFFICULTY FOR TOWER OF LONDON
PERFORMANCE OF ACUTELY ILL SCHIZOPHRENIC PATIENTS
VERSUS CONTROLS WITH AGE (MEANS & SDS in ms)







2 1646(557) 1694(1140) 1.968 .168
3 1332(369) 1277(391) 2.044 .160
4 1570(1108) 1397(520) 1.409 .242







2 1137(294) 1063(563) 2.355 .132
3 1448(434) 1225(279) 7.365 .010
4 1350(390) 1060(276) 14.824 .000







2 2093(2193) 1498(938) 1.654 .205
3 3370(1993) 3072(2115) .995 .324
4 3747(2769) 3893(2287) .098 .756







2 309(405) 334(443) .044 .835
3 996(1488) 1494(6075) .300 .587
4 1419(1064) 1640(1710) 1.083 .304
5 1115(995) 1098(1479) .557 .460
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TABLE 8
MEMORY TEST PERFORMANCE OF ACUTELY ILL SCHIZOPHRENIC
PATIENTS VERSUS CONTROLS WITH AGE (MEANS & SDS-reaction
latencies in ms)




AVLT5-6 2.2(2.7) 1.4(1.3) 1.500 .227
HEBBS 7.1(1.10 7.9(1.0) 7.200 .010
HEBBS (L) 4.5(2.3) 3.7(2.0) .250 .619
RBMT
PROFILE




48.1(2.9) 49.8(6) 6.363 .015
SS RT 842(345) 752(157) 1.847 .180




NO DELAY 91(9) 9.5(1.0) 6.670 .013
RL 3179(659) 2988(773) 4.033 .050
OS DELAY 8.0(1.8) 8.4(1.2) 1.417 .240
RL 2933(598) 3034(842) .224 .638
4S DELAY 7.4(1.6) 8.6(1.3) 8.549 .005
RL 3563(870) 3214(849) 2.179 .146
12S DELAY 6.3(1.9) 8.2(1.6) 11.907 .001
RL 4096(1043) 3767(1060) 3.418 .071
TOTAL 30.9(4.5) 34.7(3.6) 2.772 .001
RL 3412(640) 3253(761) .102
Xo\
TABLE 9
PERFORMANCE ON TESTS OF PSYCHOMOTOR ABILITY OF
ACUTELY ILL SCHIZOPHRENIC PATIENTS VERSUS CONTROLS WITH
AGE (MEANS & SDS1







581(208) 434(125) 7.444 .009
REACTION
LATENCY





44.6(14.10 57.0(12.0) 15.875 .000
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4.4 DISCUSSION
The five emergent factors from the present analysis of acutely ill schizophrenic
patients' symptoms differed greatly from those derived from studies using samples of
stable chronically ill patients e.g. Liddle (1987); Liddle and Barnes (1990), Brown
and White (1992). The factors yielded in the present study indicated separate entities
of empirically related symptoms characterised by a 'paranoid state', 'poverty of
affect', 'grandiosity', 'disorganisation and poverty of sociability' and 'delusions'. The
symptoms entered into the factor analysis, therefore, showed different relations than
those that composed the 'psychomotor poverty', 'disorganisation' and 'reality
distortion' of the above studies. The factors in the present study may, of course,
represent nothing more than spurious findings due to the small number of patients'
symptoms entered into the factor analysis. The factors are also representative of those
symptoms that appear on the rating scale being used. The use of the PANSS scale
might, therefore, expose close relations between symptoms some of which have not
been entered into previous analyses. The PANSS, however, was used due to its
comprehensive inclusion of clinically valid symptomatology and the degree to which
the severity of symptoms could be recorded (see Methods). These attributes have
been suggested as advantageous in intensive studies of schizophrenic
symptomatology over more traditional and limited measures (Kay et al., 1989) It is,
therefore, possible that the characteristics of the factors in the present study are a
comprehensive representation of the sub syndromes or pathologies of illness at an
acute or early phase of illness. The sample of early or acute phase schizophrenic
lo3>
patients is likely to be comprised of individuals of mixed prognosis i.e. that, after
experiencing a single or small number of episodes some patients are likely to recover
and not relapse i.e. patients of good prognosis. The samples of chronic patients would
comprise only those patients of poor prognosis that have not recovered. Therefore,
the comparison of symptom expression between acute and chronic stages of illness
ought to consider the differences in patient types that constitute the different groups
In effect, the repeated findings of the three syndrome 'model' of schizophrenic
symptoms might be characteristic of poor outcome and thus not representative of the
heterogeneous outcomes seen in schizophrenia as a whole. The difference in factor
type, between the acute and chronic stages of the illness, might also reflect the
instability of individual symptom profiles at an extremely florid early stage of illness
The numbers of patients used in the present study was, however, very small especially
with regard to the demands of the statistical analysis used Thus, any interpretation
should regard the present results as a preliminary analysis which might provide
direction for future larger studies. The small number of patients used in the present
study also attests to the difficulty in the recruitment and completing of relatively
demanding psychiatric and neuropsychological assessments of floridly ill patients
There were very few significant relationships between neuropsychological
performance and the emergent factors. In fact, in considering the exhaustive nature of
the neuropsychological battery used, the symptom groups appeared independent of
any direct underlying cognitive abnormalities In similar studies involving chronically
ill patients 'psychomotor poverty' has been related to slowing of mental activity
loHr
(Liddle and Morris, 1991, Brown and White, 1992) and 'disorganisation' has been
significantly related with disinhibition (Liddle and Morris, 1991). In these studies the
'reality distortion' sub syndrome has only been related to an impairment in figure-
ground perception (Liddle, 1987). In the present study, those dimensions of cognition
involving executive, memory and psychomotor functioning, as assessed by the many
varied tests used here, failed to uncover any direct underlying cognitive abnormalities
that might explain the various sub pathologies of illness at an acute stage. This may
be, in part, due to the 'state' nature of the symptom ratings of a highly unstable group
of patients whereas the neuropsychological performance of this group could be
assumed as more 'trait' like. Thus the continuous variation in acuteley ill patients
symptom expression may provide too much 'noise' to show any direct associations
with underlying neuropsychological impairments. This may, of course, mean that the
empirical relations between symptoms and, therefore, resultant syndromes are
unstable and invalid. This possibility must be taken into account during the following
interpretation of the study's findings. Despite this, the comparison of the acute patient
samples' functioning compared to healthy controls exposed a broad range of
cognitive impairment despite equivalent pre morbid functioning levels. There was a
difference in sex ratio and age between the groups that is representative of the early
stage of illness under investigation, and that males are more likely to experience first
onset of illness at a younger age than females (Kendell, 1986).
Despite the age differences between the groups, the acutely ill patients displayed
significantly poorer current general intellectual functioning. In the comparison of
ZoS
executive functioning, the patients showed significant impairments on tests measuring
verbal fluency by semantic category, attention shifting and ability to inhibit
inappropriate responses and subsequent (to the first move) motor times, especially on
the harder tasks of the Tower of London test. However, the groups could not be
differentiated on planning ability. The patient sample also showed memory
impairments on both short term auditory recall and long term episodic and semantic
memory measures. Non verbal recognition memory was also compromised
particularly on delay dependent test conditions. Robust overall and univariate
differences were exposed on the analysis of the groups' psychomotor functioning. It
has already been noted that the acutely ill patients motor times were significantly
poorer than the controls in completing the Tower of London tasks The acutely ill
group appears to have major difficulties with speed of cognitive functioning.
The emerging picture, in the present analysis, is one of acutely ill patients showing
major cognitive impairments in executive, memory and, particularly, psychomotor
functioning. All these areas of neuropsychological functioning have been implicated
as characterising schizophrenic functioning, as a whole, usually, with heterogenous
samples of patients (see Kolb and Wishaw, 1983, McKenna et al., 1990 and Pantelis
et al., 1992). In particular, the present results support the accumulating evidence for
memory dysfunction as characterising schizophrenic functioning (McKenna et al.,
1990, Tamlyn et al., 1992; Saykin et al., 1991), especially in relation to the formation
of positive symptoms e.g. Gray et al. (1991). This is noteworthy as the patients in the
present study were charaterised by the florid nature of their illnesses. However, there
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appears to be little direct association between such neuropsychological impairments
and the sub syndromes of related symptoms expressed at this stage of illness. The
expression of illness, in terms of sub syndromes of related symptoms, at the acute
stage, appears to be due to more than the direct effects of domain specific cognitive
deficits derived from performance on the types of neuropsychological tests, however
exhaustive, used in the present analysis. Rather than being independent phenomena,
the cognitive deficits, displayed by the patients at this stage, are more likely to be
secondary deficits that underpin another primary level of psychological dysfunction
more directly related to symptom expression. In any case, if a relation between
neuropsychological performance and symptoms had been found, to say that a long
term memory impairment 'causes' delusional behaviour does not explain the
mechanisms by which the impairment has affected belief acquisition and the use of
false knowledge that comprises delusional behaviour The composition of the sub
syndromes of related symptoms, together with the neuropsychological performance
data, should point to, at least, a theory of the psychological system that mediates
between poor neuropsychological performance and symptom expression. Such an
enterprise using the present data might be somewhat ambitious and would require
further investigations with more theory driven test materials. However, in the light of
recent cognitive models of paranoid delusional behaviour (e.g. Bentall, 1994), that
sub syndrome accounting for the greatest variance in the present study, we might
speculate as to the mediating processes, underpinned by fundamental cognitive
impairments, that give rise to this specific dimension of schizophrenic behaviour
Lo~\
The present study's 'paranoid state' syndrome comprised of hostility, excitement,
suspiciousness/persecution, poor rapport and hallucinations. These symptoms suggest
a process of hyperarousal involving persecutory beliefs with concomitant social
dysfunction and hallucinations. However, we cannot tell if the hallucinations, in this
instance, are paranoid in content, only that they are significantly associated with such
symptoms as suspiciousness/persecution. Further studies might benefit from
additional qualitative considerations of the symptom types. The formation of paranoid
delusions has recently been suggested as due to the schizophrenic patient's cognitive
bias in selective information processing that act as a defence against low self esteem
(Bentall, 1994). Richard Bentall's model of the formation of paranoid delusions
involves the consideration of an individual's place in the social environment, as well
as neuropsychological processes, based on the assumption that this type of delusion
shows intentionality. In essence, the environmental experiences of the schizophrenic
patient including over protective families, controlling responses from medical and
social services and feelings of powerlessness may provide the catalyst for the
formation of persecutory beliefs Research has shown that schizophrenic patients
expressing persecutory delusions make external, stable and global attributions for
negative events and excessively internal, stable and global attributions for positive
events (Kaney and Bentall, 1989). This process might lead to either persecutory or
grandiose type beliefs that may be seen as the result of the same cogntive bias. It is
interesting that a separate sub syndrome of'grandiosity' was uncovered in the present
study not related to 'paranoid state' or 'delusions' (of other types). Thus, the process
by which paranoid and grandiose behaviour/beliefs may occur in the present study
might be due to a cognitive biasing of information processing that occurs in trying to
cope with extreme stress in one's personal environment. Of course, everyone has to
cope with stress as part of everyday life, so why should the paranoid schizophrenic
individual have to form and maintain such extreme ways of dealing with stress9 The
answer is probably two fold. Firstly, paranoid/grandiose behaviour can be seen as
lying at the end of a long continuum of beliefs held by individuals or groups wishing
to make sense out of their environments. An obvious example is of religious beliefs
that provide much comfort and 'explanation' of personal circumstances for an
individual. Secondly, it has been noted that schizophrenic individuals have particular
difficulties in social inference or 'theory of mind' (Frith, 1992). A lack of 'theory of
mind' is expressed by the inability to infer mental states in others, in terms of beliefs
and intentions, and has been suggested as the basis of the social and communicative
impairments seen in autistic individuals (Baron-Cohen et al., 1985). In this model,
paranoid thinking and hallucinations of the third person are explained by a
misinterpretation of others beliefs and intentions in a negative self-referential manner
rather than lacking this ability completely (Kaney and Bentall.,1989). This type of
impairment would suggest that the formation of paranoid delusional ideas and third
person hallucinations result from poor social competence or cognition Recent studies
highlighting disproportionate episodic memory dysfunction in various groups of
schizophrenic individuals (McKenna et al., 1990; Tamlyn et al., 1992) and the misuse
of appropriate regularities of input on present functioning (Gray et al., 1991) would
signify that such cognitive impairments would underpin the schizophrenic patient's
inability to access and apply appropriate social knowledge to new situations. Whereas
deficit symptoms would signify that there has been a complete shut down of social
cognition (or due to poor experience of social situations, the knowledge for
competent social activity has not been laid down at all), the impairment resulting in
paranoid behaviour would signify that only episodic material of a self-negating bias is
retrieved or that only self-negating episodic information is laid down in the first place,
due to negative experiences. This latter explanation would tie in with the Bentall
(1994) model expressing paranoid behaviour as predominantly a cognitive bias that
results from poor personal experiences and stressful social environment along with
poor neuropsychological processes. The paranoid syndrome in the present study may
fit in with such a model and explain that the formation of such a sub syndrome is due
to more than a direct correlation relationship with poor episodic memory functioning
but that the evident dysfunction within this area compared to normal functioning has a
significant part to play in the formation and maintenance of such paranoid symptoms
The other neuropsychological impairments expressed in the acute sample would also
figure in the formation of these types of symptoms as the poor executive functioning
abilities characterised by disinhibition and semantic word fluency along with semantic
memory impairments would indicate that the system responsible for the
misinterpretation of social situations involves an impairment in the control of the
close interaction between the episodic memory system and the laying down of social
knowledge (autobiographical or otherwise) as 'facts' in the semantic system (Parkin,
1987). The impairment in executive functioning would also indicate a difficulty in
using stored social knowledge appropriately in novel situations, where the ability to
make inferences is imperative (see Shallice, 1988). The psychomotor difficulties of
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these patients may implicate that sub cortical pathology might have a significant
influence on cognitive ability, especially executive or frontal ability, that is evidently
impaired in the present patient sample. This type of impairment has been suggested as
underpinning the negative aspects of schizophrenia (Pantelis et al., 1992) and is
possibly involved in the formation of a syndrome as 'poverty of affect'. Pantelis et al.
(1992) suggested that bradyphrenia or cognitive slowing has much in common with
the the characteristics of sub-cortical dementia, which is, in turn, charactersied by
memory problems with information retrieval. As the memory impairments may be
integral to the understanding of the syndromes in the present study, the robust
psychomotor ability differences between the acute sample and controls might indicate
the specific mechanism i.e. retrieval that characterises the memory impairment shown
here.
In conclusion, the five emergent factors or sub syndrome sof acute schizophrenia
were not related to neuropsychological functioning directly The significant
impairments in the areas of executive and particularly, memory and psychomotor
functioning, might indicate which neuropsychological mechanisms underpin the
cognitive biases, that result in impaired social cognition, that, in turn, more directly
underpin the syndromes expressed at this stage of the illness. In comparison to studies
of the sub syndromes of stable chronic patients, the acute stage appears to involve
more disparate syndromes, highlighting a 'paranoid state' sub syndrome that fits into
recent studies explaining such behaviour as an amalgam of personal, environmental
and neuropsychological deficits. Future studies ought to take into account an
x»\
individuals relationship with their environment, especially in the investigation of
symptom expression in first episode schizophrenia Most first episodes of
schizophrenia arise as a disease of early adulthood, and may be explained when levels
of personal and environmental stress interact with fundamental neuropsychological
impairments that results in bizarre beliefs and behaviours which protect the
individual's self esteem, in terms of coping, but leaves a dependence on a behavioural
system incompatible with healthy social relations.
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CHAPTER 5: THE NEUROPSYCHOLOGY OF TREATMENT RESISTANT
SCHIZOPHRENIA. MEDICATION AND SYMPTOMS.
5.1 INTRODUCTION
5.1.1 Neuroleptic Medication in the treatment of Schizophrenia
Antipsychotic medication has been available to clinicians for over 40 years. Due to
their ameliorating effects on schizophrenic symptoms, in particular positive
symptoms, these drugs have enabled many patients to resume relatively normal lives.
Antipsychotic or neuroleptic medication is presently prescribed for both the treatment
of acute exacerbations of schizophrenic symptoms and for the prevention of relapse in
patients who have recovered from a psychotic episode (Marder et al., 1991).
However, the process by which neuroleptics produce their beneficial effects is largely
unknown (King, 1990). The mediation of typical neuroleptic activity has been
proposed as an affinity for blocking dopamine, in particular D2, receptors (Petroutka
and Snyder, 1980, Creese, 1983). In light of additional research demonstrating that
dopamine agonists (i.e. amphetamines) can induce psychotic behaviour (Connell,
1958, Meltzer and Stahl, 1976), overactive dopamine neurotransmission has been
favoured as an underlying explanation of schizophrenic symptomatology. In fact,
studies have shown that dopamine antagonism is necessary in the amelioration of
symptoms (Johnstone et al., 1978). However, there appears to be a delay between
neuroleptic metabolism and clinical benefit, even though dopamine receptor blockade
happens almost immediately (Cotes et al., 1978). Dopamine blockage may,
therefore, play a role secondary to modulation in a more direct neurotransmission
system or act in a combination of neurotransmissions ultimately responsible for a
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reduction in schizophrenic symptomatology (Frith, 1992). This, as yet, has to be
confirmed
Neuroleptic medication, however, is far from curative and is limited in its activity.
Not all schizophrenic patients derive beneficial effects from medication. Hogarty et al.
(1974) estimates about 50% of patients relapse within two years despite medication.
Davis et al (1980) reported that up to 20% of patients derive very little or no benefit
at all from typical neuroleptic medication
A major limitation of standard antipsychotic drugs are thier proclivity to produce,
often serious, extrapyramidal side-effects (EPS). In an epidemiological review, Ayd
(1983) found 62% of his large sample (n=5000) to have neuroleptic-induced EPS
Intermediate EPS i.e occurring after weeks/months of medication, of the
phenothiazine (e.g. chlorpromazine) and butyrophone (e.g. haloperidol) classes of
antipsychotics include parkinsonian-type symptoms e.g. rigidity, tremor, akinesia
(poor motor initiation) and bradykinesia (motor slowing) (Marsden et al., 1975).
These types of symptoms have been suggested as occurring in approximately 40% of
medicated patients (Enna and Coyle, 1983). An obvious problem of such side effects,
as akinesia and bradykinesia, is their similarity to the deficit state symtoms of
schizophrenia and their possible misinterpretation as clinical symptoms such as
flattened affect ( Mayer et al., 1985; Blanchard and Neale, 1992). However, these
type of EPS can be reduced by either concomitant anticholinergic medication e.g.
procyclidine, or by termination of medication. Akathisia, distressing subjective
restlessness, can also occur after intermediate antipsychotic administration, but has a
poorer response to adjunctive medication although beta-blockers may provide some
respite (Black et al., 1985). A more serious form of EPS which occurs after
protracted periods on antipsychotic medication i.e. months/years is tardive dyskinesia
which is characterised by abnormal involuntary movements, particularly of the mouth,
perioral area, limbs and trunk (Black et al., 1985). This state may be irreversible and
can get worse after drug withdrawal (Stahl and Wets, 1988)
Although, adjunctive medication is prescribed to counter the concomitant EPS of
neuroleptics (i.e. anticholinergics e.g. procyclidine), researchers are looking at drugs
beyond typical antipsychotics whose activity can potentially avoid disturbing and
often permanent side effects. One of the, initially, most promising of these atypical
drugs is clozapine. Clozapine is a dibenzodiazepine with a relatively weak affinity for
D1 and D2 receptors but possesses significant blocking effects for serotonergic,
alpha 1 and histaminergic receptors, as well as possessing potent anticholinergic
properties. Because of its anticholinergic properties and weak dopamine affinity,
clozapine elicits few side effects associated with typical neuroleptics, including tardive
dyskinesia (Juul Povlsen et al., 1985). Despite these encouraging observations,
clozapine has been associated with other side effects, some life threatening. Deaths
have been reported due to reduced white blood cell counts after clozapine
administration (Griffith and Saameli, 1975). Despite such potentially harmful
consequences, clinicians believe that clozapine, with close haematological monitoring,
may have a beneficial role to play in the management of patients who are treatment
refractory to typical medication (Kane et al., 1988, Marder et al, 1991) In a
multicentre trial, Kane et al. (1988) found that schizophrenic patients, shown to be
unresponsive to haloperidol, showed greater clinical improvement including negative
as well as positive aspects of the disease with clozapine than with chlorpromazine
(with adjunctive anticholinergic medication) administration (268 patients were
randomised into separate treatment groups: 126 in the clozapine group, 142 in the
chlorpromazine group). Although, no cases of agranulocytosis occurred, the authors
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suggested that clozapine be restricted to treatment refractory groups of patients as
the potentially fatal side effects of this drug cannot be ignored.
Another atypical neuroleptic of note, that has only recently been marketed in the
U.K., is risperidone. This is a benzioxazole derivative possessing potent serotinergic
(S2) and dopaminergic (D2) blocking properties, but none for cholinergic receptors
(Janssen et al., 1988; Leysen et al., 1988). It has also been shown to provoke fewer
EPS in animals (Megens et al., 1988) and in schizophrenic patients (Borison et al.,
1992) than either typical antipsychotic medication i.e. haloperidol or placebo. Marder
and Meibach (1994), in a multicentre trial in the U.S., looked at the efficacy of
risperidone versus haloperidol versus placebo. One hundred and eighty three patients
randomly assigned to specific treatment groups: placebo, 2mg, 6mg, lOmg or 16mg
Risperidone or 20 mg haloperidol, completed a double blind study of eight weeks
duration Ratings of schizophrenic symptoms were recorded on the Positive and
Negative Syndrome Scale (Kay et al., 1987). Positive symptoms were significantly
lower in the 6mg, lOmg and 16mg of Risperidone and haloperidol groups than in the
placebo condition. Negative symptoms were significantly reduced in the 6mg and
16mg conditions only compared to placebo. EPS were higher in the 16mg and
haloperidol conditions than placebo-there was no difference with the 6mg dose. The
study provided support for risperidone constituting a new potent antipsychotic which
targets both positive and negative dimensions of schizophrenia more effectively than
standard medication without EPS (at low to mid range doses). Similar to the role
proffered for clozapine, risperidone may provide a potent tool in the drug therapy of
treatment resistant patients more likely to be characterised by negative symptoms.
Also, as the efficacy of risperidone indicates a possible role for the serotinergic
system in the mediation of schizophrenic symptoms, further investigations may
Z i io
provide a clearer pattern of the combinations and relative roles of neurotransmitter
systems involved in symptom mediation (Kane, 1994).
5.1.2 Neuroleptic Medication Effects on Cognition in Schizophrenia
The changes in neurochemistry and possible clinical improvements, alluded to above,
would suggest concomitant changes in neuropsychological performance (Blanchard
and Neale, 1992). Research is, therefore, needed to create a bridge between our
understanding of biochemical pharmacology and the physiological mechanisms
underlying abnormal cognitive processes and clinical symptoms' (King, 1990 p. 799).
Indeed, several reviews exist summarising the research to date of the effects of
neuroleptics on cognitive functioning. Spohn and Strauss (1989) concluded that a
certain 'normalisation' of disordered thinking and attention/information processing
follows neuroleptic medication, although normalisation may be limited and not
directly related to clinical improvement. Also, as clinical improvement may possibly
be characterised by amelioration of primarily positive symptoms, some related
psychological functions are probably more 'medication sensitive' than others. Spohn
and Strauss's (1989) review consciously avoided an analysis of neuropsychological
test performance in favour of more general symptom related psychological functions.
In a review encompassing neuropsychological test performance and neuroleptic
effects, Cassens et al. (1990) found that acute administration of neuroleptics may
impair performance on some but not all tasks requiring vigilance and attention and
some tasks requiring motor functioning. However, improved performance on tasks
involving sustained attention and visuospatial problem solving skills appears to
follow chronic administration, less so at high doses (Spohn and Strauss, 1989)
Improved performance on nine out of twelve tests of cognitive functioning was found
after chronic administration of haloperidol and fluperlapine (an atypical neuroleptic
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resembling clozapine) despite impaired performance after single doses, fluperlapine
also improved psychomotor ability after chronic administration (Saletu et al., 1986)
Despite this dichotomy, other reviews have concluded that, despite improvement on
some tasks involving attention, there are actually very few changes in
neuropsychological test performance even after chronic continuous neuroleptic
administration (Heaton and Crowley, 1981). Medalia et al. (1988) concluded that
neuropsychological functions may be affected differentially by neuroleptic action
Memory and fine motor co-ordination impairment was related to anticholinergic
effects and dopamine blockage respectively. There was also some suggestion that
neuroleptics may compromise planning ability. However, tests of language, attention,
intelligence gave equivocal results while no changes were found in performance on
tests of visual-motor co-ordination e.g. trail making test and digit symbol substitution
In fact, no consistent evidence was found for improvement in any of the
neuropsychological tests.
The use of differing experimental designs and methods may explain the variation in
the reported effects of neuroleptics on cognition (King, 1990). More consistent
evidence exists for the deleterious effects of commonly prescribed anticholinergic
medication on cognition, in particular memory functioning (Frith, 1984).
Anticholinergics such as procyclidine and benztropine are prescribed to counter EPS.
Impaired verbal recall has been particularly implicated after anticholinergic
administration (Tune et al., 1982, Strauss et al., 1990). In a comparison using
matched recall and recognition tests, Calev (1984a) found that patients medicated
with neuroleptics and anticholinergics performed more poorly on both tests than
patients taking solely neuroleptics, and more poorly on recall than recognition
However, the same author was unable to replicate these results with a different
patient sample (Calev, 1984b) Despite this, memory problems, again characterised
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by impaired recall, have been reported research studies investigating the effects on
cognition of neuroleptics with anticholinergic properties (Perlick et al, 1986). Other
research indicates that the effect of neuroleptics on memory can be related to the
potency of their individual anticholinergic properties. Eitan et al (1992) found
thioridazine and chlorpromazine to impair short term verbal memory, noticeable only
after cumulative doses, while haloperidol and trifluoperazine improved the same
memory function. These differential drug effects on memory reflect the respective
anticholinergic properties of the individual drugs. It appears that anticholinergic
medication and neuroleptics with potent anticholinergic properties have the proclivity
to produce significant but selective memory impairments in groups of schizophrenic
patients. A problem, however, exists in the investigation of anticholinergic effects on
memory, as marked memory impairment has been recently implicated as characteristic
of the illness itself in drug naive patients (Saykin et al., 1991; 1994).
The effects of neuroleptics on cognition, described above, involve drugs with similar
pharmacological characteristics i.e. the affinity to block dopamine receptors. To date
there are very few studies investigating the effects of the so-called atypical
neuroleptics on cognition, especially concerning 'higher level' cognitive functioning,
with groups of schizophrenic patients. Goldberg et al. (1993) compared a small
sample of patients with schizophrenic symptoms on a range of neuropsychological
tests while taking conventional neuroleptics and again after an average of 15 months
on clozapine. They found that, although symptom scores declined by an average of
40%, performance on neuropsychological tests including the Wechsler Adult
Intelligence Scale-Revised (WAIS-R), the Wechsler Memory Scale (WMS) subtests
and the Wisconsin Card Sort Test (WCST) remained essentially unchanged.
However, many of the test results from both sessions indicated impaired performance
compared to normative data. Therefore, rather than regarding neuropsychological
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dysfunction as unrelated or as an epiphenomenon to the signs and symptoms of
illness, the authors believed their results provided evidence supporting
neuropsychological deficits as '..enduring and fundamental manifestations of the
illness that account for much of the chronic social and vocational disability [typical of
schizophrenic patients]' p.46. Significantly impaired performance was recorded over
time concerning visual reproduction memory, attesting to the possible potent
anticholinergic properties of clozapine.
The effects of neuroleptics on cognition in groups of schizophrenic patients appears
complex. Even considering drugs with similar pharmacological properties, neuroleptic
effects seem to depend on dose, duration of medication, the differing anticholinergic
properties and the specific neuropsychological domains under investigation. The fact
that a small but significant proportion of patients who are treatment refractory may
distort medication effects is also problematic in this type of study (Spohn and Strauss,
1989). An account of the degree and type of EPS exhibited by medicated
schizophrenic patients is also necessary as they may have significant effects on
neuropsychological test performance, especially those involving psychomotor ability,
independent of direct medication effects (Waddington, 1987; Spohn and Strauss,
1989). Researchers should, therefore, take into account all of the above in the study
of neuroleptic action on cognition for valid results.
As stated above, recent studies have attested to the clinical efficacy of the new
antipsychotic risperidone over more conventional neuroleptics (Marder and Meibach,
1994) and to the fact that there appears to be fewer concomitant EPS (Claus et al.,
1991). Its introduction into clinical practice has been heralded a milestone in the
pharmacological treatment of schizophrenia, representing important progress in a
field comprising only the second new antipsychotic drug marketed (in the U.S., at
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least) since 1975 (Kane, 1994). Researchers have also been excited at risperidone
potential to help treatment resistant patients whose only hope, until now, had been
with, clinically limited, clozapine therapy (Edwards, 1994). However, no research, at
time of writing, has been published comparing the neuropsychological sequelae of
risperidone administration against other forms of medication. It is important to see to
what degree cognitive and psychomotor abilities can be effected, with such a potent
antipsychotic, compared to standard medication as compromising of these functions
may well comprise side effects in themselves and have direct effects on clinical usage
(Edwards, 1994). This present study has allowed the comparison of symptom
expression as well as neuropsychological performance in a controlled study over time
to assess the efficacy of risperidone both clinically and neuropsychologically with
respect to standard medication regimes. To our knowledge this is the first time such a
study has been carried out with this new antipsychotic.
5.1.3 Aims of the Present Study
The present study was undertaken to assess the effects of different neuroleptic drug
regimes on neuropsychological functioning, in a controlled trial, over a specified
period, with a significant sub population of schizophrenic patients characterised by
historical treatment resistance. Such an investigation should help our understanding of
how neuropsychological functioning varies with psychopathology and dose in a
comparison of neuroleptics with known different pharmacological properties. The
study was designed to compare the symptom and neuropsychological changes before
and after intensive administration of typical and atypical neuroleptics with standard
medication with a group of patients who remain severely ill despite previous standard
medication. In turn, the results may clarify the neurobehavioural sites of drug action
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and lead to improved knowledge about the psychopharmacological mechanisms of the
respective neuroleptics (Bilder et al., 1992).
5.2 METHODS
The present study constituted a component to a larger study , carried out at the Royal
Edinburgh Hospital in the University of Edinburgh Department of Psychiatry to
compare risperidone and chlorpromazine in an intensive versus standard management
programme of treatment resistant schizophrenia.
5.2.1 Study Design
5.2.1.1 Selection Criteria
The patients were selected from in and out patients at the Royal Edinburgh Hospital
or from referrals from the East Lothian District. All patients had a contemporary
DSMIII-R diagnosis of schizophrenia and conformed to the St Louis (Feighner et al.,
1972) criteria for schizophrenia. All the patients demonstrated a degree of treatment
resistance meeting the criteria ofMay et al. (1988) for level 4 (fair responders), level
5 (poor responders) or level 6 (severe treatment resistance) - see Appendix}. . Each
patient gave written consent to their participation in the study that satisfied the
requirements of the Lothian Health Board, Psychiatry/Clinical Psychology Ethics of
Medical Research Sub-committee.
The patients were randomised into one of three different drug programmes
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All the groups received 9 weeks (63 days) active management. Groups HC and R
were characterised by intensive management. After changing all medication for
patients in groups HC and R to chlorpromazine equivalents, phased increased doses
of chlorpromazine and risperidone respectively were administered up to 150% of
baseline chlorpromazine levels or 16 mg of risperidone per day. If 150% doses were
not clinically feasible maximum tolerated doses were administered. Group C patients
continued on standard medication at the same dose (and injection frequency) together
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with any anticholinergic needed for EPS for the 9 week period, changes were allowed
according to the clinical interests of the individual patients. All drug and clinical
management was carried out by trained nursing staff and senior psychiatrists.
5.2.2 Assessments
5.2.2.1 Neuropsychological Assessment
The neuropsychological test battery constructed for the present study was designed to
encompass tests of neuropsychological functioning sensitive to the underlying
cognitive abnormalities associated with schizophrenic symptomatology. In addition,
the tests had to be presentable in parallel versions to assess functional change over
time minimising practice effects associated with repeated testing.
5.2.2.2 Neuropsychological Test Battery
The neuropsychological tests were grouped by function. The tests were chosen to
assess various dimensions of executive functioning, memory and psychomotor ability
- (see Methods chapter for theoretical background and general description of the
neuropsychological measures used in this study of the neuropsychology of
schizophrenia).
Neuropsychological testing was carried out on four critical occasions. A baseline
assessment was carried out on day 7, one week after the intensive management
groups had been medicated on chlorpromazine equivalents of their pre study
medication. Baseline was calculated on day 7 and not day 0 for two reasons. Firstly,
the patients had to undergo many baseline ratings in terms of psychiatric and
haematological assessments so, in the interests of compliance, ethics and the desire to
avoid 'assessment fatigue', baseline assessments were spread throughout the first
week of the drug trial. No changes in dose were made during this period. Secondly,
as the patients were taking drugs of various pharmacological groups during the pre
study period, taking baseline at day 7 ensured that all the patients were taking the
same medication but at their individual pre study doses, in chlorpromazine (cpz)
equivalents.
Subsequent neuropsychological assessments were made at day 21 (at the end of one
week at 50% of the baseline chlorpromazine dose), day 42 (at the end of one week on
150% of original dose of chlorpromazine for group HC, 16mg of risperidone for
group R or, if less, the individual maximum tolerated dose of the respective drugs)
and day 63 (after 3 weeks on 'maximum' doses). These days were chosen as critical
points to allow the different doses to take effect (see table p. 10).
5.2.2.3 Neuropsychological Measures (See Methods for details and justification)
a) General intellectual functioning was assessed at baseline only. Pre morbid
intellectual functioning was assessed using the National Adult Reading Test (NART)
(Nelson, 1982). Current intellectual functioning was measured using the Quick Test
(Ammons and Ammons, 1962) and general cognitive functioning using the Mini
Mental State Examination (MMSE) (Folstein et al., 1975, Dick et al, 1984).
b) The following measures of executive functioning were assessed on days 7, 21, 42
and 63 using parallel versions.
i) Verbal fluency was assessed by using the initial letters A, W, D and H (four
high frequency letters were chosen from the Thorndike and Lodge (1944) index of
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linguistic frequency for parallel testing and that 'easier' letters may be more
discriminating in schizophrenia studies (Borkowski et al., 1967) and the semantic
category animals. The initial letter and semantic category scores were totalled for
each test session.
ii) The Intradimensional/Extradimensional Shift Test from the CANTAB,
from the practice (day 7), parallel batteries 1 (day 21), 2 (day 42), 3 (day 63). This is
a test of attention shifting ability and visual discrimination learning (Robbins et al.,
1991). The number of completed sets was recorded along with the number of trials to
reach criterion on stage 6 (an intradimensional shift) and stage 8 (an extradimensional
shift). The proportion of patients per group passing or failing each stage of the test
was also recorded to give an overall impression of group performance as not all
patients were able to complete up to either stage 6 or 8.
The next set of executive functioning tests were administered on days 7 and 63 only
due to the lack of parallel versions of the tests.
iii) The Stroop test (Trenerry et al., 1989) was administered to assess change
in the ability to suppress a habitual response in favour of a novel one (Spreen and
Strauss, 1991). A word-colour condition score was calculated to assess this test
performance.
iv) A computerised version of the Continuous Performance Test (CPT) (Frith
et al., 1991) was also administered to assess the ability to suppress inappropriate
responses. The number of inappropriate responses was recorded
v) The Tower of London Test from the CANTAB was administered to assess
planning ability (Shallice and McCarthy, 1982; Robbins et al., 1991). The number of
completed sets, average moves per set, initial and subsequent movement times per set
and initial and subsequent 'pure' planning times per move per solution set
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(experimental-motor control condition times) were recorded, after Owen et al.
(1990).
c) Memory functioning was assessed using the following measures for days 7, 21,
42 and 63.
i) Working memory using digit span, forwards and backwards, was assessed
by parallel versions included in the Randt Memory battery (Randt and Brown, 1983).
ii) Long term episodic memory functioning was measured using the four
parallel versions of the Rivermead Behavioural Memory Test (RBMT, Wilson et al.,
1985). Total profile scores were recorded.
iii) Parallel versions of computerised tests of short term non-verbal
recognition memory were used from the CANTAB. Delayed matching to sample
(DMTS), pattern and spatial recognition memory tests were administered Total
correct scores were recorded for pattern and spatial recognition tests and for
simultaneous, Osec, 4sec and 12sec delay conditions on the DMTS.
d) Psychomotor ability was assessed for all four time points.
i) Average motor and reaction latencies were recorded from stage 5 of the
Reaction Time Task from the CANTAB using parallel versions.
ii) Visuo-spatial coding was assessed using the digit symbol substitution test
(from the WAIS-R; Wechsler, 1981). Parallel versions were constructed using the
original as a template by recoding the reference set. Total correct in 90s was
recorded.
5.2.3 Psychiatric Ratings
Psychiatric ratings were taken on days 7 and 63 using the Positive and Negative
Syndrome Scale (PANSS; Kay et al., 1989), covering 7 separate positive and
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negative symptoms-see Methods for details. Individual positive and negative
syndrome total scores were recorded All ratings were made by a trained senior
psychiatrist.
Signs of tardive dyskinesia were assessed by the Abnormal Involuntary Movement
Scale (AIMS, US Department of Health, Education and Welfare, 1976).
Parkinsonian-type extrapyramidal side effects (EPS) were assessed using the
Targeting Abnormal Kinetic Effects (TAKE, Wojcik et al., 1980). Totals for both
scales were recorded for days 7 and 63.
5.2.4 Subjects
Forty subjects in total, who fulfilled the entrance criteria, took part in, at least part, of
the neuropsychological investigation. The patients were randomised into the three
study groups as shown on table 3 (see Results). Eleven patients (8M, 3F) comprised
the 'high chlorpromazine' group, fourteen patients (13M, IF) comprised the
'risperidone' group and fifteen patients (9M, 6F) comprised the 'control/comparison'
group. One male patient from the risperidone group withdrew after day 21. The
patients were then medicated according to the study protocol as shown on tables 1 &
2 .
5.2.5 Data Analysis
Demographic variables were analysed by multivariate anaysis of variance
(MANOVA) for normally distributed data, by chi square for catagorical data
Symptom ratings, EPS ratings and neuropsychological performance variables were
analysed using MANOVA with repeated measures for two (beginning and end) or
four (days 7, 21, 42 and 63) time points. Within group analyses were carried out
using paired t-tests. All data analysis was carried out using SPSS 4.0 on a Macintosh
Classic II personal computer.
5.2.5.1 Missing Data
It is important to note that missing data was practically unavoidable with such groups
of severely ill patients. Missing data points for neuropsychological tests aswell as
psychiatric ratings resulted from refusal or absence. A summary of the missing data
points can be seen in the appendices. As MANOVA analysis requires full data sets for
processing, it was necessary to account for the random missing data points that
emerged during the study. Although the missing data points were few in number, to
ignore them might have seriously omitted important data sets from final statistical
analysis. To account for some of the missing data individual performance averages
were substituted for the missing points for only one missing data point for groups HC
and R (either day 21 or 42, never both) and only two missing data points for group C
(i.e. day 21 and/or 42), otherwise the points remained void. No averages were used
for day 7 or 63 assessments. This was thought to strike a balance between providing
necessary scores for analysis and accounting for medication change in the intervention
groups. This type of imputing reasonable data points, based on averages, can be
legitimised by the fact that the data points computed were assumed to relate to trends
in closely occurring time points, therefore, not confronting the problem of expected
greater variance between time points seen with more protracted longitudinal data
(Gibbons et al., 1993). However, such computational assumptions should be noted in
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* 13 cases included as one patient withdrew after day 21.
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TABLE 2
STUDY MEDICATION FOR HIGH CHLORPROMAZINE 1HC1.
RISPERIDONE 1R) AND CONTROL (CI GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS.
a) GROUP HC CPZ in mg per day unless stated. P=Procyclidine mgs per day.
PATIENT NO. DAY7 DAY 21 DAY 42 DAY 63
004 1000(1 OP)* 500** 1500 1500
008 200 100 300 300
014 500 250 750 750 (5P)
017 175 87.5 262.5 262.5
102 1000(1 OP) 500(5P) 1500 1500(5P)
103 450 225 675 675
019 400(10P) 200(20P) 600 600
020 800 (1 OP) 400(5P) 1200(5P) 1200(5P)
025 450 225 675 675
035 75 37.5 112.5 112.5
036 400 200 600 600
* (80mg Droperidol PRN) **(120mg Droperidol PRN) additional medication
b) GROUP R (Doses in mg per day)
PATIENT NO. DAY 7 DAY 21 DAY 42 DAY 63
CPZ CPZ RISPERIDONE RISPERIDONE
001 750 375 16 16
007 450 225 8 8
010 500 250 12 12
016 600 300 WITHDREW
105 200 100 8 10
018 700 350 8 8
106 350 175 6 6
022 350 175 12 12
023 700 300 16 16
108 1000 (1 OP) 500 (10P) 4 4
029 400 200 10 10
030 250 125 (10P) 10 10
033 600 300 14 14
034 250 124 6 4
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c) GROUP C (Doses in CPZ equivalents mg per day). Medication for days 21, 42 and
63 same as baseline unless stated.
PATIENT NO. DAY 7 DAY 21 DAY 42 DAY 63
005 400 (1 P/2wks)






013 640 (15P lOmg
Diazepam)
015 565(5P) 965
104 140 (5P in
12mths)
021 1045(15P) 545 (75mg
Imipramine)
107 745 635 (20mg
Tomazepam)
Tomazepam
reduced to 1 Omg
024 924 (5P) 1540
026 305
027 470 (10P)




5.3.1 Demographics (see table 3)
There was no overall group differences for sex ratio or age at the beginning of the
drug trial. No significant overall group difference was observed when duration of
psychiatric symptoms and number of hospitalisations were analysed A significant
overall group effect was demonstrated for time that the patients were judged to be
functioning on level four or more of the May et al. criteria. Further analysis showed
that, despite randomisation, the high chlorpromazine group to have spent significantly
longer on this level of functioning or treatment resistance than either the risperidone
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group (t=3.28 df(23) p< 01) or the control group (t=2.76 df(24) p<05). No
significant difference was seen between risperidone and control groups (t=-. 13 df(27)
p> .05). No overall significant group differences were observed in average cpz
equivalent medication or numbers taking procyclidine over the year preceding the
trial. Education background assessed by number of full time years spent in education
was similar for all three groups. There was no overall difference in pre morbid
intellectual functioning, as measured by NART performance, between the groups.
5.3.2 Symptom Ratings (see table 4)
Table 4 shows mean symptom totals grouped into positive and negative 'syndromes'
for the three study groups for day 7 and day 63 of the trial. Positive symptom ratings
did not show any group differences over time. Negative symptoms again could not
differentiate between the groups over time; mean symptom ratings for each group
remaining relatively constant over the nine weeks.
A within group analysis of positive and negative syndrome scores between days 7 and
63 showed no significant changes in total scores, for HC group, positive symptoms
(t=2.06 df=10 p=067), negative symptoms (t=-.37 df=10 p=.718); for R group,
positive symptoms (t=-.86 df=12 p=.407), negative symptoms (t=-.06 df=12 p=.951);
for C group, positive symptoms (t=l .32 df=14 p=207), negative symptoms (t=96
df=14 p= 355).
5.3.3 Extrapyramidal side effects (see table 5)
AIMS scores did not show any significant group effects over time. TAKE scores
showed a group by time effect indicating that the groups significantly differed on this
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measure of parkinsonian side effects from the beginning compared to the end of the
study. However, further analysis showed that no group significantly differed from
another at either day 7 or day 63, indicating that differences in scores were in
differing directions and no one condition can be considered as superior than another
in reducing scores over time. Inspection of the group means for days 7 and 63 would
appear to confirm this. The results of the individual t-tests between groups were as
follows:
HCvR; day 7 (t=l 69 df=23 p=. 104), day 63 (t=-.48 df=21 p= 633).
HCvC; day 7 (t=l .40 df=24 p=. 176), day 63 (t=-l 64 df^24 p= 115)
RvC; day 7 (t=- 65 df=27 p=.521), day 63 (t=-.76 df^=25 p=452).
5.3.4 General Intellectual Functioning (see table 6)
No overall significant group effects were observed, as assessed by the Quick IQ and
the Mini Mental State Examination at day 7, although there was a trend toward
significance on performance on the Quick IQ
5.3.5 Executive Function Performance (see tables 7 to 16)
Performance on tests measuring various aspects of executive functioning for days 7,
21, 42 and 63 are reported on table 7:
a) On a measure of verbal fluency (initial letter+semantic category totals) no overall
group difference was observed over time. However, each individual group appeared
to significantly improve (by similar degrees) on their performance over time.
b) Performance on the ID/ED Set Shifting Test can be seen on tables 7 and 8. No
overall group differences over time were observed when considering the mean totals
of successfully completed sets of the task. No group differences were also observed
over time for trials taken to reach criterion for both intradimensional and
extradimensional shift stages. Table 8 shows the proportion of subjects per group
passing and failing the intradimensional and extradimensional shift stages. The only
significant group difference occurred on day 63 of the intradimensional set shift, with
45% of high cpz subjects passing this stage, compared with 91% and 86% of
risperidone and control subjects.
Table 9 displays the group performances for the Stroop test and the Continuous
Performance Test (CPT) for days 7 and 63. No overall significant group differences
were recorded over time for the word-colour condition of the Stroop test or for
number of inappropriate responses on the CPT.
Performance on the Tower of London test can be seen on tables 10 to 16. Table 10
refers to the study groups' total number of completed sets per level of task difficulty
for days 7 and 63 of the drug trial. No significant group differences over time were
observed for any of the solution sets. The number of average moves taken to
complete each level of task difficulty for each group over time is shown on table 11
For two move solutions, a significant group by time effect was observed. Further
analysis showed no significant differences between individual groups at either day 7
or 63. The individual between group analyses were as follows:
HCvR, day 7 (t=-l .62 dff=21 p= 120), day 63 (t=. 00 df=18 p= 1.000)
HCvC, day 7 (t= 87 df=21 p= 393), day 63 (t= 36 df^22 p= 719)
RvC, day 7 (t=2.04 df=24 p=.052), day 63 (t= 36 df=22 p= 719)
No significant group by time effects were observed on average moves taken to
complete either 3, 4 or 5 move solutions. However, all three groups improved
significantly over time on their performance on the three move problems.
Table 12 shows the average times per group to complete the first move as part of the
yoked motor control condition of the Tower of London test for days 7 and 63. No
significant overall group by time differences were observed for 2, 3 or 4 move
solution sets. The groups all improved significantly on their 3 move solution
performance over time. Five move solution statistics were avoided as the high cpz
group only possessed five valid cases for analysis which was deemed too few for the
level of analysis required-as was the case for subsequent 5 move solution time
analyses. Movement times subsequent to the first move over time are shown on table
13. Again, no overall group by time effects were observed but there was a significant
overall improvement in the groups' performance on the 3 move problems between day
7 and 63.
Tables 14 and 15 refer to initiation and subsequent (to the first move) 'planning' times
respectively for the Tower of London test for each trial group for days 7 and 63
Planning times correspond to times derived from subtracting yoked motor times from
the experimental condition times. No significant group by time effects were observed
at any level of task difficulty for either initiation or subsequent planning times per
move. There was a significant time effect on subsequent planning times per move for
three move solution problems. Table 16 shows an alternative analysis of the five move
solution data A significant group difference was observed considering the proportion
of subjects reaching the five move solution problems on day 63 with only 64% of the
23b
high cpz subjects attempting this type of problem compared to 100% of risperidone
subjects and 87% of controls.
5.3.6 Memory Test Performance (see tables 17 & 18)
Table 17 shows the performances on the computerised memory tests from the
CANTAB for all three study groups over the period of the drug trial. Table 17 a) to
d) shows group performances on the delayed matching to sample task from the
CANTAB for simultaneous, 0 sec, 4 sec and 12 sec delay conditions for days 7, 21,
42 and 63. No overall significant group differences were recorded over time for any
of the delay conditions. However, for simultaneous and 12 sec delay conditions there
was a significantly similar improvement in performance for all three study groups over
the duration of the drug trial for these test conditions. Table 17 e) and f) shows group
performance on the pattern and spatial recognition memory tests from the CANTAB
for days 7, 21, 42 and 63. No overall significant group differences were observed on
this test over time, although a significant improvement in performance of all the
groups was recorded on the spatial memory test over the testing sessions.
Table 18 a) and b) shows group performances on digit span forwards and backwards
for days 7, 21, 42 and 63. Again, no significant group by time differences were
recorded. Performance on the digits forwards changed significantly to the same
degree for all three groups over the duration of the trial. Table 18 c) displays mean
total profile scores for all three groups on the Rivermead Behavioural Memory Test
(RBMT) for days 7, 21, 42 and 63. No significant overall group difference over time
was recorded
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5.3.7 Psychomotor Ability (see table 19)
Table 19 a) and b) shows the mean motor and reaction latencies from stage 5 of the
Reaction Time task from the CANTAB for days 7, 21, 42 and 63 for all three study
groups. No significant group differences over time were observed on either dimension
of the reaction time measure. Table 19 c) shows group performances on the digit
symbol substitution test over time No significant group differences were observed




DEMOGRAPHICS OF HIGH CPZ VERSUS RISPERIDONE VERSUS
CONTROL GROUPS OF TREATMENT RESISTANT SCHIZOPHRENIC
PATIENTS (MEANS AND SDS)
HIGH CPZ RISPERIDONE CONTROL F RATIO SIG.
N 11 14 15
M:F 8:3 13:1 9:6 LR=4.7 .1
AGE(yrs) 38.2(10.2) 41.7(11.7) 33.9(11.1) 1.79 181
DURATION
OF
16.5(8.7) 18 4(12.5) 12.2(7.9) 1.47 .243
SYMPTOMS
(yrs)
TIME AT 41.9(18.3) 21 7(12.5) 22.5(17.4) 6.04 .005
LEVEL
4+(mths)
No. 6.1(4.6) 7.8(7.4) 13.3(12.2) 2.38 .106
ADMINS
AV. CPZmg 493(273) 471(222) 593(465) .51 .606
last year/day
Numbers 1 2 2 LR= 18 .916
taking Proc.
EDUC.(yrs) 12.1(2.9) 12.6(2.9) 11.2(1.2) 1.41 .257
NART 112.4(8 3) 105.2(11.5) 106.6(10.4) 1.60 .216
IV\
TABLE 4
POSITIVE AND NEGATIVE SYMPTOM RATINGS TOTALS AT DAYS 7
AND 63 FOR HIGH CPZ (HC) VERSUS RISPERIDONE (R) VERSUS
CONTROL (C) GROUPS OF TREATMENT RESISTANT SCHIZOPHRENIC
PATIENTS (MEANS AND SDS)





HC(ll) 18.9 15 5 F=1.77 F=1.33 F=2.44
(7.7) (7.5)
R( 13) 17.2 18.9 P=. 184 P=.256 P=.102
(5.9) (6.7)




HC(ll) 20.2 21.7 F=. 23 F=.08 .62
(5.1) (16.4)





AIMS AND TAKE TOTALS FOR DAYS 7 AND 63 FOR HIGH CPZ
(HOVERSUS RISPERIDONE (R) VERSUS CONTROL (C) GROUPS OF
TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS (MEANS AND
SDS)
GROUP DAY 7 DAY 63 BETWEEN TIME GROUP BY
(n) SUBJECTS TIME
AIMS HC(ll) 6.9(8.8) 6.4(6.9) F=,60 F=83 F=1.59
R( 13) 6.0(6.5) 2.8(3.9) P=.554 P=.369 P=.219
C( 15) 6.3(7.0) 7.2(7.6)
TAKE HC(ll) 14.7(4 1) 12.2(3.9) F= 18 F=.05 F=4 12
R( 12) 12.2(5.0) 13.2(5 6) P=838 P=.822 P=.025
C( 15) 12.5(4 1) 14 5(3.2)
3A0
TABLE 6
CURRENT INTELLECTUAL FUNCTIONING OF HIGH CPZ (HO VERSUS
RISPERIDONE (R) VERSUS CONTROL (CI GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS AT DAY 7 (BASELINE!
(MEANS AND SDS)










95.5 (15.3) 2.59 .089
MMSE 26.8 (5.1) 26.8 (3.1) 25.3 (4.0) .647 .516
TABLE 7
EXECUTIVE FUNCTION PERFORMANCE OF HIGH CPZ (HC) VERSUS
RISPERIDONE (R) VERSUS CONTROL (CI GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS FOR DAYS 7, 21. 42 AND 63
(MEANS AND SDSL
A) VERBAL FLUENCY (TOTALS: INITIAL LETTER+SEMANTIC
CATEGORY)
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 24.6 24.6 27.7 27.5 F=. 19 F=8.36 F= 71
(6.9) (7.9) (8.6) (7.9)
R(10) 23.2 25.4 27.2 25.8 P=,83 P=.000 P=643
(7.7) (7.6) (8.1) (9.5)
C( 13) 20.6 24.6 26.5 24.8
(8.7) (9.8) (10.6) (9.0)
B) NUMBER OF COMPLETED SETS ON THE ID/ED SET SHIFTING TEST
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 5.6 6.3 (2.8) 6.6 (2.8) 4.7 (3.5) F= 1.31 F=2.38 F=76
(3.3)
R(10) 6.7 7.0(2.8) 7.4(2.2) 7.3 (2.5) P=285 P=,089 P=.603
(2.9)
C(14) 7.0 7.0 (2.8) 7.5 (2.1) 7.3 (2.6)
(2.7)
C) NUMBER OF TRIALS TO REACH CRITERION ON STAGE 6 THE
INTRADIMENSIONAL SET SHIFT ON THE ID/ED SET SHIFTING TEST
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 24.6 25.5 18.8 34.4 F=2.26 F=1.54 F=1.23
(17.9) (19.6) (17.4) (21.5)
R(10) 20.0 22.8 14.4 15.5 P= 122 P=.209 P=298
(18.8) (23.1) (13.4) (15.8)
C( 13) 17.8 16.7 12.2 111
(18.5) (15.5) (12.8) (11.9)
D) NUMBER OF TRIALS TO REACH CRITERION ON STAGE 8 THE
EXTRADIMENSIONAL SET SHIFT ON THE ID/ED SET SHIFTING TEST
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 38.6 38.1 38.5 39 5 II'Uh F= 06 F=42
(17.9) (17.4) (17.6) (17.9)
R(9) 34.6 33.1 32.9 35.9 P=642 P=.98 F=864
(18.8) (20.1) (20.4) (18.6)
C(13) 31.8 33.2 36.4 29.6
(21.0) (18.3) (14.5) (20.0)
TABLE 8
PROPORTION OF SUBJECTS SUCESSFULLY COMPLETING (PASSING)
AND FAILING STAGE 6-AN INTRADIMENSIONAL SHIFT AND STAGE 8-
AN EXTRADIMENSIONAL SHIFT ON THE ID/ED SET SHIFTING TEST
FOR DAYS 7. 21. 42. 63 FOR HIGH CPZ (HO VERSUS RISPERIDONE (R)
AND CONTROL fO GROUPS OF TREATMENT RESISTANT
SCHIZOPHRENIC PATIENTS.
A) INTRADIMENSIONAL SHIFT
DAY GROUP (n) PASS(%) FAIL(%) LIKELIHOOD RATIO PROB.
(df)
7 HC(ll) 7(64) 4(36) 1.19 (2) .552
R(14) 9(64) 5(36)
C( 15) 12(80) 3(20)
21 HC(ll) 9(82) 2(18) .60 (2) .741
R(12) 9(75) 3(25)
C(15) 13(87) 2(13)
42 HC(ll) 9(82) 2(18) .78 (2) .678
R( 11) 10(91) 1(9)
C( 13) 13(93) 1(7)
63 HC(ll) 5(45) 6(55) 7.14(2) .028
R( 11) 10(91) 1(9)
C(14) 12(86) 2(14)
B) EXTRADIMENSIONAL SHIFT
DAY GROUP (n) PASS(%) FAIL(%) LIKELIHOOD RATIO PROB.
(df)
7 HC(ll) 4(36) 7(64) .78 (2) .667
R(14) 6(43) 8(57)
C(15) 8(53) 7(47)
21 HC(ll) 4(36) 7(64) .81 (2) .668
R( 12) 5(42) 7(58)
C(15) 8(53) 7(47)
42 HC(ll) 4(36) 7(64) 1.21 (2) .547
R( 11) 5(45) 6(55)
C(14) 8(57) 6(43)
63 HC(ll) 3(27) 8(73) 1.44 (2) .486
R( 11) 5(45) 6(55)
C( 14) 7(50) 7(50)
TABLE 9
EXECUTIVE FUNCTION PERFORMANCE FOR HIGH CPZ (HC) VERSUS
RISPERIDONE (R) VERSUS CONTROL (C) GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS FOR DAYS 7 AND 63 (MEANS
AND SDS)
A) STROOP TEST WORD-COLOUR PERFORMANCE
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(ll) 26.2 (20.9) 25.1 (22.9) F=1.23 F=1.29 F=36
R(9) 34.3 (28 0) 31.1 (23.7) P=.307 P=265 P=699
C(14) 45.3 (30 8) 37.6 (31.3)
B) CONTINUOUS PERFORMANCE TEST INAPPROPRIATE RESPONSES
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY TIME
SUBJECTS
HC(ll) 1.6(2.0) 2.2 (2.0) F=. 16 F=.03 F=,71
R(i i) 2.6(3.7) 1.7(2.5) P=852 P= 862 P= 499
C( 13) 2.4(2.7) 2.4 (3.1)
2^
TABLE 10
THE TOWER OF LONDON TEST NUMBER OF COMPLETED SETS PER
DEGREE OF TASK DIFFICULTY FOR HIGH CPZ (HC) VERSUS
RISPERIDONE (R1 VERSUS CONTROL fC) GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS (MEANS AND SDS) FOR DAY
7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY63 BETWEEN TIME GROUP BY TIME
SUBJECTS
HC(ll) 1 8(6) 1.8(6) F=63 F=74 F=.80
R(10) 2.0(0) 2.0(0) P=542 P=396 P=459
C( 13) 1.7(8) 1.8(6)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY63 BETWEEN TIME GROUP BY TIME
SUBJECTS
HC(ll) 1.8(6) 1.8(6) F-.63 F=. 74 F=.396
R(10) 2.0(0) 2.0(0) P=542 P=396 P=.459
C( 13) 1.7(8) 1.8(6)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY63 BETWEEN TIME GROUP BY TIME
SUBJECTS
HC(ll) 3.6(1.2) 3.6(1.2) F=63 F=74 F= 80
R(io) 4.0(0) 4.0(0) P= 542 P=396 P= 459
C( 13) 3.4(1.5) 3.7(1.1)
D) 5 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY63 BETWEEN TIME GROUP BY TIME
SUBJECTS
HC(ll) 3.2(1.3) 3.2(1.3) F-1.09 F= 1.16 F=29
R(io) 3.7(9) 4.0(0) P=348 P=.290 P=.750
C( 13) 3.4(1.5) 3.7(1.1)
2^
TABLE 11
THE TOWER OF LONDON TEST AVERAGE MOVES TAKEN TO
COMPLETE TASKS PER DEGREE OF TASK DIFFICULTY FOR HIGH
CPZ (HC) VERSUS RISPERIDONE (R) VERSUS CONTROL (O GROUPS
OF TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS (MEANS
AND SDS) FOR DAY 7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 2.0(0) 2.0(0) F=2.29 F=4.20 F=4.09
R(10) 2.4(7) 2.0(0) P=. 119 P=050 P=.027
C(12) 1.8(6) 1.8(6)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 4.1(1.2) 3.7(,9) F=1.82 F=8.41 F=25
R(10) 4.2(1.3) 3.4(6) P=. 181 P=.007 P=.783
C(12) 3.5(1.4) 2.9(1.0)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 5.9(1.0) 6.2(1.1) F=1 32 F=46 F= 89
R(10) 6.4(9) 5.8(1.1) P=282 P=.502 P=424
C(12) 5.4(1.9) 5.3(1.8)
D) 5 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 8.9(2.0) 8.6(2.3) F=2.12 F=1 13 F=.75




THE TOWER OF LONDON TEST MOTOR INITIATION TIMES FOR
HIGH CPZ (HC) VERSUS RISPERIDONE (R) VERSUS CONTROL (CI
GROUPS OF TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS
(MEANS AND SDS in ms) FOR DAY 7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 2132(739) 1889(647) F=3 80 F=71 F=.20
R(i 0) 3755(3936) 3108(2045) P=.035 P=407 P= 823
C(11) 1698(589) 1621(857)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 2346(1034) 1439(332) F=1.22 F=5.75 F=57
R(10) 2567(2355) 2193(989) P=. 312 P=023 P-.570
C(ll) 1871(1122) 1489(509)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 1975(566) 1984(683) F=1.38 F=1.54 F=1.79
R(10) 2713(1845) 1939(605) P=268 P=224 P=. 186
C(ll) 1714(730) 1745(916)
D) 5 MOVE SOLUTIONS-GROUP 1 ONLY POSSESSED 5 VALID CASES-
TOO FEW FOR THE ABOVE STATISTICS RATHER SEE TABLE
IW1
TABLE 13
THE TOWER OF LONDON TEST MOTOR TIMES SUBSEQUENT TO THE
FIRST MOVE FOR HIGH CPZ (HQ VERSUS RISPERIDONE (R1 VERSUS
CONTROL (C) GROUPS OF TREATMENT RESISTANT SCHIZOPHRENIC
PATIENTS (MEANS AND SPS in ms) FOR DAY 7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 1602(466) 1411(625) F=3.97 F=2.24 F=34
R(10) 1721(599) 1565(541) P=.03 P=. 146 P=. 712
C(ll) 1175(241) 1144(211)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 2314(1292) 1598(396) F=2.31 F=6.89 F=.84
R(10) 2113(831) 1917(635) P=. 118 P=.014 P=.443
C(ll) 1720(553) 1341(186)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 1987(433) 1807(382) F=2.65 F=3.35 F=.01
R(10) 2354(808) 2182(790) P=088 P=.078 P=.991
C(ll) 1890(566) 1685(240)
D) 5 MOVE SOLUTIONS-GROUP 1 ONLY POSSESSED 5 VALID CASES-
TOO FEW FOR THE ABOVE STATISTICS RATHER SEE TABLE
TABLE 14
THE TOWER OF LONDON TEST PLANNING INITIATION TIMES FOR
HIGH CPZ (HC) VERSUS RISPERIDONE (R) VERSUS CONTROL (O
GROUPS OF TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS
(MEANS AND SDS in msl FOR DAY 7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 1817(1569) 1491(1719) F=.52 F=2.38 F= 18
R(10) 2692(2091) 1759(1390) P= 600 P=. 134 P= 839
can 2410(2043) 1769(1500)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 4213(3551) 3964(4320) F=. 19 F=l. 16 F=23
R(10) 5659(3999) 4266(4199) P= 830 P= 291 P=798
can 4540(3178) 3930(4273)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 4029(4486) 6139(6807) F=.03 F-. 10 F=1 42
R( i o) 5436(2686) 5912(6599) P=969 P=.760 P=.258
can 7432(12280) 3398(1820)
D) 5 MOVE SOLUTIONS-GROUP 1 ONLY POSSESSED 5 VALID CASES-
TOO FEW FOR THE ABOVE STATISTICS RATHER SEE TABLE
TABLE 15
THE TOWER OF LONDON TEST PLANNING TIMES PER MOVE
SUBSEQUENT TO THE FIRST MOVE FOR HIGH CPZ (HC) VERSUS
RISPERIDONE (R) VERSUS CONTROL (C) GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS (MEANS AND SDS in msl FOR
DAY 7 AND DAY 63.
A) 2 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 587(757) 831(1982) F=47 F=.00 F=.21
R(10) 748(680) 700(1700) P= 631 P=994 P=.810
C(ll) 516(449) 314(353)
B) 3 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 1558(2652) 611(675) F=1.84 F=7.24 F= 43
R(10) 3287(4055) 1209(1150) P= 177 P=.012 P=658
C(ll) 1640(1778) 453(567)
C) 4 MOVE SOLUTIONS
GROUP (n) DAY 7 DAY 63 BETWEEN TIME GROUP BY
SUBJECTS TIME
HC(10) 2909(1758) 3021(2767) F=1.96 F=2.33 F=.78
R(10) 3706(3409) 2616(2153) P=. 160 P=. 138 P=.470
C(ll) 2339(1965) 1076(1055)
D) 5 MOVE SOLUTIONS-GROUP 1 ONLY POSSESSED 5 VALID CASES-
TOO FEW FOR THE ABOVE STATISTICS RATHER SEE TABLE
2SO
TABLE 16
THE TOWER OF LONDON TEST PROPORTION OF SUBJECTS
COMPLETING ALL FIVE MOVE SOLUTIONS FOR HIGH CPZ (HC)
VERSUS RISPERIDONE (R) VERSUS CONTROL (CI GROUPS OF
TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS ON DAY 7 AND
DAY 63.
GROUP (n) LIKELIHOOD RATIO PROB.
(df)
HC(ll) R(14) C(15)
DAY 7 7(64%) 13(93%) 13(87%) 3 .69 (2) .158
DAY 63 7(64%) 14(100%) 13(87%) 7.62 (2) .022
TABLE 17
MEMORY TEST PERFORMANCE OF HIGH CPZ 1HC) VERSUS
RISPERIDONE (R) VERSUS CONTROL (Cj GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS FOR DAYS 7. 21, 42 AND 63
(MEANS AND SDSl.
A) DELAYED MATCHING TO SAMPLE (DMTS) SIMULTANEOUS
DISPLAY
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(10) 7.5 (3.0) 8.4(2.5) 8.5 (2.0) 8.7 (1.8) F=.71 F=4.65 F=,72
R(io) 9.0 (8.4) 8.8 (.9) 9.5(9) 9.5(7) P=498 P=.005 P=634
C(14) 8.4(2.1) 8.9(1.5) 8.9 (2.4) 9 1 (2.4)
B) DMTS 0 SEC DELAY
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(10) 6.5(1.9) 6.8 (2.7) 6.9 (2.6) 7.4 (2.8) F=66 F=2.44 F=1 36
R(io) 7.6(1.0) 7.8 (1.3) 8.3 (1.1) 7.2(1.7) P=524 P=.069 P=239
C(14) 6.4(1.7) 6.9 (1.7) 7.4 (2.4) 7.4(2.0)
1S\
C) DMTS 4 SEC DELAY
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(10) 6.0(1.9) 6.7 (18) 5.7(2.3) 6.6(2.5) F=25 F=57 F=64
R(io) 5.9(2.2) 6.8 (2.0) 7.2(1.7) 6.9(2.1) P=.780 P—1.21 P=.306
C(14) 7.0(2.6) 6.3 (2.4) 6.6 (1.6) 6.9(2.0)
D) DMTS 12 SEC DELAY
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(") SUBJECTS BY TIME
HC(10) 4 2(2.0) 5.7(1.9) 6.1 (2.9) 5.2 (2.7) F=65 F=4.53 F=1.37
R(io) 5.0(8) 7.0(2.7) 6.7 (1.8) 5.7 (2.4) P= 531 P=.005 P=233
C(14) 5.5(1.8) 5.9 (1.8) 5.2(2.3) 5.4(2.0)
E) PATTERN RECOGNITION MEMORY TEST
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 16.4 17.0 17.5 17.7 F=65 F=2.24 F=.26
(2.7) (3.4) (4.1) (4.2)
R(10) 18.0 18.4 19.6 18.9 P= 531 P=.088 P=955
(3.5) (4.3) (3.5) (2.9)
C(14) 17.3 17.5 18.1 17.6
(2.9) (3.7) (4.3) (4.3)
F) SPATIAL RECOGNITION MEMORY TEST
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 12.9 12.4 114 12.1 F=.28 F=4.75 F=.27
(2.0) (2.0) (2.5) (2.5)
R(io) 14.4 13.0 11.8 12.4 P=760 P=,004 P=.951
(2.8) (3.6) (3.4) (2.7)
C(14) 13.4 12.5 11.7 12.8
(36) (23) (31) (35)
2-S1
TABLE 18
MEMORY TEST PERFORMANCE (CONT.) OF HIGH CPZ (HC) VERSUS
RISPERIDONE (R1 VERSUS CONTROL (C) GROUPS OF TREATMENT
RESISTANT SCHIZOPHRENIC PATIENTS FOR DAYS 7. 21. 42 AND 63
(MEANS AND SDS1
A) DIGIT SPAN FORWARDS
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 7.3(2.6) 8.1 (1.3) 7.7 (1.2) 7.3 (1.3) F=01 F=3.80 F=38
R(10) 7.5(1.3) 7.7(1.5) 7.6(1.4) 7.4(1.8) P=986 P=.02 P=887
C(14) 7.4(1.3) 7.8 (1.1) 7.5(1.6) 7.3 (1.7)
B) DIGIT SPAN BACKWARDS
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 4.5(1.8) 4.1 (1.6) 4.5 (1.8) 4.6(1.7) F=89 F=1.47 F=,72
R(iO) 5.0(2.2) 5.4(1.8) 5.5 (1.5) 5.5(1.4) P=.419 P=.227 P=632
C(14) 4.4(1.8) 4.7(1.9) 4.9 (1.8) 4.8 (1.7)
C) RIVERMEAD BEHAVIOURAL MEMORY TEST PROFILE SCORE
TOTALS
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(ll) 17.0 18.6 17.0 17.8 F=47 F=.81 F=96
(6.4) (5.8) (5.3) (43)
R(io) 18.6 19.2 18.8 19.3 P=626 P=498 P=462
(5.3) (3.9) (2.8) (4.3)
C( 14) 16.7 16.9 17.6 16.9
(5.6) (62) (5.4) (6.4)
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TABLE 19
PSYCHOMOTOR ABILITY TEST PERFORMANCE OF HIGH CPZ (HC)
VERSUS RISPERIDONE (R) VERSUS CONTROL (C) GROUPS OF
TREATMENT RESISTANT SCHIZOPHRENIC PATIENTS FOR DAYS 7. 21.
42 AND 63 (MEANS AND SDS)
A) MOTOR LATENCY FROM REACTION TIME TEST LEVEL 5
(CANTAB) (ms)
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(9) 646 646 661 617 F=.07 F=1.64 F=1.52
(327) (299) (312) (226)
R(10) 592 606 633 743 P= 937 P=.202 P=. 190
(148) (113) (135) (188)
C(14) 633 674 711 658
(198) (226) (251) (183)
B) REACTION LATENCY FROM REACTION TIME TEST LEVEL5
(CANTAB) (ms)
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(9) 427 403 421 431 F=. 15 F=1.67 F=69
(145) (113) (137) (120)
R(io) 395 393 504 424 P=857 P=. 196 P=658
(109) (101) (422) (138)
C( 14) 424 383 (63) 403 (91) 390
(125) (960
C) DIGIT SYMBOL SUBSTITUTION TEST PERFORMANCE
GROUP DAY 7 DAY 21 DAY 42 DAY 63 BETWEEN TIME GROUP
(n) SUBJECTS BY TIME
HC(9) 33.9 37.3 38.5 41.8 F=,01 F=3.12 F=.90
(12.1) (13.5) (13.5) (12.0)
R(io) 35.8 35.7 38.4 37.9 P=985 P=.040 P=.503
(13.0) (14.7) (13.9) (14.6)
C( 14) 35 8 37.5 38.6 38.1
(13.20 (10.7) 02.1) (14.7)
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5.4 DISCUSSION
The present study failed to show any discernible differences in neuropsychological
functioning between groups of treatment resistant schizophrenic patients on differing
drug regimes over time. There were no significant group differences in either positive
or negative symptomatology when ratings were compared at the beginning and the
end of the trial. Although an overall group by time effect was observed on
parkinsonian-type (TAKE) scores, further analysis failed to show superior
improvement of one regime over another. The AIMS also showed no group
differences over time. Therefore, although previous research has pointed to the
superior clinical efficacy of the atypical neuroleptic risperidone over standard
treatments (Marder and Meibach, 1994), the current study suggests intensive use of
this atypical neuroleptic possesses no clinical advantage over intensive use of
chlorpromazine or standard neuroleptic therapies with groups of treatment resistant
schizophrenic patients. The same response pattern applied for the analysis of
extrapyramidal side effects associated with each regime.
Despite the lack of clinical evidence supporting one type of neuroleptic intervention
over another, the study's major aim was to investigate if neuropsychological
performance changed with drug type and dose over time and, if so, what relation
performance had with clinical symptom ratings. In particular, the study aimed to
investigate the neuropsychological effects of the new atypical neuroleptic,
risperidone, and its relation to the neuropsychological effects of standard 'typical'
drug regimes In fact, no discernible group by time effects were observed on any of
the various neuropsychological measures administered Risperidone did not appear to
possess any neuropsychological, as well as clinical, advantage (or disadvantage) over
the standard regimes Of the vast amount of performance data extracted from the
groups, during the trial, only performance on average moves taken to complete two
move solutions on the Tower of London planning task showed a significant group by
time effect. The two move solution problems were, however, the initial and easiest of
the planning tasks. In fact, it appears that the Risperidone group was the only group
to display poorer performance, over time, on this level of task difficulty, though not
significantly. The more complex solution problems showed no significant group by
time differences, although the groups, as a whole, showed poorer performances, over
time, on the three move tasks. These problems, on face value at least, are probably
more discriminating of planning ability than the easy but novel two move solutions.
This being so, the high chlorpromazine group did show significantly fewer patients
completing all the most difficult five move solutions. A group by time analysis of
planning times for these solutions was unfeasible due to the small number of cases
completing the five move solutions from the high chlorpromazine group. In addition,
fewer of the members of the high chlorpromazine group succeeded on the
intradimensional shift stage of the ID/ED set shifting task, compared to the other
groups. Although these results might suggest that the high chlorpromazine patients
found these particular executive tasks more difficult than the other groups, no overall
significant discriminant executive impairment could be attributed to this group as, for
the other executive tests, relative performances were similar.
The individual groups showed significant concurrent changes in performance over
time on some of the neuropsychological tests. Performance on tests of verbal fluency,
simultaneous and 12 sec delay conditions of a delayed matching to sample task, a
spatial recognition memory task, a visuo-spatial coding task and digit span forwards
test improved over time for all groups. All these tests used four parallel versions. It
would seem that this improvement in performance indicated marked practice effects,
ironically, on tests designed to avoid such confounders. However, as practice effects,
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although controlled for as much as possible, might be an unavoidable fact of life,
especially with testing time points so close together, a failure to show expected test-
retest benefits after drug interventions has been suggested as implying an adverse
effect of medication (Medalia et al., 1988). Practice effects, however, do remain a
problem in the interpretation of drug effects on neuropsychological performance,
involving repeated testing, despite the use of parallel versions. The tests showing
possible practice effects, here, could be considered less demanding than other tests
more 'cognitively complex' i.e. composed of multifunctional tasks e.g. ID/ED Set
Shifting Test and Rivermead Behavioural Memory Test, which did not show
improved performance over the four test sessions. Improved performance for the
treatment refractory patients, as a whole, could be dependent on the degree of
cognitive effort or combination of cognitive functions required to attempt a particular
test.
In summary, it seems that neither intensive typical or atypical medication nor standard
drug therapy gives clinical or neuropsychological function advantage over the other
when administered to treatment resistant schizophrenic patients. This would imply
that this type of patients' clinical symptoms do not vary according to dose and type of
pharmacological action of the neuroleptics they are given. Performance on an array of
neuropsychological tests mirrors this non differentiation of response. Research has,
however, shown a selective clinical response, with this type of patient, in favour of
the atypical neuroleptic clozapine over chlorpromazine after a six week trial (Kane et
al., 1988). We might have expected a selective positive response for those patients on
risperidone after the U.S. multicentre trial who found it significantly more clinically
beneficial than haloperidol in a sub group of long term hospitalised patients (more
than six months at the start of the trial), likely to have shown long term resistance to
typical neuroleptics (Marder and Meibach, 1994). However, these results were
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derived from a post hoc analysis of these patients clinical well being, thus this group
was not so stringently classified (and randomised) as the present study's sample. The
U.S. multitrial study also found that the optima/ dose with the fewest EPS was 6mg
of risperidone. In the present study, only optimum doses were analysed against each
other. The mean optimum dose of risperidone in the present study was appreciably
higher, lOmg, than in the multicentre trial. Thus, any future analyses of risperidone
against typical neuroleptics with treatment resistant schizophrenic patients should
address comparisons of clinical efficacy at lower doses than used in the present study.
Unfortunately, the design of the study did not allow analysis of the patients on 6mg
as the optimum dose for these patients was dictated clinically and ranged from 4 to 16
mg of risperidone
As far as the analysis of the relationship between neuropsychological functioning and
clinical profiles is concerned, Goldberg et al. (1993) demonstrated clinical
improvement with clozapine without any variation in neuropsychological test
performance. This would imply that certain cognitive deficits are relatively
independent of clinical improvement in schizophrenia. This study, however, did not
involve specifically treatment resistant patients. In the present study the relative
stability of symptoms and neuropsychology, after three differing drug regimes, would
suggest that, in our group(s), treatment resistance presents a relatively intractable
state of affairs insensitive to drug manipulation including the novel atypical
neuroleptic, risperidone, at high doses, demonstrating little effect on either symptom
state or putative underlying neuropsychological dysfunction. It is of interest that,
although no improvement was observed in the neuropsychological functioning of the
groups relative to each other, the groups showed often poor neuropsychological
functioning at baseline compared with published normative data e.g. Stroop and
Rivermead scores. However, despite this, and, perhaps surprisingly for such a group
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of long term treatment resistant patients, both pre morbid and current IQ levels fell
within normal limits. These results do not necessarily mean that neuropsychological
dysfunction comprises epiphenomena in the expression of schizophrenic symptoms
with such a group of patients. It may signify that the certain areas of
neuropsychological functioning are fundamental stubborn characteristics of treatment
resistant schizophrenia and in tune, with Goldberg et al. (1993), might account for
much of the enduring social and occupational disabilties seen with such patients.
The above observations were derived from small numbers of treatment resistant
patients in each group. These small samples attest to the difficulty in recruiting and
maintaining such severely ill patients in an intensive trial involving drug manipulation.
Most of the patients screened for the trial, by definition, have had largely ambivalent
experiences of several types of neuroleptics without any lasting clinical benefit. The
use of small samples does affect the statistical power of the multivariate analyses used
in the present study and thus the generalisation of the results. To clarify our results,
additional analyses of individual cases, ffom each group, to check for individual
changes in symptom and related neuropsychological performance, could be elicited
ffom the wealth of data produced by such an intensive investigation Despite this, it
must be emphasised that the number of treatment resistant patients generated for the
study was the product of two years recruitment by a senior psychiatrist who was
employed specifically for this task. To date, we believe this study to be the largest of
its kind with this problematic type of patient.
The presenting results also rely upon two fundamental assumptions. Firstly, as all the
medication for the experimental groups was administered orally, we had to assume
full compliance with taking the prescribed doses. Secondly, even if full compliance
was in fact the case, we had to assume some universality of metabolism of the drugs
existed. The way to overcome such assumptions is to record neuroleptic serum levels
of the patients at critical intervals, however, this facility was not available for the
present study. This being so, the patients in the high chlorpromazine and risperidone
groups were inpatients for at least 6 of the 9 weeks of the trial on a professorial
research ward, designated for this type of research, with the accompanying close care
and observation of trained clinical staff.
The present study was seen as an opportunity to compare neuropsychological
performance between groups of severely ill schizophrenic patients taking optimum
doses of neuroleptics with distinctly different biochemical activities. The
neuropsychological test batteries were designed to assess a wide range of
neuropsychological functions putatively sensitive to compromised behaviours in the
expression of schizophrenic symptoms. The relative differing pharmacological
activities and doses of the different drug regimes may have promised concomitant
differentiation in symptom relief and neuropsychological performance. Dopamine
antagonists have been thought to facilitate flexibility in response organisation i e
decreased redundancy or perseverative responding (Bilder et al., 1992). However, in
the present study in a comparison of high doses of a strong dopamine antagonist
(chlorpromazine) with a strong dopamine and strong serotonergic antagonist
(risperidone) at high doses with largely low dose dopamine antagonists (control
group) no differences were seen on tests reputed to be sensitive to executive
'organisational' functioning involving response flexibility i.e set shifting or Tower of
London performance. Thus when comparing drugs with different pharmacological
effects at differing doses, none discriminately changes the behavioural aspects of the
treatment resistant patients over the other. Perhaps there is a biochemical response
ceiling for this type of patient with these types of neuroleptics, limited in their action
on stubborn and continuous dysfunctional symptoms and neuropsychological status.
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It may be the case that these treatment resistant patients may be suffering the
consequences of long term medication on the brain involving receptor regulation and
cellular adaptation (Bilder et al., 1992). Thus, dependent on the degree of this effect,
the potency of the drugs used in the present study at high doses may have decreased
efficacy. This would be extremely difficult to adequately assess in any study of long
term schizophrenia. Despite this, as stated above, even atypical neuroleptics, such as
clozapine, that show significant symptom reduction in groups of treatment resistant
patients may, nevertheless, fail to improve neuropsychological functioning (Kane et
al., 1988; Goldberg et al., 1993).
Although, even with heterogeneous groups of schizophrenic patients neuroleptic drug
effects on cognition have been seen as variable (King, 1990), for greater clarification,
the results from the present study would require larger group studies with equally
rigorously defined treatment resistant patients using wider, especially optimal, dose
ranges and alternative types of neuroleptics preferably involving serum drug level
records. Such studies may clarify the nature of treatment resistance in schizophrenia,
its relation to neuropsychological functioning and symptom expression. It is of the
utmost importance that treatments are found that may affect the fundamental
functional deficits characteristic of a significant sub population of severely ill patients
who remain relatively resistant to what is presently available in terms of neuroleptic
medication. It may be the case that the therapeutic net needs to be widened to
encompass tailored psychological and social aspects of functioning in concert with
medication, which may have a useful maintenance role with these patients, to address
the particular functional problems of presently treatment unresponsive schizophrenic
patients.
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CHAPTER 6: A NEUROPSYCHOLOGICAL STUDY OF GOOD VERSUS
POOR OUTCOME SCHIZOPHRENIA
6.1 INTRODUCTION
It is increasingly recognised that schizophrenia is a heterogeneous condition with, as
yet unidentified, causal factors and a variable outcome (Cooper, 1987). Although
Kraepelin first conceived of dementia praecox as characterised largely by a
progressive deterioration (Kraepelin, 1896), he later showed that some 13% of his
'dementia praecox' patients apparently reached full recovery (Kraepelin, 1919).
Contemporary researchers and clinicians now realise there is a wide spectrum of
response to the available treatment strategies for schizophrenia (e.g. May et al.,
1988).
A substantial proportion of diagnosed schizophrenic patients experience some form of
recovery, particularly since the advent of neuroleptic medication (especially the
phenothiazines) in the early 1950s, and a possible change of public and professional
attitudes towards caring for the mentally ill. In a review of 5 recent long term
outcome studies, Harding et al. (1992) reported that at least half of each cohort had
significantly improved or recovered when assessed at 20, 30 and 40 year follow up
Despite this, neuroleptic drug therapy, the major therapeutic tool in clinical practice,
has been considered ineffectual with 10 to 30% of schizophrenic patients (Davis et
al., 1980). In addition, other studies have shown that a significant sub group of
initially responsive patients relapsed within two years of maintenance treatment
(Kane & Lieberman, 1987) It is estimated that forty percent of initially drug
responsive patients will suffer a relapse in the following year (Hogarty, 1984). Even
despite relapse rates, at any given time, only 15-40% of non-relapsed schizophrenic
patients are employed (Mosher and Feinsilver, 1973). In addition, with patients who
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have been through psychosocial rehabilitation programmes, there is twice the
expected relapse rate during the second year of follow-up (Hogarty, 1988), indicating
that present forms of rehabilitation may play a delaying rather than a preventative
role.
Given that this heterogeneous pattern of treatment response has been established,
from a clinical and public health viewpoint it would be of great practical benefit to
determine exactly which factors (whether clinical, pathophysiological, psychological
or social) characterise the course and outcome of schizophrenia. In keeping with
previous work suggesting differing typologies of schizophrenia, based on varying
pathophysiology and/or treatment response (Crow, 1980), differentiating subtype by
outcome may well enable the targeting of more homogeneous illness groups for
suitable treatment regimes. In recent years researchers have constructed scales to aid
the pursuit of typing by outcome along various functional dimensions (e.g. clinical,
social, occupational etc.). For instance, May et al. (1988) have proposed a systematic
approach encompassing 6 levels of treatment response which includes symptom
amelioration and social/occupational status) (see Appendix 1). This has enabled the
differentiation of heterogeneous groups of schizophrenic patients according to
outcome, useful in the study of what factors predict or characterise treatment
response.
6.1.1 Factors predicting outcome
In a recent, comprehensive, review Lieberman and Sobel (1993) listed the most
consistent and robust correlates (predictors) of outcome in schizophrenia,
a) Pre morbid social adjustment
b) Pre morbid level of functioning
c) Mode of illness onset
d) Age of illness onset
e) Duration of illness
f) Duration of symptoms prior to first treatment
g) Negative symptoms of the defect state
When considering acute response to treatment, Lieberman et al (1992) found that pre
morbid levels of functioning, younger age of illness onset and duration of illness were
predictors of poor outcome (time to and level of remission). Lobel et al (1992) also
stated that poor outcome was characterised by the duration of psychotic symptoms
prior to treatment. Primary negative symptoms that persisted after psychotic
symptom remission were also predictive of poor outcome McEvoy et al (1992) also
revealed that the shorter the period between onset of symptoms and initiation of
treatment, the better the outcome.
With regard to long term outcome, early onset (< 19yrs) and long duration of illness
(>6 months) prior to admission correlate with poor outcome over 5, 10 and 15 year
follow ups, from a sample of 330 first admission schizophrenic patients (Tsoi and
Wong, 1991). Leff et al (1992), in the five year follow up of the International Pilot
Study of Schizophrenia, found that both clinical and social outcome was better in
'developing' countries than in the industrialised world (perhaps due to cultural
attitudes and increased social and vocational pressures/expectations of the
'industrialised individual'). Good outcome was characterised by abrupt onset of
illness and female gender, whereas poor outcome was significantly associated with
poor pre morbid social adjustment. The social status of the schizophrenic individual
was also highlighted by Tien and Eaton (1992) who found that lower pre morbid
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employment, social and education status were predictive risk factors for
schizophrenia. Schmid et al (1991) in a 22.4 year follow up of 502 schizophrenic
patients found that pre morbid status dominated all other measures accounting for
outcome variance.
6.1.2 Psvcholo2ical functioning and outcome in schizophrenia
In addition to outcome assessments along clinical and social functioning scales,
researchers have also investigated the relation of various psychological aspects of
functioning to outcome. Johnstone et al. (1990) used the Psychological Impairments
Ratings Scale (Jablensky et al. 1980) in an investigation of functioning such as
psychological tempo/slowness, initiative, social skills and personality factors, in
relation to outcome status, defined by occupational status and number of inpatient
days spent in hospital. Only lack of'special assets', (including intelligence(weakly) and
physical presentation were associated with poor occupational status, 'social charm'
was relatively intact. Neither of these psychological functions was related to outcome
in terms of hospital duration.
6.1.3 Neuropsychological functioning and Schizophrenia
Originally, Kraepelin (1919) and later Bleuler (1950) believed intellectual functioning
to be left relatively intact in dementia praecox or the schizophrenias However, recent
studies have revealed significant intellectual impairment as a product of course (the
'dementia' of'dementia praecox') (Johnstone et al, 1978; Nelson et al., 1990; Frith et
al., 1991). Studies have shown gross neuropsychological impairments in group (Kolb
and Wishaw, 1983) and single case study reports (Shallice et al., 1991). The vast
majority of group studies, however, have tended to compare heterogeneous groups of
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schizophrenic patients with either control or other psychiatric groups (e.g. Morice et
al., 1990). The establishment of heterogeneous outcome now warrants research into
how groups of different outcome function neuropsychologically.
It has been observed that neuropsychological deficits may be of significance in
contributing to functional deficits in the areas of social and occupational activities
(Jaeger et al. 1992). In terms of outcome studies some researchers have found
neuropsychological test performance to be a valid predictor of treatment response, in
terms of social and vocational disability (Marder et al. 1984). Kolalowska et al.
(1985) found that poor outcome schizophrenic patients displayed significantly poorer
performance on verbal memory ability, conceptual ability and spatial ability compared
to good outcome patients. These cognitive deficits were related to severity of
symptoms, social deterioration and resistance to treatment. Vocational outcome on
follow up has been significantly associated with Wisconsin Card Sort Test
performance on discharge (Jaeger and Douglas, 1992). Despite this, there is still no
agreed pattern of relationships between neuropsychological performance and the
other functional deficits observed in schizophrenia (Jaeger et al. 1992). If a pattern
could be established, neuropsychological test performance may provide invaluable
information that could be, potentially, prescriptive for specialised neurorehabilitation
programmes.
This study will test the hypothesis that neuropsychological impairment will be
associated with poor psychosocial outcome in schizophrenia.
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6.1.4 Aims of the present study
1) To characterise the neuropsychological differences between a group of treatment
responsive (good outcome) and treatment resistant (poor outcome) schizophrenic
patients, using a variety of measures sensitive to various aspects of cognitive
functioning putatively impaired in schizophrenia. To determine which
neuropsychological functions best characterise poor outcome (i.e. executive, memory,
psychomotor ability, lateralisation)
2) To assess the influence of various demographic and medication variables on the
performance of the two responder groups
6.2 METHOD
6.2.1 Subjects
Patients were recruited from in-, day- and out-patient populations at the Royal
Edinburgh Hospital and associated hospitals. Patients were diagnosed as having
schizophrenia in accordance with DSM-IIIR criteria (American Psychiatric
Association, 1987). Their notes were examined for details of personal, family, social
and psychiatric history: details which were recorded on a revised version of the
DHSS Survey form (MacMillan et al, 1986). Patients were interviewed using the
structured interview Present State Examination (PSE: Wing et al., 1974).
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Patients had their outcome determined as treatment-responsive (good outcome) or
treatment-resistant (poor outcome), according to the descriptive clinical criteria of
May et al. (1988). Treatment responsiveness was limited to level 2, resistance- level 5
(see Appendix 1) (patients falling into treatment responsiveness level 1 were not
included as response within one week of developing symptoms is not indicative of
schizophrenia, patients in treatment response level 6 were not included due to the
demands of the drug intake (haematological) analysis required). Presenting symptoms
were assessed using the Manchester Symptoms Scale (Krawiecka et al., 1977).
Outcome in social terms was assessed using Cooper's Scale (1961) and McGlashan's
Cross-Sectional Outcome Scale (1984). All the psychiatric ratings were completed by
a trained senior scientist.
The May et al. (1988) classification yielded two groups of 20 patients each, either
treatment responsive or treatment resistant, who were then individually matched for
age, sex and length of time since first episode.
The patients were also assessed for their personal medication history particularly for
their exposure to anticholinergic drugs that might effect neuropsychological
performance, especially in terms ofmemory performance (Frith, 1984).
6.2.3 Neuropsychological Assessment
For full details of the neuropsychological test battery see main Methods chapter.
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a) General intellectual functioning was assessed by National Adult Reading Test
(NART; Nelson, 1982) for pre morbid levels; Current intellectual level was assessed
using the Quick IQ measure (Ammons and Ammons, 1962) and general cognitive
functioning by the Mini Mental State Examination (Folstein et al., 1975; Dick et al,
1984). Paternal occupation (measured by The Standard Occupation Classifications;
OPCS, 1991) was also used as a crude measure of socio-economic background to
indicate pre morbid social advantage on account of possible problems associated with
the interpretation of NART scores with groups of long term hospitalised patients
(Crawford et al., 1992).
b) Executive functioning was assessed using the following measures: Verbal fluency
(Animals and letter 'A'- 60 sees each), Stroop test (Trenerry et al., 1989), Trail
Making Task A&B (Reitan, 1958), a computerised version of the Continuous
Performance Test-CPT (Frith et al, 1991), the intradimensional/extradimensional set
shift test (from CANTAB, Robbins et al., 1991); Tower of London test (from
CANTAB).
c) Memory functioning was assessed using the following measures: short term
working memory was assessed using the digit span test (forwards and backwards)
(RANDT memory battery version A, Randt and Brown, 1983). Non verbal
recognition memory was assessed using the Pattern recognition test, Spatial
recognition test, Delayed matching to sample test (all from CANTAB) Long term
episodic memory was assessed using the Rivermead Behavioural Memory Test
(RBMT, Wilson et al., 1985).
d) Lateralisation indices were calculated using Letter cancellation test; Star
cancellation test, Line bisection test, Handedness scale (Wilson et al., 1987).
e) Psychomotor ability was assed using the Reaction time task (from CANTAB) and
Digit symbol substitution test (WA1S-R, Wechsler, 1981).
f) Attention and Co-operation was assessed on a 5 point scale following Shakow
(1981). These were not standardised scales but subjective indices of subject
behaviour, by the examiner, at the time of testing.
6.2.4 Analysis of results
The results were analysed on a Macintosh Classic II computer using SPSS version
4.0. Demographic and medication variables were analysed by t-test and chi squared
statistics dependent on the nature of the data set. Because the exercise was, in
essence, exploratory, multiple comparisons were made, therefore, across the two
groups using MANOVA. After initial analysis education, in terms of full time years
of education, was entered as a covariate in further analysis of neuropsychological
performance as the good outcome patients had experienced significantly more full
time years of education than the poor outcome patients
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Neuropsychological variables with incomplete data sets which were not included in
the MANOVA, as they were few in number, were additionally analysed by
independent t-tests.
Exposure to neuroleptics/anticholinergics and status at time of testing was analysed
by chi squared statistics. Duration of medication status and levels of medication at
time of testing were analysed by t-tests. Paternal occupation was analysed by a chi
squared test. Pearson's correlations were used to test the association between
education and neuropsychological performance. Neuropsychological variables, were
also correlated (Pearsons) with anticholinergic status and hospital duration
Spearmans correlations were used to assess the relations between neuropsychological
performance and clinical and other functional measures as these scales can not be
assumed to be normally distributed.
6.2.5 Procedure
The above tests were administered on the day of the clinical interview (+/-1). The full
battery took approximately 2 hours to complete, including appropriate rest periods
suited to the individual testee.
Because of the nature of the patients under investigation i.e.. some being extremely
ill, data loss during the relatively demanding investigation procedure was unavoidable.
21 \
Sometimes it was impossible to carry out a full neuropsychological examination at
one sitting (e.g.. because of patient fatigue, , irritability). Therefore, due to some
patients not attending follow up appointments some data sets were left incomplete.
Analyses were based, therefore, on varying data sets per group
6.2.6 Missing data sets
One good outcome patient (female) refused to complete any of the
neuropsychological tests. One (male) good outcome group did not complete the
Stroop test. Another (male) in the same group did not complete Trails A & B, the
Mini Mental State Examination, all the lateralisation tests and the Stroop test.
As one would expect there was more missing data from the poor outcome group.
One (male) did not complete digit symbol substitution, Trails A & B, Stroop, the
Continuous Performance Test and all the CANTAB measures Another (male)
refused to complete the reaction time measure on CANTAB One (female) missed the
Trails A & B, The Mini Mental State Examination, the lateralisation tests and the
Stroop test. However, the actual proportion of missing data that the above
represented was surprisingly small, considering the type of patients and the size of the
neuropsychological battery used. No major compensation for the missing data was
thought necessary as group effects would not be grossly effected by providing
averages etc., to provide for, at worst, the one or two missing data points.
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6. 3 RESULTS
6.3.1 Pemo2raphic and Clinical details (see table 1)
The two groups of good and poor outcome patients were well matched for sample
size and gender ratio. The groups were also well matched for age and average
duration of their illnesses. The two groups differed significantly with regard to
education background, as good outcome patients had experienced significantly more
years of full time education than members of the poor outcome group. The groups
did not differ in terms of socio-economic background as assessed by paternal
occupations.
Unsurprisingly, the poor outcome patients had experienced significantly more
psychiatric admissions and had endured longer periods in hospital than the good
outcome patients. Members of the poor outcome group were taking, on average,
significantly greater doses of neuroleptics (chlorpromazine (CPZ) equivalents) than
the good outcome patients at time of testing. Both outcome groups were taking
equivalent doses, on average, of anticholinergic medication at time of testing. Good
outcome patients had experienced significantly shorter periods on anticholinergic
medication than the poor outcome patients.
A brief comparison of the clinical symptom profiles using Manchester symptom scale
totals showed a highly significant between group difference: the good outcome
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patients showing less severe symptomatology than the poor outcome patients. On
further analysis of the individual symptoms of the Manchester scale, only the ratings
for coherently expressed delusions (P<0001), hallucinations (P<0001) and
psychomotor retardation (P< 05) showed any significant outcome group differences
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6.3.2 Neuropsychological test performance
6.3.2.1 General intellectual functioning (see table 2)
There was a highly significant difference between good and poor outcome groups pre
morbid (NART) and current IQ (Quick IQ) scores. There was a decline in both
groups intellectual performance from pre morbid to present states. The degree of the
decline, however, was similar in both groups (t=-1.33 P=192). On a measure of
global cognitive ability (MMSE) the good outcome patients ( X(sd): 28.3 (1.8))
scored significantly better than the poor outcome patients ( X(sd): 25.2 (3 .7)) (t=3.16
P<005).
6.3.2.2 Executive functioning (see tables 3 to 15)
Overall group performances indicated that a significant between group difference
occurred across the measures. Univariate analyses revealed that on the Continuous
Performance Test, no group differences emerged when comparing omission scores.
However, the poor outcome patients made significantly more commissions
(inappropriate responses) than the good outcome patients. A highly significant
difference in performance was recorded when Stroop (control minus experimental
conditions) scores were compared in favour of the good outcome patients.
Performance on a timed measure of attention switching, after controlling for simple
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psychomotor speed [TRAILS (B-A)] showed no significant group differences. On a
timed (category dependent) word fluency test no significant group differences were
observed when the subjects produced words beginning with the letter A'. However,
when the category changed to 'types of animals' the good outcome patients produced
significantly more words than the poor outcome patients.
Set shifting ability was compared across the groups using the CANTAB ID/ED set
shifting task. Tble 4 shows the proportions of patients from each outcome group
successfully reaching criterion on each stage of the ID/ED set shifting task. No
significant between group differences were recorded when the proportions of each
group reaching criterion were compared at any of the 9 stages.
Table 5 shows trials taken to reach criterion at each stage for those patients who
successfully reached stage 9 (last stage) of the task (11 'good' and 10 'poor'). No
overall significant between group differences were observed Table 6 shows group
comparisons of trials to reach criterion for all patients completing each stage. No
significant between group differences were observed at any stage.
Table 7 shows the number of errors made in reaching criterion at each stage for those
patients successfully reaching stage 9 No overall significant between group difference
was recorded. Table 8 compares all available error score data, from each group, for
those patients successfully reaching criterion at each stage of the task. Only when
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comparing error scores on stage 1 does any significant between group difference
emerge, in favour of the good outcome group.
Planning ability was assessed by performance on the Tower of London test (see tables
9 to 15). All the patients (both good and poor outcome) were able to complete all the
2 and 3 move solution tests. All the good outcome patients were able to complete the
4 move solutions, 18 completed all the 5 move solutions, one good outcome patient
was unable to complete any of these. 17 poor outcome patients were able to complete
all 4 move solutions-one was unable to complete any. Fifteen poor outcome patients
completed all the 5 move solutions. One poor outcome patient completed three 5
move solutions, one patient could complete only two of these problems and one was
unable to complete any. Both groups completed roughly the same number of solution
sets at each level of task difficulty.
No significant overall group differences emerged when average moves taken to
complete each set were compared (table 10). This observation was based on those
patients per group who had completed at least one 5 move solution successfully.
Univariate analyses revealed a significant group difference when average scores taken
to complete solution set 5 were compared. Table 11 refers to the proportion of
patients per group who were able to complete solution sets in the minimum number
of moves possible. No significant between group differences were observed although
it is of note that the majority of the patients (of either group) could not complete the
4 or 5 move problems with minimum moves.
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Table 12 displays the motor latencies for the yoked motor control condition of the
Tower of London test. No significant overall differences emerged when comparing
initiation and execution ('pick up' and 'place') times for each group at each level of
task difficulty. Tables 13 and 14 show the initial and subsequent (to the first move)
'pure' planning times for each level of task difficulty. No significant group differences
were observed
m
6.3.2.3 Memory test performance (see tables 15 & 16)
Multivariate analysis of variance revealed an overall significant between group
difference in memory functioning. On a delayed matching to sample task good
outcome patients displayed better performance at 0 sec delay condition. Recognition
(matching) scores were not significantly different at simultaneous, 4, or 12 sec delay
conditions. Pattern recognition memory performance did not differ significantly
between the groups. Spatial recognition memory performance did show a significant
group difference in performance in favour of the good outcome group.
Short term auditory working memory, as assessed by a digit span measure, showed a
significant group difference solely on digits backward, again in favour of the good
outcome patients.
Performance on the Rivermead Behavioural Memory Test (profile score) revealed a
highly significant between group difference. Good outcome patients displayed
markedly superior scores on this test of long term episodic memory functioning.
Table 15 shows multivariate analysis of the of the Rivermead raw scores for each
subtest. Highly significant univariate differences were seen on the story recall
(immediate and delayed recall) and to a lesser degree on remembering a message
(immediate and delayed), orientation and remembering to ask a question on cue. It is
interesting to note that no group differences were observed on the recognition tasks.
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6.3.2.4 Performance on tests of ne£lect and lateralisation (see table 17)
No overall significant between group differences were observed on any of the
measures of hemispatial neglect. Handedness was also recorded, the proportion of
right handed patients was roughly equal in both groups (LR=.617 P=432).
6.3.2.5 Psychomotor ability (see table 18)
Although no overall between group differences were observed, the resulting analysis
showed a trend towards significance (P=053). No univariate differences were
recorded on a computerised reaction time task in terms of movement or reaction
latencies. A highly significant difference, however, was observed when age scaled
performances on the digit symbol substitution task were compared, in favour of the
good outcome patients.
6.3.2.6 Examiner ratings of attention/concentration (see table 19)
Table 19 refers to the examiner's subjective appraisal of the patients' attention and
cooperation throughout the test period. Good outcome patients were subjectively
assessed as attending to the test situation and cooperating with the task demands
significantly better than the poor outcome patients during testing.
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6.3.2.7 Neuropsychological test performance and education (see tables 20 to 24)
As the educational backgrounds of the two outcome groups differed significantly (see
table 1) and as the years of full time education correlated significantly with many of
the test performances (Table 20), education was entered as a covariate and all the
between group analyses of the neuropsychological variables were repeated (see tables
21 to 23). The many Tower of London variables were not entered as no significant
differences were detected on initial analysis. The same reason applied to the
omittance of lateralisation performance from this analysis.
No overall or univariate significant between group differences in executive
functioning performance after controlling for education (table 21).
After controlling for education with the memory test performances, no overall
significant between groups differences were recorded (table 22). On inspection of the
univariate analyses, only Rivermead profile performance significantly discriminated
between the groups still at a high level of significance (P< 005).
No significant group differences, in terms of psychomotor ability, between outcome
groups was observed after controlling for education (table 23).
U\
After controlling for education, there still emerged a significant between group
difference concerning attention/cooperation during testing, in favour of the good
outcome patients, but at a reduced level of significance (table 24) .
6.3.2.8 Rivermead Behavioural Memory Test and current intellectual
functioning
The Rivermead Profile performance (RPT) correlated at a high level of significance
with both present state IQ (Quick IQ) (r=.7089, P<01) and Mini Mental State
Examination (r= 5778, P<01). Both these variables were then entered as covariates
with the RPT scores. After controlling for present IQ, the RPT scores still
differentiated between the two outcome groups (in favour of the good outcome
patients) still at an elevated level of significance (F=9.47, P<005). The significant
between group difference also remained after controlling for global cognitive ability
(MMSE results) (F=8.45, P< 007).
6.3.2.9 Medication and neuropsychological test performance
It has been suggested that memory can be affected by medication status, especially
relating to anticholinergic intake (Frith, 1984). Therefore, the effects of
anticholinergic medication were analysed with respect to the Rivermead scores. There
was no significant difference between the numbers in each group who had ever
experienced anticholinergic medication (LR=3.38 CHISQ=659). As the levels of
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anticholinergics at testing were similar in each group (see table 1) no correlations
were performed with this variable. However, as the groups differed in duration of
anticholinergic exposure (table 1), duration was correlated with RPT scores. The
resulting correlation was statistically insignificant (r=-.006). Poor outcome patients
were receiving higher doses of neuroleptics at the time of assessment and, therefore,
chlorpromazine (CPZ) equivalents were correlated with RBMT performance (r=-.036
P< 05). RBMT scores were, therefore, reanalysed using CPZ dose equivalents as a
covariate, the between group differences remained highly significant (F= 11.8
P=,002). When duration of psychiatric admissions was considered, RBMT scores
correlated significantly (r==443 P< 01) indicating that poor RBMT performance was
associated with long inpatient duration.
6.3.2.10 Analyses of the relationships between measures showine outcome group
differences and education and the functional and symptom scales used as
outcome measures (see tables 25 to 28)
Spearman's correlations were used to analyse these relationships as the functional
(Cooper and McGlashan) and symptom (Manchester/Krawiecka) rating scales
produce categorical data.
As far as the rating of symptoms is concerned (table 25) all the neuropsychological
performances were correlated at the 1-5% level of significance with coherently
expressed delusions except for spatial recognition ability. Hallucinations were related
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to many of the neuropsychological performances except spatial recognition, global
cognitive ability (MMSE) and number of commissions on the CPT and age scaled
digit symbol substitution performance. Incoherence/irrelevance of speech was only
related to age scaled digit symbol substitution performance. Education was related to
incoherent affect. Finally, Rivermead scores were significantly related to both
flattened affect and psychomotor retardation. There were no other significant
correlations between neuropsychological performance and symptom ratings.
On the McGlashan cross sectional outcome scale (functioning in the last year) again
most of the neuropsychological performances were significantly related to the
individual constituents of the scale (table 26): Duration of hospitalisation except age
scaled digit symbol substitution and commissions on the CPT, Employment except
age scaled digit symbol substitution, Global functioning except spatial recognition,
Psychopathology except age scaled digit symbol substitution, spatial recognition and
present IQ. Social contact scores were again all significantly related to
neuropsychological performances excluding spatial recognition memory.
The McGlashan follow-up outcome scale (present functioning) showed a similar
overall connection between neuropsychological performance and constituent
functional abilities (table 27). Duration of hospitalisation all except age scaled digit
symbol substitution, global cognitive ability (MMSE), the Stroop test and number of
commissions on the CPT. Employment all except age scaled digit symbol substitution,
Global functioning all were significantly related, Psychopathology all except digit
2W
span backwards, age scaled digit symbol substitution performance and MMSE. Social
contacts were all significantly related except spatial recognition and the
attention/cooperation scale.
On the Coopers social outcome scale all the neuropsychological performances were
significantly related to the three components of the scale (table 28). All performances
were significantly related to the degree of self care exhibited by the subjects, all
performances except spatial recognition were related to social liability (the ability to
maintain interpersonal relationships). As far as economic status is concerned, again
most of the neuropsychological test performances were significantly related, however,




DEMOGRAPHIC INFORMATION OF POOR AND GOOD OUTCOME
SCHIZOPHRENIC PATIENTS (MEANS AND SDS)
GOOD POOR SIGNIFICANCE
SEX 10M 10F 10M 10F
AGE (yrs) 36.5(9.9) 34.7(10.3) P=577
(df=38. t=.56)
EDUCATION (yrs) 13.98(2.83) 10.93(1.17) P<001
(df=38. t=4.45)











NEUROLEPTIC MEDICATION AT TIME











11 55(14 36) 39.8(57.39) P=0.02
(df=38.t=-2.14)








GENERAL INTELLECTUAL ABILITY FOR GOOD VERSUS POOR











114.5(10.3) 101 2(9.5) 17.65 .000
QUICK IQ 107.4(18.0) 89.1(14.9) 12.00 001
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TABLE 3
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS










CPTF ■2(4) .7(1.6) 1.56 .221
CPTI 1.0(1.4) 3.3 (3.3) 6.56 .015
STRPWC 16.7(17.9) 41.0(19.5) 14.69 .001
TRAILS 49.8(25.6) 60.4(36.5) 98 .329
VFLA 13.4 (7.5) 9.6(5.3) 2.97 .094
VFLB 20.2(8.7) 14.2(7.1) 4.94 .033
KEY:
CPT=CONTINUOUS PERFORMANCE TEST
F=FAILURES TO RESPOND TO AN E' (omissions)
I=INAPPROPRIATE RESPONSES(comissions)
STRPWC=STROOP TEST (WORD-COLOUR)




PROPORTION OF GOOD AND POOR OUTCOME SCHIZOPHRENIC
PATIENTS REACHING CRITERION ON EACH STAGE OF THE ID/ED
SET SHIFTING TEST
STAGE GOOD (%) POOR (%) LIKELIHOOD RATIO PROB.
1 19(100) 19 (100)
2 18 (94.7) 17 (89.5) .37 .544
3 18 (94.7) 16(84.2) 1.16 .281
4 18 (94.7) 15 (78.9) 2.20 .138
5 17(89.5) 15 (78.9) .81 .370
6 17(89.5) 14 (73.7) 1.62 .203
7 15 (78.9) 12(63.2) 1.16 .281
8 11 (57.9) 10(52.6) .11 .744
9 11 (57.9) 7(36.8) 1.70 .192
TABLE 5
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATINETS TRIALS
TAKEN TO REACH CRITERION (PER STAGE) ON THE ID/ED SET
SHIFTING TASK
Comparisons based on scores of those subjects attempting stage 9




1 7.4(2.8) 11.2(6.1) 3.59 .073
2 9.6(4.2) 8.4(3.4) .53 .475
3 7.7(2.6) 10.3(8.1) 1.00 .330
4 7.4(3.1) 9.2(5.10 1.02 .326
5 7.7(1.6) 11.0(6.5) 2.60 .123
6 6.8(1.2) 7.9(2.5) 1.65 .214
7 13.5(5.4) 17.5(14.6) .73 .402
8 10.5(5.3) 11.7(9.4) .14 .710
9 10.0(5.8) 26.1(20.5) 6.25 .022
TABLE 6
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS TRIALS
TAKEN TO REACH CRITERION FOR SUBJECTS COMPLETING EACH
STAGE OF THE ID/ED SET SHIFTING TASK
















































GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS NUMBERS
OF ERRORS MADE ATTEMPTING EACH STAGE OF THE ID/ED SET
SHIFTING TASK
Comparisons are made between patients completing up to stage 9
STAGE GOOD POOR F VALUE PROB.
n=l 1 n=10 MANOVA (1,19) df 1.69 .204
1 ■7(1.5) 3.2(2.8) 6.63 .019
2 2.1(1.4) 1.6(1.1) .82 .377
3 •8(1.0) 2.3(5.0) .94 .346
4 •5(1.2) 1.7(2.2) 2.72 .116
5 13(5) 2.9(2.8) 3.61 .073
6 6(8) 1.0(1.3) .58 .454
7 3.8(2.8) 6.2(7.6) .95 .342
8 2.4(1.9) 3.3(5.3) .30 .591
9 2.5(2.7) 9.2(10.0) 4.62 .045
TABLE 8
GOOD VERSUS POOR OUTCOME SCHIZOPHRENICS NUMBERS OF
ERRORS MADE DURING THE COMPLETION OF EACH STAGE OF THE
ID/ED SET SHIFTING TASK IALL CASES)















































GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
COMPLETED SETS OF THE TOWER OF LONDON TASK1MEANS AND
SDS
Univariate analyses (1,35) df.
SET GOOD (n=19) POOR (n-18) F VALUE PROB.
2 2.0(0) 2.0(0) N/A N/A
3 2.0(0) 2.0(0) N/A N/A
4 4.0(0) n=17 1.06 .311
3.8(9)
5 n=18 3.6 .47 .497
3.8(9) (12)
TABLE 10
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
AVERAGE MOVES TAKEN TO COMPLETE EACH SET ON THE TOWER
OF LONDON TASK1MEANS AND SDS)
Based on those patients who were able to complete at least one 5 move solution




2 20(1) 2.1(4) .93 .341
3 35(7) 3.9(1.0) 1.57 219
4 5.6(1.2) 6.1(8) 1.96 .171
5 7.5(1.2) 8.7(1.5) 6.51 .016
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TABLE 11
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
COMPLETING TOWER OF LONDON TASKS IN MINIMUM MOVE
SOLUTIONS
SET GOOD POOR FISHERS EXACT PROB.
2 18 16 .479
3 10 5 114
4 3 0 .125
5 1 0 .514
TABLE 12
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS MOTOR
(CONTROL CONDITION) PERFORMANCE (in his) ON THE TOWER OF
LONDON TASK (MEANS AND SDS)
I) INITIATION TIME (1,33) df
SET GOOD (n=18) POOR (n=17) F VALUE PROB.
MANOVA .45 .770
2 2663(2236) 4001(3970) 1.53 .224
3 2178(1093) 2718(1637) 1.34 .256
4 2107(1254) 2572(1390) 1.08 .306
5 1845(806) 2138(993) .92 .344
II) PICK UP TIME (1,33) df
SET GOOD (n=18) POOR (n=17) F VALUE PROB.
MANOVA 1.98 .124
2 2130(1220) 2073(1275) .02 .829
3 1744(473) 2668(1630) 5.32 .027
4 1750(628) 2030(716) 1.51 .227
5 1538(624) 1764(552) 1.27 .267
Ill) PLACE TIME (1,33) df
SET GOOD (n=18) POOR (n=17) F VALUE PROB.
MANOVA .76 .562
2 534(270) 578(193) .31 .579
3 513(317) 637(274) 1.55 .222
4 509(202) 586(203) 1.28 .267
5 472(156) 548(150) 2.12 155
TABLE 13
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS INITIAL









2 2054(496) 2876(423) .86 .362
3 5895(1324) 6226(1342) .02 .884
4 7070(426) 6226(434) .14 .714
5 6132(536) 4795(546) 1.01 .322
TABLE 14
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
SUBSEQUENT (TO THE FIRST MOVE) PLANNING TIMES PER MOVE









2 251(122) 1095(112) 3.00 .093
3 1625(254) 2284(331) .57 .457
4 2548(476) 3287(446) .74 .397
5 1843(437) 2311(557) .67 418
TABLE 15
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
PERFORMANCE ON TESTS OF MEMORY (MEANS AND SDS1
TEST GOOD
(n=19)

























































RPT= RIVERMEAD PROFILE SCORES
TABLE 16
SCORES ON THE SUBTESTS OF THE RIVERMEAD BEHAVIOURAL
MEMORY TEST FOR GOOD VERSUS POOR OUTCOME









FIRST NAME 1.9 1.5 3.35 .075
SECOND NAME 18 1.4 3.65 .064
BELONGING 3.3 3.0 .64 .429
APPOINTMENT 1.8 1.4 4.57 .039
PICTURE RECOG¬
NITION
9.9 9.6 2.76 .105
STORY IMMEDIATE 8.7 5.0 12.58 .001
STORY DELAYED 7.8 3.8 14.83 .000
FACE RECOGNITION 4.8 4.7 1.08 .305
ROUTE IMMEDIATE 4.9 4.9 .00 .958
ROUTE DELAYED 4.8 4.8 .11 .740
MESSAGE IMMEDIATE 3.0 2.6 5.34 .027
MESSAGE DELAYED 2.9 2.6 4.78 .035
ORIENTATION 8.9 8.2 7.28 .010
DATE .9 .8 .65 .426
TOTAL 64.9 53.7 22.06 .000
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TABLE 17
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS






MANOVA (1,35) df 1.37 .265
LCT -.1(8) -.4(6) 1.25 .271










GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS

























CRTML5=MOVEMENT LATENCY STAGE 5 (CANTAB)
CRTRL5=REACTION LATENCY STAGE 5 (CANTAB)
DSS=DIGIT SYMBOL SUBSTITUTION TEST AGE SCALED SCORES
m
TABLE 19
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
ATTENTION AND CO OPERATION SCORES (INVESTIGATOR









ATTENTION 4.7(6) 3.9(1.1) 8.3 .006
COOPERATION 4.5(5) 4.2(8) 9.08 .005
TABLE 20
CORRELATIONS BETWEEN NEUROPSYCHOLOGICAL TEST
PERFORMANCE AND YEARS OF FULL TIME EDUCATION
TEST r TEST r TEST r
NART IQ (WAIS
EQUIV.)
.6980** CTLAM5 -.4328** RPT .4381**
QUICK IQ .4777** CDMSS .1977 LCT .0104
MMSE .3858* CDMS0 .3804* SCT -.0899
CPTF -.1474 CDMS4 .2984 XLINE -.0936
CPTI -.3638* CDMS12 .3570* CRTML5 -.2484
STRPWC -.6326** CPRT .0767 CRTRL5 -.2585
TRAILS -.3963* CSRT .3678* DSS .5564**
VELA .4222** DSF .3109 RAT .2874
VFLB .4815 DSB 5444** RCT .2253
*P< 05 **P<01
TABLE 21
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
PERFORMANCE ON TESTS OF EXECUTIVE FUNCTIONING










CPTF ■2(4) .7(1.6) .87 .359
CPTI 1.0(1.4) 3.3 (3.3) 2.36 .135
STRPWC 16.7(17.9) 41.0(19.5) 2.46 .127
TRAILS 49.8(25.6) 60.4(36.5) .32 .575
VFLA 13.4 (7.5) 9.6(5.3) .08 .780
VFLB 20.2(8.7) 14.2(7.1) .32 .576
TABLE 22
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
PERFORMANCE ON TESTS OF MEMORY CONTROLLING FOR FULL
TIME YEARS OF EDUCATION1MEANS AND SDS)
TEST GOOD
(n=19)




CDMSS 9 4(.7) 8.7(2.0) .73 .399
CDMSO 8.2(1.5) 6.6(2.5) 1.38 .247
CDMS4 7.8(1.2) 6.7(2.5) .67 .419
CDMS12 6.7(1.7) 5.6(1.9) .63 .435
CPRT 19.3(4.1) 17.8(3.0) 1.38 .248
CSRT 15.4(2.3) 13.6(3.0) .76 .390
DSFR 7.5(1.4) 7.3(1.2) .44 .514
DSBR 5.3(1.9) 3.7(1 3) 1.08 .306
RPT 21.7(1.9) 17.3(3.8) 9.72 .004
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TABLE 23
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
PERFORMANCE ON TESTS OF PSYCHOMOTOR FUNCTIONINGIin ms)




















DSS 8.6(2.4) 6.4(2.0) 1.51 .291
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TABLE 24
GOOD VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS
ATTENTION AND CO OPERATION (AT TIME OF TESTING)










ATTENTION 4.7(6) 3.9(1.1) 4.54 .040
CO-OPERATION 4.8(5) 4.2(8) 6.73 .014
3)02
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TABLE 26
SPEARMANS CORRELATIONS OF NEUROPSYCHOLOGICAL
PERFORMANCES SHOWING GROUP DIFFERENCES FOR GOOD




MCD MCE MCG MCP MCS MCT
CSRT .3776** .3740** .2087 .1812 .0952 .3160*
DSBR 3971** .3967** .3532* .3477* .4301** 4737***
DSS .1956 .2455 .3174* .2096 .3259* .3120*
EDUC .4401** .4443** 4738*** .3720** 4749*** 5104***
MMSE .3934** .3531** .3551* .3716** 4459** 4791***
N(WAIS) .4353** .3862** .4367** .2776* .5675*** .5077***
010 .3008* .4051** 398i** .2634 5394*** .4480**
RATS .4510** .4885*** .4282** .3214* .2117 4470***
RCT .4293** .4809*** .5030*** .3901** .3723** .5534***
RPT .5193*** 5886*** .5763*** 5029*** 4H5** .6216***
STRPWC -.3025* -.5400*** - 4939*** -.3467* - 5442*** _5573***
VFLB .2982* .4347** .4762*** .3901** .5090*** .4661***
CPTI -.2534 -.3549* -.2703* -.3472* -.3822** -.4148**
* P< 05 **P< 01 ***P< 001
KEY:
D DURATION OF HOSPITALISATION P PSYCHOPATHOLOGY
E EMPLOYMENT S SOCIAL CONTACTS
G GLOBAL FUNCTIONING T TOTALS
TABLE 27
SPEARMANS CORRELATIONS OF NEUROPSYCHOLOGICAL
PERFORMANCES SHOWING GROUP DIFFERENCES FOR GOOD
VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS AGAINST
McGLASHAN (FOLLOW-UP) SCORES
TEST FACTORS
MCD MCE MCG MCP MCS MCT
CSRT .3939** .3477* 3130* .3144* .0699 3574*
DSBR .3549* .3339* 3945** .1531 .3323* 3685**
DSS .1885 .0716 3214* .2561 .3148* 2312
EDUC .4552** .3145* 4820*** .3799** .3997** 4773***
MMSE .1952 .3532* 3317* .2363 .3606* 3374*
N(WAIS) .4505** .2723* 4328** .2941* .4727** 4521**
QIQ .3097* .3046* 4093** .2817* 4899** 4254**
RATS .3689** .4575** 4368** .3151* .2629 4356**
RCT .3592* .5073*** 4724*** .3379* .4183** 5200***
RPT .4572** 4948*** 5137*** .5729*** .3146* 5651***
STRPWC -.2768 -.4775** .5102*** -.3194* - 4915*** . 4848**
VFLB 3827** .3336* .4207** .4222** .4134** .4656***
CPTI -.1911 -.2951* -.3252* -.2741* -.2949* -.3234*
* P< 05 **P< 01 *** P< 001
TABLE 28
SPEARMANS CORRELATIONS OF NEUROPSYCHOLOGICAL
PERFORMANCES SHOWING GROUP DIFFERENCES FOR GOOD
VERSUS POOR OUTCOME SCHIZOPHRENIC PATIENTS AGAINST
COOPERS SOCIAL OUTCOME SCALE SCORES
TEST FACTORS
SELF-CARE ECONOMIC SOCIAL LIABILITY TOTAL
CSRT .3991** .3590* .2574 .3722*
DSBR .3816** .2717* 4146*** .4405**
DSS .4293** .2323 4772*** .4126**
EDUC .5501*** .4808*** .5226*** 5942* * *
MMSE .4616** .2740* 4439*** 4772***
N(WAIS) .5158*** .2771* .5690*** 5300***
QIQ 4939* ** .2366 .5348*** .4803***
RATS .4523** .3095* .4450** .4688***
RCT .4881*** .3329* .5152*** .53938***
RPT .6598*** .4733*** 5995*** 6537***
STRPWC -.5241*** -.4770** _ 5630*** -.6308***
VFLB .3795** .3420* .4265** .4457**
CPTI -.4279** -.2892* -.4632** .4883***
* P< 05 **P< 01 ***P< 001
6.4 DISCUSSION
The aim of this study was to analyse which neuropsychological impairments
discriminate between a group of schizophrenic patients dichotomised by outcome.
The patients were selected according to their degree of treatment response, social and
vocational status, and symptom profiles. Careful recruitment resulted in two groups
well matched for sex, age and duration of illness. The two groups were coined good
outcome (treatment responsive) and poor outcome (treatment unresponsive/resistant)
patients. It was no surprise that the poor outcome patients had spent significantly
longer in hospital, had more psychiatric admissions and were currently on higher
doses of neuroleptics (and experienced longer periods on anticholinergic medication)
than the good outcome patients. Of particular importance was the significant
discrepancy in terms of number of full time years of education experienced by the two
groups, in favour of the good outcome patients. Because of the close relation of
education level and neuropsychological performance (Lezak, 1983), this discrepancy
needed to be accounted for in the analysis and interpretation of the
neuropsychological test performances of the two groups. This will be discussed with
relevance to the emergent results later.
The neuropsychological analysis comprised of testing the two groups with a large
battery of tests encompassing the functional domains of general intellectual level,
executive functioning, memory functioning, psychomotor ability and degree of
hemispatial neglect. Associations of the neuropsychological data were analysed with
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respect to the symptom and functional outcome scales used in selection of the patient
samples. Statistical analysis was performed using multiple comparisons to account for
the large amount of neuropsychological data obtained from the individual tests under
the general functional domains cited above. Although this was something of an
exploratory exercise, the domains of cognitive functioning investigated were
consistent with those currently implicated as underpinning the behavioural phenomena
of schizophrenia (see Methods). The implications of such an exercise ought to expose
particular areas of impairment, over general impairment, that are closely associated
with outcome status which may provide an emphasis for the future of cognitive
analysis of outcome and/or raise issues for treatment or neurorehabilitation of those
patients who are presently not responding to current therapies.
The comparative analysis of the neuropsychological performances of the two
outcome groups provided significantly different levels of functioning in the domains
of general intellectual ability, executive functioning and memory functioning.
Although there was no overall difference in psychomotor ability, individual test
performance analysis indicated a significant difference on a timed visuo-spatial coding
test. No differences were observed on the groups degree of hemispatial neglect. All
the significant differences recorded attested to the superior performance of the good
outcome patient group over the poor outcome patient group. It may be argued that
the poor outcome group might be expected to do poorly on a wide range of tests
compared to remitted patients, due to their general illness status affecting motivation.
To account for this, a subjective analysis of motivation in terms of attention/
cooperation was recorded by the examiner at testing. This crude appraisal indeed did
show a significant demotivated state of the poor outcome patients. Whether
demotivation arises from the illness state, duration of hospitalisation or drug effects is
uncertain, however, all were experienced at elevated levels in the poor outcome
group. Although these issues ought to be recognised in the interpretation of the
neuropsychological results, it may well be that it is the putative neuropsychological
impairments of the poor outcome group that account for the problems in attending
and cooperating with demanding testing.
Both pre morbidly and currently, the poor outcome patients displayed significantly
depressed levels of general intellectual ability. Recently, however, the standard
measure of pre morbid ability, the NART, has been shown as possibly compromised
by the disease process in groups of long term hospitalised schizophrenic patients (i.e.
poor outcome patients), not observed in community based schizophrenic patients
(Crawford et al., 1992). It might be safe to assume that the present study's outcome
groups mirrored the Crawford et al.'s samples. To clarify the pre morbid status of the
two outcome groups, avoiding possible illness effects, a crude measure of paternal
occuapational status was used to assess pre morbid status in terms of socio-economic
background. This, of course, was not a neuropsychological analysis but was useful in
confirming that there was no difference in social advantage between the two groups.
Thus, we might conclude, with caution, that any emergent difficulties in
neuropsychological performance (and, indeed, in educational experience) did not arise
from a disparity in pre morbid status as assessed by social background. However, one
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interprets the validity of NART performance with regard to the poor outcome
patients, whether affected by the illness process or not, the two groups can be
differentiated on their ability to perform the NART and also show differing levels of
current intellectual ability in favour of the good outcome patients. Again these results
need to be accounted for in the interpretation of any neuropsychological performance
differences between the two groups as they may products of general intellectual
(dis)ability.
From the initial analyis of the wealth of neuropsychological data obtained, there
appeared to be a pattern of neuropsychological impairment that discriminated
between the groups, indicating a particular pattern of impairment associated with
poor outcome. The cognitive profile of the poor outcome group was characterised by
particular deficits in executive and memory functioning. It has been established that
both heterogeneous group studies (Kolb and Wishaw, 1983) and single case reports
(Shallice et al., 1991) have implicated 'frontal' type dysfunction or a dysexecutive
syndrome in schizophrenia. These deficits have been linked to a difficulty in the self
generation activity and/or organising information for environmentally appropriate
behaviour (Shallice, 1988; Frith, 1992). In this study, the poor outcome patients
displayed specific executive impairment on tests involving sustained attention and the
inability to suppress inappropriate responding (i.e. disinhibition). There was also a
significant impairment on word production ability when defined by a semantic
category rather than by an initial letter paradigm. Difficulties with tests involving
inhibitory processes have been associated with symptoms of incongruity and
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incoherence (Liddle and Morris, 1991; Frith et al., 1991). However, there was no
significant association in this study. Again, although poor verbal fluency has been
associated with psychomotor poverty type symptoms (Liddle and Morris, 1991) here
it was neither related to poverty of speech nor psychomotor retardation symptoms.
The present test results were related to coherently expressed delusions and
hallucination symptom ratings. Although, disorganisation type cognitive impairments
are not usually associated with abnormal experiences (Liddle, 1987, Liddle and
Morris, 1991), the present relationship between symptoms could be explained in
terms of a combination of disinhibition along with poor word access/retrieval from a
semantic memory system. A similar process of cognitive impairment has already been
suggested to account for the expression of positive symptomatology in schizophrenia.
Gray et al., (1991) suggested that the inability to inhibit all but relevant memories
from current behaviour could result in delusional and hallucinatory experiences
through the inability to use specific, appropriate, learned behaviours in current
functioning. Of course, the association between these symptoms and the impaired
neuropsychological performances could be due to delusions and hallucinations (along
with psychomotor retardation) being the only symptom ratings between the groups.
This does not detract from the pattern that underlying such symptoms are, at least in
part, the specific executive impairments observed here.
Implied in the above conclusions is that some memory access or organisation of
memory processing systems might be connected with the abnormal experiences that
define the poor outcome patients. The analysis of the memory performance of the
outcome groups did expose particular poor memory dysfunction on the part of the
poor outcome patients. Of note was the poor episodic memory functioning of the
poor outcome patients characterised by poor recall (immediate and delayed) memory
rather than recognition memory. In addition, poor short term working, in terms of
repeating digit sets backwards, discriminated between the groups in favour of the
good outcome patients. Recognition memory in terms of the short term computerised
tests did not discriminate between the groups with regard to pattern and delayed
matching to sample (except in the later's case for 0 sec delay), but the poor outcome
patients did display poorer short term spaital recognition memory than the good
outcome patients. Therefore, memory functioning discriminated between the outcome
groups according to short term auditory and spatial recognition memory and
immediate and delayed recall on an episodic memory test, the poor outcome group
displaying the markedly depressed functioning. From these results one can conclude
that poor outcome in schizophrenia may well be characterised by gross memory
difficulties, along with impaired inhibitory capability and verbal fluency demanding
semantic access/retrieval. Memory difficulties have been recently highlighted as
characteristic of heterogeneous groups of schizophrenic patients, disproportionate to
the level of general intellectual impairment (McKenna et al.,1990; Tamlyn et al.,
1992), the effect has been also observed with neuroleptic naive patients (Saykin et al.,
1991). The former two studies found a particular deficit in episodic memory
functioning, as assessed by the Rivermead Behavioural Memory Test, as used in the
present study. However, it is unclear what pattern of dysfunction characterised these
impairments as no breakdown of subtest scores was available The Rivermead scores
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and the short term working memory performances were, like the executive
discriminants, associated with coherently expressed delusions and hallucinations.
There may be emerging a pattern of neuropsychological deficits charaterised by
particular executive and memory dysfunction that, when coexisting, may underpin the
formation of the positive symptoms of schizophrenia, and dependent on the degree to
which these impairments are expressed may characterise the stubborness of these
symptoms to available therapies and form the basis of poor outcome. The link
between the executive and episodic memory deficits expressed in the present study
might have basis in the interdepentability of episodic and semantic memory systems
(Tulving, 1983). Aswell as episodic impairments, semantic memory difficulties have
been implicated in the formation of delusional and hallucinatory behaviour (McKenna,
1991; Hoffman, 1987). McKenna (1991) has indicated that delusions arise from an
impairment in the continuous gathering and reality checking of knowledge so that
false memories are laid down which become delusions. This , in turn, would imply a
deficit in both semantic and episodic memory systems. Cutting and Murphy (1988)
suggested, at the heart of delusions and formal thought disorder, there was a
deficiency in real world knowledge. In turn, Frith (1992) has proffered a universal
deficit in the systems that represent knowledge as underpinninng all positive and
negative symptoms of schizophrenia As stated above, Gray et al. (1991) proposed a
specific deficit in the access appropriate stored memories for minute to minute
appropriate functioning in the formation of positive symptoms. The results here
would suggest that, not only do they support a fundamental memory impairment in
schizophrenia as a whole, but that patients who have been carefully selected, along
clinical and everyday functioning scales, to be of poor outcome are especially
characterised by these neuropsychological deficits. The combination of inhibitory
deficits, semantic memory access/retrieval and episodic memory functioning (as well
as short term memory problems) would support the kind of theoretical standpoint
associating fundamental memory difficulties, and importantly, the appropriate
utilisation of stored memories, in the formation of the characteristic positive signs of
schizophrenia
As stated above, there was a large discrepancy in the education background of the
two outcome groups, the good outcome patients experiencing significantly more full
time years of education than the poor outcome counterparts. It has already been
established that poor outcome is characterised by early and insidious onset of illness
(Lieberman and Sobel, 1993). A difference in education background, therefore might
not be unexpected. Jones et al. (1993) observed that poor outcome, in terms of social
and occupational status, is associated with poor educational qualifications To assess
whether the large difference in education affected the neuropsychological
performance between the two groups, the multivariate analysis was repeated
controlling for education In a preliminaer analysis, the discriminating
neuropsychological performances were all, bar semantic verbal fluency, significantly
correlated with education background When education had been controlled for, the
executive significant differences disappeared as did the majority of the memory
performance differences. However, despite the influence of the disparity in education,
the groups were still significantly differentiated on episodic memory performance, still
at a high level of significance. Subjective attention/cooperation ratings were also still
significantly different in favour of the good outcome patients. The robust status of
episodic memory as characteristic of poor outcome was supported when present
intellectual functioning, anticholinergic duration and present levels of neuroleptics had
been controlled for, the highly significant between group difference remaining.
However, there was an indication that episodic memory performance might be
influenced by long term hospitalisation. It may not be surprising that episodic memory
performance was not grossly influenced by education or current intellectual factors
as, in the original conception of the test, it was designed to avoid just such factors
(Wilson et al., 1985).
A picture, therefore, emerged that either poor outcome schizophrenia was
characterised by a combination of particular executive and memory dysfunction or
that, compensating for the difference in education background, it was episodic
memory dysfunction alone that discriminated between the two outcome groups. It
would, however, appear that episodic memory dysfunction is the most robust
neuropsychological discriminant of outcome, from the present results. A problem in
leaving our conclusions there is that researchers have tended to associate long term
chronic medicated schizophrenic functioning with primarily 'frontal' or executive
dysfunction (Shallice et al., 1991; Weinberger et al, 1988). In addition, the emergent
emphasis on memory dysfunction has been suggested as secondary to
'frontaPimpairment (Goldberg et al., 1989). The debate, between which impairment is
of primary importance in underpinning schizophrenic symptoms, rages on. It cannot
be ignored that one might expect executive impairments characterising a group of
poor outcome patients' functioning as many of the everyday fiicntioning that defines
them as poor outcome obviously involves some degree of impaired organisational,
planning and scheduling activity i.e. fundamental executive abilities. A criticism, of
the executive tests widely used in neuropsychological studies, is that they do not
relate to the planning and organisational demands faced in everyday functioning
(Shallice et al., 1991). Shallice and Burgess (1991) have proposed more ecologically
valid tests e.g. the Six Elements Test that requires the subject to organise behaviour
over a longer period of time than traditional tests. The same authors showed that
'frontal' patients, who showed normal functioning on standard tests of executive
functioning, nevertheless showed impaired performance on this more everyday related
test of planning ability. This approach might prove useful in further studies of
associating neuropsychological deficits with outcome in schizophrenia.
The implications of the above results should be assessed with regard to the type of
neurorehabilitation resources offered to patients with persistent psychopathology and
impaired social and vocational functioning. Mueser et al. (1991) have already
highlighted that with heterogeneous groups of schizophrenic patients, both baseline
social skills deficits and rate of social skill acquisition in a training programme were
associated with severity of memory impairments. If poor outcome patients have
particularly poor episodic memory dysfunction then, for instance, social functioning
may be optimised by focussing on social skill acquisition, compensating for the
neuropsychological disadvantage that such patients appear to be suffering from. In
addition, both vocational and social dysfunctioning implicate cognitive problems
involving problem solving in novel situations and utilising memory appropriately in
the correct environment (Jaeger et al, 1992). Future neuropsychological studies
ought to investigate the incidence and degree of such impairments using both
executive and memory measures of ecological validity, that would, in turn, aid
therapists and doctors that have been faced with a substantial proportion of
schizophrenic patients as yet unresponsive to contemporary rehabilitation techniques.
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CHAPTER 7: GENERAL DISCUSSION
7.1 Restatement of the aims of the thesis
This thesis attempted to provide an explanation of schizophrenic behaviour, in terms
of underlying cognitive processes, through neuropsychological assessment. As
schizophrenia is presently considered a heterogeneous condition, neuropsychological
functioning was analysed with respect to symptom expression. The
neuropsychological assessments were carried out with respect to illness duration,
medication status and treatment response or outcome status. The methodology for
the investigations involved neuropsychological testing using traditional (e.g. Stroop
and verbal fluency tests) and novel measures (e.g. computerised Intra-and
Extradimensional Set Shifting and Tower of London tests from CANTAB). The
measures were chosen to assess executive, memory, psychomotor functioning and
hemispatial neglect. Deficits in all three domains have been implicated as
characteristic of functioning in various groups of schizophrenic patients. The
relationship between these functional deficits and particular symptoms or groups of
related symptoms has been less well documented. These areas of neuropsychological
functioning were analysed with respect to symptoms and medication status involving
high and standard doses of typical neuroleptic medication and the atypical
neuroleptic, risperidone, with historically treatment resistant patients The relationship
between poor outcome schizophrenia and neuropsychological test performance was
also assessed
7.2 Symptoms and illness duration
Factor analysis of symptom ratings from the Positive and Negative Syndrome Scale
(Kay et al., 1986) generated different sub syndromes of related symptoms between
acute and chronic stages of schizophrenic illness. In the study involving a large
sample of chronic schizophrenic patients sub syndromes relating to reality distortion,
poverty of sociability and affect, disorganisation and excitability (grandiosity/hostility)
emerged from the factor analysis. These sub syndromes related closely to Liddle and
Barnes (1990) three sub syndrome model of schizophrenic symptomatology, but, due
to the composition of the PANSS rating scale an extra sub syndrome of symptoms,
indicating a sub pathology of 'overarousal', emerged The presence of this extra sub
syndrome might be due to the limitations of the Liddle et al rating scales, different
types of chronic patients in the respective studies-the present study used a large sub
population of treatment resistant patients whose illnesses might have been less stable
than the Liddle et al. sample, or might represent a further valid independent sub
pathology of illness present at the chronic stage of illness. Recently, researchers have
indicated that if symptoms that reflect the affective and 'overarousal' features of the
illness are added to the analysis, two further sub syndromes of depression and
psychomotor excitation emerge (Liddle, unpublished data cited in Liddle et al., 1994).
The latter of these sub syndrome may have much in common with the excitability sub
syndrome from the present study
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At the acute stage of illness five factors or sub syndromes reflecting paranoid state,
poverty of affect, disorganisation and poverty of sociability and delusions emerged.
The number of acute stage schizophrenic patients' symptom ratings entered for
analysis was small and, thus, the endeavour was considered a preliminary
investigation of symptom expression at this stage of illness. A major caveat in the
interpretation of such sub syndromes of illness was that the patient sample, by
definition, consisted of floridly ill patients whose symptom profile might be extremely
variable from day to day, thus not rendering reliable associations between symptoms.
Therefore, the emergent sub syndromes might be invalid as indicators of independent
sub pathologies of schizophrenia characteristic of this stage of illness. Despite this,
the emergent sub syndromes could be demonstrating that different sub pathologies of
illness are present at the early stage of illness than the chronic stage.
The process of factor analysing symptom rating scales does help overcome the
heterogeneity of the schizophrenic condition. However, it is an empirical process that
produces factors based entirely on which symptoms are entered into the analysis and
what meaning the investigator attaches to the emergent factors (Bentall et al., 1988).
Also, Frith (1992) suggested that, before entering specific symptoms into the factor
analysis, one ought to have an idea of what clusters are likely based on a theory of
underlying cognitive deficits. Bentall et al. (1988) criticised factor analytic studies for
being biased toward highly symptomatic hospitalised samples, therefore giving
inflated correlations between symptoms unrepresentative of schizophrenic patients as
a whole. In the present thesis it would appear that different samples, selected by stage
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of illness, do display different relations between symptoms and, thus, indicate
different sub pathologies of illness at different stages of illness. It is necessary,
however, that emergent factors should be meaningful, not only in terms of face
validity, but that constituent symptoms ought to be predicted to co-exist due to
common underlying dysfunctional cognitive processes.
7.3 Sub syndromes and neuropsychological functioning
The sub syndromes of poverty of sociability and affect and disorganisation were
directly related to impaired short term working memory and episodic memory ability
at the chronic stage of illness. There was also evidence to suggest that a semantic
accessing difficulty was associated with poverty of sociability and affect, and that
executive difficulties, involving response inhibition, were related to disorganisation,
but were also related to global intellectual levels of functioning. The sub syndromes
of reality distortion and grandiosity/hostility, representative of abnormal experiential
behaviour were not directly related to neuropsychological performance At the acute
stage of illness no direct relation of neuropsychological performance was observed
with any of the emergent sub syndromes. This inability to relate sub syndromes to
neuropsychological functioning might also reflect the instability of symptom
expression in this group and support the invalidity of the emergent factors as
representing stable sub pathologies of illness at this stage
Both acute and chronic populations showed impaired functioning compared to
healthy controls across executive, memory and psychomotor functioning domains.
The chronic patients showed equivalent hemispatial functioning compared to the
control group, possibly due to the 'normalising' effect of long term medication. The
patients in both groups were impaired on the executive, memory and psychomotor
tests despite intact global pre morbid and current intellectual levels. However, there
was a difference in the number of full time years of education between chronic
patients and controls but not between acute patients and controls. Educational
disadvantage was highlighted as characteristic of poor outcome in Chapter 6. This
would imply that the chronic group consists of patients of poor outcome and that the
acute group would consist of patients, conservatively, of mixed prognosis. The
different groups may comprise different types of patients, which may explain, in part,
the difference in sub syndrome expression derived from the factor analysis.
A pattern emerged that both chronic and acute patient groups were functioning below
normal limits on a wide range of neuropsychological tests. Impairment was only
directly related to poverty of sociability and affect and disorganisation at the chronic
stage. Neither sub syndromes comprising of abnormal experiences, at the chronic
stage, nor all of the sub syndromes, at the acute stage, were directly associated with
neuropsychological performance. Therefore, the sub syndromes not related directly to
neuropsychological functioning were seen as being underpinned by
neuropsychological dysfunction as a secondary phenomenon to other more complex
mediating psychological processes more closely related to the symptom groups in
question
As far as the direct relationships between sub syndromes and neuropsychological
functioning are concerned, the association between poverty of sociability and affect
with poor short term and episodic memory might be explained by poor social
cognition. Poor social cognition could be due to a depleted store of appropriate social
knowledge due to poor developmental social experiences. Also, the inability to infer
others' beliefs and intentions, in the social arena, might be due to an inability to apply
appropriate old memories to cope with novel situations, therefore, resulting in
impoverished social encounters. Studies have shown that schizophrenic patients are
impaired in appropriately distinguishing and labelling emotional expressions (Gessler
et al., 1989) i.e. incorrectly inferring non-verbal information crucial for engaging in
appropriate social behaviour. The inability to infer others intentions and beliefs, and
one's own intentions, in terms of generating spontaneous willed action, has been
proposed as underlying many of the behavioural phenomena of schizophrenia (Frith,
1992). This has been coined lacking a 'theory of mind' or an impairment in
metarepresentation where awareness of one's own and others goals and willed
intentions is crucial for self-awareness. Without such an ability appropriate social and
affective behaviour would be extremely difficult due to a basic poverty of
communication between the schizophrenic patient and their environment. Within the
present context of poor social relations, the episodic memory dysfunction is the prime
candidate for the neuropsychological mechanism that contributes to this inability for
conscious awareness. Episodic memory dysfunction was primarily associated with
disorganisation at the chronic stage of illness, although executive dysfunction
involving disinhibition was implicated as related to this sub syndrome. This relation is
due to a possible dysfunction in the organisation and temporal ordering of appropriate
information for recall, reminiscent of frontal lobe amnesia (Shallice, 1988). However,
one would have to examine the content of such recall for confirmation.
As stated above, the sub syndromes of reality distortion and excitability, at the
chronic stage of illness, and the sub syndromes of paranoid state, grandiosity and
(other) delusions, at the acute stage, could not be directly explained by
neuropsychological impairment on testing. The formation of such sub syndromes was
thought, speculatively to have some theoretical basis in the work of Richard Bentall
(1994) and his model of the formation of paranoid delusions. This speculation was
pursued on account of three major reasons. Firstly, the paranoid state at the acute
stage was characterised by hostility, excitement, suspiciousness/persecution, poor
rapport and hallucinations and appeared to contain not only abnormal experiential
phenomena but, also, how such thinking would be expressed, behaviourally, in the
patient's immediate environment. Secondly, paranoid and grandiose behaviour has
been suggested as different manifestations of the same underlying cognitive bias in
Bentall's (1994) model. Thirdly, the obvious neuropsychological impairments
expressed by both groups, compared to controls, might underpin the more primary
cognitive abnormalities responsible for the expression of the abnormal experiential
sub syndromes, in concert with other environmental and personal factors. In Bentall's
model paranoid and grandiose delusions derive from a cognitive bias in the
schizophrenic patient's information processing in an attempt to cope with feelings of
low self esteem and perceived stress in one's environment. Persecutory beliefs arise
from the patient attributing positive events to the self and negative events to the
environment (Kaney and Bentall, 1989). Poor social cognition may also play a part in
this process through the misinterpretation of others' intentions and beliefs in a
negative self-referential manner (or positive in the case of grandiose beliefs). Poor
social cognition, characterised by difficulties in social inference, again reflects a lack
of 'theory of mind' which Frith (1992) suggests underpins most schizophrenic
symptomatology. The lack of awareness of social convention and inference would
imply a poverty of executive and memory functioning, which was expressed by the
acute and chronic groups An executive dysfunction would impair the choice of
appropriate behavioural schema in novel situations. Memory dysfunction,
characterised by impaired episodic memory, would result in a inability to access
contextually specific social information, whether stored or not, for use in routine or
novel situations. The inability to access contextually specific information might serve
to enhance the paranoid belief system of the persecuted patient, as disconfirmatory
evidence would not be forthcoming to annul the initial threat felt in a social situation
Future assessments of such abnormal experiences should look further than trying to
find neuropsychological correlates of these type of symptoms. The behaviour derives
from an individual, with certain fundamental neuropsychological impairments, who,
despite these deficits, has to make sense of their social universe and form belief
systems that help coping. Unfortunately, it appears that the protection of the self,
through persecutory belief systems, is born of a coping strategy underpinned by faulty
neuropsychological functioning and serves to alienate the individual from an already
perceived hostile environment.
7.4 Medication, symptoms and neuropsychology
The analysis of neuropsychological functioning of a group of historically treatment
resistant schizophrenic patients was undertaken within a controlled drug trial
involving optimum doses of standard (chlorpromazine) and atypical (risperidone)
neuroleptics Neuropsychological assessment comprised of executive, memory and
psychomotor testing. After a nine week trial, having been neuropsychological^
assessed at four time points, no differentiation in functioning could be observed
between the groups on high doses of standard and atypical neuroleptics and a control
group on a standard medication regime. All the trial groups showed
neuropsychological impairment at baseline on many of the tests, of the three domains
of functioning, which had comparative normative data. None of the treatment regimes
was more beneficial than another in terms of symptom improvement, and amelioration
of side effects, at the end of the nine week trial. Within subject analyses showed no
significant improvement, over time, on any of the drug regimes. It would appear that
a sub group of chronic schizophrenic patients exist that are resistant not only to
standard neuroleptic medication at high doses, but also new atypical neuroleptics with
different pharmacological action It has long been realised that a sub group of up to
20% of schizophrenic patients will derive little or no benefit from neuroleptic
medication (Davis et al., 1980). The patients in this study might be representative of
such a sub population However, some studies would indicate that patients resistant
to standard, though potent, medication, such as haloperidol, do show significant
symptomatic improvement with the atypical neuroleptic clozapine (Kane et al.,
1988). Although risperidone has been seen as clinically more beneficial over
haloperidol and placebo, in terms of symptom amelioration and reduced side effects
with heterogeneous groups of patients (Marder and Meibach, 1994), the present
study would not support its use specifically with treatment resistant patients as it
appears to provide little clinical advantage over more standard, and less expensive,
neuroleptics. Despite this, in the Marder and Meibach (1994) multicentre trial of
risperidone, clinical advantage was seen at mid range doses. In the present study
symptom comparison was recorded between low dose standard neuroleptic status and
optimum doses of the atypical drug. Further research may, therefore, need to
concentrate on finding the optimal dose for individual patients by careful titration of
the drug and close monitoring of symptom levels, with increasing dose, with
treatment resistant patients.
Although clozapine appears to be the best candidate, at present, for drug therapy with
treatment resistant patients, research has shown that neuropsychological improvement
dose not covary with clinical improvement with the drug (Goldberg et al., 1993). This
study did not specifically involve treatment resistant patients. The authors suggested
that, as their sample showed impaired neuropsychological functioning at baseline,
neuropsychological dysfunction would appear to constitute an abiding core feature of
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schizophrenic illness, in the chronic state, and may account for much of the chronic
social and vocational disabilities characteristic of chronic schizophrenia. Such a
conclusion ought to make clinicians pause and reassess whether medication regimes
by themselves can be expected to produce benefits, in everyday functioning, needed
to improve the quality of an individual's life over symptomatic improvement. The
present results indicate that a sub group of patients exists that is treatment resistant to
the majority of contemporary drug therapies. This would imply, on a biological level,
that the dysfunctional brain systems putatively underlying symptomatic expression are
either more complex than the integration of dopamine and serotinergic systems
presently thought as culpable, or that these systems are so damaged that, even at high
doses, the available drugs are ineffective. In the later case it would be of more
benefit to treat such patients as needing, at least in addition to maintenance
medication, neurorehabilitation services to focus on the social and vocational aspects
of their illness, to address the abiding fundamental neuropsychological problems
characteristic of this type of patient. Such a strategy would need to assess which
neuropsychological functions are specifically related to the everyday functional
deficits associated with treatment resistance in order to tailor appropriate
neurorehabilitation therapies. In the final chapter of this thesis these issues were
addressed in an assessment of the neuropsychological correlates of poor outcome in
schizophrenia.
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7.5 Poor outcome in schizophrenia and neuropsychology
The neuropsychological analysis of good versus poor outcome in schizophrenia
provided increased support for a fundamental episodic memory impairment
characterising poor outcome. Executive impairment, characteristic of poor outcome,
was also observed in terms of sustained attention, inhibition of inappropriate
responding and semantic word fluency. However, these executive impairments
became non significant after accounting for the significantly poorer educational
backgrounds of the poor outcome patients. The memory impairment was robust
despite education. This poverty of educational experience was seen as a product of an
insidious disease process, of early onset, as the two groups came from similar socio¬
economic groups. This pattern of illness onset has been singled out as a predictor of
poor prognosis previously (Lieberman and Sobel, 1993). The patients were
dichotomised by clinical and social functioning levels. Therefore, the
neuropsychological functioning of a group of patients, which had been categorised as
poor outcome due to persistent symptoms (mainly positive) and poor social
functioning, was found to be characterised by poor episodic memory. The theoretical
associations between memory and social functioning has been addressed above (7.3)
and appears to be especially related to overall poor outcome in schizophrenia,
possibly due to a neurodevelopmental disorder. We, therefore, may be beginning to
realise what underlying neuropsychological impairments are associated with the social
dysfunction characteristic of schizophrenia, and more relevantly, of poor outcome
3x3
It has been noted that contemporary drug regimes may only have limited benefit for
treatment resistant or poor outcome schizophrenic patients (7.4). The present results
should provide a basis for casting the therapeutic net further than concentrating on
medication issues with these patients, who display stubborn and fundamental
neuropsychological and related social (and vocational) dysfunction. It has already
been highlighted that baseline social skills deficits and rate of social skill acquisition
are related to the severity of memory impairments in groups of heterogeneous
schizophrenic patients (Mueser et al., 1991). Social skills therapies would profit from
the realisation that episodic memory functioning is a fundamental impairment in
particularly poor outcome schizophrenia. There would appear to be a need to
construct therapies that account for these core deficits. More emphasis on socially
based therapies seems to be necessitated in a programme of therapy, involving
medication, for treatment resistant patients. These patients require, by definition,
greater therapeutic input to increase their quality of life, in terms of social and
vocational functioning, than an overreliance on medication regimes, sufficient for
more treatment responsive patients. The present neuropsychological findings ought to
help create rehabilitation therapies that meet with more success, being derived from
scientifically based neuropsychological research. Alternatively, as the charateristic
fundamental cognitive deficits, of treatment resistant patients, are being understood,
therapies might concentrate rather on the cognitive strengths of these patients i.e.
those areas of functioning relatively less damaged than memory functioning, to
enhance the possibility of therapeutic success.
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7.6 Conclusions
The use of neuropsychological assessment on the analysis of symptoms, medication
and outcome in schizophrenia highlighted three important features. Firstly, that
episodic memory impairment appears to be directly related to much of the social
difficulties characteristic of the deficit symptoms of schizophrenia, but especially with
regard to poor outcome. Secondly, this type of assessment appears to be limited in an
explanation of the direct cognitive processes responsible for abnormal experiential
behaviour. However, the patterns of neuropsychological dysfunction and emergent
sub syndromes of schizophrenia enabled reasonable speculation as to the genesis of
such symptoms, highlighting a wider appreciation of personal and environmental
issues, that interact with cognitive deficits, in the formation of abnormal beliefs and
experiences. Further studies using measures that are theory lead ought to clarify the
interaction of these variables in the formation of positive symptomatology. The use of
general neuropsychological measures, in the present studies, was exhaustive and
focussed on the integration of functioning with respect to schizophrenic
symptomatology. However, the specificity of information; personal, environmental
and neuropsychological, required to formulate a idiosyncratic model of schizophrenic
functioning necessiates less general measures than those derived from general
neurological sources. Thirdly, the significant proportion of treatment resistant patients
were seen as necessitating more involved service input emphasising social, as well as
drug, therapies to account for the fundamental neuropsychological deficits,
i2\
particularly of memory, expressed by these type of patients that deprive them of
enriching social experiences and maintain a disturbing and alienating illness state
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MISSING NEUROPSYCHOLOGICAL TEST DATA FROM THE STUDY OF
HIGH CPZ (1) VERSUS RISPERIDONE (2) VERSUS CONTROL (3)




019 1 Refused DMTS day 7. Refused all testing day 21.
103 1 RT aborted due to failure; no idea how to attempt Tower of
London day 7.
036 1 DNA for all testing day 21 (no psychiatric ratings on day 21
for same reason).
105 2 No NART (day 7) or Stroop (days 7&63) as S refuses to
speak.
016 2 Refused all CANTAB day 21. No testing after day 21 as S
withdrew from the study.
033 2 No Stroop, DMTS, Tower of London days 7&63 as S is
colour blind. Refused all tesing days 21&42.
108 2 Refused all CANTAB day 21
030 2 Refused all testing days 42&63.
023 2 Refused all testing day 63.
101 3 Unable to attempt Tower of London days 7&63.
012 3 Refused all testing day 21.
005 3 Unable to attempt Tower of London day 7. Refused all
testing days 21&42 (no psychiatric ratings for the same
reason).
027 3 Refused all testing days 21&42 (no psychiatric ratings day 42
for the same reason).
032 3 Tower of London aborted after three inital problems failed
day 7.
107 3 Refused all CANTAB day 21
039 3 Refused all testing day 63.
040 3 Refused digit span, digit symbol substitution test, verbal
fluency and Rivermead Behavioural Memory Test day 21.
Refused all testing days 42&63.
APPENDIX 2
A SYSTEMATIC CATEGORISATION OF LEVELS OF
TREATMENT RESPONSE IN SCHIZOPHRENIA
Taken from:-
May P R.A., Dencker S.J., Hubbard J.W., Midha K.K. and Liberman R.P
(1988). A systematic approach to treatment resistance in schizophrenic
disorders. In: Treatment Resistance in Schizophrenia, pages 22-33 Editors -
Dencker S.J. and Kulhanek F. Published by Vieweg,
Braunschweig/Wiesbaden.
Pe2ree of Resistance
Treatment Resistance is not an all-or-nothing, present or absent
phenomenon, it is a matter of degrees of resistance. Six levels or stages of
treatment resistance may be defined, these are arbitrarily based on the time
taken to respond to what would be considered a "good" level of treatment
by current standards, which is "appropriate" to the particular stage of the
disorder and to that of treatment - i.e. pharmacotherapy, psychosocial
treatment, and psychotherapeutic management, suitably adjusted to
individual needs.
Level 1 (excellent responders): total remission within a week, whatever
treatment is given
Level 2 (very good responders): patients who respond well within one
month when given antipsychotic medication in usually recommended
dosages. There is "clinical remission", in that they are able to return to the
same social situation as before the illness, with little, if any residual scarring.
Level 3 (good responders): patients who show major reduction of
symptoms within a month, but still have definite signs of residual
schizophrenic disorder, such as autistic thinking or behaviour, or disturbed
ego identity. There is "social remission", in that they are able to return to
their earlier social existence, but show some (though not great) reduced
ability to study or to work.
Level 4 (fair responders): patients whose condition heals slowly and
incompletely; besides antipsychotic medication, they also need a structured
rehabilitation programme, after a long or fairly long period of hospital stay.
There is no clinical remission and only partial social remission. They can
leave the hospital, but continued support and/or rehabilitation are required if
they are to survive in society.
345
Level 5 (poor responders): patients who have been given antipsychotic
medication in conventional doses for a minimum of six months, as well as
standard rehabilitation and non-drug treatment programmes at a defined
supportive level, but whose psychotic symptoms or disturbed behaviour do
not remit sufficiently to permit entry into ordinary group rehabilitation
programmes, or where treatment has had to be abandoned because of
toxicity or other unwanted effects. The severity of their residual symptoms
is such that these patients will remain for a long while to hospital or in some
alternative form of caring milieu, such as a hostel or family care. There is
neither social nor clinical remission
Level 6 (severe treatment resistance): patients who show a failure to
respond to any useful extent after six months' hospital treatment including
antipsychotic drugs given with measured and presumably adequate plasma
levels, and accompanied by an intensive level of psychosocial intervention.
They remain in hospital or equivalent care
In hospital practice, there is a concern particularly with level 5 and 6 of
treatment resistance.
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Trial number Medication code number Patient's Initials
POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) RATING FORM
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COOPERS SOCIAL OUTCOME SCALE
1. ECONOMIC STATUS
(a) Supporting self entirely and possibly others in household, during
most of previous 12 months - Score Q_
(b) Working sometimes but partly dependent financially on relatives or
some state assistance-Score 1.
(c) Unemployed and completely dependent financially.Includes
inpatients.-Score o
2. SOCIAL LIABILITY
(a) Behaving normally, restored to pre-morbid personality or only mild
residual personality changes -Score 2
(b) Suffering persistent or recurrent psychotic symptoms, but not
grossly disturbed in behaviour and able to maintain interpersonal
relationships to a reasonable degree-Score 1
(c) Showing gross behaviour disturbances due to psychotic
symptoms,and unable to maintain interpersonal relationships-Score q
3. SELF-CARE
(a) Normal standard, no help needed regarding personal
appearance,dress,toilet or use of money -Score 2
(b) Slovenly,apathetic or withdrawn,requiring some supervision and
occasional help with appearance,toilet or use of money-Score 1
(c) Incapable of self-care through persistent mental illness, and
needing considerable help with dress, toilet and money -Score o
4. TOTAL SOCIAL ADJUSTMENT SCORE
Total of 1. 2. 3.-Varying from 0 to 6-
Total of 5 or 6 - Good
Total of 3 or 4 - Fair
Total of 0 or 1 or 2 - Poor.
jt2
Cross-Sect;onai Dotcome Scale (McGlsshan 1984)
Item 1. Duration of hospitalization in th§ past year for psychiatric disorder
4. Not in hospital in past year (exclude hospitalization af time of first inter/ievv if less than one month
following first interview)
3. Hospitalized less than three months in pasi year.
2. Hospitalized three to six months in past year.
1. Hospitalized over six months, up to nine months in past year.
0. Hospitalized more than nine months in the past year.
item 2. Social contacts ( The approximate number of times the patient has met with
friends outside the family over the last year.)
4. Meets with friends on average at least once a week.
3. Meets with friends every two weeks.
2. Meets with friends about once a month.
1. Meets only at work or at school.
0. Does not meet with friends .
Item 3. Usefully employed (include work as housewife, student. Exclude time in
hospital.)
4. Full-time: >40 h.vweex
3. Part-time: >20 hr.'week
2. Part-time: <20hn'week
1. Unemployed but capable of working.
0. Receiving assistance and not capable ol working.
Item 4. Psychopathology (which in the pasi month best describes the patients
experience in terms cf anxiety, depression, cr other signs and symptoms of
emotional tension).
t. No signs or symptoms.Slight signs arid sy ptoms most of the lime, or moderate signs and symptoms on rare occasions
2. Moderate signs and Symptoms scrne of the time.
1. Severe signs and symptoms some of the time or moderate signs and symptoms continuously.
0. Continuous and severe signs and symptoms.
Item 5. Global Functioning. (Rate the patient's overall ievel cf functiorhng in the past
year.)
4. <Xo impairment.
3. Some, but not much, impairment.
2. Moderate irrr rr. v
1. A lot o( impairment.
0. impairment,
flffettDW),
Total Follow-up Period /Outcome Scale (tVfcGlashan 1984)
Item 1. Duration of hospitalization for psychiatric disorder (inc. day hospitals
and halfway houses) since first diagnosis
4. No time (or less than 5% of the time)
3. About 25% of the time.
2. About 50% of the time.
1. About 75% of the time.
0. Just about all the time.
Item 2. Social contacts (Check the number of times the patient currently meets with
friends outside the family)
4. Meets with friends at least once a week.
3. Meets with friends once every two weeks.
2. Meets with friends about once a month.
1. Meets only at work or school.
0. Does not meet with friends .
Item 3. Employment (employment means working for pay, pursuing studies as a
student, caring for a household and raising children or engaging in volunteer work.)
4. Just about al! ihe time.
3. About 75% of ihe time.
2. About 50% of the time.
1. About 25% of the time.
0. No useful work.
Item 4. Psychopathology (the percentage of time since discharge the patient has
experienced anxiety, dpression, or symptoms of emotional tension that were
experienced before first diagnosis.
4. Seldom or not at ail.
3. About 25% of the time.
2. About 50% of the time.
1. About 75% of the t;rne.
0. All the time.
Item 5. Global Functioning ( Take as "norma!" someone fully employed,
experiencing no symptoms or need for treatment, and engaged meaningfully in
family and social relationships; compared with the "normal", rate the patient's overall
level of functioning since first diagnosis.)
4. Normal.
3. About 75% of normal.
2. About 50% of normal.
1. About 25% of normai.
0. No period of normal function. sic
